<!DOCTYPE html>
<html >
  <head >

    <meta charset="UTF-8">
    <meta http-equiv="refresh" content="3600; URL=http://127.0.0.1:3000/index.html"> <!--300sごとに更新-->

    <title>My Website</title>
  </head>
  <body id="mybody" >
  <button id="myButton" onclick="changeColor()" >ダークモード</button>
  <button id="tdnetButton" onclick="tdnetButton()" >TDNET</button>
  <br>  
  <table  id="myTable" >  
      <thead>           
        <tr>
            <th>
              <span>Name</span> 
                <span class="ui-icon ui-icon-caret-2-n-s"></span>  <!--△--> <!--spanで画像挿入できる-->
          </th>  <!--<th>要素はテーブルのヘッダーを定義するために使用-->　
          <th>date
            <span class="ui-icon ui-icon-caret-2-n-s"></span> 
          </th>  
          <th>title
            <span class="ui-icon ui-icon-caret-2-n-s"></span> 
          </th>
          <th>url
            <span class="ui-icon ui-icon-caret-2-n-s"></span> 
          </th>
          <!-- <th>
            <select id="mySelect">
              <option value="">選択してください</option>
              <option value="option1">zz</option>
              <option value="option2">z</option>
              <option value="option3">オプション3</option>
            </select>
          </th> -->
        </tr>
      </thead>
      <tbody><tr>
    <td>BioStock</td>
    <td>2023/05/18 20:44</td>
    <td>FGEN社 化学療法による貧血を対象としたRoxadustatの中国での重要な第3相臨床試験の良好なトップライン結果を発表</td>
    <td><a href=https://finance.yahoo.com/quote/FGEN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/FGEN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/05/18 20:50</td>
    <td>EYPTがYUTIQを$ALIMに$82.5Mの現金とロイヤルティで売却。</td>
    <td><a href=https://finance.yahoo.com/quote/EYPT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EYPT</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/19 06:12</td>
    <td>ファイザー、母体用RSVワクチンでFDA AdComの支持を獲得</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/19 05:59</td>
    <td>サーモフィッシャー、子癇前症の血液検査でFDAの承認を獲得 - WSJ</td>
    <td><a href=https://finance.yahoo.com/quote/TMO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TMO</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/05/18 21:00</td>
    <td>PDSB社、HPV16陽性進行頭頸部がんを対象としたVERSATILE-002第2相臨床試験の免疫チェックポイント阻害剤ナイーブアームの登録を完了</td>
    <td><a href=https://finance.yahoo.com/quote/PDSB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PDSB</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/19 05:37</td>
    <td>Monogram Orthopedicsの株価が$17MのIPOで91%急騰（更新）。</td>
    <td><a href=https://finance.yahoo.com/quote/MGRM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MGRM</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/05/18 21:07</td>
    <td>BIIB、カナダ保健省がLEQEMBIの早期アルツハイマー型認知症に対する新薬申請を受理</td>
    <td><a href=https://finance.yahoo.com/quote/BIIB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BIIB</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/19 05:34</td>
    <td>薩摩の片頭痛治療薬がFDAの審査に受理される</td>
    <td><a href=https://finance.yahoo.com/quote/STSA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/STSA</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/05/18 21:13</td>
    <td>AWS、インドに127億円投資へ。$AMZN</td>
    <td><a href=https://t.co/Lk9JKFH0TI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://t.co/Lk9JKFH0TI</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/19 05:26</td>
    <td>Ambrx Biopharma、Stephen Gloverを取締役会長に任命</td>
    <td><a href=https://finance.yahoo.com/quote/AMAM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMAM</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/18 21:22</td>
    <td>モータスGI、350万ドルの第三者割当増資で19％下落</td>
    <td><a href=https://finance.yahoo.com/quote/MOTS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MOTS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/18 21:20</td>
    <td>Emergent BioSolutionsが$150Mの株式売却を発表。</td>
    <td><a href=https://finance.yahoo.com/quote/EBS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EBS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/18 21:20</td>
    <td>貧血の中国臨床試験でroxadustatがSepoと一致し、FibroGen社の株価が上昇しました。</td>
    <td><a href=https://finance.yahoo.com/quote/FGEN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/FGEN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/18 20:49</td>
    <td>アリメラ、アイポイントとの眼障害治療薬「ユーティック」の取引で48％急伸</td>
    <td><a href=https://finance.yahoo.com/quote/EYPT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EYPT</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/18 20:35</td>
    <td>リリーの関節リウマチ治療薬「ペレゾリマブ」、中間段階の試験で有望視される</td>
    <td><a href=https://finance.yahoo.com/quote/LLY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LLY</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/18 20:19</td>
    <td>Protalix社、ファブリー病治療薬の承認取得で$20Mのマイルストーンを獲得</td>
    <td><a href=https://finance.yahoo.com/quote/PLX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PLX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/18 19:51</td>
    <td>ガレラ、膵臓がん治療薬でFDAの希少疾病用医薬品に指定される</td>
    <td><a href=https://finance.yahoo.com/quote/GRTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GRTX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/18 19:45</td>
    <td>Revvity社、遺伝子編集技術をAstraZeneca社にライセンス供与、がん・免疫疾患治療薬として使用可能に</td>
    <td><a href=https://finance.yahoo.com/quote/AZN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AZN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/18 18:33</td>
    <td>英国の薬価監視機関がCara、ViforのKapruviaのNHSでの使用を支持</td>
    <td><a href=https://finance.yahoo.com/quote/CARA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CARA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/18 17:47</td>
    <td>バイエル薬品の腎臓病治療薬「ケレンディア」、中国規制当局の使用拡大認可を取得</td>
    <td><a href=https://finance.yahoo.com/quote/BAYRY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BAYRY</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/18 15:59</td>
    <td>Addex TherapeuticsがNasdaqのコンプライアンス違反通知を受ける</td>
    <td><a href=https://finance.yahoo.com/quote/ADXN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ADXN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/18 15:41</td>
    <td>Cabaletta Bioが1％増、$87Mのオファリングを実施。</td>
    <td><a href=https://finance.yahoo.com/quote/CABA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CABA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/18 08:48</td>
    <td>SPAC Forbion European、カナダのバイオテクノロジー企業enGeneと合併へ</td>
    <td><a href=https://finance.yahoo.com/quote/FRBN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/FRBN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/18 07:39</td>
    <td>Abcam創業者Jonathan Milner氏が臨時株主総会を開催することを要請</td>
    <td><a href=https://finance.yahoo.com/quote/ABCM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ABCM</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/18 07:23</td>
    <td>なぜ今日、Doximityの株価は下がったのか？期待はずれのガイダンス</td>
    <td><a href=https://finance.yahoo.com/quote/DOCS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DOCS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/18 07:11</td>
    <td>FTC、PBMに代わって活動する購買組織を調査中</td>
    <td><a href=https://finance.yahoo.com/quote/CVS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CVS</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/05/17 20:02</td>
    <td>RNA社、FDAによるAOC 1001の部分的な臨床保留を「緩和」すると発表。FDAはAOC 1001の2mg / kgの新規参加者登録を許可 2023年末に予定されているMARINA-OLE試験のデータを初めて見ることができるようになる</td>
    <td><a href=https://finance.yahoo.com/quote/RNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RNA</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/05/17 20:04</td>
    <td>フェニルケトン尿症（PKU）の成人および小児患者を対象としたsepiapterinのフェーズ3試験「APHENITY」において、$PTCT主要評価項目を達成しました。主要解析対象集団における平均血中Phe減少率63％（p<0.0001)</td>
    <td><a href=https://finance.yahoo.com/quote/PTCT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PTCT</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/05/17 20:13</td>
    <td>FTCの提訴 $AMGN $HZNP</td>
    <td><a href=https://finance.yahoo.com/quote/AMGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMGN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/05/17 20:31</td>
    <td>XPHOZAH(tenapanor)のNDA再提出のFDA受理と6ヶ月間審査を発表 PDUFA 10 / 17 / 23</td>
    <td><a href=https://finance.yahoo.com/quote/ARDX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ARDX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/18 06:23</td>
    <td>エボフェム・バイオサイエンス、1対125の株式併合を発表</td>
    <td><a href=https://finance.yahoo.com/quote/EVFM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EVFM</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/18 06:21</td>
    <td>オーリニア・ファーマシューティカルズは、ホルダー投票が行われる中、2人の取締役が辞任し、利益を得る。</td>
    <td><a href=https://finance.yahoo.com/quote/AUPH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AUPH</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/05/17 21:01</td>
    <td>BIOCの1対30の株式併合</td>
    <td><a href=https://finance.yahoo.com/quote/BIOC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BIOC</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/18 05:54</td>
    <td>アイノス、Celia Wuの後任としてAmanda SungをCFOに起用</td>
    <td><a href=https://finance.yahoo.com/quote/AIMD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AIMD</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/05/17 21:12</td>
    <td>JPモルガンCEO、他の苦境にある銀行を買収する可能性は低いと発言。JPM $FRC バンキングクライシス</td>
    <td><a href=https://finance.yahoo.com/quote/JPM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/JPM</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/18 05:52</td>
    <td>ナノストリング、ドイツの裁判所が同社製品の差し止め命令を10x Genomicsに下したため、株価が下落</td>
    <td><a href=https://finance.yahoo.com/quote/NSTG target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NSTG</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/17 22:28</td>
    <td>チヌーク、短報に続きグッゲンハイムで擁護される</td>
    <td><a href=https://finance.yahoo.com/quote/KDNY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/KDNY</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/17 22:23</td>
    <td>XBiotech、$80Mの自社株買いオファーで15%追加。</td>
    <td><a href=https://finance.yahoo.com/quote/XBIT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/XBIT</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/17 22:15</td>
    <td>ローブサイエンス、鎌状赤血球症治療薬「アルテミア」の販売でペンテックヘルス社と提携</td>
    <td><a href=https://finance.yahoo.com/quote/LOBEF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LOBEF</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/17 22:07</td>
    <td>シエンタ、ポートファインダー技術でFDAの承認を獲得</td>
    <td><a href=https://finance.yahoo.com/quote/SIEN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SIEN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/17 21:59</td>
    <td>コエプティス セラピューティクス、CFOを任命</td>
    <td><a href=https://finance.yahoo.com/quote/COEP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/COEP</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/17 21:15</td>
    <td>医薬品メーカーからの買収関心報道を受け、アルジェンクスが上昇</td>
    <td><a href=https://finance.yahoo.com/quote/ARGX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ARGX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/17 21:14</td>
    <td>バイオセプト、1株を30株にする株式併合を実施</td>
    <td><a href=https://finance.yahoo.com/quote/BIOC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BIOC</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/17 21:03</td>
    <td>Ardelyx社のtenapanorのNDA再申請がFDAに受理されました。</td>
    <td><a href=https://finance.yahoo.com/quote/ARDX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ARDX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/17 20:45</td>
    <td>Avidityは、FDAがリード資産の臨床保留を一部緩和したことで上昇した。</td>
    <td><a href=https://finance.yahoo.com/quote/RNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RNA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/17 20:41</td>
    <td>スペクトラム・ファーマシューティカルズ、ナスダックの最低入札価格要件への準拠を回復</td>
    <td><a href=https://finance.yahoo.com/quote/SPPI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SPPI</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/17 20:23</td>
    <td>Google Cloud、創薬を加速させるAI主導のソリューションを公開</td>
    <td><a href=https://finance.yahoo.com/quote/GOOG target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GOOG</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/17 20:15</td>
    <td>ファイザー、セーゲンの買収資金として8シリーズ310億ドルの債務募集を実施</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/17 19:07</td>
    <td>癌に特化したバウンドレス・バイオがバイエル、RAキャピタルが主導する1億ドルの資金調達を完了</td>
    <td><a href=https://finance.yahoo.com/quote/BAYRY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BAYRY</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/17 18:41</td>
    <td>アストラゼネカの化学療法剤「タグリッソ」の併用療法が試験で肺がんの進行リスクを低減</td>
    <td><a href=https://finance.yahoo.com/quote/AZN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AZN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/17 18:06</td>
    <td>ロシュのMS治療薬が脳病変を縮小、第2相試験の目標を達成</td>
    <td><a href=https://finance.yahoo.com/quote/RHHBY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RHHBY</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/05/16 06:25</td>
    <td>$GOOG Google、誤解を招く画像やAI画像を特定するツールを提供開始。  - 画像検索結果には追加情報が含まれるようになる - AIが生成したコンテンツはプラットフォームによってそのように表示されるようになる</td>
    <td><a href=https://finance.yahoo.com/quote/GOOG target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GOOG</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/05/16 09:18</td>
    <td>FTCが$HZNPの買収を阻止する動きを見せているとの憶測について、$AMGNのスポックス声明、私宛。   "我々は、委員会によるいかなる決定も承知していない。  詳細な情報が得られたら、適切な最新情報を提供します。"</td>
    <td><a href=https://finance.yahoo.com/quote/AMGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMGN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/05/16 10:06</td>
    <td>AMGN $HZNP FTCがAmgenのHorizon Therapeutics買収案件を阻止すべく提訴へ。</td>
    <td><a href=https://finance.yahoo.com/quote/AMGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMGN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/05/16 19:12</td>
    <td>HD Home Depot Q1 EPS $3.82は予想$3.80を上回る、売上 $372Bは予想$383Bを上回る。  Q1既存店売上高は4.6%減。FY'23の見通しを下方修正</td>
    <td><a href=https://finance.yahoo.com/quote/HD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HD</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/05/16 19:35</td>
    <td>オッペンハイマーで$MDGLのPTを350ドルに引き上げました。</td>
    <td><a href=https://finance.yahoo.com/quote/MDGL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MDGL</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/05/17 07:26</td>
    <td>Seagen, FTC Amgen / Horizon訴訟で影響を受け、6%減で閉鎖。</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 21:30</td>
    <td>米国特許商標庁（USPTO）、Evoke Pharma社にGIMOTIを対象とする製剤特許を付与</td>
    <td><a href=https://finance.yahoo.com/quote/EVOK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EVOK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 21:30</td>
    <td>トリニティ・バイオテック、ライフサイエンス供給事業をバイオシンス社に3,000万ドルで売却と発表</td>
    <td><a href=https://finance.yahoo.com/quote/TRIB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TRIB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 21:30</td>
    <td>SELLAS Life Sciences社、新規高選択的CDK9阻害剤GFH009の急性骨髄性白血病を対象とした第I相臨床試験用量漸増を成功裏に完了</td>
    <td><a href=https://finance.yahoo.com/quote/SLS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SLS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 21:30</td>
    <td>Windtree Therapeutics社、1,080万ドルの引受公募増資の価格決定を発表</td>
    <td><a href=https://finance.yahoo.com/quote/WINT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/WINT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 21:30</td>
    <td>バイオヴィ、生物学的精神医学会年次総会でNE3107の第2相非盲検試験のデータを発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/BIVI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BIVI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 21:30</td>
    <td>サラリウス・ファーマシューティカルズ、米国がん研究協会年次総会でSP-3164標的タンパク質分解装置の2つのポスターで説得力のあるデータを発表</td>
    <td><a href=https://finance.yahoo.com/quote/SLRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SLRX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 21:30</td>
    <td>第33回ECCMID年次総会におけるContraFectのデータ発表により、Lysin CF-370の抗生物質耐性グラム陰性病原体に対する有効性の可能性が示されました。</td>
    <td><a href=https://finance.yahoo.com/quote/CFRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CFRX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 21:30</td>
    <td>Lisata Therapeutics社、ニュージャージー州技術ビジネス税証明譲渡プログラムを通じて220万ドルの非希薄化資本を獲得</td>
    <td><a href=https://finance.yahoo.com/quote/LSTA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LSTA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 21:30</td>
    <td>Wave Life Sciences社、Waveプラットフォームケミストリーを用いて設計されたベストインクラスsiRNAの可能性を示すNucleic Acids Research誌の掲載を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/20/2651000/0/en/Wave-Life-Sciences-Announces-Nucleic-Acids-Research-Publication-Highlighting-Potential-Best-in-Class-siRNAs-Designed-with-Wave-Platform-Chemistry.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/20/2651000/0/en/Wave-Life-Sciences-Announces-Nucleic-Acids-Research-Publication-Highlighting-Potential-Best-in-Class-siRNAs-Designed-with-Wave-Platform-Chemistry.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/20 21:10</td>
    <td>ノバルティス社とBeiGene社のティスリズマブ、胃がん/食道がん試験で主要目標を達成</td>
    <td><a href=https://finance.yahoo.com/quote/NVS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NVS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/20 20:26</td>
    <td>武田薬品、カナダ・ブラッド・サービス社と免疫不全症治療薬に関する契約を締結</td>
    <td><a href=https://finance.yahoo.com/quote/TAK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TAK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 21:03</td>
    <td>カタリスト・ファーマシューティカルズ、FYCOMPA®（ペランパネル）に関する第三者による抄録を、来る米国神経学会2023年年次総会で発表することを発表</td>
    <td><a href=https://finance.yahoo.com/quote/CPRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CPRX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 21:01</td>
    <td>アキュタス・メディカル、2023年第1四半期（未監査）決算速報を発表</td>
    <td><a href=https://finance.yahoo.com/quote/AFIB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AFIB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 21:01</td>
    <td>オーシャンバイオメディカル（NASDAQ：OCEA）は、科学的共同創設者であるJack A. Elias博士に発行された画期的な肺線維症治療薬に関する米国特許出願が許可されたことをお知らせします。</td>
    <td><a href=https://finance.yahoo.com/quote/OCEA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OCEA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 21:00</td>
    <td>Ocugen社、Association for Research in Vision and Ophthalmology 2023 Annual Meetingで講演を実施</td>
    <td><a href=https://finance.yahoo.com/quote/OCGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OCGN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 21:00</td>
    <td>ProQR、4月と5月に開催される投資家向け説明会のお知らせ</td>
    <td><a href=https://finance.yahoo.com/quote/PRQR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PRQR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 21:00</td>
    <td>ベターライフ、2023年ブルーム・バートン・アンド・カンパニーでプレゼンテーションを行う。ヘルスケア投資家会議</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/20/2650909/0/en/BetterLife-To-Present-at-the-2023-Bloom-Burton-Co-Healthcare-Investor-Conference.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/20/2650909/0/en/BetterLife-To-Present-at-the-2023-Bloom-Burton-Co-Healthcare-Investor-Conference.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 21:00</td>
    <td>RBC、マギル大学ヘルスセンター（MUHC）内のアート＆ヘリテージセンターに資金提供</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/20/2650918/0/en/RBC-Funds-the-Art-Heritage-Centre-at-the-McGill-University-Health-Centre-MUHC.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/20/2650918/0/en/RBC-Funds-the-Art-Heritage-Centre-at-the-McGill-University-Health-Centre-MUHC.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 21:00</td>
    <td>RBC、マギル大学ヘルスセンター（MUHC）のアート＆ヘリテージセンターに資金提供</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/20/2650918/0/fr/RBC-finance-le-Centre-des-arts-et-du-patrimoine-du-Centre-universitaire-de-sant%C3%A9-McGill-CUSM.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/20/2650918/0/fr/RBC-finance-le-Centre-des-arts-et-du-patrimoine-du-Centre-universitaire-de-sant%C3%A9-McGill-CUSM.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 20:30</td>
    <td>ヌサノ共同創業者ハワード・ルウィン博士が、Truist Securities Virtual Radiopharmaceuticals Eventに参加します。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/20/2650870/0/en/Nusano-Co-Founder-Dr-Howard-Lewin-to-Participate-in-Truist-Securities-Virtual-Radiopharmaceuticals-Event.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/20/2650870/0/en/Nusano-Co-Founder-Dr-Howard-Lewin-to-Participate-in-Truist-Securities-Virtual-Radiopharmaceuticals-Event.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/20 20:09</td>
    <td>NYSEがランネット・カンパニーの上場廃止を決定、店頭市場で取引されることに</td>
    <td><a href=https://finance.yahoo.com/quote/LCI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LCI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 20:30</td>
    <td>Sensei Biotherapeutics社、条件付活性型VISTA阻害抗体「SNS-101」の米国FDAによるINDクリアランスを取得し、フェーズ1開始を発表</td>
    <td><a href=https://finance.yahoo.com/quote/SNSE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SNSE</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/20 19:57</td>
    <td>Dermata climbs ~28% after update on acne candidate
</td>
    <td><a href=https://finance.yahoo.com/quote/DRMA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DRMA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 20:30</td>
    <td>ブルーウォーター、FDA承認の前立腺肥大症治療薬「ENTADFI®」の買収について</td>
    <td><a href=https://finance.yahoo.com/quote/BWV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BWV</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/20 19:55</td>
    <td>ブルーウォーターへのENTADFIカプセル事業売却でヴェル社の株価上昇</td>
    <td><a href=https://finance.yahoo.com/quote/VERU target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VERU</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 20:30</td>
    <td>Kane Biotech社、ProgenaCare Global社と抗菌創傷ジェル「coactiv+™」の販売契約を締結</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/20/2650881/0/en/Kane-Biotech-Announces-Distribution-Agreement-with-ProgenaCare-Global-for-its-coactiv-Antimicrobial-Wound-Gel.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/20/2650881/0/en/Kane-Biotech-Announces-Distribution-Agreement-with-ProgenaCare-Global-for-its-coactiv-Antimicrobial-Wound-Gel.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/20 19:47</td>
    <td>エリート・ファーマシューティカルズ、代謝拮抗薬のジェネリック医薬品でFDAの承認を目指す</td>
    <td><a href=https://finance.yahoo.com/quote/ELTP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ELTP</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/20 19:31</td>
    <td>ノバルティス「Kesimpta」、多発性硬化症患者の5年データで有用性を示す</td>
    <td><a href=https://finance.yahoo.com/quote/NVS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NVS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 20:05</td>
    <td>The Joint Corp.が5月4日（木）に2023年第1四半期業績に関するカンファレンスコールを開催します。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/20/2650852/32957/en/The-Joint-Corp-to-Host-Conference-Call-on-Thursday-May-4th-to-Discuss-First-Quarter-2023-Results.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/20/2650852/32957/en/The-Joint-Corp-to-Host-Conference-Call-on-Thursday-May-4th-to-Discuss-First-Quarter-2023-Results.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 20:00</td>
    <td>オルファラン社、ウィルソン病治療薬「Cuvrior™」の米国での商業販売開始を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/20/2650813/0/en/Orphalan-announces-US-commercial-launch-of-Cuvrior-for-the-treatment-of-Wilson-disease.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/20/2650813/0/en/Orphalan-announces-US-commercial-launch-of-Cuvrior-for-the-treatment-of-Wilson-disease.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 20:00</td>
    <td>Tiziana Life Sciences社、2023年第2四半期にForalumab経鼻投与のアルツハイマー病INDを申請へ</td>
    <td><a href=https://finance.yahoo.com/quote/TLSA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TLSA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 20:00</td>
    <td>マイクロビクス、「2023ブルーム・バートン会議」で発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/20/2650829/0/en/Microbix-Presenting-at-the-2023-Bloom-Burton-Conference.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/20/2650829/0/en/Microbix-Presenting-at-the-2023-Bloom-Burton-Conference.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 20:00</td>
    <td>カリナン・オンコロジー、Stifel社の「2023 Targeted Oncology Days」に参加へ</td>
    <td><a href=https://finance.yahoo.com/quote/CGEM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CGEM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 20:00</td>
    <td>アルジャーノン・ファーマシューティカルズ社が発表したライツ・オファリングと締切日時のお知らせ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/20/2650840/0/en/Algernon-Pharmaceuticals-Reminds-Shareholders-of-Previously-Announced-Rights-Offering-and-Approaching-Cut-Off-Date-and-Time.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/20/2650840/0/en/Algernon-Pharmaceuticals-Reminds-Shareholders-of-Previously-Announced-Rights-Offering-and-Approaching-Cut-Off-Date-and-Time.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 20:00</td>
    <td>iSpecimen、2023年5月4日に2023年第1四半期決算を発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/ISPC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ISPC</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 20:00</td>
    <td>サムスンバイオエピス、2023年のARVO（Association for Research in Vision and Ophthalmology）年次総会で、Eylea（アフリベルセプト）のバイオシミラー候補であるSB15の新データを発表する。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/20/2650846/0/en/Samsung-Bioepis-to-Present-New-Data-for-SB15-a-proposed-biosimilar-to-Eylea-aflibercept-at-the-2023-Association-for-Research-in-Vision-and-Ophthalmology-ARVO-Annual-Meeting.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/20/2650846/0/en/Samsung-Bioepis-to-Present-New-Data-for-SB15-a-proposed-biosimilar-to-Eylea-aflibercept-at-the-2023-Association-for-Research-in-Vision-and-Ophthalmology-ARVO-Annual-Meeting.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 19:45</td>
    <td>Veru社、ENTADFI®事業を2000万ドルで売却、さらに販売マイルストーンにより最大8000万ドルを追加で獲得</td>
    <td><a href=https://finance.yahoo.com/quote/VERU target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VERU</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 19:31</td>
    <td>Augmedix、HCAヘルスケアとのパートナーシップを発表 AI対応アンビエント・ドキュメンテーションの開発促進へ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/20/2650798/0/en/Augmedix-Announces-Partnership-with-HCA-Healthcare-to-Accelerate-the-Development-of-AI-enabled-Ambient-Documentation.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/20/2650798/0/en/Augmedix-Announces-Partnership-with-HCA-Healthcare-to-Accelerate-the-Development-of-AI-enabled-Ambient-Documentation.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 19:30</td>
    <td>テレフレックス、2023年第1四半期決算のカンファレンスコール情報を発表</td>
    <td><a href=https://finance.yahoo.com/quote/TFX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TFX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 19:30</td>
    <td>オーグメディックス、HCAヘルスケアおよびRedmile Groupから戦略的資金調達を獲得</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/20/2650794/0/en/Augmedix-Secures-Strategic-Financing-from-HCA-Healthcare-and-Redmile-Group.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/20/2650794/0/en/Augmedix-Secures-Strategic-Financing-from-HCA-Healthcare-and-Redmile-Group.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/20 18:57</td>
    <td>ブリストル・マイヤーズ、抗がん剤開発でTubulisと最大10億ドルのライセンス契約を締結</td>
    <td><a href=https://finance.yahoo.com/quote/BMY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BMY</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/20 18:36</td>
    <td>GSKのコンシューマーヘルス事業のスピンオフ会社であるHaleonは、23年度の有機的な収益の伸びを見通しのトップエンドとする。</td>
    <td><a href=https://finance.yahoo.com/quote/GSK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GSK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 18:37</td>
    <td>クリアマインド メディスン社、初のヒト臨床試験をサポートする経験豊富な受託研究機関として参加</td>
    <td><a href=https://finance.yahoo.com/quote/CMND target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CMND</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 18:00</td>
    <td>ビスティンファーマASA 2023年第1四半期コンファレンスコールへのご招待</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/20/2650730/0/en/Vistin-Pharma-ASA-Invitation-to-Q1-2023-conference-call.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/20/2650730/0/en/Vistin-Pharma-ASA-Invitation-to-Q1-2023-conference-call.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/20 17:44</td>
    <td>ロシュの「Polivy」コンボが血液がんサブタイプの治療薬としてFDAの承認を取得</td>
    <td><a href=https://finance.yahoo.com/quote/RHHBY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RHHBY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 15:00</td>
    <td>SENISCA、特発性肺線維症（IPF）治療用オリゴヌクレオチド治療薬の開発で英国イノベイト社の助成金を獲得。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/20/2650670/0/en/SENISCA-awarded-Innovate-UK-grant-to-develop-oligonucleotide-therapeutics-for-the-treatment-of-idiopathic-pulmonary-fibrosis-IPF.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/20/2650670/0/en/SENISCA-awarded-Innovate-UK-grant-to-develop-oligonucleotide-therapeutics-for-the-treatment-of-idiopathic-pulmonary-fibrosis-IPF.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/20 14:15</td>
    <td>ノバルティス、再発性多発性硬化症患者を対象とした「ケシンプタ®」（一般名：オファツムマブ）の障害アウトカムと安全性に関する5年間の新データを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/20/2650654/0/en/Novartis-presents-new-five-year-data-on-disability-outcomes-and-safety-of-Kesimpta-ofatumumab-in-people-living-with-relapsing-multiple-sclerosis.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/20/2650654/0/en/Novartis-presents-new-five-year-data-on-disability-outcomes-and-safety-of-Kesimpta-ofatumumab-in-people-living-with-relapsing-multiple-sclerosis.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 16:00</td>
    <td>Nouscom、AACR 2023で個別化ネオアンチゲンがん免疫療法NOUS-PEVのポジティブなトランスレーショナルフェーズ1bデータを後発で発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/18/2648632/0/en/Nouscom-Presents-New-Positive-Translational-Phase-1b-Data-of-NOUS-PEV-a-Personalized-Neoantigen-Cancer-Immunotherapy-in-a-Late-Breaking-Abstract-at-AACR-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/18/2648632/0/en/Nouscom-Presents-New-Positive-Translational-Phase-1b-Data-of-NOUS-PEV-a-Personalized-Neoantigen-Cancer-Immunotherapy-in-a-Late-Breaking-Abstract-at-AACR-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 15:30</td>
    <td>ネクスティム・ピーエルシー ストックオプション2020Aに基づく株式引受、制限付き単元株制度に基づく株式発行及び有向株発行に関する取締役会の決定について</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/18/2648617/0/en/Nexstim-Plc-Share-subscriptions-based-on-stock-options-2020A-and-decisions-of-the-Board-of-Directors-regarding-issuance-of-shares-under-the-restricted-share-unit-plan-and-directed-.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/18/2648617/0/en/Nexstim-Plc-Share-subscriptions-based-on-stock-options-2020A-and-decisions-of-the-Board-of-Directors-regarding-issuance-of-shares-under-the-restricted-share-unit-plan-and-directed-.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 15:30</td>
    <td>Nexstim Plc：新株予約権付社債2020Aの引受および取締役会による譲渡制限付株式単位制度および取締役会による株式発行の決定について</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/18/2648617/0/fi/Nexstim-Oyj-Osakkeiden-merkint%C3%A4-optio-oikeuksilla-2020A-ja-hallituksen-p%C3%A4%C3%A4t%C3%B6kset-osakkeiden-laskemisesta-liikkeelle-rajoitetussa-osakeyksik%C3%B6iden-jakamisohjelmassa-sek%C3%A4-suunnatulla-.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/18/2648617/0/fi/Nexstim-Oyj-Osakkeiden-merkint%C3%A4-optio-oikeuksilla-2020A-ja-hallituksen-p%C3%A4%C3%A4t%C3%B6kset-osakkeiden-laskemisesta-liikkeelle-rajoitetussa-osakeyksik%C3%B6iden-jakamisohjelmassa-sek%C3%A4-suunnatulla-.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 15:30</td>
    <td>Nexstim Plc：ストックオプション2020Aに基づく新株引受、および取締役会による条件付株式プログラムによる株式発行の決定、および有向発行について</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/18/2648617/0/sv/Nexstim-Abp-Aktieteckningar-baserade-p%C3%A5-aktieoptioner-2020A-och-Styrelsens-beslut-g%C3%A4llande-emission-av-aktier-under-bolagets-villkorade-aktieandelsprogram-och-riktad-emission.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/18/2648617/0/sv/Nexstim-Abp-Aktieteckningar-baserade-p%C3%A5-aktieoptioner-2020A-och-Styrelsens-beslut-g%C3%A4llande-emission-av-aktier-under-bolagets-villkorade-aktieandelsprogram-och-riktad-emission.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 15:23</td>
    <td>Spexis社、ColiFin®フェーズ3試験開始に向け、SPRIM Global Investments（SGI）から450万米ドルの資本コミットメントを完了したことを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/18/2648611/0/en/Spexis-announces-closing-of-capital-commitment-of-USD-4-5-million-from-SPRIM-Global-Investments-SGI-to-enable-initiation-of-ColiFin-Phase-3-study.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/18/2648611/0/en/Spexis-announces-closing-of-capital-commitment-of-USD-4-5-million-from-SPRIM-Global-Investments-SGI-to-enable-initiation-of-ColiFin-Phase-3-study.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/18 08:44</td>
    <td>ABBV社、「QULIPTA」（atogepant）を慢性片頭痛の成人患者向けにFDAが承認</td>
    <td><a href=https://finance.yahoo.com/quote/ABBV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ABBV</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 15:00</td>
    <td>救急外来で発熱した小児患者の診断を改善する先駆的なMeMed BV技術を検証する臨床データ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/18/2648601/0/en/Clinical-data-validate-pioneering-MeMed-BV-technology-improves-diagnosis-of-pediatric-patients-with-fever-in-the-Emergency-Department.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/18/2648601/0/en/Clinical-data-validate-pioneering-MeMed-BV-technology-improves-diagnosis-of-pediatric-patients-with-fever-in-the-Emergency-Department.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 14:15</td>
    <td>Basilea社、抗生物質「ceftobiprole」の米国食品医薬品局への新薬承認申請に関する最新情報を提供</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/18/2648585/0/en/Basilea-provides-update-on-New-Drug-Application-to-the-US-Food-and-Drug-Administration-for-antibiotic-ceftobiprole.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/18/2648585/0/en/Basilea-provides-update-on-New-Drug-Application-to-the-US-Food-and-Drug-Administration-for-antibiotic-ceftobiprole.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 14:15</td>
    <td>Basilea社、米国食品医薬品局へのceftobiproleの薬事申請に関する最新情報を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/18/2648585/0/de/Basilea-informiert-%C3%BCber-Stand-des-Zulassungsantrags-f%C3%BCr-Ceftobiprol-bei-der-US-amerikanischen-Arzneimittelbeh%C3%B6rde-Food-and-Drug-Administration.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/18/2648585/0/de/Basilea-informiert-%C3%BCber-Stand-des-Zulassungsantrags-f%C3%BCr-Ceftobiprol-bei-der-US-amerikanischen-Arzneimittelbeh%C3%B6rde-Food-and-Drug-Administration.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 14:00</td>
    <td>ハイロリス社、米国FDAから要請されたMaxigesic® IVのパッケージデータの提出を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/18/2648578/0/en/Hyloris-announces-submission-of-Maxigesic-IV-packaging-data-requested-by-the-US-FDA.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/18/2648578/0/en/Hyloris-announces-submission-of-Maxigesic-IV-packaging-data-requested-by-the-US-FDA.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 14:00</td>
    <td>Hyloris社、Maxigesic® IVのパッケージングデータを米国FDAに提出したことを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/18/2648578/0/fr/Hyloris-annonce-la-soumission-des-donn%C3%A9es-relatives-au-conditionnement-de-Maxigesic-IV-demand%C3%A9es-par-la-FDA-aux-Etats-Unis.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/18/2648578/0/fr/Hyloris-annonce-la-soumission-des-donn%C3%A9es-relatives-au-conditionnement-de-Maxigesic-IV-demand%C3%A9es-par-la-FDA-aux-Etats-Unis.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 14:00</td>
    <td>argenx、米国神経学会2023年年次総会で複数の発表を行い、全般性重症筋無力症の治療目標の再定義に向けたコミットメントを表明</td>
    <td><a href=https://finance.yahoo.com/quote/ARGX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ARGX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 14:00</td>
    <td>バイオセニックがEPOから重要な欧州特許を取得、がん、感染症、免疫疾患のさらなる治療開発に向けて</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/18/2648581/0/en/BioSenic-receives-key-European-patent-from-EPO-for-further-therapeutic-development-in-cancer-infectious-and-immune-diseases.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/18/2648581/0/en/BioSenic-receives-key-European-patent-from-EPO-for-further-therapeutic-development-in-cancer-infectious-and-immune-diseases.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 14:00</td>
    <td>バイオセニック、がん、感染症、免疫疾患に対する治療法の開発に関する重要な欧州特許をEPOから取得</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/18/2648581/0/fr/BioSenic-re%C3%A7oit-un-brevet-europ%C3%A9en-cl%C3%A9-de-l-OEB-pour-le-d%C3%A9veloppement-de-th%C3%A9rapies-contre-les-cancers-et-les-maladies-infectieuses-et-immunitaires.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/18/2648581/0/fr/BioSenic-re%C3%A7oit-un-brevet-europ%C3%A9en-cl%C3%A9-de-l-OEB-pour-le-d%C3%A9veloppement-de-th%C3%A9rapies-contre-les-cancers-et-les-maladies-infectieuses-et-immunitaires.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 09:00</td>
    <td>HUTCHMED社、Fruquintinibのセカンドライン胃がんに対する中国での新薬承認申請を受理したと発表</td>
    <td><a href=https://finance.yahoo.com/quote/HCM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HCM</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/18 08:08</td>
    <td>今日、Modernaの株価はなぜ下がったのか？ mRNAがん治療データ</td>
    <td><a href=https://finance.yahoo.com/quote/MRNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRNA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/18 07:52</td>
    <td>Viridian は、甲状腺眼症資産の可能性について、Wells Fargo にてオーバーウエイトで開始された。</td>
    <td><a href=https://finance.yahoo.com/quote/VRDN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VRDN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/18 07:10</td>
    <td>Carisma Therapeutics、$300Mの混合シェルフオファリングを申請</td>
    <td><a href=https://finance.yahoo.com/quote/CARM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CARM</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/18 06:46</td>
    <td>Nektar Therapeutics up 7% after hours on restructuring plan
</td>
    <td><a href=https://finance.yahoo.com/quote/NKTR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NKTR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 07:18</td>
    <td>ラコビナ・セラピューティクス、2023年4月19日に開催されるエマージング・グロース・カンファレンスでプレゼンテーションを実施</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2648535/0/en/Rakovina-Therapeutics-to-Present-at-the-Emerging-Growth-Conference-on-April-19-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2648535/0/en/Rakovina-Therapeutics-to-Present-at-the-Emerging-Growth-Conference-on-April-19-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 07:00</td>
    <td>プレディクティブ・オンコロジーの臨時株主総会の延期について</td>
    <td><a href=https://finance.yahoo.com/quote/POAI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/POAI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 06:01</td>
    <td>Nkarta社、2023年AACR年次総会で遺伝子ノックアウト戦略およびNK細胞ベースの治療薬との併用療法を探索する前臨床データを発表</td>
    <td><a href=https://finance.yahoo.com/quote/NKTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NKTX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/17 01:02</td>
    <td>YCBD社 1対45の株式併合</td>
    <td><a href=https://finance.yahoo.com/quote/YCBD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/YCBD</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 05:54</td>
    <td>ルメートル、2023年第1四半期決算を5月2日に発表予定</td>
    <td><a href=https://finance.yahoo.com/quote/LMAT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LMAT</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/17 01:08</td>
    <td>NKGen Biotech、Graf Acquisition Corp.との経営統合により株式公開会社へ IV. NKGN $GFOR</td>
    <td><a href=https://finance.yahoo.com/quote/NKGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NKGN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 05:45</td>
    <td>ハーバード・バイオサイエンス、2023年第1四半期決算コンファレンスコールを4月25日午前9時（日本時間）に開催</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2648489/11635/en/Harvard-Bioscience-Schedules-First-Quarter-2023-Earnings-Conference-Call-for-April-25-2023-at-9-00-AM-ET.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2648489/11635/en/Harvard-Bioscience-Schedules-First-Quarter-2023-Earnings-Conference-Call-for-April-25-2023-at-9-00-AM-ET.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/17 04:02</td>
    <td>AFMD社、AACR23において、重度前治療歴のある再発・難治性末梢性T細胞リンパ腫患者を対象としたAFM13フェーズ2 REDIRECT試験の安全性と有効性を実証する最終データを発表</td>
    <td><a href=https://finance.yahoo.com/quote/AFMD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AFMD</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 05:30</td>
    <td>議決権および株式の総数に関する情報</td>
    <td><a href=https://finance.yahoo.com/quote/NYXH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NYXH</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/17 19:31</td>
    <td>24価肺炎球菌ワクチン候補「VAX-24」の65歳以上の成人を対象としたフェーズ2試験の良好なデータ、成人フェーズ1/2試験およびフェーズ2試験の6カ月間の安全性データの全容を報告</td>
    <td><a href=https://finance.yahoo.com/quote/PCVX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PCVX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/17 20:06</td>
    <td>AMRN、Aaron Bergを暫定社長兼CEOに任命</td>
    <td><a href=https://finance.yahoo.com/quote/AMRN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMRN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/18 06:27</td>
    <td>Quipt Home Medical announces $35M bought deal offering, stock falls 11%
</td>
    <td><a href=https://finance.yahoo.com/quote/QIPT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/QIPT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 05:30</td>
    <td>議決権および株式の総数に関する情報</td>
    <td><a href=https://finance.yahoo.com/quote/NYXH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NYXH</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 05:30</td>
    <td>Monte Rosa Therapeutics、AACR 2023でMYC駆動型がんに特化したGSPT1分解プログラムによる前臨床データを発表</td>
    <td><a href=https://finance.yahoo.com/quote/GLUE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GLUE</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/17 20:30</td>
    <td>AGEN社、大腸がんに対するBotensilimabおよびBalstilimabのファストトラック指定を受ける</td>
    <td><a href=https://finance.yahoo.com/quote/AGEN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AGEN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/18 06:27</td>
    <td>Innoviva rises 6% on FDA panel backing for bacterial pneumonia drug
</td>
    <td><a href=https://finance.yahoo.com/quote/INVA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/INVA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 05:25</td>
    <td>バイオンドバックス、2022年度財務諸表および年次報告書（Form 10-K）を提出、およびビジネスアップデートを提供</td>
    <td><a href=https://finance.yahoo.com/quote/BVXV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BVXV</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/17 21:03</td>
    <td>CADL社、CAN-2409のNSCLCに対するファストトラック指定をFDAから取得</td>
    <td><a href=https://finance.yahoo.com/quote/CADL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CADL</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/18 06:19</td>
    <td>Vaxcyte down 5% after hours on underwritten public offering
</td>
    <td><a href=https://finance.yahoo.com/quote/PCVX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PCVX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 05:15</td>
    <td>NANOBIOTIX、2023年4月24日に業務アップデートと2022年通期決算を発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/NBTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NBTX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/17 21:27</td>
    <td>Google、A.I.ライバルを撃退するために検索を根本的に変えることを考案中。$GOOG $MSFT Bing ChatGPT</td>
    <td><a href=https://finance.yahoo.com/quote/GOOG target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GOOG</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/18 05:15</td>
    <td>マラバイ・ライフサイエンス社、2023年5月8日（月）に決算説明会を開催予定</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2648457/0/en/Maravai-LifeSciences-To-Host-Earnings-Conference-Call-on-Monday-May-8-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2648457/0/en/Maravai-LifeSciences-To-Host-Earnings-Conference-Call-on-Monday-May-8-2023.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/17 23:08</td>
    <td>OCULのパートナーであるAffaMed Therapeutics社が、眼科手術後の眼炎症・疼痛治療薬DEXTENZAの中国本土における第3相登録臨床試験開始の承認を取得したことを発表</td>
    <td><a href=https://finance.yahoo.com/quote/OCUL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OCUL</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/18 06:01</td>
    <td>PAAリサーチからのショートコールを受け、Trupanionが下落。</td>
    <td><a href=https://finance.yahoo.com/quote/TRUP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TRUP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 21:30</td>
    <td>スタンダード・バイオツールズがHyperion XTiイメージング・システムを発表、空間生物学の大幅な進歩のために障壁を破る</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2647951/0/en/Standard-BioTools-introduces-the-Hyperion-XTi-Imaging-System-breaks-barriers-to-power-significant-advancement-in-spatial-biology.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2647951/0/en/Standard-BioTools-introduces-the-Hyperion-XTi-Imaging-System-breaks-barriers-to-power-significant-advancement-in-spatial-biology.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 21:30</td>
    <td>米国Cormedix Inc. ロバート・A・スチュワート氏の取締役就任を発表</td>
    <td><a href=https://finance.yahoo.com/quote/CRMD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CRMD</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 21:15</td>
    <td>HeartSciences が Planet MicroCap Showcase でプレゼンテーションを行う： ベガス2023</td>
    <td><a href=https://finance.yahoo.com/quote/HSCSW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HSCSW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 21:15</td>
    <td>インテルジェネックス、「RIZAFILM®」の急性片頭痛治療薬としてFDAの承認を取得したと発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2647913/0/en/IntelGenx-Announces-FDA-Approval-of-RIZAFILM-for-the-Treatment-of-Acute-Migraine.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2647913/0/en/IntelGenx-Announces-FDA-Approval-of-RIZAFILM-for-the-Treatment-of-Acute-Migraine.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 21:05</td>
    <td>オルソペディアトリクス社、2023年5月2日に2022年第1四半期決算を発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/KIDS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/KIDS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 21:05</td>
    <td>Panavance Therapeutics、卵巣がん治療におけるGP-2250の単剤および併用療法のポジティブな前臨床データを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2647903/0/en/Panavance-Therapeutics-Announces-Positive-Preclinical-Data-Demonstrating-GP-2250-Single-Agent-and-Combination-Activity-for-the-Treatment-of-Ovarian-Cancer.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2647903/0/en/Panavance-Therapeutics-Announces-Positive-Preclinical-Data-Demonstrating-GP-2250-Single-Agent-and-Combination-Activity-for-the-Treatment-of-Ovarian-Cancer.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 21:03</td>
    <td>ITM、Roger Estafanosを米国総支配人に任命、ニュージャージー州プリンストンに米国本社を開設し、プレゼンスを拡大</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2647897/0/en/ITM-Appoints-Roger-Estafanos-as-U-S-General-Manager-and-Expands-Presence-with-Opening-of-U-S-Headquarters-in-Princeton-New-Jersey.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2647897/0/en/ITM-Appoints-Roger-Estafanos-as-U-S-General-Manager-and-Expands-Presence-with-Opening-of-U-S-Headquarters-in-Princeton-New-Jersey.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 21:01</td>
    <td>オーシャン・バイオメディカル社（NASDAQ: OCEA）が革新的研究とIND充填に1億3400万ドルの資金援助を発表、プラットフォームの前進、マラリア、肺線維症、腫瘍における新規発見について最新情報を提供します。</td>
    <td><a href=https://finance.yahoo.com/quote/OCEA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OCEA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 21:00</td>
    <td>ダクソー、「MedAxiom Cardiovascular Transforum Conference Spring'23」に出展し、血液量診断装置（BVA-100®）の認知度向上と普及を推進へ。</td>
    <td><a href=https://finance.yahoo.com/quote/DXR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DXR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 21:00</td>
    <td>プラクシス・プレシジョン・メディシンズ社、ウリキサカルタミドの発表会・イベント開催予定について</td>
    <td><a href=https://finance.yahoo.com/quote/PRAX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PRAX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 21:00</td>
    <td>Windtree Therapeutics社、SERCA2a活性化剤の新規二重機構特許を取得</td>
    <td><a href=https://finance.yahoo.com/quote/WINT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/WINT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 21:00</td>
    <td>binx health、ポイントオブケアの全米展開をサポートするコマーシャルチームをさらに拡大</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2647852/0/en/binx-health-Further-Expands-Commercial-Team-in-Support-of-Point-of-Care-National-Rollout.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2647852/0/en/binx-health-Further-Expands-Commercial-Team-in-Support-of-Point-of-Care-National-Rollout.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/17 20:57</td>
    <td>肺炎球菌ワクチンの中間期データを受けてVaxcyteが急騰</td>
    <td><a href=https://finance.yahoo.com/quote/PCVX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PCVX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 21:00</td>
    <td>ペプジェン社、2023年米国神経学会年次総会でのデータ発表予定について</td>
    <td><a href=https://finance.yahoo.com/quote/PEPG target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PEPG</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/17 20:23</td>
    <td>HLSセラピューティクス、CEOを任命</td>
    <td><a href=https://finance.yahoo.com/quote/HLTRF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HLTRF</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 21:00</td>
    <td>Vincerx Pharma、2023年米国がん研究協会（AACR）年次総会でファーストインクラスの低分子薬物複合体（SMDC）であるVIP236の前臨床データを発表</td>
    <td><a href=https://finance.yahoo.com/quote/VINC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VINC</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/17 20:11</td>
    <td>アマリン社、暫定社長兼CEOにAaron Bergを指名</td>
    <td><a href=https://finance.yahoo.com/quote/AMRN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMRN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 21:00</td>
    <td>CymaBay Therapeutics、NASDAQで開催されるH.C. Wainwright BioConnect Investor Conferenceでプレゼンテーションを実施</td>
    <td><a href=https://finance.yahoo.com/quote/CBAY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CBAY</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/17 20:06</td>
    <td>アッヴィ、クローン病治療薬「Rinvoq」のEUでの承認を獲得</td>
    <td><a href=https://finance.yahoo.com/quote/ABBV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ABBV</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/17 20:01</td>
    <td>Eterna Therapeutics、ホルダーによる293万株の募集を申請</td>
    <td><a href=https://finance.yahoo.com/quote/ERNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ERNA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 20:30</td>
    <td>リジェネロン社、取締役会会長のP.Roy Vagelos博士の退任を発表 医師、実業家、業界の著名人として活躍</td>
    <td><a href=https://finance.yahoo.com/quote/REGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/REGN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 20:30</td>
    <td>ファルネシルトランスフェラーゼ阻害剤と標的治療薬の併用による相乗効果を強調する前臨床試験データを発表</td>
    <td><a href=https://finance.yahoo.com/quote/KURA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/KURA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 20:30</td>
    <td>Radiopharm Theranostics社、TerThera社とテルビウム-161アイソトープの供給契約を締結</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2647815/0/en/Radiopharm-Theranostics-Enters-Into-Supply-Agreement-with-TerThera-for-Terbium-161-Isotope.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2647815/0/en/Radiopharm-Theranostics-Enters-Into-Supply-Agreement-with-TerThera-for-Terbium-161-Isotope.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 20:15</td>
    <td>Aurora Spine社、MIS仙腸関節固定装置「SiLO TFX™」による初期手術の実施を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2647788/36935/en/Aurora-Spine-Announces-Initial-Surgeries-Conducted-Using-its-SiLO-TFX-MIS-Sacroiliac-Joint-Fixation-System.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2647788/36935/en/Aurora-Spine-Announces-Initial-Surgeries-Conducted-Using-its-SiLO-TFX-MIS-Sacroiliac-Joint-Fixation-System.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 20:05</td>
    <td>ヘリウス・メディカル・テクノロジーズ、2023年米国神経学会年次総会でPoNSデバイスの拡大認可を紹介 ブース1685</td>
    <td><a href=https://finance.yahoo.com/quote/HSDT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HSDT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 20:01</td>
    <td>Gritstone bio社、SARS-CoV-2（CORAL）に対する自己増幅型mRNA（samRNA）を評価する2つのフェーズ1試験から6ヶ月間の中和抗体（nAb）データをECCMID 2023で提示する。</td>
    <td><a href=https://finance.yahoo.com/quote/GRTS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GRTS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 20:00</td>
    <td>メディセナ、AACR年次総会でIL-13スーパーキンの前臨床試験データを発表</td>
    <td><a href=https://finance.yahoo.com/quote/MDNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MDNA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 20:00</td>
    <td>センチュリー・セラピューティクス、Chardan社の第7回遺伝子治療薬・細胞治療薬製造バーチャルサミットでプレゼンテーションを実施</td>
    <td><a href=https://finance.yahoo.com/quote/IPSC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IPSC</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 20:00</td>
    <td>先進的なパートナーシップにより、ケベック州に大麻入りアイスティーを新発売</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2647750/0/en/Forward-thinking-partnership-brings-new-cannabis-infused-iced-tea-to-Qu%C3%A9bec.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2647750/0/en/Forward-thinking-partnership-brings-new-cannabis-infused-iced-tea-to-Qu%C3%A9bec.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 20:00</td>
    <td>先見性のあるパートナーシップにより、ケベック州に大麻入りアイスティーが新登場</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2647750/0/fr/Un-partenariat-visionnaire-permet-d-offrir-au-Qu%C3%A9bec-un-nouveau-th%C3%A9-glac%C3%A9-infus%C3%A9-au-cannabis.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2647750/0/fr/Un-partenariat-visionnaire-permet-d-offrir-au-Qu%C3%A9bec-un-nouveau-th%C3%A9-glac%C3%A9-infus%C3%A9-au-cannabis.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 20:00</td>
    <td>ARVOにおけるアフリベルセプト8mgおよびEYLEA®（アフリベルセプト）注射液の発表により、重篤な網膜疾患の治療に関する新たな知見を得ることができました。</td>
    <td><a href=https://finance.yahoo.com/quote/REGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/REGN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 20:00</td>
    <td>グリットストーンバイオ、2023年AACR年次総会でネオアンチゲン予測およびがんワクチン免疫原性の進歩を発表</td>
    <td><a href=https://finance.yahoo.com/quote/GRTS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GRTS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 20:00</td>
    <td>トニックス・ファーマシューティカルズ、TNX-1500（抗CD40L mAb）が非ヒトサルの腎移植および心臓移植の生存期間を延長するデータを米国移植学会誌に2報掲載したと発表</td>
    <td><a href=https://finance.yahoo.com/quote/TNXP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TNXP</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/17 19:41</td>
    <td>Amneal pops 3% after early look at Q1 results, re-affirms FY23 guidance
</td>
    <td><a href=https://finance.yahoo.com/quote/AMRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMRX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 20:00</td>
    <td>アマリン社、Aaron Bergを暫定社長兼最高経営責任者に、Oliver O'Connorを取締役に任命</td>
    <td><a href=https://finance.yahoo.com/quote/AMRN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMRN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/17 19:39</td>
    <td>Prometheus soars 70%, Merck dips after ~$11B buyout deal
</td>
    <td><a href=https://finance.yahoo.com/quote/MRK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 19:30</td>
    <td>キネータ、AACR年次総会2023で新たなVISTAバイオマーカーデータとKVA12123フェーズ1/2臨床試験のアップデートを発表</td>
    <td><a href=https://finance.yahoo.com/quote/KA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/KA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 19:30</td>
    <td>Vaxcyte社、24価肺炎球菌ワクチン候補「VAX-24」の65歳以上の成人を対象としたフェーズ2試験の良好なデータおよび成人フェーズ1/2試験およびフェーズ2試験の6カ月間の安全性データ全文を発表</td>
    <td><a href=https://finance.yahoo.com/quote/PCVX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PCVX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 19:00</td>
    <td>ブライトピーク、AACRで新データを発表 BPT567 ファーストインクラスの多機能PD1-IL18イミュノサイトカイン</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2647674/0/en/Bright-Peak-Presents-New-Data-at-AACR-BPT567-A-First-in-Class-Multifunctional-PD1-IL18-Immunocytokine.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2647674/0/en/Bright-Peak-Presents-New-Data-at-AACR-BPT567-A-First-in-Class-Multifunctional-PD1-IL18-Immunocytokine.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/17 18:43</td>
    <td>GSK社の経口UTI抗生物質が後期臨床試験で重要な目標を達成しました。</td>
    <td><a href=https://finance.yahoo.com/quote/GSK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GSK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 17:00</td>
    <td>新CEO就任のお知らせ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2647616/0/da/Ans%C3%A6ttelse-af-ny-CEO.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2647616/0/da/Ans%C3%A6ttelse-af-ny-CEO.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 17:00</td>
    <td>新CEO就任のお知らせ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2647616/0/en/Appointment-of-new-CEO.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2647616/0/en/Appointment-of-new-CEO.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 15:52</td>
    <td>2023年の財務カレンダー変更と米国での集団訴訟に関する最新情報</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2647580/0/en/Change-to-Financial-Calendar-for-2023-and-update-regarding-class-action-lawsuit-in-United-States.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2647580/0/en/Change-to-Financial-Calendar-for-2023-and-update-regarding-class-action-lawsuit-in-United-States.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 15:00</td>
    <td>グリコトープ、2023年米国がん研究協会（AACR）総会で糖鎖工学に基づく細胞ラインを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2647557/0/en/Glycotope-Presents-Glyco-Engineered-Cell-Lines-at-the-2023-American-Association-for-Cancer-Research-AACR-Meeting.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2647557/0/en/Glycotope-Presents-Glyco-Engineered-Cell-Lines-at-the-2023-American-Association-for-Cancer-Research-AACR-Meeting.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 15:00</td>
    <td>米国がん研究協会（AACR）年次総会：Cellectis社、トリプルネガティブ乳がんを標的とした有効性が向上したTALEN®編集MUC1 CAR T細胞の前臨床データを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2647559/0/fr/R%C3%A9union-annuelle-de-l-American-Association-for-Cancer-Research-AACR-Cellectis-pr%C3%A9sente-des-donn%C3%A9es-pr%C3%A9cliniques-sur-les-cellules-CAR-T-MUC1-%C3%A9dit%C3%A9es-par-TALEN-avec-une-efficacit%C3%A9-am.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2647559/0/fr/R%C3%A9union-annuelle-de-l-American-Association-for-Cancer-Research-AACR-Cellectis-pr%C3%A9sente-des-donn%C3%A9es-pr%C3%A9cliniques-sur-les-cellules-CAR-T-MUC1-%C3%A9dit%C3%A9es-par-TALEN-avec-une-efficacit%C3%A9-am.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 15:00</td>
    <td>Mendus AB: Mendus (publ) が2022年版年次報告書を発行、17日に投資家向け電話会議を開催</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2647558/0/en/Mendus-AB-Mendus-publ-publishes-the-Annual-Report-for-2022-and-holds-investor-call-on-April-17th.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2647558/0/en/Mendus-AB-Mendus-publ-publishes-the-Annual-Report-for-2022-and-holds-investor-call-on-April-17th.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 15:00</td>
    <td>Mendus AB: Mendus AB (publ) が2022年の年次報告書を発行、4月17日に投資家向け説明会を開催</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2647558/0/sv/Mendus-AB-Mendus-AB-publ-offentligg%C3%B6r-%C3%A5rsredovisning-f%C3%B6r-2022-och-h%C3%A5ller-investerarpresentation-den-17-april.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2647558/0/sv/Mendus-AB-Mendus-AB-publ-offentligg%C3%B6r-%C3%A5rsredovisning-f%C3%B6r-2022-och-h%C3%A5ller-investerarpresentation-den-17-april.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 15:00</td>
    <td>セレクティス、米国がん研究学会（AACR）年次総会でTALEN®編集MUC1 CAR T細胞のトリプルネガティブ乳がんに対する有効性を高める前臨床データを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2647561/0/en/Cellectis-Presents-Preclinical-Data-on-TALEN-edited-MUC1-CAR-T-cells-to-Enhance-Efficacy-in-Targeting-Triple-Negative-Breast-Cancer-at-the-American-Association-for-Cancer-Research-.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2647561/0/en/Cellectis-Presents-Preclinical-Data-on-TALEN-edited-MUC1-CAR-T-cells-to-Enhance-Efficacy-in-Targeting-Triple-Negative-Breast-Cancer-at-the-American-Association-for-Cancer-Research-.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 15:00</td>
    <td>Genmab社とargenx社が免疫学および腫瘍学における抗体治療の進歩に向けた提携を締結</td>
    <td><a href=https://finance.yahoo.com/quote/GMAB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GMAB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 15:00</td>
    <td>ネクスチム社、「NBS 6」を米国で発売</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2647564/0/en/Nexstim-Releases-NBS-6-in-the-United-States.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2647564/0/en/Nexstim-Releases-NBS-6-in-the-United-States.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/17 13:58</td>
    <td>Lifecore Biomedical、四半期報告書提出遅延によるコンプライアンス違反の通知を受領</td>
    <td><a href=https://finance.yahoo.com/quote/LFCR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LFCR</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/17 13:46</td>
    <td>新日本バイオメディカル、1株当たり0.91ドルの現金で薩摩製薬を買収することで合意</td>
    <td><a href=https://finance.yahoo.com/quote/STSA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/STSA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/17 14:00</td>
    <td>Smart Immune社、胸腺を利用したProTcell治療プラットフォームの更なる発展を目指し、500万ドルの投資を受ける。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/17/2647538/0/en/Smart-Immune-receives-5-million-investment-to-further-its-thymus-empowered-ProTcell-therapy-platform.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/17/2647538/0/en/Smart-Immune-receives-5-million-investment-to-further-its-thymus-empowered-ProTcell-therapy-platform.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/14 20:46</td>
    <td>OCGN社、網膜色素変性症および先天性黒内障を対象とした遺伝子治療製品候補OCU400の第1/2相臨床試験の安全性および有効性の肯定的な予備結果を発表</td>
    <td><a href=https://finance.yahoo.com/quote/OCGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OCGN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/14 21:31</td>
    <td>株式併合の理由を説明する株主説明会を開催します。😂</td>
    <td><a href=https://finance.yahoo.com/quote/AKBA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AKBA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/16 02:38</td>
    <td>メルス社、前治療歴のある頭頸部扁平上皮がんに対するペトセムタマブ単剤療法の抄録がAACR2023年年次総会のプレナリーセッションでの口頭発表に選ばれ、プログラムおよび規制に関する最新情報を発表することを発表</td>
    <td><a href=https://finance.yahoo.com/quote/MRUS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRUS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/16 02:38</td>
    <td>メルス、前治療歴のある頭頸部扁平上皮がんに対するペトセムタマブ単剤療法について、AACR2023年次総会でのプレナリーセッション発表の演題を発表、プログラムおよび規制に関する最新情報をお知らせします。</td>
    <td><a href=https://finance.yahoo.com/quote/MRUS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRUS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/16 00:28</td>
    <td>メルス、進行胃・食道腺がんに対するペトセムタマブの2023年AACR年次総会での発表要旨の掲載を発表</td>
    <td><a href=https://finance.yahoo.com/quote/MRUS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRUS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/16 00:28</td>
    <td>メルス、進行胃/食道腺がんに対するペトセムタマブのAACR年次総会2023年発表の演題を公開すると発表</td>
    <td><a href=https://finance.yahoo.com/quote/MRUS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRUS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/15 09:19</td>
    <td>NKGen Biotech, Inc.のGraf Acquisition Corp.との経営統合による上場会社化について IV</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/15/2647418/0/en/NKGen-Biotech-Inc-to-Become-Publicly-Traded-Company-via-Business-Combination-with-Graf-Acquisition-Corp-IV.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/15/2647418/0/en/NKGen-Biotech-Inc-to-Become-Publicly-Traded-Company-via-Business-Combination-with-Graf-Acquisition-Corp-IV.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/15 07:32</td>
    <td>Scilex Holding Company、年次株主総会の最終延期を発表</td>
    <td><a href=https://finance.yahoo.com/quote/SCLX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SCLX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/15 12:52</td>
    <td>米連邦最高裁のアリト氏、中絶薬への抑制を一時停止</td>
    <td><a href=https://finance.yahoo.com/quote/CVS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CVS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/15 05:48</td>
    <td>バイオメリカ、2023年度第3四半期決算を発表</td>
    <td><a href=https://finance.yahoo.com/quote/BMRA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BMRA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/15 05:47</td>
    <td>プレディシン、AACR 2023カンファレンスでPredicineALERT™ MRDアッセイを発表し、12本のポスターを発表へ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/14/2647368/0/en/Predicine-to-Introduce-PredicineALERT-MRD-Assay-and-Present-Twelve-Posters-at-AACR-2023-Conference.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/14/2647368/0/en/Predicine-to-Introduce-PredicineALERT-MRD-Assay-and-Present-Twelve-Posters-at-AACR-2023-Conference.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/15 07:25</td>
    <td>Precipioは$50Mの混合シェルフオファリングを申請する。</td>
    <td><a href=https://finance.yahoo.com/quote/PRPO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PRPO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/15 05:35</td>
    <td>ライフコア・バイオメディカル株式会社 四半期報告書の遅延に関するナスダックからの通知について</td>
    <td><a href=https://finance.yahoo.com/quote/LFCR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LFCR</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/15 07:24</td>
    <td>CytoMedの株価は$10MのIPO後、横ばいで終了（更新）。</td>
    <td><a href=https://finance.yahoo.com/quote/GDTC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GDTC</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/15 05:10</td>
    <td>ヘンプドクター、画期的なナノ乳化グミ「Kayo Rapid Release Gummies」を新発売</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/14/2647350/0/en/The-Hemp-Doctor-Launches-Kayo-Rapid-Release-Gummies-a-Revolutionary-Nano-Emulsified-Gummy.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/14/2647350/0/en/The-Hemp-Doctor-Launches-Kayo-Rapid-Release-Gummies-a-Revolutionary-Nano-Emulsified-Gummy.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/15 07:19</td>
    <td>ランネットCFOジョン・コズロウスキーが退任へ</td>
    <td><a href=https://finance.yahoo.com/quote/LCI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LCI</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/15 12:52</td>
    <td>米連邦最高裁のアリト氏、中絶薬への抑制を一時停止</td>
    <td><a href=https://finance.yahoo.com/quote/CVS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CVS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/15 09:19</td>
    <td>NKGen Biotech, Inc.のGraf Acquisition Corp.との経営統合による上場会社化について IV</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/15/2647418/0/en/NKGen-Biotech-Inc-to-Become-Publicly-Traded-Company-via-Business-Combination-with-Graf-Acquisition-Corp-IV.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/15/2647418/0/en/NKGen-Biotech-Inc-to-Become-Publicly-Traded-Company-via-Business-Combination-with-Graf-Acquisition-Corp-IV.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/15 07:25</td>
    <td>Precipioは$50Mの混合シェルフオファリングを申請する。</td>
    <td><a href=https://finance.yahoo.com/quote/PRPO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PRPO</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/15 07:24</td>
    <td>CytoMedの株価は$10MのIPO後、横ばいで終了（更新）。</td>
    <td><a href=https://finance.yahoo.com/quote/GDTC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GDTC</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/15 07:19</td>
    <td>ランネットCFOジョン・コズロウスキーが退任へ</td>
    <td><a href=https://finance.yahoo.com/quote/LCI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LCI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/15 07:32</td>
    <td>Scilex Holding Company、年次株主総会の最終延期を発表</td>
    <td><a href=https://finance.yahoo.com/quote/SCLX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SCLX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/15 06:47</td>
    <td>がん治療薬開発のLadRx社、ナスダック上場を申請、株式公開へ</td>
    <td><a href=https://finance.yahoo.com/quote/LADX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LADX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/15 05:48</td>
    <td>バイオメリカ、2023年度第3四半期決算を発表</td>
    <td><a href=https://finance.yahoo.com/quote/BMRA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BMRA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/15 05:47</td>
    <td>プレディシン、AACR 2023カンファレンスでPredicineALERT™ MRDアッセイを発表し、12本のポスターを発表へ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/14/2647368/0/en/Predicine-to-Introduce-PredicineALERT-MRD-Assay-and-Present-Twelve-Posters-at-AACR-2023-Conference.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/14/2647368/0/en/Predicine-to-Introduce-PredicineALERT-MRD-Assay-and-Present-Twelve-Posters-at-AACR-2023-Conference.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/15 05:35</td>
    <td>ライフコア・バイオメディカル株式会社 四半期報告書の遅延に関するナスダックからの通知について</td>
    <td><a href=https://finance.yahoo.com/quote/LFCR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LFCR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/15 05:10</td>
    <td>ヘンプドクター、画期的なナノ乳化グミ「Kayo Rapid Release Gummies」を新発売</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/14/2647350/0/en/The-Hemp-Doctor-Launches-Kayo-Rapid-Release-Gummies-a-Revolutionary-Nano-Emulsified-Gummy.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/14/2647350/0/en/The-Hemp-Doctor-Launches-Kayo-Rapid-Release-Gummies-a-Revolutionary-Nano-Emulsified-Gummy.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/15 05:05</td>
    <td>23andMe社、CD200R1を標的とする治験用抗体23ME-00610のファースト・イン・ヒト第1/2a相試験結果を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ME target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ME</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/15 06:01</td>
    <td>リバノバCEOが退任、コは第1四半期の売上高がコンセンサスを上回る速報値を発表</td>
    <td><a href=https://finance.yahoo.com/quote/LIVN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LIVN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/15 05:01</td>
    <td>InflaRx社、4,000万ドルの普通株式公募の終了を発表</td>
    <td><a href=https://finance.yahoo.com/quote/IFRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IFRX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/15 05:33</td>
    <td>MEIファーマ、1対20の株式併合で下落</td>
    <td><a href=https://finance.yahoo.com/quote/MEIP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MEIP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/15 05:01</td>
    <td>HOOKIPA、ナスダック上場規則5635(c)(4)に基づく誘引賞の付与を発表</td>
    <td><a href=https://finance.yahoo.com/quote/HOOK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HOOK</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/15 04:02</td>
    <td>Carisma jumps 14% as Baird starts at Outperform on lead asset
</td>
    <td><a href=https://finance.yahoo.com/quote/CARM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CARM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/15 05:01</td>
    <td>Ocular Therapeutix™、2023年視覚・眼科学会（ARVO）年次総会で前臨床データおよび臨床データを発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/OCUL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OCUL</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/15 03:33</td>
    <td>CytoMed, cancer drug developer, sees stock fall 10% after $10M IPO
</td>
    <td><a href=https://finance.yahoo.com/quote/GDTC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GDTC</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/15 05:01</td>
    <td>ポリピッド、ナスダックにおける最低株主資本規制の不遵守に関する通知の受領を発表</td>
    <td><a href=https://finance.yahoo.com/quote/PYPD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PYPD</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/15 04:55</td>
    <td>ジョージ・レーム（JD）、InkSpace Imagingの取締役に就任</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/14/2647332/0/en/George-Rehm-JD-appointed-to-InkSpace-Imaging-Board-of-Directors.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/14/2647332/0/en/George-Rehm-JD-appointed-to-InkSpace-Imaging-Board-of-Directors.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/15 03:19</td>
    <td>大麻改革派のコーリー・ブッカー上院議員は大麻を「危険な薬物」と呼ぶ。</td>
    <td><a href=https://finance.yahoo.com/quote/ACB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ACB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 21:48</td>
    <td>レブメド、地域および世界の慈善団体を支援することを約束</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/14/2647061/0/en/RevMed-Commits-to-Supporting-Local-and-Global-Charities.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/14/2647061/0/en/RevMed-Commits-to-Supporting-Local-and-Global-Charities.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 21:31</td>
    <td>ニューサイトイメージング、ロボットや産業用オートメーション市場向けに高精度な3Dマッピングを実現する最先端のリファレンスデザイン「MT LiDAR 3.1」を発売開始</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/14/2647044/0/en/Newsight-Imaging-Launches-MT-LiDAR-3-1-a-State-of-the-Art-Reference-Design-for-Accurate-3D-Mapping-for-Robotics-and-Industrial-Automation-Markets.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/14/2647044/0/en/Newsight-Imaging-Launches-MT-LiDAR-3-1-a-State-of-the-Art-Reference-Design-for-Accurate-3D-Mapping-for-Robotics-and-Industrial-Automation-Markets.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/14 21:05</td>
    <td>FDAが抗がん剤の追加陽性結果を求めているため、Soligenixの株価は沈む。</td>
    <td><a href=https://finance.yahoo.com/quote/SNGX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SNGX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 21:30</td>
    <td>欧州石灰化組織学会（ECTS）において、ENPP1欠損症を対象としたフェーズ1/2試験の速報値を発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/INZY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/INZY</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/14 20:42</td>
    <td>TransCode Therapeutics社、White Lion Capital社から出資を受ける</td>
    <td><a href=https://finance.yahoo.com/quote/RNAZ target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RNAZ</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 21:30</td>
    <td>シエンタ、4月の配当金について</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/14/2647035/0/en/Sienna-Announces-April-Dividend.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/14/2647035/0/en/Sienna-Announces-April-Dividend.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/14 20:24</td>
    <td>MindMed gains 10% as mid-stage depression trial meets key goal
</td>
    <td><a href=https://finance.yahoo.com/quote/MNMD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MNMD</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/14 20:19</td>
    <td>カジア、最低入札価格要件をめぐりナスダックへの準拠を回復</td>
    <td><a href=https://finance.yahoo.com/quote/KZIA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/KZIA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 21:05</td>
    <td>Spero Therapeutics、第33回欧州臨床微生物学・感染症学会でデータ発表を実施</td>
    <td><a href=https://finance.yahoo.com/quote/SPRO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SPRO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 21:00</td>
    <td>アカリ・セラピューティクス社、「地理的萎縮と長時間作用型PAS-Nomacopanのアンメット・ニーズへの対応可能性」に関するキー・オピニオン・リーダー向けウェビナーを開催</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/14/2647002/0/en/Akari-Therapeutics-to-Host-Key-Opinion-Leader-Webinar-on-Geographic-Atrophy-and-the-Potential-of-Long-Acting-PAS-Nomacopan-to-Address-Significant-Unmet-Needs.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/14/2647002/0/en/Akari-Therapeutics-to-Host-Key-Opinion-Leader-Webinar-on-Geographic-Atrophy-and-the-Potential-of-Long-Acting-PAS-Nomacopan-to-Address-Significant-Unmet-Needs.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 21:00</td>
    <td>アチーブメント・ライフサイエンス、「Life Science Innovation Northwest 2023 Conference」でプレゼンテーションを実施</td>
    <td><a href=https://finance.yahoo.com/quote/ACHV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ACHV</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 21:00</td>
    <td>アライメントヘルスケア、2023年第1四半期決算発表とカンファレンスコールの開催を5月4日（木）に決定</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/14/2647005/0/en/Alignment-Healthcare-to-Announce-First-Quarter-2023-Financial-Results-and-Host-Conference-Call-Thursday-May-4-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/14/2647005/0/en/Alignment-Healthcare-to-Announce-First-Quarter-2023-Financial-Results-and-Host-Conference-Call-Thursday-May-4-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 21:00</td>
    <td>セントジェンヌ、4月に開催されるカンファレンスに参加決定</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/14/2647012/0/en/CENTOGENE-to-Participate-in-Upcoming-Conferences-in-April.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/14/2647012/0/en/CENTOGENE-to-Participate-in-Upcoming-Conferences-in-April.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 20:45</td>
    <td>遺伝子治療薬候補であるOCU400の網膜色素変性症および先天性黒内障を対象とした第1/2相臨床試験の安全性および有効性に関する良好な予備的結果を発表</td>
    <td><a href=https://finance.yahoo.com/quote/OCGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OCGN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 20:35</td>
    <td>Entourage Health、2022年度末のカンファレンスコールを4月28日に実施するタイミングを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/14/2646980/0/en/Entourage-Health-Announces-Timing-of-Fiscal-Year-End-2022-Conference-Call-for-April-28.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/14/2646980/0/en/Entourage-Health-Announces-Timing-of-Fiscal-Year-End-2022-Conference-Call-for-April-28.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 20:00</td>
    <td>Axsome Therapeutics、第22回Needham Virtual Healthcare Conferenceでプレゼンテーションを実施</td>
    <td><a href=https://finance.yahoo.com/quote/AXSM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AXSM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 20:00</td>
    <td>TransCode Therapeutics、膠芽腫治療薬TTX-MC138の開発資金としてWhite Lion Capitalから出資を受けることを発表</td>
    <td><a href=https://finance.yahoo.com/quote/RNAZ target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RNAZ</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 20:00</td>
    <td>エステティックメディカルインターナショナル、2023年4月21日に2022年度の有価証券報告書を発表へ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/14/2646940/0/en/Aesthetic-Medical-International-to-Announce-FY2022-Annual-Report-on-April-21-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/14/2646940/0/en/Aesthetic-Medical-International-to-Announce-FY2022-Annual-Report-on-April-21-2023.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/14 19:57</td>
    <td>エンゾ・バイオケム、ランサムウェア攻撃で業績悪化</td>
    <td><a href=https://finance.yahoo.com/quote/ENZ target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ENZ</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/14 19:56</td>
    <td>ユナイテッドヘルス、第1四半期にビート、EPS見通し引き上げで高値刻み</td>
    <td><a href=https://finance.yahoo.com/quote/UNH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/UNH</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 19:00</td>
    <td>QIAGEN、AACR Annual Meeting 2023でがん研究を推進する最新技術を紹介</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/14/2646880/8690/en/QIAGEN-showcases-latest-technologies-to-advance-cancer-research-at-AACR-Annual-Meeting-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/14/2646880/8690/en/QIAGEN-showcases-latest-technologies-to-advance-cancer-research-at-AACR-Annual-Meeting-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 19:00</td>
    <td>QIAGEN が米国がん研究協会年次総会でがん研究のための最新技術を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/14/2646884/0/de/QIAGEN-pr%C3%A4sentiert-neueste-Technologien-f%C3%BCr-die-Krebsforschung-beim-Jahrestreffen-der-American-Association-for-Cancer-Research.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/14/2646884/0/de/QIAGEN-pr%C3%A4sentiert-neueste-Technologien-f%C3%BCr-die-Krebsforschung-beim-Jahrestreffen-der-American-Association-for-Cancer-Research.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 18:48</td>
    <td>ライプチヒで開催されるドイツ核医学会年次大会にITMが招待され、シンポジウムと展示ブースを出展します。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/14/2646871/0/en/ITM-l%C3%A4dt-zu-Symposium-und-Messestand-auf-der-Jahrestagung-der-Deutschen-Gesellschaft-f%C3%BCr-Nuklearmedizin-in-Leipzig-ein.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/14/2646871/0/en/ITM-l%C3%A4dt-zu-Symposium-und-Messestand-auf-der-Jahrestagung-der-Deutschen-Gesellschaft-f%C3%BCr-Nuklearmedizin-in-Leipzig-ein.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/14 18:32</td>
    <td>ガーナ、オックスフォードによる新しいマラリアワクチンの承認を世界で初めて取得</td>
    <td><a href=https://finance.yahoo.com/quote/GSK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GSK</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/14 17:51</td>
    <td>CytoMed Therapeutics、960万ドルの公募価格を決定。</td>
    <td><a href=https://finance.yahoo.com/quote/GDTC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GDTC</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/14 17:32</td>
    <td>Reliq、2つの州で医師会、在宅医療機関と契約を締結</td>
    <td><a href=https://finance.yahoo.com/quote/RQHTF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RQHTF</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 17:00</td>
    <td>Imprivata、ヘルスケアIT、セキュリティ、クリニカルリーダー向けに開発された初のデジタルアイデンティティ成熟度モデルおよびアセスメントを提供開始</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/14/2646833/0/en/Imprivata-Launches-First-Digital-Identity-Maturity-Model-and-Assessment-Developed-for-Healthcare-IT-Security-and-Clinical-Leadership.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/14/2646833/0/en/Imprivata-Launches-First-Digital-Identity-Maturity-Model-and-Assessment-Developed-for-Healthcare-IT-Security-and-Clinical-Leadership.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/14 15:59</td>
    <td>Teva down 2%after receiving FDA response letter for AVT02 biologics
</td>
    <td><a href=https://finance.yahoo.com/quote/TEVA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TEVA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 15:00</td>
    <td>Ultimovacs ASA - 年次総会の議決権行使の開示について</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/14/2646805/0/en/Ultimovacs-ASA-Disclosure-of-voting-rights-of-Annual-General-Meeting.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/14/2646805/0/en/Ultimovacs-ASA-Disclosure-of-voting-rights-of-Annual-General-Meeting.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 14:30</td>
    <td>ZERVIATE」の中国での新薬承認申請により、2024年からNicox社にロイヤリティ収入が追加されます。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/14/2646799/0/en/Additional-Future-Royalty-Revenue-Stream-for-Nicox-from-2024-following-New-Drug-Application-Submission-for-ZERVIATE-in-China.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/14/2646799/0/en/Additional-Future-Royalty-Revenue-Stream-for-Nicox-from-2024-following-New-Drug-Application-Submission-for-ZERVIATE-in-China.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 14:30</td>
    <td>ニコックス：「ZERVIATE」の中国での販売承認申請を受けて、2024年から追加ロイヤリティを予定</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/14/2646799/0/fr/Nicox-Redevances-suppl%C3%A9mentaires-attendues-%C3%A0-partir-de-2024-suite-au-d%C3%A9p%C3%B4t-d-une-demande-d-autorisation-de-mise-sur-le-march%C3%A9-de-ZERVIATE-en-Chine.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/14/2646799/0/fr/Nicox-Redevances-suppl%C3%A9mentaires-attendues-%C3%A0-partir-de-2024-suite-au-d%C3%A9p%C3%B4t-d-une-demande-d-autorisation-de-mise-sur-le-march%C3%A9-de-ZERVIATE-en-Chine.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 14:00</td>
    <td>Vivoryon Therapeutics N.V.の2022年通期決算と経営状況の報告を2023年4月19日に行うことについて</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/14/2646793/0/en/Vivoryon-Therapeutics-N-V-to-Report-Full-Year-2022-Financial-Results-and-Operational-Progress-on-April-19-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/14/2646793/0/en/Vivoryon-Therapeutics-N-V-to-Report-Full-Year-2022-Financial-Results-and-Operational-Progress-on-April-19-2023.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/14 09:29</td>
    <td>自己免疫薬開発のAcelyrinが1億ドルのIPOを申請</td>
    <td><a href=https://finance.yahoo.com/quote/SLRN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SLRN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 09:45</td>
    <td>AVT02で開発された包皮小腸の形成とその評価</td>
    <td><a href=https://finance.yahoo.com/quote/ALVOW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ALVOW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 09:45</td>
    <td>Alvotech社、AVT02生物学的製剤ライセンス申請に関する規制当局の最新情報を提供</td>
    <td><a href=https://finance.yahoo.com/quote/ALVOW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ALVOW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 06:35</td>
    <td>AVITA Medical、オートメーションデバイスのアップデートを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2646762/0/en/AVITA-Medical-Announces-Update-to-Automation-Device.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2646762/0/en/AVITA-Medical-Announces-Update-to-Automation-Device.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 06:12</td>
    <td>アークポイント、ビジネスアップデートと2022年第4四半期および通年の業績に関するカンファレンスコールを開催</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2646757/0/en/ARCPOINT-TO-HOST-CONFERENCE-CALL-TO-PROVIDE-BUSINESS-UPDATE-AND-DISCUSS-2022-Q4-AND-FULL-YEAR-FINANCIAL-RESULTS.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2646757/0/en/ARCPOINT-TO-HOST-CONFERENCE-CALL-TO-PROVIDE-BUSINESS-UPDATE-AND-DISCUSS-2022-Q4-AND-FULL-YEAR-FINANCIAL-RESULTS.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 06:10</td>
    <td>マラカイト・イノベーションズ、Bernie Kosar、Edward Feighanおよび外部の民間投資会社2社を引受先とする資金調達を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2646754/0/en/MALACHITE-INNOVATIONS-ANNOUNCES-CAPITAL-RAISE-LED-BY-BERNIE-KOSAR-EDWARD-FEIGHAN-AND-TWO-OUTSIDE-PRIVATE-INVESTMENT-FIRMS.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2646754/0/en/MALACHITE-INNOVATIONS-ANNOUNCES-CAPITAL-RAISE-LED-BY-BERNIE-KOSAR-EDWARD-FEIGHAN-AND-TWO-OUTSIDE-PRIVATE-INVESTMENT-FIRMS.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 06:00</td>
    <td>キャリガン・パートナーズとの協業契約締結について</td>
    <td><a href=https://finance.yahoo.com/quote/ANIK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ANIK</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/13 06:49</td>
    <td>ChatGPT 親 @OpenAI がバグバウンティプログラムを開始しました。</td>
    <td><a href=https://t.co/LWjovgfnjt target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://t.co/LWjovgfnjt</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 06:00</td>
    <td>Travere Therapeutics、ナスダック上場規則5635(c)(4)に基づく誘引助成金を報告</td>
    <td><a href=https://finance.yahoo.com/quote/TVTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TVTX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/14 06:26</td>
    <td>Anika Therapeutics社がCaligan Partners社との提携契約を締結、取締役に取締役を追加</td>
    <td><a href=https://finance.yahoo.com/quote/ANIK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ANIK</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/13 08:34</td>
    <td>2営業日以内に自己破産を申請するための$PLXP。</td>
    <td><a href=https://finance.yahoo.com/quote/PLXP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PLXP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 06:00</td>
    <td>Oncternal Therapeutics、Oppenheimer & Co.のVirtual Fireside Chatに参加： 血液悪性腫瘍および固形がんにおけるROR1 CAR T細胞療法に関する議論</td>
    <td><a href=https://finance.yahoo.com/quote/ONCT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ONCT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 05:52</td>
    <td>Safe group、2023年第1四半期に150万ユーロの売上高を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2646745/0/en/Safe-group-announces-revenues-of-1-5-million-in-Q1-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2646745/0/en/Safe-group-announces-revenues-of-1-5-million-in-Q1-2023.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/14 06:16</td>
    <td>エクセレクシス、委任状争奪戦に直面するファラロンの取締役候補者2名を支援</td>
    <td><a href=https://finance.yahoo.com/quote/EXEL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EXEL</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/13 20:01</td>
    <td>アレルギー性結膜炎を対象とした第3相臨床試験「INVIGORATE-2」の登録が完了 23年上半期のトップラインデータ</td>
    <td><a href=https://finance.yahoo.com/quote/ALDX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ALDX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 05:52</td>
    <td>ERRATUM: Safe groupが2023年第1四半期の売上高を150万ユーロと発表しました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2646745/0/fr/ERRATUM-Safe-group-annonce-un-chiffre-d-affaires-de-1-5M-au-premier-trimestre-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2646745/0/fr/ERRATUM-Safe-group-annonce-un-chiffre-d-affaires-de-1-5M-au-premier-trimestre-2023.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/13 20:30</td>
    <td>レイモンド・ジェームズが$RLAYをアウトパフォームで開始しました。PT $29</td>
    <td><a href=https://finance.yahoo.com/quote/RLAY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RLAY</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/14 05:51</td>
    <td>FDA、イーライリリーの潰瘍性大腸炎治療薬mirikizumabのライセンス申請を却下</td>
    <td><a href=https://finance.yahoo.com/quote/LLY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LLY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 05:31</td>
    <td>Syneos Health、2023年第1四半期の決算説明会を5月10日（水）に開催予定。</td>
    <td><a href=https://finance.yahoo.com/quote/SYNH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SYNH</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/13 21:37</td>
    <td>SABS社、複数株への高い交差反応性を有するインフルエンザ免疫療法「SAB-176」のファストトラック指定取得を決定</td>
    <td><a href=https://finance.yahoo.com/quote/SABS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SABS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/14 05:47</td>
    <td>FDA、オピオイド系鎮痛剤の安全性要件を更新</td>
    <td><a href=https://finance.yahoo.com/quote/COLL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/COLL</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/14 05:30</td>
    <td>オレマ・オンコロジー、「Canaccord Genuity 2023 Horizons in Oncology Virtual Conference」に参加決定</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2646735/0/en/Olema-Oncology-to-Participate-in-Canaccord-Genuity-2023-Horizons-in-Oncology-Virtual-Conference.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2646735/0/en/Olema-Oncology-to-Participate-in-Canaccord-Genuity-2023-Horizons-in-Oncology-Virtual-Conference.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/13 22:08</td>
    <td>AMLX社、ウォルフラム症候群治療薬AMX0035の第2相試験で最初の被験者を投与</td>
    <td><a href=https://finance.yahoo.com/quote/AMLX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMLX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/14 05:41</td>
    <td>モータスGIのCEOが退任し、コスト削減策を実施するためのコー</td>
    <td><a href=https://finance.yahoo.com/quote/MOTS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MOTS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/13 22:16</td>
    <td>Ocean Biomedical rises ~10% on upcoming US patent linked to malaria therapy
</td>
    <td><a href=https://finance.yahoo.com/quote/OCEA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OCEA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 22:17</td>
    <td>インテルジェネックス、グローバルな成長戦略を支える組織変更を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2646320/0/en/IntelGenx-Announces-Organizational-Changes-to-Support-Global-Growth-Strategy.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2646320/0/en/IntelGenx-Announces-Organizational-Changes-to-Support-Global-Growth-Strategy.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/13 22:11</td>
    <td>Surgalign、コンプライアンス違反に関するNasdaqレターを受領</td>
    <td><a href=https://finance.yahoo.com/quote/SRGA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SRGA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 22:07</td>
    <td>ZyVersa Therapeutics、軽度認知障害およびアルツハイマー病における薬理学的標的としてのミクログリア炎症活性を扱った論文がFrontiers in Pharmacology誌に掲載されたことを発表</td>
    <td><a href=https://finance.yahoo.com/quote/ZVSA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ZVSA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/13 21:57</td>
    <td>WalgreensとProthena、早期アルツハイマー病試験で協定を締結</td>
    <td><a href=https://finance.yahoo.com/quote/PRTA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PRTA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 22:06</td>
    <td>Genesis Robotic Systemで1,000人以上の心臓病患者を治療</td>
    <td><a href=https://finance.yahoo.com/quote/STXS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/STXS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/13 21:55</td>
    <td>ロングCOVID用経鼻フォラルマブの開発計画でティツィアナの株価が急上昇</td>
    <td><a href=https://finance.yahoo.com/quote/TLSA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TLSA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/13 21:36</td>
    <td>MediPharm to cut ~30% staff amid restructuring
</td>
    <td><a href=https://finance.yahoo.com/quote/MEDIF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MEDIF</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 22:00</td>
    <td>エディタス メディスン、新会長および新取締役の就任により取締役会を強化</td>
    <td><a href=https://finance.yahoo.com/quote/EDIT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EDIT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 22:00</td>
    <td>Imprivata、ヘルスケアIT、セキュリティ、クリニカルリーダー向けに開発された初のデジタルアイデンティティ成熟度モデルおよびアセスメントを提供開始</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2646255/0/en/Imprivata-Launches-First-Digital-Identity-Maturity-Model-and-Assessment-Developed-for-Healthcare-IT-Security-and-Clinical-Leadership.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2646255/0/en/Imprivata-Launches-First-Digital-Identity-Maturity-Model-and-Assessment-Developed-for-Healthcare-IT-Security-and-Clinical-Leadership.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 22:00</td>
    <td>リサ・マーティンソンがヴィスタント社に財務経理担当として入社</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2646256/0/en/Lisa-Martinson-Joins-Vistant-as-Finance-Controller.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2646256/0/en/Lisa-Martinson-Joins-Vistant-as-Finance-Controller.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 22:00</td>
    <td>マイケル・ブラックトンがエレクトロファイのテクニカルオペレーション担当シニアバイスプレジデントに就任しました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2646265/0/en/Michael-Blackton-Appointed-as-Senior-Vice-President-of-Elektrofi-s-Technical-Operations-as-Elektrofi-Continues-to-Bolster-Leadership-Bench-with-Industry-Veterans.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2646265/0/en/Michael-Blackton-Appointed-as-Senior-Vice-President-of-Elektrofi-s-Technical-Operations-as-Elektrofi-Continues-to-Bolster-Leadership-Bench-with-Industry-Veterans.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 22:00</td>
    <td>ミネソタ州初： パーク・ニコレット・メソジスト病院が最新鋭の乳がん治療法を導入</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2646270/0/en/First-in-Minnesota-Park-Nicollet-Methodist-Hospital-Incorporates-New-State-of-the-Art-Breast-Cancer-Treatment.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2646270/0/en/First-in-Minnesota-Park-Nicollet-Methodist-Hospital-Incorporates-New-State-of-the-Art-Breast-Cancer-Treatment.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 22:00</td>
    <td>サナバイオテクノロジー、「Nature Communications」に掲載された前臨床試験データにより、当社の低免疫性同種CD19指向性CAR T細胞が免疫拒絶反応を回避し、持続的な抗腫瘍反応をもたらすことを実証すると発表</td>
    <td><a href=https://finance.yahoo.com/quote/SANA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SANA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 22:00</td>
    <td>バイオメアフュージョン、大型公募増資の終了と引受人の追加購入オプションの完全行使を発表</td>
    <td><a href=https://finance.yahoo.com/quote/BMEA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BMEA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 21:58</td>
    <td>ニューロネティクス社、TMS療法の保険適用拡大に向けた機運が高まっていることを発表</td>
    <td><a href=https://finance.yahoo.com/quote/STIM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/STIM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 21:47</td>
    <td>Hillstream BioPharma社、抗がん機序を有するリード化合物HSB-1216の臨床および薬事開発を進めるためOncoBay Clinicalを選択</td>
    <td><a href=https://finance.yahoo.com/quote/HILS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HILS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 21:30</td>
    <td>SCYNEXIS、4月15日から18日までデンマークで開催される第33回欧州臨床微生物・感染症会議（ECCMID）でIbrexafungerpのデータを発表へ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2646187/0/en/SCYNEXIS-to-Present-Ibrexafungerp-Data-at-the-33rd-Annual-European-Congress-of-Clinical-Microbiology-Infectious-Diseases-ECCMID-April-15-18-in-Denmark.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2646187/0/en/SCYNEXIS-to-Present-Ibrexafungerp-Data-at-the-33rd-Annual-European-Congress-of-Clinical-Microbiology-Infectious-Diseases-ECCMID-April-15-18-in-Denmark.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 21:30</td>
    <td>Allogene Therapeutics、今後開催される4つの投資家向けカンファレンスに参加することを発表</td>
    <td><a href=https://finance.yahoo.com/quote/ALLO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ALLO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 21:30</td>
    <td>ガレクト、AACR年次総会2023で2件のポスター発表を実施</td>
    <td><a href=https://finance.yahoo.com/quote/GLTO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GLTO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 21:30</td>
    <td>Surgalign、Nasdaq Deficency Noticeの受領とコンプライアンス回復のための計画提出を発表</td>
    <td><a href=https://finance.yahoo.com/quote/SRGA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SRGA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 21:30</td>
    <td>SAB Biotherapeutics社、複数のインフルエンザ株に高い交差反応性を持つインフルエンザ免疫療法「SAB-176」がFDAからファストトラック指定される。</td>
    <td><a href=https://finance.yahoo.com/quote/SABSW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SABSW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 21:30</td>
    <td>セレバンス社、「BNA International Festival of Neuroscience」でのポスター発表を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2646195/0/en/Cerevance-Announces-Poster-Presentation-at-the-BNA-International-Festival-of-Neuroscience.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2646195/0/en/Cerevance-Announces-Poster-Presentation-at-the-BNA-International-Festival-of-Neuroscience.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/13 21:04</td>
    <td>プレシジョン・バイオサイエンス、遺伝子編集技術に関連する米国特許を取得へ</td>
    <td><a href=https://finance.yahoo.com/quote/DTIL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DTIL</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 21:30</td>
    <td>アセンジス・ファーマ、2023年第1四半期決算とビジネスアップデートのカンファレンスコールを4月27日に開催すると発表</td>
    <td><a href=https://finance.yahoo.com/quote/ASND target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ASND</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/13 20:54</td>
    <td>Sarepta sheds 11% as report hints at early FDA opposition to gene therapy
</td>
    <td><a href=https://finance.yahoo.com/quote/SRPT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SRPT</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/13 20:19</td>
    <td>メルクのキイトルーダコンボが胃がん、食道がんの初回治療薬としてFDAの審査を取得</td>
    <td><a href=https://finance.yahoo.com/quote/MRK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 21:01</td>
    <td>オーシャン・バイオメディカル社（NASDAQ：OCEA）、マラリア治療薬の「全く新しいクラス」の開発に関する米国特許出願が、共同設立者のジョナサン・カーティス博士に許可されたことを発表</td>
    <td><a href=https://finance.yahoo.com/quote/OCEA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OCEA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 21:00</td>
    <td>Arcoma Aktiebolagの年次総会をお知らせします。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2646104/0/sv/Kallelse-till-%C3%A5rsst%C3%A4mma-i-Arcoma-Aktiebolag.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2646104/0/sv/Kallelse-till-%C3%A5rsst%C3%A4mma-i-Arcoma-Aktiebolag.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 21:00</td>
    <td>Chinook Therapeutics、Robert W. Azelbyの取締役就任を発表</td>
    <td><a href=https://finance.yahoo.com/quote/KDNY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/KDNY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 21:00</td>
    <td>Revolo Biotherapeuticsが第8回食物アレルギー基金サミットで講演を行います。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2646107/0/en/Revolo-Biotherapeutics-to-Present-at-the-8th-Food-Allergy-Fund-Summit.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2646107/0/en/Revolo-Biotherapeutics-to-Present-at-the-8th-Food-Allergy-Fund-Summit.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 21:00</td>
    <td>ソリッドバイオサイエンスが第22回Needham Healthcare Conferenceで講演を行います。</td>
    <td><a href=https://finance.yahoo.com/quote/SLDB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SLDB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 21:00</td>
    <td>IntelyCare、看護師の労働力問題を軽減するUKGとの技術提携を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2646121/0/en/IntelyCare-Introduces-Technology-Partnership-with-UKG-to-Alleviate-Nursing-Workforce-Challenges.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2646121/0/en/IntelyCare-Introduces-Technology-Partnership-with-UKG-to-Alleviate-Nursing-Workforce-Challenges.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 21:00</td>
    <td>Jasper Therapeutics社、Matthew Ford氏を人事担当副社長に任命したと発表</td>
    <td><a href=https://finance.yahoo.com/quote/JSPR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/JSPR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 21:00</td>
    <td>インターセプト、2023年4月27日に2023年第1四半期決算発表とNASHの商業的発売戦略に関する最新情報を発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/ICPT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ICPT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 20:30</td>
    <td>センセイバイオセラピューティクス、Canaccord Genuity's Horizons in Oncology Virtual Conferenceに参加へ</td>
    <td><a href=https://finance.yahoo.com/quote/SNSE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SNSE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 20:26</td>
    <td>ノボノルディスク、2023年の売上高と営業利益の見通しを上方修正</td>
    <td><a href=https://finance.yahoo.com/quote/NVO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NVO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 20:15</td>
    <td>HCW BiologicsがAACR年次総会2023でポスター発表</td>
    <td><a href=https://finance.yahoo.com/quote/HCWB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HCWB</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/13 19:36</td>
    <td>ViewRayの株価は、第1四半期前期の売上高の未達と見通しの下方修正を受けて下落、選択肢を模索中</td>
    <td><a href=https://finance.yahoo.com/quote/VRAY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VRAY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 20:05</td>
    <td>AAMI、人工知能に関する特別レポートを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2646061/0/en/AAMI-Releases-Special-Report-on-Artificial-Intelligence.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2646061/0/en/AAMI-Releases-Special-Report-on-Artificial-Intelligence.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 20:00</td>
    <td>Axsome Therapeutics、2023年第1四半期決算を5月8日に発表</td>
    <td><a href=https://finance.yahoo.com/quote/AXSM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AXSM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 20:00</td>
    <td>トニックス・ファーマシューティカルズ、線維筋痛症および慢性偏頭痛のプログラムを迅速化</td>
    <td><a href=https://finance.yahoo.com/quote/TNXP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TNXP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 20:00</td>
    <td>CoVaRR-Netの専門家によると、新型コロナの症例数の高い定常状態が懸念される。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2646039/0/en/High-steady-state-of-COVID-19-case-levels-are-a-concern-according-to-CoVaRR-Net-experts.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2646039/0/en/High-steady-state-of-COVID-19-case-levels-are-a-concern-according-to-CoVaRR-Net-experts.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 20:00</td>
    <td>新型コロナ感染者の高い定常状態がCoVaRR-Netの専門家を悩ます。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2646039/0/fr/L-%C3%A9tat-stable-%C3%A9lev%C3%A9-du-nombre-de-cas-de-COVID-19-inqui%C3%A8te-les-experts-du-r%C3%A9seau-CoVaRR-Net.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2646039/0/fr/L-%C3%A9tat-stable-%C3%A9lev%C3%A9-du-nombre-de-cas-de-COVID-19-inqui%C3%A8te-les-experts-du-r%C3%A9seau-CoVaRR-Net.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 20:00</td>
    <td>アジオス、2023年第1四半期決算のカンファレンスコールを5月4日にウェブキャストで配信へ</td>
    <td><a href=https://finance.yahoo.com/quote/AGIO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AGIO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 20:00</td>
    <td>CLS Americas、前立腺組織および前立腺がんのMRI/超音波融合ガイド下FLAを研究する米国国立衛生研究所臨床センターとの共同研究を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2646045/0/en/CLS-Americas-Announces-Research-Collaboration-with-the-National-Institutes-of-Health-Clinical-Center-to-Study-MRI-Ultrasound-Fusion-Guided-FLA-of-Prostate-Tissue-and-Prostate-Cance.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2646045/0/en/CLS-Americas-Announces-Research-Collaboration-with-the-National-Institutes-of-Health-Clinical-Center-to-Study-MRI-Ultrasound-Fusion-Guided-FLA-of-Prostate-Tissue-and-Prostate-Cance.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 20:00</td>
    <td>ティツィアナライフサイエンス、ロングCOVID治療用経鼻フォラルマブの開発推進を決定</td>
    <td><a href=https://finance.yahoo.com/quote/TLSA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TLSA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 20:00</td>
    <td>バイオシネックス、Chemio Diagnostics, Inc.株式に対する公開買付けを延長</td>
    <td><a href=https://finance.yahoo.com/quote/CEMI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CEMI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 20:00</td>
    <td>クリスタル・バイオテック、Association for Research in Vision and Ophthalmology Annual Meetingで講演を実施</td>
    <td><a href=https://finance.yahoo.com/quote/KRYS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/KRYS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 19:30</td>
    <td>CloudMD、2023年4月24日（月）に第4四半期決算を発表へ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2646002/0/en/CloudMD-to-Report-Fourth-Quarter-Financial-Results-on-Monday-April-24-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2646002/0/en/CloudMD-to-Report-Fourth-Quarter-Financial-Results-on-Monday-April-24-2023.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/13 18:19</td>
    <td>GlucoTrack slumps ~35% after plans for common stock offering
</td>
    <td><a href=https://finance.yahoo.com/quote/GCTK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GCTK</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/13 18:02</td>
    <td>控訴裁判所は中絶薬への限定的なアクセスを許可し、テキサス州判決の一部を阻止する。</td>
    <td><a href=https://finance.yahoo.com/quote/BIIB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BIIB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 18:31</td>
    <td>Ultimovacs社、UV1がんワクチンとチェックポイント阻害剤の組み合わせに関する欧州特許について、付与意向の通知を受領</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2645960/0/en/Ultimovacs-Receives-Intention-to-Grant-Notice-on-European-Patent-on-UV1-Cancer-Vaccine-Checkpoint-Inhibitor-Combinations.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2645960/0/en/Ultimovacs-Receives-Intention-to-Grant-Notice-on-European-Patent-on-UV1-Cancer-Vaccine-Checkpoint-Inhibitor-Combinations.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 18:00</td>
    <td>オリオン、2023年4月27日（木）に2023年1-3月期中間報告書を発行</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2645949/0/en/Orion-publishes-Interim-Report-for-January-March-2023-on-Thursday-27-April-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2645949/0/en/Orion-publishes-Interim-Report-for-January-March-2023-on-Thursday-27-April-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 18:00</td>
    <td>オリオンは、2023年4月27日（木）に中間報告書1-3 / 2023を発行します。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2645949/0/fi/Orion-julkaisee-osavuosikatsauksen-1-3-2023-torstaina-27-4-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2645949/0/fi/Orion-julkaisee-osavuosikatsauksen-1-3-2023-torstaina-27-4-2023.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/13 18:00</td>
    <td>アングルがクレッシェンド・バイオロジックスのファーマサービス契約を獲得</td>
    <td><a href=https://finance.yahoo.com/quote/ANPCY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ANPCY</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/13 16:47</td>
    <td>Mirum Pharmaceuticals、2億7500万ドル相当のノートを販売開始</td>
    <td><a href=https://finance.yahoo.com/quote/MIRM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MIRM</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/13 15:24</td>
    <td>Better Therapeutics up 8% on raising ~$6.5M
</td>
    <td><a href=https://finance.yahoo.com/quote/BTTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BTTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 15:02</td>
    <td>Chr. Hansen Holding A %5C%2F S Interim Report Q2 2022 %5C%2F 23
</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2645875/0/en/Chr-Hansen-Holding-A-S-Interim-Report-Q2-2022-23.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2645875/0/en/Chr-Hansen-Holding-A-S-Interim-Report-Q2-2022-23.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 14:00</td>
    <td>ロシュのデータは、ARVO 2023において、眼科のポートフォリオの強さと眼科医療の進歩へのコミットメントを強調しています。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2645842/0/en/Roche-data-highlights-strength-of-ophthalmology-portfolio-and-commitment-to-advancing-eye-care-at-ARVO-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2645842/0/en/Roche-data-highlights-strength-of-ophthalmology-portfolio-and-commitment-to-advancing-eye-care-at-ARVO-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 14:00</td>
    <td>Strong first quarter performance with 16% topline growth to €181 million
</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2645845/0/en/Strong-first-quarter-performance-with-16-topline-growth-to-181-million.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2645845/0/en/Strong-first-quarter-performance-with-16-topline-growth-to-181-million.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/13 14:00</td>
    <td>Sterk eerste kwartaal met 16% omzetgroei naar €181 miljoen
</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/13/2645845/0/nl/Sterk-eerste-kwartaal-met-16-omzetgroei-naar-181-miljoen.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/13/2645845/0/nl/Sterk-eerste-kwartaal-met-16-omzetgroei-naar-181-miljoen.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/13 08:19</td>
    <td>PLx Pharma intends to file for bankruptcy, inks stalking horse deal; stock +9% after hours
</td>
    <td><a href=https://finance.yahoo.com/quote/PLXP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PLXP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 21:35</td>
    <td>AIMイミュノテック、バイオテクノロジーのパイオニアであるW. Neal Burnette博士を科学諮問委員会（SAB）の委員長に任命</td>
    <td><a href=https://finance.yahoo.com/quote/AIM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AIM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 21:30</td>
    <td>Teladoc Health社、2023年第1四半期決算発表のお知らせ</td>
    <td><a href=https://finance.yahoo.com/quote/TDOC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TDOC</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 21:30</td>
    <td>Blue Water Vaccines社、テキサス大学ヘルスサイエンスセンター・アット・サンアントニオ校と受託研究契約を締結し、経口投与可能な生きたクラミジアワクチンの非ヒト霊長類試験を開始することを発表</td>
    <td><a href=https://finance.yahoo.com/quote/BWV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BWV</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 21:30</td>
    <td>センチュリー・セラピューティクス、役員人事異動を発表</td>
    <td><a href=https://finance.yahoo.com/quote/IPSC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IPSC</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 21:15</td>
    <td>インディアナ大学医学部主導の「CPP-1X-T」の最近発症したI型糖尿病を対象としたJDRF出資の第II相試験で最初の患者さんが登録されました。</td>
    <td><a href=https://finance.yahoo.com/quote/PBLA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PBLA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 21:00</td>
    <td>第19回欧州皮膚腫瘍学会（EADO）において、Day Oneが講演を行います。</td>
    <td><a href=https://finance.yahoo.com/quote/DAWN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DAWN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 21:00</td>
    <td>Myriad Genetics社とSimonMed® Imaging社、新たな遺伝子リスク評価プログラムで精密医療を推進するために協業</td>
    <td><a href=https://finance.yahoo.com/quote/MYGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MYGN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 21:00</td>
    <td>PDS Biotech社、インターロイキン12（IL-12）イムノサイトキンに焦点を当てたKOLラウンドテーブルを2023年4月21日に開催。</td>
    <td><a href=https://finance.yahoo.com/quote/PDSB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PDSB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 21:00</td>
    <td>アコヤバイオサイエンス、PhenoCyclerと融合したワークフローを簡素化する「PhenoCode Discovery Panels」を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/12/2645262/0/en/Akoya-Biosciences-Introduces-PhenoCode-Discovery-Panels-to-Simplify-PhenoCycler-Fusion-Workflow.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/12/2645262/0/en/Akoya-Biosciences-Introduces-PhenoCode-Discovery-Panels-to-Simplify-PhenoCycler-Fusion-Workflow.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 21:00</td>
    <td>ViCentraがMedTech Strategist Innovation SummitとLSX London Conferenceに参加します。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/12/2645263/0/en/ViCentra-to-Participate-at-the-upcoming-MedTech-Strategist-Innovation-Summit-and-LSX-London-Conference.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/12/2645263/0/en/ViCentra-to-Participate-at-the-upcoming-MedTech-Strategist-Innovation-Summit-and-LSX-London-Conference.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 21:00</td>
    <td>キューバイオファーマ、業界のベテランであるパトリック・ヴァーヘイエン氏を取締役に迎え入れる</td>
    <td><a href=https://finance.yahoo.com/quote/CUE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CUE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 21:00</td>
    <td>Viridian Therapeutics、Tony Cascianoをチーフ・コマーシャル・オフィサーに任命</td>
    <td><a href=https://finance.yahoo.com/quote/VRDN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VRDN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 21:00</td>
    <td>コージェント・バイオサイエンス、投資家向けカンファレンスへの出展を発表</td>
    <td><a href=https://finance.yahoo.com/quote/COGT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/COGT</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/12 20:26</td>
    <td>キャノピー・バイオサイエンスとイネーブル・メディシン、空間生物学の研究を推進</td>
    <td><a href=https://finance.yahoo.com/quote/BRKR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BRKR</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/12 20:05</td>
    <td>Mirum Pharmaceuticals、転換社債型シニアノートの募集を発表</td>
    <td><a href=https://finance.yahoo.com/quote/MIRM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MIRM</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/12 20:02</td>
    <td>Centogene社、希少疾患向け全ゲノムシークエンス検査「CentoGenome」の提供を開始</td>
    <td><a href=https://finance.yahoo.com/quote/CNTG target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CNTG</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 20:30</td>
    <td>Adaptive Biotechnologies、血液悪性腫瘍パイプラインにおけるclonoSEQ®アッセイを用いた微小残存病変の測定に関する武田薬品との共同研究を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ADPT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ADPT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 20:30</td>
    <td>Theratechnologies、2023年第1四半期の業績および事業に関する最新情報を発表</td>
    <td><a href=https://finance.yahoo.com/quote/THTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/THTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 20:30</td>
    <td>Theratechnologies、2023年第1四半期の決算と商業活動の最新情報を発表</td>
    <td><a href=https://finance.yahoo.com/quote/THTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/THTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 20:30</td>
    <td>コグニション・セラピューティクス社、シグマ2受容体を標的とした加齢性変性疾患の治療可能性に関する新たな科学論文を発表</td>
    <td><a href=https://finance.yahoo.com/quote/CGTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CGTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 20:30</td>
    <td>ザイネルバ・ファーマシューティカルズ、第55回ガトリンバーグ・カンファレンスでZygel™のデータを発表</td>
    <td><a href=https://finance.yahoo.com/quote/ZYNE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ZYNE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 20:14</td>
    <td>CorVel社、薬剤師資格（CPhT）試験対策プログラムの提供を開始</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/12/2645211/34735/en/CorVel-Launches-Pharmacy-Technician-Certification-CPhT-Test-Preparation-Program.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/12/2645211/34735/en/CorVel-Launches-Pharmacy-Technician-Certification-CPhT-Test-Preparation-Program.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 20:05</td>
    <td>クリアサイドバイオメディカル、第22回Needham Virtual Healthcare Conferenceでファイヤーサイドチャットに参加へ</td>
    <td><a href=https://finance.yahoo.com/quote/CLSD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CLSD</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 20:00</td>
    <td>マイノリティおよび退役軍人におけるKidneyIntelXの有用性を支持するデータをNational Kidney Foundation Spring Clinical Meetingで発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/RNLX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RNLX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 20:00</td>
    <td>ONL Therapeutics、ファーストインクラスのFas阻害剤の黄斑部網膜剥離患者を対象とした第2相臨床試験で最初の患者を投与したことを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/12/2645181/0/en/ONL-Therapeutics-Announces-First-Patient-Dosed-in-Phase-2-Clinical-Trial-of-First-in-Class-Fas-Inhibitor-in-Patients-with-Macula-Off-Rhegmatogenous-Retinal-Detachment.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/12/2645181/0/en/ONL-Therapeutics-Announces-First-Patient-Dosed-in-Phase-2-Clinical-Trial-of-First-in-Class-Fas-Inhibitor-in-Patients-with-Macula-Off-Rhegmatogenous-Retinal-Detachment.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 20:00</td>
    <td>ソシアルCDMO、既存顧客と複数のプロジェクト拡大契約を締結</td>
    <td><a href=https://finance.yahoo.com/quote/SCTL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SCTL</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 20:00</td>
    <td>Arbor Biotechnologies、Daniel Ory博士を最高医学責任者に任命</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/12/2645176/0/en/Arbor-Biotechnologies-Appoints-Dr-Daniel-Ory-as-Chief-Medical-Officer.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/12/2645176/0/en/Arbor-Biotechnologies-Appoints-Dr-Daniel-Ory-as-Chief-Medical-Officer.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 20:00</td>
    <td>Chiesi Farmaceutici S.p.A.によるAmryt Pharma Plcの買収を完了しました。</td>
    <td><a href=https://finance.yahoo.com/quote/AMYT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMYT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 20:00</td>
    <td>Atea社、2023年欧州臨床微生物・感染症学会で新型コロナ患者の入院減少を示すBemnifosbuvirデータを発表すると発表</td>
    <td><a href=https://finance.yahoo.com/quote/AVIR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AVIR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 20:00</td>
    <td>インヴィヴィッド社、ロバート・アレン氏を最高科学責任者、ステイシー・プライス氏を最高技術・製造責任者に任命</td>
    <td><a href=https://finance.yahoo.com/quote/IVVD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IVVD</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 20:00</td>
    <td>プラス・セラピューティクス、2023年第1四半期決算発表およびカンファレンスコールの開催を4月20日に決定</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/12/2645189/0/en/Plus-Therapeutics-to-Announce-First-Quarter-2023-Financial-Results-and-Host-Conference-Call-on-April-20-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/12/2645189/0/en/Plus-Therapeutics-to-Announce-First-Quarter-2023-Financial-Results-and-Host-Conference-Call-on-April-20-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 20:00</td>
    <td>Verrica Pharmaceuticals社、基底細胞癌治療薬VP-315を評価する第2相試験のパート2の最初の患者さんの投与を発表</td>
    <td><a href=https://finance.yahoo.com/quote/VRCA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VRCA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 20:00</td>
    <td>オーロラ・スパイン社、米国神経外科学会年次総会でDEXA技術に関する講演を行うことを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/12/2645193/36935/en/Aurora-Spine-Announces-Presentation-on-DEXA-Technology-at-the-American-Association-of-Neurological-Surgeons-Annual-Meeting.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/12/2645193/36935/en/Aurora-Spine-Announces-Presentation-on-DEXA-Technology-at-the-American-Association-of-Neurological-Surgeons-Annual-Meeting.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/12 19:42</td>
    <td>キュテラ、後継者争いの中、CEOと執行会長を解任、見通し撤回</td>
    <td><a href=https://finance.yahoo.com/quote/CUTR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CUTR</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/12 18:55</td>
    <td>Novo Nordisk、糖尿病／肥満の新薬開発でAspect Biosystemsに当初7500万ドルを支払う。</td>
    <td><a href=https://finance.yahoo.com/quote/NVO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NVO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 19:30</td>
    <td>CloudMD、Benefits Allianceとの提携を拡大し、Kiiの全サービスを提供開始</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/12/2645162/0/en/CloudMD-Expands-Partnership-with-Benefits-Alliance-to-Include-Full-Suite-of-Kii-Services.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/12/2645162/0/en/CloudMD-Expands-Partnership-with-Benefits-Alliance-to-Include-Full-Suite-of-Kii-Services.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 19:30</td>
    <td>Kineta社、進行性固形がんを対象としたKVA12123の臨床第1/2相試験で最初の患者を投与したことを発表</td>
    <td><a href=https://finance.yahoo.com/quote/KA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/KA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 19:30</td>
    <td>セントジェネ社、希少疾患や神経変性疾患の診断に最適な全ゲノムシークエンスソリューション「CentoGenome®」を新発売</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/12/2645159/0/en/CENTOGENE-Launches-NEW-CentoGenome-World-s-Most-Comprehensive-Whole-Genome-Sequencing-Solution-for-Diagnosis-of-Rare-and-Neurodegenerative-Diseases.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/12/2645159/0/en/CENTOGENE-Launches-NEW-CentoGenome-World-s-Most-Comprehensive-Whole-Genome-Sequencing-Solution-for-Diagnosis-of-Rare-and-Neurodegenerative-Diseases.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 19:00</td>
    <td>ニューロナセント社、取締役会の増員を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/12/2645129/0/en/Neuronascent-Announces-the-Expansion-of-its-Board-of-Directors.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/12/2645129/0/en/Neuronascent-Announces-the-Expansion-of-its-Board-of-Directors.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/12 18:11</td>
    <td>FDAがMS治療薬evobrutinibの治験で新規患者を一時停止したことを受けてMerck KGaAの株価が下落</td>
    <td><a href=https://finance.yahoo.com/quote/MKGAF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MKGAF</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 17:58</td>
    <td>アスペクト・バイオシステムズとノボ ノルディスクが糖尿病と肥満のためのバイオプリント組織治療薬の開発でパートナーシップを締結</td>
    <td><a href=https://finance.yahoo.com/quote/NVO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NVO</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/12 17:33</td>
    <td>アステラス製薬とCiRA、iPS細胞の医療利用に関する研究を推進</td>
    <td><a href=https://finance.yahoo.com/quote/ALPMF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ALPMF</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/12 15:57</td>
    <td>InflaRx社、$40Mの募集価格を決定</td>
    <td><a href=https://finance.yahoo.com/quote/IFRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IFRX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 14:30</td>
    <td>オンワード、科学・投資家向けイベントへの出展を決定</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/12/2645042/0/en/ONWARD-to-Attend-Upcoming-Scientific-and-Investor-Events.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/12/2645042/0/en/ONWARD-to-Attend-Upcoming-Scientific-and-Investor-Events.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 14:30</td>
    <td>オンワードは、今後開催される科学・投資家向けカンファレンスに参加します。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/12/2645042/0/de/ONWARD-nimmt-an-bevorstehenden-Wissenschafts-und-Investorenkonferenzen-teil.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/12/2645042/0/de/ONWARD-nimmt-an-bevorstehenden-Wissenschafts-und-Investorenkonferenzen-teil.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 14:30</td>
    <td>オンワードは、今後開催される学術イベントや投資家向けイベントに参加します。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/12/2645042/0/fr/ONWARD-participera-aux-%C3%A9v%C3%A9nements-scientifiques-et-d-investisseurs-%C3%A0-venir.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/12/2645042/0/fr/ONWARD-participera-aux-%C3%A9v%C3%A9nements-scientifiques-et-d-investisseurs-%C3%A0-venir.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 14:30</td>
    <td>オンワードは、今後開催される科学技術イベントや投資家向けイベントに参加します。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/12/2645042/0/nl/ONWARD-neemt-deel-aan-komende-wetenschappelijke-en-beleggersevents.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/12/2645042/0/nl/ONWARD-neemt-deel-aan-komende-wetenschappelijke-en-beleggersevents.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 12:47</td>
    <td>Junshiバイオサイエンス社、セナパリブの進行性卵巣がんに対する一次治療後の維持療法を対象とした第3相臨床試験が主要評価項目を達成したことを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/12/2645033/0/en/Junshi-Biosciences-Announces-Phase-3-Clinical-Study-of-Senaparib-for-Advanced-Ovarian-Cancer-Maintenance-Treatment-Following-First-line-Therapy-Met-Primary-Endpoint.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/12/2645033/0/en/Junshi-Biosciences-Announces-Phase-3-Clinical-Study-of-Senaparib-for-Advanced-Ovarian-Cancer-Maintenance-Treatment-Following-First-line-Therapy-Met-Primary-Endpoint.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 12:34</td>
    <td>手術可能なNSCLC患者の周術期治療薬としてのトリパリマブの追加新薬承認申請の受理について（Junshi Biosciences</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/12/2645031/0/en/Junshi-Biosciences-Announces-Acceptance-of-the-Supplemental-New-Drug-Application-for-Toripalimab-as-Perioperative-Treatment-for-Operable-NSCLC-Patients.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/12/2645031/0/en/Junshi-Biosciences-Announces-Acceptance-of-the-Supplemental-New-Drug-Application-for-Toripalimab-as-Perioperative-Treatment-for-Operable-NSCLC-Patients.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 11:00</td>
    <td>Araris Biotech AG、Samsung Venturesとの戦略的出資を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/12/2645027/0/en/Araris-Biotech-AG-Announces-Strategic-Investment-with-Samsung-Ventures.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/12/2645027/0/en/Araris-Biotech-AG-Announces-Strategic-Investment-with-Samsung-Ventures.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 10:08</td>
    <td>InflaRx社、4,000万ドルの普通株式公募の価格決定を発表</td>
    <td><a href=https://finance.yahoo.com/quote/IFRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IFRX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 09:00</td>
    <td>HUTCHMED、米国がん研究学会年次総会2023での発表内容を紹介</td>
    <td><a href=https://finance.yahoo.com/quote/HCM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HCM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 07:50</td>
    <td>Aligos Therapeutics、欧州肝臓学会（EASL）2023年大会でB型慢性肝炎および肝細胞癌のプログラムデータを発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/ALGS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ALGS</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/11 07:27</td>
    <td>AGRX、1対50の株式併合を発表</td>
    <td><a href=https://finance.yahoo.com/quote/AGRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AGRX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 07:20</td>
    <td>オキュジェン、2023年4月14日にバーチャル投資家・アナリスト向けイベントを開催へ</td>
    <td><a href=https://finance.yahoo.com/quote/OCGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OCGN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/11 19:03</td>
    <td>Twitter is Dead フロリダ州南部地区で提出された書類によると、Twitter IncはX Corpと合併し、現在Twitterは存在しないとのことです。  X Corpの親会社はX Holding Corpsです。 Twitterの新局面はX Corp.となる。 これは、すべてのアプリの始まりなのでしょうか？</td>
    <td><a href=https://t.co/vposdXKbGV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://t.co/vposdXKbGV</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 05:30</td>
    <td>Cellectis社、自社製品候補「UCART22」の欧州における最初の患者さんへの投与を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/11/2644953/0/fr/Cellectis-annonce-le-dosage-de-son-premier-patient-en-Europe-avec-le-produit-candidat-UCART22-fabriqu%C3%A9-en-interne.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/11/2644953/0/fr/Cellectis-annonce-le-dosage-de-son-premier-patient-en-Europe-avec-le-produit-candidat-UCART22-fabriqu%C3%A9-en-interne.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/12 06:29</td>
    <td>Horizon Acquisition rises 12% on terminating merger agreement with Flexjet
</td>
    <td><a href=https://finance.yahoo.com/quote/HZON target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HZON</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/11 21:01</td>
    <td>KDNY 健康なボランティアを対象とした進行中の第1相臨床試験におけるCHK-336の投与は、重大な有害事象（SAE）の徹底的な調査を行うために自主的に一時停止されました。</td>
    <td><a href=https://finance.yahoo.com/quote/KDNY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/KDNY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 05:30</td>
    <td>セレクティス社、自社製造候補品「UCART22」の欧州における最初の患者さんへの投与開始を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/11/2644955/0/en/Cellectis-Announces-Dosing-of-the-First-Patient-in-Europe-with-its-In-house-Manufactured-Product-Candidate-UCART22.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/11/2644955/0/en/Cellectis-Announces-Dosing-of-the-First-Patient-in-Europe-with-its-In-house-Manufactured-Product-Candidate-UCART22.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 05:29</td>
    <td>Elucida Oncology、2023年AACR年次総会で新たな臨床データおよび前臨床データを発表へ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/11/2644957/0/en/Elucida-Oncology-to-Present-New-Clinical-and-Preclinical-Data-at-the-2023-AACR-Annual-Meeting.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/11/2644957/0/en/Elucida-Oncology-to-Present-New-Clinical-and-Preclinical-Data-at-the-2023-AACR-Annual-Meeting.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/11 21:03</td>
    <td>MAIA社、NSCLCを対象としたTHIO-101フェーズ2試験のパートA安全性リードインから良好なトップラインデータを発表</td>
    <td><a href=https://finance.yahoo.com/quote/MAIA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MAIA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/12 06:19</td>
    <td>Nutex Health、1億ドルの前払い契約締結を発表</td>
    <td><a href=https://finance.yahoo.com/quote/NUTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NUTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 05:28</td>
    <td>PLx Pharma Inc. ナスダック上場廃止の通知を受ける</td>
    <td><a href=https://finance.yahoo.com/quote/PLXP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PLXP</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/11 21:05</td>
    <td>ADAP AdaptimmuneとGSKは、PRAMEおよびNY-ESOターゲットプログラムをAdaptimmuneに戻すための譲渡条件を合意した -Adaptimmuneは、進行中のNY-ESO臨床試験の移行に関連して、30百万ポンドを受け取る -。</td>
    <td><a href=https://finance.yahoo.com/quote/ADAP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ADAP</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/12 05:52</td>
    <td>PLx Pharma、4月13日にナスダックから上場廃止へ</td>
    <td><a href=https://finance.yahoo.com/quote/PLXP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PLXP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 05:15</td>
    <td>株式資本を構成する議決権および株式の総数に関する月次情報</td>
    <td><a href=https://finance.yahoo.com/quote/NBTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NBTX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/11 21:13</td>
    <td>2030年までにがんや心臓病などの新しいワクチンの提供を目指すと語る$MRNA</td>
    <td><a href=https://finance.yahoo.com/quote/MRNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRNA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/12 05:25</td>
    <td>ユニティ・バイオテックの最高医療責任者ジェイミー・ダナンバーグが会社を退社へ</td>
    <td><a href=https://finance.yahoo.com/quote/UBX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/UBX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/12 05:15</td>
    <td>議決権および株式数 当社の資本金</td>
    <td><a href=https://finance.yahoo.com/quote/NBTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NBTX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/12 10:25</td>
    <td>IFRX社 941万株 価格4.25ドル/株</td>
    <td><a href=https://finance.yahoo.com/quote/IFRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IFRX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/12 05:23</td>
    <td>InflaRx社、普通株式の公募を開始</td>
    <td><a href=https://finance.yahoo.com/quote/IFRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IFRX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/11 22:43</td>
    <td>カリディタス、米国でIgA腎症患者に対するNefeconと最善の支持療法との費用対効果分析結果を発表</td>
    <td><a href=https://finance.yahoo.com/quote/CALT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CALT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/11 22:07</td>
    <td>ZyVersa TherapeuticsのCEO、Stephen C. グラバー、プラネット・マイクロキャップ・ショーケースでプレゼンテーションを実施</td>
    <td><a href=https://finance.yahoo.com/quote/ZVSA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ZVSA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/11 22:00</td>
    <td>ヴィームドヘルスケア、ブルーム・バートン・アンド・カンパニーでプレゼンテーションを行う。ヘルスケアカンファレンス</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/11/2644449/0/en/Viemed-Healthcare-to-Present-at-Bloom-Burton-Co-Healthcare-Conference.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/11/2644449/0/en/Viemed-Healthcare-to-Present-at-Bloom-Burton-Co-Healthcare-Conference.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/11 22:00</td>
    <td>ベリテバイオ、スターガルト病の後期開発段階にあるRBP4拮抗薬Tinlarebantに関するキーオピニオンリーダーのウェビナーを開催1</td>
    <td><a href=https://finance.yahoo.com/quote/BLTE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BLTE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/11 22:00</td>
    <td>2022年、キエーシに： 国際的な成長を続けるグループ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/11/2644473/0/en/2022-for-Chiesi-The-Group-s-international-growth-continues.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/11/2644473/0/en/2022-for-Chiesi-The-Group-s-international-growth-continues.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/11 22:00</td>
    <td>プリビアヘルス、5月4日（木）に2023年第1四半期決算を発表へ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/11/2644479/0/en/Privia-Health-to-Report-First-Quarter-2023-Results-on-Thursday-May-4.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/11/2644479/0/en/Privia-Health-to-Report-First-Quarter-2023-Results-on-Thursday-May-4.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/11 22:00</td>
    <td>トラウマ研究家のリポフ博士と作家のジェイミー・マスタードが、革命的なPTSD治療を紹介する新刊を発売</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/11/2644480/0/en/Eminent-Trauma-Researcher-Dr-Lipov-and-Author-Jamie-Mustard-Release-New-Book-to-Introduce-Revolutionary-PTSD-Treatment-to-the-Masses.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/11/2644480/0/en/Eminent-Trauma-Researcher-Dr-Lipov-and-Author-Jamie-Mustard-Release-New-Book-to-Introduce-Revolutionary-PTSD-Treatment-to-the-Masses.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/11 22:02</td>
    <td>IN8bioは、細胞治療のデータ読み出しを控えていることから、利益を得る。</td>
    <td><a href=https://finance.yahoo.com/quote/INAB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/INAB</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/11 21:58</td>
    <td>アイアンウッド・ファーマシューティカルズ、COOの役割を廃止</td>
    <td><a href=https://finance.yahoo.com/quote/IRWD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IRWD</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/11 22:00</td>
    <td>AXIM® Biotechnologies、FDA認可の眼科診断用アッセイの商業生産を開始</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/11/2644482/0/en/AXIM-Biotechnologies-Commences-Commercial-Manufacturing-of-FDA-Cleared-Proprietary-Ocular-Diagnostic-Assays.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/11/2644482/0/en/AXIM-Biotechnologies-Commences-Commercial-Manufacturing-of-FDA-Cleared-Proprietary-Ocular-Diagnostic-Assays.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/11 21:56</td>
    <td>米司法省、テキサス州判事の中絶薬判決の阻止を控訴審に要請</td>
    <td><a href=https://finance.yahoo.com/quote/BIIB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BIIB</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/11 21:32</td>
    <td>Chinook、初期段階の試験で有害事象が発生し、下落。</td>
    <td><a href=https://finance.yahoo.com/quote/KDNY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/KDNY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/11 21:30</td>
    <td>サビザブリンがポックスウイルスを抑制することを実証する前臨床試験の結果を発表しました。</td>
    <td><a href=https://finance.yahoo.com/quote/VERU target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VERU</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/11 21:30</td>
    <td>アポロミクスの共同創業者であるSanjeev Redkar博士が第23回R. Bryan Miller Symposiumで講演</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/11/2644395/0/en/Apollomics-Co-Founder-and-President-Sanjeev-Redkar-Ph-D-to-Speak-at-23rd-Annual-R-Bryan-Miller-Symposium.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/11/2644395/0/en/Apollomics-Co-Founder-and-President-Sanjeev-Redkar-Ph-D-to-Speak-at-23rd-Annual-R-Bryan-Miller-Symposium.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/11 21:30</td>
    <td>プレリュード・セラピューティクス、米国がん研究学会2023年大会で発表へ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/11/2644399/0/en/Prelude-Therapeutics-to-Present-at-American-Association-for-Cancer-Research-2023-Conference.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/11/2644399/0/en/Prelude-Therapeutics-to-Present-at-American-Association-for-Cancer-Research-2023-Conference.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/11 21:20</td>
    <td>Shockwave Medical、Neovasc社の買収を完了</td>
    <td><a href=https://finance.yahoo.com/quote/NVCN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NVCN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/11 21:15</td>
    <td>Panbela社、家族性腺腫性ポリポーシス（FAP）患者を対象としたFlynpoviTMの全世界における開発・販売権を獲得</td>
    <td><a href=https://finance.yahoo.com/quote/PBLA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PBLA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/11 21:00</td>
    <td>エレクトロコア、帝人から日本における独占的権利の年間ライセンス料を送金されることを発表</td>
    <td><a href=https://finance.yahoo.com/quote/ECOR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ECOR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/11 21:00</td>
    <td>クリーンテックBlue-Zone Technologies、Respirair Globalと契約を締結</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/11/2644300/0/en/Cleantech-Blue-Zone-Technologies-Signs-Agreement-With-Respirair-Global.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/11/2644300/0/en/Cleantech-Blue-Zone-Technologies-Signs-Agreement-With-Respirair-Global.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/11 21:00</td>
    <td>Eterna Therapeutics社とLincoln Park Capital社が1,000万ドルを上限とする普通株式購入契約を締結</td>
    <td><a href=https://finance.yahoo.com/quote/ERNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ERNA</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/10 20:33</td>
    <td>MRK社とエーザイ、切除不能または転移性黒色腫の成人患者に対する一次治療としてKEYTRUDAとLENVIMAを評価する第3相LEAP-003試験の中止を決定。ESALY社</td>
    <td><a href=https://finance.yahoo.com/quote/MRK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRK</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/10 21:01</td>
    <td>甲状腺眼症（TED）患者を対象としたTEPEZZA第4相臨床試験で良好なトップラインデータを発表</td>
    <td><a href=https://finance.yahoo.com/quote/HZNP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HZNP</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/10 21:08</td>
    <td>SCHWの新規資産530億ドルという声明には、ひとつ注意が必要です。 新たに見つかった現金が現金のままでない限り、これはシュワブにとって良いことではない。おそらく起こっているのは、現金が銀行を離れ、MMファンドや国債に投資されるために$SCHWに行くということでしょう。 これでは、$SCHWが資金難から脱することはできません。</td>
    <td><a href=https://finance.yahoo.com/quote/SCHW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SCHW</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/11 19:03</td>
    <td>Twitter is Dead フロリダ州南部地区で提出された書類によると、Twitter IncはX Corpと合併し、現在Twitterは存在しないとのことです。  X Corpの親会社はX Holding Corpsです。 Twitterの新局面はX Corp.となる。 これは、すべてのアプリの始まりなのでしょうか？</td>
    <td><a href=https://t.co/vposdXKbGV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://t.co/vposdXKbGV</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/11 21:01</td>
    <td>KDNY 健康なボランティアを対象とした進行中の第1相臨床試験におけるCHK-336の投与は、重大な有害事象（SAE）の徹底的な調査を行うために自主的に一時停止されました。</td>
    <td><a href=https://finance.yahoo.com/quote/KDNY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/KDNY</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/11 21:03</td>
    <td>MAIA社、NSCLCを対象としたTHIO-101フェーズ2試験のパートA安全性リードインから良好なトップラインデータを発表</td>
    <td><a href=https://finance.yahoo.com/quote/MAIA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MAIA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/11 21:00</td>
    <td>バイデン氏、COVID国家非常事態を終わらせる法案に署名</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/11 21:05</td>
    <td>ADAP AdaptimmuneとGSKは、PRAMEおよびNY-ESOターゲットプログラムをAdaptimmuneに戻すための譲渡条件を合意した -Adaptimmuneは、進行中のNY-ESO臨床試験の移行に関連して、30百万ポンドを受け取る -。</td>
    <td><a href=https://finance.yahoo.com/quote/ADAP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ADAP</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/11 21:13</td>
    <td>2030年までにがんや心臓病などに対する新しいワクチンの提供を目指すという$MRNA</td>
    <td><a href=https://finance.yahoo.com/quote/MRNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRNA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/11 20:56</td>
    <td>インフルエンザ予防接種が早期成功の基準を満たせず、試験継続となりModernaの株価は下落</td>
    <td><a href=https://finance.yahoo.com/quote/MRNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRNA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/11 20:17</td>
    <td>RedHill Biopharma jumps 4% on regaining compliance with Nasdaq
</td>
    <td><a href=https://finance.yahoo.com/quote/RDHL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RDHL</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/11 20:10</td>
    <td>Quince Therapeutics、Echo Lake Capitalからの未承諾プロポーザルを拒否。</td>
    <td><a href=https://finance.yahoo.com/quote/QNCX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/QNCX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/08 07:50</td>
    <td>Molecular Templates、MT-0169の第1相試験の一部臨床保留を発表</td>
    <td><a href=https://finance.yahoo.com/quote/MTEM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MTEM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/08 05:30</td>
    <td>MDxHealth Shareholder Transparency Declaration
</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/07/2643295/0/en/MDxHealth-Shareholder-Transparency-Declaration.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/07/2643295/0/en/MDxHealth-Shareholder-Transparency-Declaration.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/08 05:30</td>
    <td>MDxHealth社株主透明性ステートメント</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/07/2643295/0/fr/D%C3%A9claration-de-Transparence-d-un-Actionnaire-de-MDxHealth.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/07/2643295/0/fr/D%C3%A9claration-de-Transparence-d-un-Actionnaire-de-MDxHealth.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/08 09:01</td>
    <td>中絶薬ミフェプリストンの合法性は最高裁に向かう可能性が高い</td>
    <td><a href=https://finance.yahoo.com/quote/CVS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CVS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/08 05:00</td>
    <td>Arcutis Biotherapeutics、ナスダック上場規則5635(c)(4)に基づく誘引付与の報告について</td>
    <td><a href=https://finance.yahoo.com/quote/ARQT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ARQT</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/07 21:53</td>
    <td>メルクとエーザイ、主要目標未達でキイトルーダ併用試験2件を終了</td>
    <td><a href=https://finance.yahoo.com/quote/MRK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/08 02:00</td>
    <td>ATLAS社からの転換通知による議決権総数（分母）についての情報です。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/07/2643271/0/en/Information-on-the-Total-Number-of-Voting-Rights-Denominator-following-Conversion-Notice-from-ATLAS.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/07/2643271/0/en/Information-on-the-Total-Number-of-Voting-Rights-Denominator-following-Conversion-Notice-from-ATLAS.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/07 21:24</td>
    <td>オンコサイト社、転移性大腸がんを対象としたAtezoTRIBE試験のDetermaIO試験結果を発表</td>
    <td><a href=https://finance.yahoo.com/quote/OCX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OCX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/07 06:34</td>
    <td>DBV Technologies、2億5000万ドルのミックスシェルフオファリングを申請</td>
    <td><a href=https://finance.yahoo.com/quote/DBVT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DBVT</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/07 06:02</td>
    <td>アボット社、数百万台のグルコースモニター「FreeStyle Libre」をリコール（最新情報）</td>
    <td><a href=https://finance.yahoo.com/quote/ABT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ABT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/07 21:15</td>
    <td>Makena®のFDAによる承認取り下げに関するCovis社の声明文</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/07/2643181/0/en/Covis-Statement-on-FDA-Decision-to-Withdraw-Approval-of-Makena.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/07/2643181/0/en/Covis-Statement-on-FDA-Decision-to-Withdraw-Approval-of-Makena.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/08 02:19</td>
    <td>PEAR Pear Therapeuticsが破産を申し立てた件</td>
    <td><a href=https://finance.yahoo.com/quote/PEAR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PEAR</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/08 09:01</td>
    <td>中絶薬ミフェプリストンの合法性は最高裁に向かう可能性が高い</td>
    <td><a href=https://finance.yahoo.com/quote/CVS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CVS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/08 09:01</td>
    <td>連邦判事、中絶薬「ミフェプリストン」のFDA認可を一時停止</td>
    <td><a href=https://finance.yahoo.com/quote/CVS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CVS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/08 07:50</td>
    <td>Molecular Templates、MT-0169の第1相試験の一部臨床保留を発表</td>
    <td><a href=https://finance.yahoo.com/quote/MTEM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MTEM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/08 05:30</td>
    <td>MDxHealth Shareholder Transparency Declaration
</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/07/2643295/0/en/MDxHealth-Shareholder-Transparency-Declaration.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/07/2643295/0/en/MDxHealth-Shareholder-Transparency-Declaration.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/08 05:30</td>
    <td>MDxHealth社株主透明性ステートメント</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/07/2643295/0/fr/D%C3%A9claration-de-Transparence-d-un-Actionnaire-de-MDxHealth.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/07/2643295/0/fr/D%C3%A9claration-de-Transparence-d-un-Actionnaire-de-MDxHealth.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/07 21:53</td>
    <td>メルクとエーザイ、主要目標未達でキイトルーダ併用試験2件を終了</td>
    <td><a href=https://finance.yahoo.com/quote/MRK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/08 05:00</td>
    <td>Arcutis Biotherapeutics、ナスダック上場規則5635(c)(4)に基づく誘引付与の報告について</td>
    <td><a href=https://finance.yahoo.com/quote/ARQT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ARQT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/08 02:00</td>
    <td>ATLAS社からの転換通知による議決権総数（分母）についての情報です。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/07/2643271/0/en/Information-on-the-Total-Number-of-Voting-Rights-Denominator-following-Conversion-Notice-from-ATLAS.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/07/2643271/0/en/Information-on-the-Total-Number-of-Voting-Rights-Denominator-following-Conversion-Notice-from-ATLAS.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/07 06:34</td>
    <td>DBV Technologies、2億5000万ドルのミックスシェルフオファリングを申請</td>
    <td><a href=https://finance.yahoo.com/quote/DBVT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DBVT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/07 21:24</td>
    <td>オンコサイト社、転移性大腸がんを対象としたAtezoTRIBE試験のDetermaIO試験結果を発表</td>
    <td><a href=https://finance.yahoo.com/quote/OCX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OCX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/07 06:02</td>
    <td>アボット社、数百万台のグルコースモニター「FreeStyle Libre」をリコール（最新情報）</td>
    <td><a href=https://finance.yahoo.com/quote/ABT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ABT</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/08 02:19</td>
    <td>PEAR Pear Therapeuticsが破産を申し立てた件</td>
    <td><a href=https://finance.yahoo.com/quote/PEAR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PEAR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/07 21:15</td>
    <td>Makena®のFDAによる承認取り下げに関するCovis社の声明文</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/07/2643181/0/en/Covis-Statement-on-FDA-Decision-to-Withdraw-Approval-of-Makena.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/07/2643181/0/en/Covis-Statement-on-FDA-Decision-to-Withdraw-Approval-of-Makena.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/07 05:31</td>
    <td>なぜ今日、イチョウバイオワークスの株価が急上昇したのか？センシブルバイオとのタイアップ</td>
    <td><a href=https://finance.yahoo.com/quote/DNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DNA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/07 21:53</td>
    <td>メルクとエーザイ、主要目標未達でキイトルーダ併用試験2件を終了</td>
    <td><a href=https://finance.yahoo.com/quote/MRK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/07 21:24</td>
    <td>オンコサイト社、転移性大腸がんを対象としたAtezoTRIBE試験のDetermaIO試験結果を発表</td>
    <td><a href=https://finance.yahoo.com/quote/OCX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OCX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/07 21:15</td>
    <td>Makena®のFDAによる承認取り下げに関するCovis社の声明文</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/07/2643181/0/en/Covis-Statement-on-FDA-Decision-to-Withdraw-Approval-of-Makena.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/07/2643181/0/en/Covis-Statement-on-FDA-Decision-to-Withdraw-Approval-of-Makena.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/07 15:00</td>
    <td>ファグロン、年次株主総会の議案を公表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/07/2643080/0/en/Fagron-publishes-agenda-for-annual-shareholders-meeting.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/07/2643080/0/en/Fagron-publishes-agenda-for-annual-shareholders-meeting.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/07 15:00</td>
    <td>ファグロン、年次株主総会の議案を公表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/07/2643080/0/nl/Fagron-publiceert-agenda-jaarlijkse-aandeelhoudersvergadering.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/07/2643080/0/nl/Fagron-publiceert-agenda-jaarlijkse-aandeelhoudersvergadering.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/07 06:30</td>
    <td>SmileDirectClub、2023年5月9日に2023年第1四半期決算を発表へ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2643034/0/en/SmileDirectClub-to-Report-First-Quarter-2023-Results-on-May-9-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2643034/0/en/SmileDirectClub-to-Report-First-Quarter-2023-Results-on-May-9-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/07 06:16</td>
    <td>Jushi Holdings Inc. 2,000万ドルの非希薄化デットファイナンスの完了を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2643030/0/en/Jushi-Holdings-Inc-Announces-Closing-of-20-Million-Non-Dilutive-Debt-Financing.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2643030/0/en/Jushi-Holdings-Inc-Announces-Closing-of-20-Million-Non-Dilutive-Debt-Financing.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/07 05:33</td>
    <td>管理職及びその近親者によるGenmab A / Sの株式及び関連する証券の取引について</td>
    <td><a href=https://finance.yahoo.com/quote/GMAB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GMAB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/07 05:16</td>
    <td>Wi-Fi機能で強化されたニューロスター®アドバンストセラピー</td>
    <td><a href=https://finance.yahoo.com/quote/STIM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/STIM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/07 05:15</td>
    <td>Clearmind Medicine社、350万米ドルの公募を完了</td>
    <td><a href=https://finance.yahoo.com/quote/CMND target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CMND</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/07 05:15</td>
    <td>AnaptysBio社、Rita Jain氏の取締役就任を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ANAB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ANAB</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/07 06:34</td>
    <td>DBV Technologies、2億5000万ドルのミックスシェルフオファリングを申請</td>
    <td><a href=https://finance.yahoo.com/quote/DBVT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DBVT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/07 05:15</td>
    <td>トニックス・ファーマシューティカルズ、ワールド・ワクチン・コングレスでワクチン開発プログラムからのデータを発表</td>
    <td><a href=https://finance.yahoo.com/quote/TNXP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TNXP</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/07 06:02</td>
    <td>アボット社、数百万台のグルコースモニター「FreeStyle Libre」をリコール</td>
    <td><a href=https://finance.yahoo.com/quote/ABT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ABT</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/06 20:01</td>
    <td>エンタ社、呼吸器症候群治療薬として開発中の経口L蛋白質阻害剤「EDP-323」がFDAのファストトラック指定を受ける</td>
    <td><a href=https://finance.yahoo.com/quote/ENTA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ENTA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/07 05:05</td>
    <td>ソシアルCDMO、新入社員への導入補助金を報告</td>
    <td><a href=https://finance.yahoo.com/quote/SCTL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SCTL</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/07 05:31</td>
    <td>なぜ今日、イチョウバイオワークスの株価が急上昇したのか？センシブルバイオとのタイアップ</td>
    <td><a href=https://finance.yahoo.com/quote/DNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DNA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/07 05:05</td>
    <td>Mersana Therapeutics、ナスダック上場規則5635(c)(4)に基づく誘引助成を発表</td>
    <td><a href=https://finance.yahoo.com/quote/MRSN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRSN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/06 21:32</td>
    <td>Initial Jobless Claims 228K vs 200k Est. Continuing Jobless Claims 1.82M Vs 1.69M Expected
</td>
    <td><a href= target="_blank" rel="noopener noreferrer" style="display: inline-block;"></a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/07 05:31</td>
    <td>ライフコア・バイオメディカル、O社のオリーブオイルおよびビネガー事業の売却を完了</td>
    <td><a href=https://finance.yahoo.com/quote/LFCR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LFCR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 22:30</td>
    <td>Biostage社、臨床試験前進のための600万ドルの資金調達を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642687/0/en/Biostage-Announces-6-Million-Financing-to-Advance-Clinical-Trial.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642687/0/en/Biostage-Announces-6-Million-Financing-to-Advance-Clinical-Trial.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/06 22:08</td>
    <td>Tilray Medical、欧州での展開に向けパートナーシップを締結</td>
    <td><a href=https://finance.yahoo.com/quote/TLRY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TLRY</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/06 22:07</td>
    <td>ジャガーは、潜在的な違法空売りを検出するためにさらなる精査を計画しています。</td>
    <td><a href=https://finance.yahoo.com/quote/JAGX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/JAGX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 22:25</td>
    <td>Merit Medical Systems社、2023年第1四半期決算を4月26日に発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/MMSI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MMSI</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/06 21:45</td>
    <td>サーモフィッシャー、フランス拠点に早期開発機能を追加</td>
    <td><a href=https://finance.yahoo.com/quote/TMO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TMO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 22:20</td>
    <td>LumiraDx社、戦略的再集中とコスト構造改革プログラムについて発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642670/0/en/LumiraDx-Announces-Strategic-Refocus-and-Cost-Restructuring-Program.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642670/0/en/LumiraDx-Announces-Strategic-Refocus-and-Cost-Restructuring-Program.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/06 21:43</td>
    <td>ビオナノ、遺伝性眼疾患解析におけるOGMの可能性に注目</td>
    <td><a href=https://finance.yahoo.com/quote/BNGO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BNGO</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/06 21:22</td>
    <td>超音波生検装置「EDAP ExactVu」、日本での承認を取得</td>
    <td><a href=https://finance.yahoo.com/quote/EDAP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EDAP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 22:00</td>
    <td>Praxis Precision Medicines、第22回Needham Virtual Healthcare Conferenceでプレゼンテーションを実施</td>
    <td><a href=https://finance.yahoo.com/quote/PRAX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PRAX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 22:00</td>
    <td>ルーシーサイエンティフィックディスカバリー、自社株買いを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642630/0/en/Lucy-Scientific-Discovery-Announces-Share-Repurchase-Program.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642630/0/en/Lucy-Scientific-Discovery-Announces-Share-Repurchase-Program.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 22:00</td>
    <td>Palisade Bio社、開発中のリードプログラム「LB1148」の組成をカバーするカナダ特許を取得</td>
    <td><a href=https://finance.yahoo.com/quote/PALI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PALI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 22:00</td>
    <td>自転車健康調査により、遠隔治療でOUDの治療を受ける患者さんの実態が判明</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642634/0/en/Bicycle-Health-Survey-Provides-Insight-into-Patients-In-Treatment-for-OUD-via-Telemedicine.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642634/0/en/Bicycle-Health-Survey-Provides-Insight-into-Patients-In-Treatment-for-OUD-via-Telemedicine.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 21:45</td>
    <td>一つのコミュニティ、一つの質問： あなたの骨髄腫ストーリーは何ですか？</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642593/0/en/One-Community-One-Question-What-Is-Your-MYelomaSTORY.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642593/0/en/One-Community-One-Question-What-Is-Your-MYelomaSTORY.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 21:45</td>
    <td>Tilray Medical、欧州での事業基盤を拡大し、チェコ共和国での販売も拡大</td>
    <td><a href=https://finance.yahoo.com/quote/TLRY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TLRY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 21:30</td>
    <td>エボーク・ファーマ、GIMOTI関連特許についてUSPTOから許可通知を受領</td>
    <td><a href=https://finance.yahoo.com/quote/EVOK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EVOK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 21:30</td>
    <td>Diaccurate社、新規PAM経路阻害剤「DIACC3010」のER+ HER2-転移性乳がん患者に対する最新データをAACR 2023で発表予定と発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642549/0/en/Diaccurate-Announces-Updated-Data-on-its-Novel-PAM-Pathway-Inhibitor-DIACC3010-in-Patients-with-ER-HER2-Metastatic-Breast-Cancer-to-be-Presented-at-AACR-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642549/0/en/Diaccurate-Announces-Updated-Data-on-its-Novel-PAM-Pathway-Inhibitor-DIACC3010-in-Patients-with-ER-HER2-Metastatic-Breast-Cancer-to-be-Presented-at-AACR-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 21:30</td>
    <td>Diaccurate社、ER+ HER2-転移性乳がんを対象とした新規PAM経路阻害剤DIACC3010の最新データをAACR 2023で発表へ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642549/0/fr/Diaccurate-pr%C3%A9sentera-des-donn%C3%A9es-actualis%C3%A9es-de-son-nouvel-inhibiteur-de-la-voie-PAM-DIACC3010-dans-le-cancer-du-sein-m%C3%A9tastatique-ER-HER2-%C3%A0-l-AACR-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642549/0/fr/Diaccurate-pr%C3%A9sentera-des-donn%C3%A9es-actualis%C3%A9es-de-son-nouvel-inhibiteur-de-la-voie-PAM-DIACC3010-dans-le-cancer-du-sein-m%C3%A9tastatique-ER-HER2-%C3%A0-l-AACR-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 21:30</td>
    <td>CPP-1X（DFMO）の内分泌学会総会でのポスター発表演題の受諾について</td>
    <td><a href=https://finance.yahoo.com/quote/PBLA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PBLA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 21:30</td>
    <td>ContraFect、第33回ECCMID年次総会で複数の新データを発表</td>
    <td><a href=https://finance.yahoo.com/quote/CFRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CFRX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/06 21:08</td>
    <td>Pfizer posts 82% efficacy for maternal RSV vaccine in full data release
</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 21:30</td>
    <td>ABVC BioPharma、Vitargusの最新情報を提供 タイのRamathibodi病院で実施されたフェーズIIサイト開始のための訪問について</td>
    <td><a href=https://finance.yahoo.com/quote/ABVC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ABVC</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/06 20:47</td>
    <td>レイモンド・ジェームズによる20のトップ・ストック・ペア・トレーディング</td>
    <td><a href=https://finance.yahoo.com/quote/MMC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MMC</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/06 20:25</td>
    <td>Enanta RSV治療薬EDP-323がFDAトラックステータスを取得</td>
    <td><a href=https://finance.yahoo.com/quote/ENTA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ENTA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 21:01</td>
    <td>オーシャン・バイオメディカル社（NASDAQ: OCEA）は、肺線維症の発見をヘルマンスキー・プドラク症候群の新規治療薬として採用する。</td>
    <td><a href=https://finance.yahoo.com/quote/OCEA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OCEA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 21:00</td>
    <td>EDAP社、マイクロ超音波「ExactVu」の日本での薬事承認取得を発表</td>
    <td><a href=https://finance.yahoo.com/quote/EDAP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EDAP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 21:00</td>
    <td>アコヤ、2023年5月8日に2023年第1四半期決算を発表へ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642490/0/en/Akoya-to-Report-First-Quarter-2023-Financial-Results-on-May-8th-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642490/0/en/Akoya-to-Report-First-Quarter-2023-Financial-Results-on-May-8th-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 21:00</td>
    <td>エレクトロコア株式会社 インドネシア、マレーシア、南アフリカでの製品登録を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ECOR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ECOR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 21:00</td>
    <td>スペクトラルメディカル、投資家向け最新情報カンファレンスコールを実施</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642505/0/en/Spectral-Medical-Announces-Investor-Update-Conference-Call.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642505/0/en/Spectral-Medical-Announces-Investor-Update-Conference-Call.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 21:00</td>
    <td>レッチェ・ファーマシューティカルズ、973,144豪ドルの研究開発費前渡しを受ける</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642507/0/en/Recce-Pharmaceuticals-Receives-Further-A-973-144-Research-and-Development-R-D-Advance.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642507/0/en/Recce-Pharmaceuticals-Receives-Further-A-973-144-Research-and-Development-R-D-Advance.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 21:00</td>
    <td>4月16日～19日のAACR年次総会で、HTGの技術が多数の学術ポスターで紹介されました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642508/34580/en/HTG-Technology-Featured-in-Numerous-Scientific-Posters-at-the-AACR-Annual-Meeting-April-16-19.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642508/34580/en/HTG-Technology-Featured-in-Numerous-Scientific-Posters-at-the-AACR-Annual-Meeting-April-16-19.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 21:00</td>
    <td>エクステンドケア、2023年第1四半期決算とカンファレンスコールの開催時期を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642509/0/en/Extendicare-Announces-Timing-of-2023-First-Quarter-Results-and-Conference-Call.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642509/0/en/Extendicare-Announces-Timing-of-2023-First-Quarter-Results-and-Conference-Call.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 21:00</td>
    <td>バイオアダプティブス、World Wellness, LLCと非独占的マーケティング契約を締結し、AIを活用した体組成測定アプリを含む体重管理システムおよび新健康食品の発売を開始することを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642510/0/en/BioAdaptives-Announces-Signing-of-Non-Exclusive-Marketing-Agreement-With-World-Wellness-LLC-for-the-Launching-of-Weight-Management-System-Including-an-AI-Supported-Body-Composition.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642510/0/en/BioAdaptives-Announces-Signing-of-Non-Exclusive-Marketing-Agreement-With-World-Wellness-LLC-for-the-Launching-of-Weight-Management-System-Including-an-AI-Supported-Body-Composition.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 20:30</td>
    <td>スイートウォーター・ブリューイング・カンパニー、西海岸の流通をネバダ州にも拡大</td>
    <td><a href=https://finance.yahoo.com/quote/TLRY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TLRY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 20:00</td>
    <td>レボリューション・メディシンズ、来る2023年米国癌学会年次総会で前臨床データを発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/RVMD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RVMD</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 20:00</td>
    <td>Arbor Biotechnologies、2023 Cell & Gene Meeting on Medで講演を実施</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642398/0/en/Arbor-Biotechnologies-to-Present-at-2023-Cell-Gene-Meeting-on-the-Med.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642398/0/en/Arbor-Biotechnologies-to-Present-at-2023-Cell-Gene-Meeting-on-the-Med.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 20:00</td>
    <td>TransCode Therapeutics、AACR Annual Meeting 2023で講演を実施</td>
    <td><a href=https://finance.yahoo.com/quote/RNAZ target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RNAZ</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 20:00</td>
    <td>StateHouseが1周年を迎えました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642406/0/en/StateHouse-Celebrates-One-Year-Anniversary.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642406/0/en/StateHouse-Celebrates-One-Year-Anniversary.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 20:00</td>
    <td>プレシジョンハートケアを革新するリーダー企業HeartFlow社が、Bain Capital Life Sciences社主導で2億1500万ドルのシリーズF資金を調達しました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642409/0/en/HeartFlow-Leader-in-Revolutionizing-Precision-Heart-Care-Closes-215-Million-in-Series-F-Funding-Led-by-Bain-Capital-Life-Sciences.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642409/0/en/HeartFlow-Leader-in-Revolutionizing-Precision-Heart-Care-Closes-215-Million-in-Series-F-Funding-Led-by-Bain-Capital-Life-Sciences.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 20:00</td>
    <td>Sernova社、反体制派株主の誤解を招く発言への対応と会社情報の更新を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642417/0/en/Sernova-Responds-to-Dissident-Shareholders-Misleading-Statements-and-Provides-Corporate-Updates.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642417/0/en/Sernova-Responds-to-Dissident-Shareholders-Misleading-Statements-and-Provides-Corporate-Updates.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 19:30</td>
    <td>Clearday Inc.とViveon Health Acquisition Corp. 革新的な長寿技術プラットフォームの市場投入を加速するための正式な合併契約を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642372/0/en/Clearday-Inc-and-Viveon-Health-Acquisition-Corp-Announce-Definitive-Merger-Agreement-to-Accelerate-Innovative-Longevity-Tech-Platform-to-Market.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642372/0/en/Clearday-Inc-and-Viveon-Health-Acquisition-Corp-Announce-Definitive-Merger-Agreement-to-Accelerate-Innovative-Longevity-Tech-Platform-to-Market.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 19:00</td>
    <td>Immuron Q3 Sales reach 150% of 1H Sales
</td>
    <td><a href=https://finance.yahoo.com/quote/IMRN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IMRN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/06 18:40</td>
    <td>Everest社の腎臓病治療薬「Nefecon」がシンガポールで審査を受ける</td>
    <td><a href=https://finance.yahoo.com/quote/CLTEF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CLTEF</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/06 18:20</td>
    <td>キュリス、新入社員に135.45万株のストックオプションを付与へ</td>
    <td><a href=https://finance.yahoo.com/quote/CRIS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CRIS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/06 17:56</td>
    <td>GSK、英裁判所からZejulaの販売でAstraZenecaにロイヤリティの追加支払いを命じられる-報告書</td>
    <td><a href=https://finance.yahoo.com/quote/GSK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GSK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 16:15</td>
    <td>エベレストグループ、ライフサイエンス分野のセールス＆マーケティングオペレーションPEAK Matrix®アセスメント2023でIndegeneをリーダーとして認定</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642277/0/en/Everest-Group-recognizes-Indegene-as-a-Leader-in-its-Life-Sciences-Sales-and-Marketing-Operations-PEAK-Matrix-Assessment-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642277/0/en/Everest-Group-recognizes-Indegene-as-a-Leader-in-its-Life-Sciences-Sales-and-Marketing-Operations-PEAK-Matrix-Assessment-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 16:00</td>
    <td>アニュアルレポート2022を発行しました</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642272/0/sv/%C3%85rsredovisning-2022-%C3%A4r-nu-publicerad.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642272/0/sv/%C3%85rsredovisning-2022-%C3%A4r-nu-publicerad.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 15:00</td>
    <td>VALNEVA - 株式および議決権に関する宣言 - 2023年3月31日</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642250/0/en/VALNEVA-Declaration-of-shares-and-voting-rights-March-31-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642250/0/en/VALNEVA-Declaration-of-shares-and-voting-rights-March-31-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 15:00</td>
    <td>VALNEVA - 株式および議決権に関する宣言：2023年3月31日</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642250/0/fr/VALNEVA-D%C3%A9claration-d-actions-et-de-droits-de-vote-31-mars-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642250/0/fr/VALNEVA-D%C3%A9claration-d-actions-et-de-droits-de-vote-31-mars-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 15:00</td>
    <td>CROSSJECT - クロスジェクト</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642255/0/fr/CROSSJECT.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642255/0/fr/CROSSJECT.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 14:00</td>
    <td>イドルシア、2023年定時株主総会の案内状を発行</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642241/0/en/Idorsia-issues-invitation-to-the-2023-Annual-General-Meeting-of-Shareholders.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642241/0/en/Idorsia-issues-invitation-to-the-2023-Annual-General-Meeting-of-Shareholders.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 14:00</td>
    <td>イドルシア、2023年定時株主総会の案内状を公開</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/06/2642241/0/de/Idorsia-ver%C3%B6ffentlicht-Einladung-zur-ordentlichen-Generalversammlung-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/06/2642241/0/de/Idorsia-ver%C3%B6ffentlicht-Einladung-zur-ordentlichen-Generalversammlung-2023.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/06 10:03</td>
    <td>エクセリクシス、投資家ファラロン・キャピタルとの委任状争奪戦に直面（最新情報）</td>
    <td><a href=https://finance.yahoo.com/quote/EXEL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EXEL</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/06 08:46</td>
    <td>エクセリクシス、ファラロン・キャピタルの書簡に回答</td>
    <td><a href=https://finance.yahoo.com/quote/EXEL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EXEL</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 08:48</td>
    <td>2022年アニュアルレポートのハイライト</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2642221/0/en/2022-ANNUAL-REPORT-HIGHLIGHTS.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2642221/0/en/2022-ANNUAL-REPORT-HIGHLIGHTS.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 06:27</td>
    <td>Scilex Holding Company、年次株主総会の延期を発表</td>
    <td><a href=https://finance.yahoo.com/quote/SCLX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SCLX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 05:31</td>
    <td>UPDATE--Noxメディカル、睡眠研究中の呼吸努力の計算に関する新特許を取得</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2642182/0/en/UPDATE-Nox-Medical-Secures-New-Patent-for-Calculating-Respiratory-Effort-During-Sleep-Studies.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2642182/0/en/UPDATE-Nox-Medical-Secures-New-Patent-for-Calculating-Respiratory-Effort-During-Sleep-Studies.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 05:30</td>
    <td>デンツプライシロナ、5月3日に第1四半期カンファレンスコールを開催</td>
    <td><a href=https://finance.yahoo.com/quote/XRAY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/XRAY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 05:05</td>
    <td>ImmuCell社、2023年第1四半期の販売実績（速報値、未監査値）を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ICCC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ICCC</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 05:05</td>
    <td>Corcept Therapeutics、公開買付けの最終結果を発表</td>
    <td><a href=https://finance.yahoo.com/quote/CORT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CORT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 05:05</td>
    <td>RxSight, Inc.がNeedham Healthcare Conferenceでプレゼンテーションを行います。</td>
    <td><a href=https://finance.yahoo.com/quote/RXST target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RXST</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/06 07:15</td>
    <td>Aerovate Therapeutics、バンクオブアメリカとの75MドルATM募集を発表 - 出願中。</td>
    <td><a href=https://finance.yahoo.com/quote/AVTE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AVTE</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/05 20:25</td>
    <td>AUPH社、AURORA試験における腎生検サブスタディの有望なトップラインデータを発表</td>
    <td><a href=https://finance.yahoo.com/quote/AUPH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AUPH</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 05:03</td>
    <td>PROCEPT BioRobotics、2023年4月27日に2023年第1四半期決算を発表、ラスベガスのBank of America 2023 Health Care Conferenceでプレゼンテーションを行う。</td>
    <td><a href=https://finance.yahoo.com/quote/PRCT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PRCT</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/06 06:16</td>
    <td>なぜ今日、サイレックスの株価は急上昇したのか？配当金に関する裁判所命令</td>
    <td><a href=https://finance.yahoo.com/quote/SCLX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SCLX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 03:33</td>
    <td>ZSFab社、ACDF用ZSFab Cervical Interbody Systemの米国における初の臨床使用を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2642127/0/en/ZSFab-Announces-First-US-Clinical-Use-of-ZSFab-Cervical-Interbody-System-for-ACDF.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2642127/0/en/ZSFab-Announces-First-US-Clinical-Use-of-ZSFab-Cervical-Interbody-System-for-ACDF.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/05 20:46</td>
    <td>LMNL、現金7.50ドル/株の非要求型非拘束型取引提案の受領を確認</td>
    <td><a href=https://finance.yahoo.com/quote/LMNL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LMNL</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/06 06:04</td>
    <td>Quince Therapeutics、未承諾の買収提案を受けてポイズンピルを採択</td>
    <td><a href=https://finance.yahoo.com/quote/QNCX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/QNCX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 02:00</td>
    <td>180 Life Sciences Corp. 300万ドルの公募増資と私募増資を同時に発表</td>
    <td><a href=https://finance.yahoo.com/quote/ATNFW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ATNFW</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/05 20:58</td>
    <td>AEZS社製成人用「マクリレン」、5月23日をもって米国での販売を一時中止へ</td>
    <td><a href=https://finance.yahoo.com/quote/AEZS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AEZS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/06 06:00</td>
    <td>なぜ今日、ジョンソン・エンド・ジョンソンの株価は上がったのか？タルクの和解に新たな希望</td>
    <td><a href=https://finance.yahoo.com/quote/JNJ target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/JNJ</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/06 00:41</td>
    <td>Eurobio Scientific: 2022 ANNUAL RESULTS - 非常に好調な業績とコアビジネスの強化</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641992/0/fr/Eurobio-Scientific-RESULTATS-ANNUELS-2022-Tr%C3%A8s-solide-performance-et-renforcement-du-C%C5%93ur-d-Activit%C3%A9.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641992/0/fr/Eurobio-Scientific-RESULTATS-ANNUELS-2022-Tr%C3%A8s-solide-performance-et-renforcement-du-C%C5%93ur-d-Activit%C3%A9.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/05 21:39</td>
    <td>LIVMARLI」の進行性家族性肝内胆汁うっ滞症に対する欧州での承認申請について</td>
    <td><a href=https://finance.yahoo.com/quote/MIRM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MIRM</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/06 05:51</td>
    <td>AbbVie 2023年EPSガイダンスレンジはコンセンサスを下回る。</td>
    <td><a href=https://finance.yahoo.com/quote/ABBV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ABBV</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 22:00</td>
    <td>WellnessSpace Brands、ABCフィットネスソリューションにAPI統合を実施</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641727/0/en/WellnessSpace-Brands-Implements-API-Integration-to-ABC-Fitness-Solutions.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641727/0/en/WellnessSpace-Brands-Implements-API-Integration-to-ABC-Fitness-Solutions.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 22:00</td>
    <td>高麗人参はリビドーにどう関係するのか？</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641729/0/en/What-Does-Ginseng-Have-to-Do-With-Libido.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641729/0/en/What-Does-Ginseng-Have-to-Do-With-Libido.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 22:00</td>
    <td>天然成分で親密度を高めるブランド</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641732/0/en/The-Brand-Extending-Intimacy-With-Natural-Ingredients.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641732/0/en/The-Brand-Extending-Intimacy-With-Natural-Ingredients.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 22:00</td>
    <td>OXOS Medical、ヘルスケアバリューチェーン全体に「箱入り放射線科」を提供するため、2300万ドルのシリーズAを調達</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641743/0/en/OXOS-Medical-Raises-23M-Series-A-to-Deliver-Radiology-Department-in-a-Box-to-the-Entire-Healthcare-Value-Chain.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641743/0/en/OXOS-Medical-Raises-23M-Series-A-to-Deliver-Radiology-Department-in-a-Box-to-the-Entire-Healthcare-Value-Chain.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 21:48</td>
    <td>Aeterna falls 13% after halting U.S. sales of lead product
</td>
    <td><a href=https://finance.yahoo.com/quote/AEZS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AEZS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 22:00</td>
    <td>ジェナバルブ、ケン・マクラウド博士を取締役に任命</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641749/0/en/JenaValve-Appoints-Ken-MacLeod-Ph-D-to-Board-of-Directors.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641749/0/en/JenaValve-Appoints-Ken-MacLeod-Ph-D-to-Board-of-Directors.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 22:00</td>
    <td>セルラリティ・インク（Celularity Inc. 6百万ドルの登録型直接募集を発表</td>
    <td><a href=https://finance.yahoo.com/quote/CELUW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CELUW</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 21:47</td>
    <td>CymaBay、肝臓疾患候補でWilliam Blairのアウトパフォームに着手</td>
    <td><a href=https://finance.yahoo.com/quote/CBAY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CBAY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 22:00</td>
    <td>Y-mAbs社、GD2-SADAの臨床第1相試験で最初の患者を投与したことを発表</td>
    <td><a href=https://finance.yahoo.com/quote/YMAB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/YMAB</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 21:29</td>
    <td>CareDx社とMiromatrix社、移植用バイオエンジニアリング臓器の研究で提携</td>
    <td><a href=https://finance.yahoo.com/quote/CDNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CDNA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 21:09</td>
    <td>TransCode stock soars ~25% on NIH grant to develop cancer drug TTX-MC138
</td>
    <td><a href=https://finance.yahoo.com/quote/RNAZ target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RNAZ</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 21:35</td>
    <td>MHRA、ADvantage Therapeuticsの新規リード製品「AD04™」のアルツハイマー病を対象としたフェーズ2b試験のILAP（Innovative Licensing and Access Pathway）指定を決定</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641695/0/en/MHRA-Grants-ADvantage-Therapeutics-Innovative-Licensing-and-Access-Pathway-ILAP-Designation-for-Novel-Lead-Product-AD04-for-Phase-2b-Trial-in-Alzheimer-s-Disease.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641695/0/en/MHRA-Grants-ADvantage-Therapeutics-Innovative-Licensing-and-Access-Pathway-ILAP-Designation-for-Novel-Lead-Product-AD04-for-Phase-2b-Trial-in-Alzheimer-s-Disease.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 21:35</td>
    <td>Palisade Bio社、LB1148を評価するニューソアラ第3相臨床試験で最初の患者を登録したことを発表</td>
    <td><a href=https://finance.yahoo.com/quote/PALI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PALI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 21:30</td>
    <td>CytoDyn社、ウェブキャストを開催し、最新情報を提供します。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641690/19782/en/CytoDyn-to-Hold-Webcast-to-Provide-a-Company-Update.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641690/19782/en/CytoDyn-to-Hold-Webcast-to-Provide-a-Company-Update.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 21:30</td>
    <td>RespireRx Pharmaceuticals Inc. ユニバーシティ・カレッジ・ロンドンとGRIA疾患の治療におけるAMPAkineの使用に関する研究協力関係を構築</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641673/0/en/RespireRx-Pharmaceuticals-Inc-Establishes-Research-Collaboration-With-University-College-London-to-Study-the-Use-of-AMPAkines-for-the-Treatment-of-GRIA-Disorders.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641673/0/en/RespireRx-Pharmaceuticals-Inc-Establishes-Research-Collaboration-With-University-College-London-to-Study-the-Use-of-AMPAkines-for-the-Treatment-of-GRIA-Disorders.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 21:30</td>
    <td>Surrozen社、Eric Bjerkholt氏の就任により取締役会を強化</td>
    <td><a href=https://finance.yahoo.com/quote/SRZN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SRZN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 21:30</td>
    <td>22ndセンチュリー・グループ（XXII）、クッキー社との完全統合型シングルソース戦略的ライセンス、製造、販売契約を締結を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641689/0/en/22nd-Century-Group-XXII-Announces-Fully-Integrated-Single-Source-Strategic-License-Manufacturing-and-Distribution-Agreement-with-Cookies.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641689/0/en/22nd-Century-Group-XXII-Announces-Fully-Integrated-Single-Source-Strategic-License-Manufacturing-and-Distribution-Agreement-with-Cookies.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 21:00</td>
    <td>バイオベンタス社、CEOの交代を発表</td>
    <td><a href=https://finance.yahoo.com/quote/BVS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BVS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 21:00</td>
    <td>Immuneering社、米国癌学会年次総会2023でユニバーサルRASプログラムIMM-1-104の初期第1相薬物動態、薬力学モデリングおよび安全性データを発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/IMRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IMRX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 21:00</td>
    <td>サンシャイン・バイオファーマ、2022年12月期通期決算報告およびコーポレートアップデートを発表</td>
    <td><a href=https://finance.yahoo.com/quote/SBFM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SBFM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 21:00</td>
    <td>Arcutis Announces New Coverage for ZORYVE® (Roflumilast) Cream 0.3% with National and Regional Health Plan Formularies, Bringing Total Commercial Covered Lives to Over 110 Million
</td>
    <td><a href=https://finance.yahoo.com/quote/ARQT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ARQT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 21:00</td>
    <td>ProSomnus®、当社の新型精密睡眠時無呼吸症候群治療器の反復滴定技術に関する米国実用新案権を追加取得</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641624/0/en/ProSomnus-Receives-Additional-U-S-Utility-Patent-Covering-Iterative-Titration-Technology-for-Company-s-Novel-Precision-Sleep-Apnea-Medical-Devices.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641624/0/en/ProSomnus-Receives-Additional-U-S-Utility-Patent-Covering-Iterative-Titration-Technology-for-Company-s-Novel-Precision-Sleep-Apnea-Medical-Devices.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 21:00</td>
    <td>バイオアダプティブス社（OTC BDPT）、取締役に新任 - 国際的に著名な健康科学者、作家、特許保持者であるYaguang Liu博士を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641625/0/en/BioAdaptives-Inc-OTC-BDPT-Announces-New-Appointment-to-the-Board-of-Directors-Internationally-Acclaimed-Health-Scientist-Author-and-Patent-Holder-Dr-Yaguang-Liu.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641625/0/en/BioAdaptives-Inc-OTC-BDPT-Announces-New-Appointment-to-the-Board-of-Directors-Internationally-Acclaimed-Health-Scientist-Author-and-Patent-Holder-Dr-Yaguang-Liu.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 21:00</td>
    <td>Hazelden Betty Ford FoundationとTELUS Healthが薬物使用障害治療とメンタルヘルスサポートの拡大に向けて協業</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641631/0/en/The-Hazelden-Betty-Ford-Foundation-and-TELUS-Health-collaborate-to-expand-substance-use-disorder-treatment-and-mental-health-support.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641631/0/en/The-Hazelden-Betty-Ford-Foundation-and-TELUS-Health-collaborate-to-expand-substance-use-disorder-treatment-and-mental-health-support.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 21:00</td>
    <td>Hazelden Betty Ford FoundationとTELUS Healthが薬物使用障害治療とメンタルヘルスケアへのアクセス拡大で提携</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641631/0/fr/La-fondation-Hazelden-Betty-Ford-et-TELUS-Sant%C3%A9-s-associent-pour-%C3%A9largir-l-acc%C3%A8s-au-traitement-des-troubles-li%C3%A9s-%C3%A0-la-consommation-de-substances-et-aux-soins-en-sant%C3%A9-mentale.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641631/0/fr/La-fondation-Hazelden-Betty-Ford-et-TELUS-Sant%C3%A9-s-associent-pour-%C3%A9largir-l-acc%C3%A8s-au-traitement-des-troubles-li%C3%A9s-%C3%A0-la-consommation-de-substances-et-aux-soins-en-sant%C3%A9-mentale.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 20:52</td>
    <td>Immunic surges ~20% as IMU-838 shows promise in ulcerative colitis trial
</td>
    <td><a href=https://finance.yahoo.com/quote/IMUX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IMUX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 21:00</td>
    <td>フルクラムセラピューティクス、CFOの辞任を発表</td>
    <td><a href=https://finance.yahoo.com/quote/FULC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/FULC</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 20:34</td>
    <td>Ginkgo Bioworks社、StrideBio社から遺伝子治療資産を取得</td>
    <td><a href=https://finance.yahoo.com/quote/DNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DNA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 21:00</td>
    <td>AIセラピューティクス社、C9ORF72筋萎縮性側索硬化症（ALS）患者を対象としたAIT-101の第2a相バイオマーカー主導型臨床試験で良好な結果を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641635/0/en/AI-Therapeutics-Announces-Positive-Results-from-Phase-2a-Biomarker-driven-Trial-of-AIT-101-in-Patients-with-C9ORF72-Amyotrophic-Lateral-Sclerosis-ALS.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641635/0/en/AI-Therapeutics-Announces-Positive-Results-from-Phase-2a-Biomarker-driven-Trial-of-AIT-101-in-Patients-with-C9ORF72-Amyotrophic-Lateral-Sclerosis-ALS.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 20:07</td>
    <td>民主党の上院議員、メディケアでのCOVID検査の無償化を維持するよう米国に要請</td>
    <td><a href=https://finance.yahoo.com/quote/QDEL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/QDEL</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 20:07</td>
    <td>Aurinia社のLupkynis、18ヶ月間の腎生検データで有望視される</td>
    <td><a href=https://finance.yahoo.com/quote/AUPH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AUPH</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 20:30</td>
    <td>Syneos Healthが2023年ViE賞を受賞しました。</td>
    <td><a href=https://finance.yahoo.com/quote/SYNH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SYNH</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 20:30</td>
    <td>OpGen社の子会社であるCuretis社がFIND社との研究開発協力の拡大を締結</td>
    <td><a href=https://finance.yahoo.com/quote/OPGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OPGN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 20:30</td>
    <td>ザイネルバ・ファーマシューティカルズ、第55回ガトリンバーグ会議でのポスター発表のお知らせ</td>
    <td><a href=https://finance.yahoo.com/quote/ZYNE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ZYNE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 20:30</td>
    <td>ジェネレーション・バイオ社、Yalonda Howze, J.D.を最高法務責任者に任命</td>
    <td><a href=https://finance.yahoo.com/quote/GBIO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GBIO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 20:20</td>
    <td>Endogena Therapeutics社、EA-2353の網膜色素変性症治療に関する第1/2a相臨床試験で用量漸増を完了</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641564/0/en/Endogena-Therapeutics-Completes-Dose-Escalation-in-the-Phase-1-2a-Clinical-Trial-of-EA-2353-for-the-Treatment-of-Retinitis-Pigmentosa.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641564/0/en/Endogena-Therapeutics-Completes-Dose-Escalation-in-the-Phase-1-2a-Clinical-Trial-of-EA-2353-for-the-Treatment-of-Retinitis-Pigmentosa.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 20:05</td>
    <td>Kraig Biocraft Laboratories、米国国防総省のクモの糸の国産化に関する情報提供要請に対する回答書を作成中</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641550/0/en/Kraig-Biocraft-Laboratories-Preparing-Response-to-U-S-Department-of-Defense-Request-for-Information-on-Domestic-Biomanufacturing-of-Spider-Silk.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641550/0/en/Kraig-Biocraft-Laboratories-Preparing-Response-to-U-S-Department-of-Defense-Request-for-Information-on-Domestic-Biomanufacturing-of-Spider-Silk.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 20:05</td>
    <td>クリアサイドバイオメディカル、網膜の権威ある医師2名を迎え科学諮問委員会を強化</td>
    <td><a href=https://finance.yahoo.com/quote/CLSD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CLSD</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 20:00</td>
    <td>ロングボード・ファーマシューティカルズがLP352の臨床開発を支援するCDMOサービスを提供するため、ソシアルCDMOを選定しました。</td>
    <td><a href=https://finance.yahoo.com/quote/SCTL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SCTL</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 20:00</td>
    <td>SparingVision、Joseph C. Papaを会長に任命</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641518/0/en/SparingVision-appoints-Joseph-C-Papa-as-Chairman.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641518/0/en/SparingVision-appoints-Joseph-C-Papa-as-Chairman.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 20:00</td>
    <td>トニックス・ファーマシューティカルズ、米国がん研究協会年次総会2023でのポスター発表を発表</td>
    <td><a href=https://finance.yahoo.com/quote/TNXP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TNXP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 20:00</td>
    <td>プロキシジェン、MSDと新規分子接着剤分解剤の発見と開発に関する共同研究およびライセンス契約を締結と発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641521/0/en/Proxygen-Announces-Collaboration-and-License-Agreement-with-MSD-for-the-Discovery-and-Development-of-Novel-Molecular-Glue-Degraders.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641521/0/en/Proxygen-Announces-Collaboration-and-License-Agreement-with-MSD-for-the-Discovery-and-Development-of-Novel-Molecular-Glue-Degraders.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 20:00</td>
    <td>ACイミューン、アルツハイマー病の早期診断と予防に関するキーオピニオンリーダー向けウェブセミナーを開催</td>
    <td><a href=https://finance.yahoo.com/quote/ACIU target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ACIU</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 20:00</td>
    <td>オキュリス、今後開催される投資家向けコンファレンスに参加予定</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641523/0/en/Oculis-to-Participate-at-Upcoming-Investor-Conferences.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641523/0/en/Oculis-to-Participate-at-Upcoming-Investor-Conferences.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 20:00</td>
    <td>ウォルデン バイオサイエンシズ、CFAカート・デュワンを最高財務責任者に昇格</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641526/0/en/Walden-Biosciences-Promotes-Curt-Dewan-CFA-to-Chief-Financial-Officer.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641526/0/en/Walden-Biosciences-Promotes-Curt-Dewan-CFA-to-Chief-Financial-Officer.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 20:00</td>
    <td>TransCode Therapeutics、米国国立衛生研究所（NIH）からTTX-MC138の臨床評価を支援する3年目の助成金授与の通知を受ける</td>
    <td><a href=https://finance.yahoo.com/quote/RNAZ target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RNAZ</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 18:52</td>
    <td>サノフィとBARDA、ペンシルバニア州の新インフルエンザワクチン施設を起工</td>
    <td><a href=https://finance.yahoo.com/quote/SNY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SNY</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 18:11</td>
    <td>バイエル、ウクライナのトウモロコシ種子生産拠点に6,000万ユーロを投資</td>
    <td><a href=https://finance.yahoo.com/quote/BAYRY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BAYRY</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 17:52</td>
    <td>アストラゼネカ ImfinziとLynparzaのコンボが卵巣がん試験で無増悪生存期間を改善</td>
    <td><a href=https://finance.yahoo.com/quote/MRK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 16:00</td>
    <td>SiSaf、リチャード・グッドフェロー博士を取締役に任命</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641367/0/en/SiSaf-Appoints-Dr-Richard-Goodfellow-to-Board-of-Directors.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641367/0/en/SiSaf-Appoints-Dr-Richard-Goodfellow-to-Board-of-Directors.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 15:35</td>
    <td>バイオポルトA / Sにおける年次総会の招集通知</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641357/0/en/Notice-convening-the-Annual-General-Meeting-in-BioPorto-A-S.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641357/0/en/Notice-convening-the-Annual-General-Meeting-in-BioPorto-A-S.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 15:30</td>
    <td>ゲルベ：イントラセンス社の株式公開買付けに関するお知らせ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641352/0/fr/GUERBET-COMMUNIQUE-RELATIF-A-L-OFFRE-PUBLIQUE-D-ACHAT-VISANT-LES-ACTIONS-DE-LA-SOCIETE-INTRASENSE.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641352/0/fr/GUERBET-COMMUNIQUE-RELATIF-A-L-OFFRE-PUBLIQUE-D-ACHAT-VISANT-LES-ACTIONS-DE-LA-SOCIETE-INTRASENSE.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 15:30</td>
    <td>2023年4月4日時点の総会報告書</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641353/0/en/General-Meeting-s-report-as-of-4th-of-April-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641353/0/en/General-Meeting-s-report-as-of-4th-of-April-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 15:30</td>
    <td>2023年4月4日の総会結果について</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641353/0/fr/R%C3%A9sultats-de-l-Assembl%C3%A9e-G%C3%A9n%C3%A9rale-du-4-Avril-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641353/0/fr/R%C3%A9sultats-de-l-Assembl%C3%A9e-G%C3%A9n%C3%A9rale-du-4-Avril-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 15:00</td>
    <td>2023年4月に開催予定のカンファレンスへの参加と、4月17日のアニュアルレポート発行後の投資家向け電話会議の開催について</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641341/0/en/Mendus-to-participate-in-upcoming-conferences-in-April-2023-and-to-hold-investor-call-following-Annual-Report-publication-on-April-17th.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641341/0/en/Mendus-to-participate-in-upcoming-conferences-in-April-2023-and-to-hold-investor-call-following-Annual-Report-publication-on-April-17th.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 15:00</td>
    <td>メンダスは2023年4月に複数のカンファレンスに参加し、4月17日にオンライン投資家ミーティングにご招待します。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641341/0/sv/Mendus-deltar-i-flera-konferenser-i-april-2023-och-bjuder-in-till-investerarm%C3%B6te-den-17-april-online.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641341/0/sv/Mendus-deltar-i-flera-konferenser-i-april-2023-och-bjuder-in-till-investerarm%C3%B6te-den-17-april-online.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 15:00</td>
    <td>総会開催通知と案内状の発行について</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/05/2641345/0/en/Notice-of-General-Meeting-and-Publication-of-Circular.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/05/2641345/0/en/Notice-of-General-Meeting-and-Publication-of-Circular.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 14:00</td>
    <td>アドデックス、5.0百万ドルのエクイティファイナンスを完了</td>
    <td><a href=https://finance.yahoo.com/quote/ADXN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ADXN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 12:05</td>
    <td>Exelixis、投資家Farallon Capitalとの委任状争奪戦に直面 - レポート</td>
    <td><a href=https://finance.yahoo.com/quote/EXEL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EXEL</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 10:00</td>
    <td>TransCode Therapeutics、以前に発表したシリーズA優先株の売却の中止を発表</td>
    <td><a href=https://finance.yahoo.com/quote/RNAZ target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RNAZ</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 08:00</td>
    <td>ソディバイオの2022年第4四半期および通期決算と最近の注目点</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2641273/0/zh-hans/%E7%A1%95%E8%BF%AA%E7%94%9F%E7%89%A92022%E5%B9%B4%E7%AC%AC%E5%9B%9B%E5%AD%A3%E5%BA%A6%E5%92%8C%E5%85%A8%E5%B9%B4%E8%B4%A2%E5%8A%A1%E4%B8%9A%E7%BB%A9%E4%BB%A5%E5%8F%8A%E8%BF%91%E6%9C%9F%E4%BA%AE%E7%82%B9.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2641273/0/zh-hans/%E7%A1%95%E8%BF%AA%E7%94%9F%E7%89%A92022%E5%B9%B4%E7%AC%AC%E5%9B%9B%E5%AD%A3%E5%BA%A6%E5%92%8C%E5%85%A8%E5%B9%B4%E8%B4%A2%E5%8A%A1%E4%B8%9A%E7%BB%A9%E4%BB%A5%E5%8F%8A%E8%BF%91%E6%9C%9F%E4%BA%AE%E7%82%B9.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 06:57</td>
    <td>HealthEquity、Microsoft Azureによるクラウドへの移行へ</td>
    <td><a href=https://finance.yahoo.com/quote/HQY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HQY</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 06:43</td>
    <td>NGM Biopharmaceuticals to cut workforce by 33%, incur restructuring charges of ~$5M
</td>
    <td><a href=https://finance.yahoo.com/quote/NGM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NGM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 07:30</td>
    <td>Gritstone bio社、ECCMID 2023でSARS-CoV-2に対する自己増幅型mRNA（samRNA）を評価するプレゼンテーションを発表</td>
    <td><a href=https://finance.yahoo.com/quote/GRTS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GRTS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 05:43</td>
    <td>1億ドルの公募でプロタゴニアが陥落</td>
    <td><a href=https://finance.yahoo.com/quote/PTGX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PTGX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 05:37</td>
    <td>Thorne社、脳用栄養補助食品の試験でポジティブなデータを発表</td>
    <td><a href=https://finance.yahoo.com/quote/THRN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/THRN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 05:26</td>
    <td>タルク訴訟でJ&Jが破産を申請、89億ドルの支払いを提案</td>
    <td><a href=https://finance.yahoo.com/quote/JNJ target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/JNJ</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 05:21</td>
    <td>セリアドオンコロジー、ナスダックからコンプライアンス違反の通知を受ける</td>
    <td><a href=https://finance.yahoo.com/quote/CYAD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CYAD</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 05:19</td>
    <td>ヘルスカタリスト、コンテクチュアと複数年のパートナーシップを締結</td>
    <td><a href=https://finance.yahoo.com/quote/HCAT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HCAT</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 05:12</td>
    <td>ネオジェノミクス、2023年度のガイダンスを維持、改善傾向は続くとコメント</td>
    <td><a href=https://finance.yahoo.com/quote/NEO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NEO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 05:30</td>
    <td>セレクティスは欧州投資銀行とワラント引受契約を締結し、最初のトランシェである20百万ユーロの引き当てを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2641230/0/fr/Cellectis-a-conclu-le-contrat-de-souscription-de-bons-de-souscription-d-actions-avec-la-Banque-Europ%C3%A9enne-d-Investissement-et-annonce-le-tirage-de-la-premi%C3%A8re-tranche-de-20-million.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2641230/0/fr/Cellectis-a-conclu-le-contrat-de-souscription-de-bons-de-souscription-d-actions-avec-la-Banque-Europ%C3%A9enne-d-Investissement-et-annonce-le-tirage-de-la-premi%C3%A8re-tranche-de-20-million.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 05:30</td>
    <td>Cellectis社、欧州投資銀行とクレジットファシリティ契約に関連するワラント契約を締結、第1トランシェの2,000万ユーロの引き当てを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2641229/0/en/Cellectis-enters-into-warrant-agreement-with-the-European-Investment-Bank-related-to-credit-facility-agreement-and-announces-the-drawdown-of-the-first-tranche-of-20-million.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2641229/0/en/Cellectis-enters-into-warrant-agreement-with-the-European-Investment-Bank-related-to-credit-facility-agreement-and-announces-the-drawdown-of-the-first-tranche-of-20-million.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 05:25</td>
    <td>HealthEquity、マイクロソフトと提携し、クラウド機能を活用した医療給付の未来を急ぐ</td>
    <td><a href=https://finance.yahoo.com/quote/HQY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HQY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 05:15</td>
    <td>トレース、「ESGレポート」を創刊</td>
    <td><a href=https://finance.yahoo.com/quote/TMCI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TMCI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 05:05</td>
    <td>X4ファーマシューティカルズ、ナスダック上場規則5635(c)(4)に基づく誘引付与を発表</td>
    <td><a href=https://finance.yahoo.com/quote/XFOR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/XFOR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 05:05</td>
    <td>Codexis社、Patrick Yang博士の取締役再任を見送る決定を発表</td>
    <td><a href=https://finance.yahoo.com/quote/CDXS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CDXS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 05:02</td>
    <td>サラリウス・ファーマシューティカルズ、ダイヤモンド・エクイティ・リサーチのエマージング・グロース・インビテーショナル・カンファレンスで講演</td>
    <td><a href=https://finance.yahoo.com/quote/SLRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SLRX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 05:01</td>
    <td>セリアド・オンコロジー、ナスダックの通知受領を発表</td>
    <td><a href=https://finance.yahoo.com/quote/CYAD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CYAD</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 05:01</td>
    <td>G Medical Innovations Holdings Ltd. 公募増資の終了について</td>
    <td><a href=https://finance.yahoo.com/quote/GMVDW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GMVDW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 04:53</td>
    <td>ノックスメディカル、睡眠検査時の呼吸努力量を算出する新特許を取得</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2641186/0/en/Nox-Medical-Secures-New-Patent-for-Calculating-Respiratory-Effort-During-Sleep-Studies.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2641186/0/en/Nox-Medical-Secures-New-Patent-for-Calculating-Respiratory-Effort-During-Sleep-Studies.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 04:19</td>
    <td>Sorrento、Scilex社の株式に関する情報を求める裁判所命令を発表</td>
    <td><a href=https://finance.yahoo.com/quote/SRNEQ target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SRNEQ</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 04:13</td>
    <td>InflaRx surges 60% on FDA authorization of COVID drug vilobelimab
</td>
    <td><a href=https://finance.yahoo.com/quote/IFRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IFRX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/04 19:02</td>
    <td>シティで$SRPTが買いで開始され、フォーカスリストに追加されました。PT $179</td>
    <td><a href=https://finance.yahoo.com/quote/SRPT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SRPT</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/04 19:31</td>
    <td>CORTはPiperのOverweightで開始されました。PT $27</td>
    <td><a href=https://finance.yahoo.com/quote/CORT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CORT</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/04 19:47</td>
    <td>CING社、ADHD治療薬CTx-1301（デクスメチルフェニデート）の成人発症・持続時間に関する第3相試験の最初のコホートを完了。データQ3</td>
    <td><a href=https://finance.yahoo.com/quote/CING target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CING</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/04 20:07</td>
    <td>$FRLN to pause development of FLT190 in Fabry disease. Reduce workforce by 30%       
</td>
    <td><a href=https://finance.yahoo.com/quote/FRLN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/FRLN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/04 20:38</td>
    <td>武田薬品から$ARWR $40Mのマイルストンを受領。 α1アンチトリプシン欠乏性肝疾患を対象としたFazirsiranの第3相REDWOOD試験で最初の患者が投与されました。</td>
    <td><a href=https://finance.yahoo.com/quote/ARWR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ARWR</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/04 20:41</td>
    <td>LokavantがRoivant Sciencesから複数の業界との提携で誕生。 ドルROIV</td>
    <td><a href=https://finance.yahoo.com/quote/ROIV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ROIV</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/04 20:56</td>
    <td>ABUS社、$PFE社および$BTNX社に対し、新型コロナ mRNA-LNPワクチンの製造・販売に関する特許権侵害の損害賠償を求める訴訟を提起</td>
    <td><a href=https://finance.yahoo.com/quote/ABUS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ABUS</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/04 20:57</td>
    <td>VBIVハルト</td>
    <td><a href=https://finance.yahoo.com/quote/VBIV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VBIV</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/04 21:02</td>
    <td>VBIV社、B型肝炎への注力強化、組織変更、株式併合を発表</td>
    <td><a href=https://finance.yahoo.com/quote/VBIV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VBIV</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/04 21:05</td>
    <td>$VBIV to reduce workforce by 30-35% Implement 1-for-30 reverse stock split CFO Christopher McNulty to resign        
</td>
    <td><a href=https://finance.yahoo.com/quote/VBIV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VBIV</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/04 21:38</td>
    <td>再発・難治性多発性骨髄腫に対する同種CAR-T細胞治療薬「CB-011」の$CRBUファストトラック指定取得のお知らせ</td>
    <td><a href=https://finance.yahoo.com/quote/CRBU target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CRBU</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 04:12</td>
    <td>シエンタ、2023年第1四半期決算の発表日およびカンファレンスコールを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2641176/0/en/Sienna-Announces-First-Quarter-2023-Results-Release-Date-and-Conference-Call.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2641176/0/en/Sienna-Announces-First-Quarter-2023-Results-Release-Date-and-Conference-Call.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 03:55</td>
    <td>InflaRx社、重症の新型コロナ患者に対するGohibic（vilobelimab）のFDA緊急使用認可を取得</td>
    <td><a href=https://finance.yahoo.com/quote/IFRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IFRX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 02:56</td>
    <td>JNJ、タルク関連がん訴訟停止に向け2度目の破産を検討</td>
    <td><a href=https://finance.yahoo.com/quote/JNJ target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/JNJ</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 03:05</td>
    <td>Syneos Health、コミュニケーション担当社長にJeanine O'Kaneを任命</td>
    <td><a href=https://finance.yahoo.com/quote/SYNH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SYNH</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 03:00</td>
    <td>州がHFMAピアレビューの指定を更新</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2641144/0/en/State-Renews-HFMA-Peer-Review-Designation.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2641144/0/en/State-Renews-HFMA-Peer-Review-Designation.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 02:10</td>
    <td>パルデスバイオサイエンス、COVIDの薬害でJefferiesにカットされる</td>
    <td><a href=https://finance.yahoo.com/quote/PRDS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PRDS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 01:44</td>
    <td>ボストン・サイエンティフィック、アポロ・エンドサージェリーの615Mドル買収を完了</td>
    <td><a href=https://finance.yahoo.com/quote/BSX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BSX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 01:55</td>
    <td>アクシオム、「Clinical Trial Supply New England 2023」に出展</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2641112/0/en/Axiom-Exhibiting-at-Clinical-Trial-Supply-New-England-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2641112/0/en/Axiom-Exhibiting-at-Clinical-Trial-Supply-New-England-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 01:10</td>
    <td>AB Science社、筋萎縮性側索硬化症を対象としたマシチニブのEMA規制審査における120日目の質問に対する回答を提出したことを発表、カナダ保健省への回答に関する新しいスケジュールを明らかにする</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2641085/0/en/AB-Science-announces-that-it-has-submitted-its-response-to-the-day-120-questions-in-the-EMA-regulatory-review-of-masitinib-in-amyotrophic-lateral-sclerosis-and-clarifies-the-new-ti.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2641085/0/en/AB-Science-announces-that-it-has-submitted-its-response-to-the-day-120-questions-in-the-EMA-regulatory-review-of-masitinib-in-amyotrophic-lateral-sclerosis-and-clarifies-the-new-ti.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 00:58</td>
    <td>Absci、M2GENと提携し、抗がん剤の早期上市を目指す</td>
    <td><a href=https://finance.yahoo.com/quote/ABSI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ABSI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 01:10</td>
    <td>AB Science社、ALSにおけるmasitinibのEMA条件付き申請におけるD120の質問に対する回答と、カナダ保健省への新たな回答スケジュールの概要を発表しました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2641085/0/fr/AB-Science-annonce-avoir-r%C3%A9pondu-aux-questions-au-D120-de-la-proc%C3%A9dure-EMA-de-demande-d-autorisation-conditionnelle-du-masitinib-dans-la-scl%C3%A9rose-lat%C3%A9rale-amyotrophique-et-pr%C3%A9cise-.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2641085/0/fr/AB-Science-annonce-avoir-r%C3%A9pondu-aux-questions-au-D120-de-la-proc%C3%A9dure-EMA-de-demande-d-autorisation-conditionnelle-du-masitinib-dans-la-scl%C3%A9rose-lat%C3%A9rale-amyotrophique-et-pr%C3%A9cise-.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 00:51</td>
    <td>サナラの創傷洗浄液「Biasurge」がFDAの認可を取得</td>
    <td><a href=https://finance.yahoo.com/quote/SMTI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SMTI</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 00:31</td>
    <td>Encompass Health up 11% on proposed Medicare rehab payment increase
</td>
    <td><a href=https://finance.yahoo.com/quote/EHC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EHC</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 01:00</td>
    <td>メンダス、ネグマグループによる転換社債の転換要請を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2641076/0/en/Mendus-announces-request-for-conversion-of-convertible-bonds-by-Negma-Group.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2641076/0/en/Mendus-announces-request-for-conversion-of-convertible-bonds-by-Negma-Group.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/05 01:00</td>
    <td>メンダス、ネグマグループからの転換社債の転換要請を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2641076/0/sv/Mendus-tillk%C3%A4nnager-beg%C3%A4ran-fr%C3%A5n-Negma-Group-om-konvertering-av-konvertibla-skuldebrev.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2641076/0/sv/Mendus-tillk%C3%A4nnager-beg%C3%A4ran-fr%C3%A5n-Negma-Group-om-konvertering-av-konvertibla-skuldebrev.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 00:20</td>
    <td>MariMed、メリーランド州で高用量エディブルの販売認可を取得</td>
    <td><a href=https://finance.yahoo.com/quote/MRMD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRMD</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/05 00:11</td>
    <td>ファイザー、肺がんコンボ治療薬の申請がFDAに受理される</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 23:35</td>
    <td>BullFrog surges ~55% on license deal for AI tech with Johns Hopkins
</td>
    <td><a href=https://finance.yahoo.com/quote/BFRG target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BFRG</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 23:22</td>
    <td>Clearmind medicine plunges 58% on $3.5M public offering
</td>
    <td><a href=https://finance.yahoo.com/quote/CMND target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CMND</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 22:52</td>
    <td>VBI Vaccines falls 40% on portfolio reorganization, reverse stock split
</td>
    <td><a href=https://finance.yahoo.com/quote/VBIV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VBIV</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 23:01</td>
    <td>コーラインバイオメディカル社（publish）の年次総会をお知らせします。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640922/0/sv/KALLELSE-TILL-%C3%85RSST%C3%84MMA-I-CORLINE-BIOMEDICAL-AB-PUBL.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640922/0/sv/KALLELSE-TILL-%C3%85RSST%C3%84MMA-I-CORLINE-BIOMEDICAL-AB-PUBL.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 22:52</td>
    <td>イルミナは、GRAILの売却の可能性が高いことから、ストリートからの支持を得る。</td>
    <td><a href=https://finance.yahoo.com/quote/ILMN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ILMN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 23:00</td>
    <td>メディジーン社、TCR-T療法開発の最適化に向けた体系的かつ連続的なエンド・ツー・エンドのプラットフォーム・アプローチを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640898/0/en/Medigene-AG-Presents-Systematic-and-Sequential-End-To-End-Platform-Approach-to-Optimize-TCR-T-Therapy-Development.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640898/0/en/Medigene-AG-Presents-Systematic-and-Sequential-End-To-End-Platform-Approach-to-Optimize-TCR-T-Therapy-Development.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 22:39</td>
    <td>バンクオブアメリカによる第2四半期の上位10銘柄にネットフリックス、FedExがランクイン</td>
    <td><a href=https://finance.yahoo.com/quote/NFLX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NFLX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 22:38</td>
    <td>FDAの会合後のvonoprazanの再申請計画でPhathom社の株価が上昇</td>
    <td><a href=https://finance.yahoo.com/quote/PHAT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PHAT</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 22:17</td>
    <td>経口新型コロナ治療薬の計画についてFDAが協議に応じることを受けてVeruが急騰</td>
    <td><a href=https://finance.yahoo.com/quote/VERU target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VERU</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 22:15</td>
    <td>ディファーマ、イタリアのR&Dセンターを拡張し、分析サービスを拡充</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640829/0/en/Dipharma-expands-its-Italian-R-D-Center-to-increase-its-analytical-services.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640829/0/en/Dipharma-expands-its-Italian-R-D-Center-to-increase-its-analytical-services.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 22:15</td>
    <td>Sanara MedTech Inc. BIASURGE™ Advanced Surgical Solutionの510(k)クリアランスを発表しました。</td>
    <td><a href=https://finance.yahoo.com/quote/SMTI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SMTI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 22:00</td>
    <td>フィリップスとノースウェル・ヘルス社が提携、企業全体の患者モニタリングの標準化と将来性の確保を目指す</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640724/0/en/Philips-and-Northwell-Health-partner-to-standardize-and-future-proof-patient-monitoring-across-the-enterprise.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640724/0/en/Philips-and-Northwell-Health-partner-to-standardize-and-future-proof-patient-monitoring-across-the-enterprise.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 22:00</td>
    <td>Progyny社、Janet Choi医学博士を最高医学責任者に任命</td>
    <td><a href=https://finance.yahoo.com/quote/PGNY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PGNY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 22:00</td>
    <td>ヴァロン・ファーマシューティカルズ、GRIバイオとの合併案に関する委任状投票の最新情報と、2023年3月6日現在の株主名簿に記載された株主に対し、2023年4月11日午後11時59分（日本時間）までに投票するよう呼びかけを実施</td>
    <td><a href=https://finance.yahoo.com/quote/VLON target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VLON</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 22:00</td>
    <td>Inovalon Expands Patient Data Connectivity Network by 110% Over 12 Months – Now Enabling Access to More Than 67% of U.S. Healthcare Providers
</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640776/34825/en/Inovalon-Expands-Patient-Data-Connectivity-Network-by-110-Over-12-Months-Now-Enabling-Access-to-More-Than-67-of-U-S-Healthcare-Providers.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640776/34825/en/Inovalon-Expands-Patient-Data-Connectivity-Network-by-110-Over-12-Months-Now-Enabling-Access-to-More-Than-67-of-U-S-Healthcare-Providers.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 22:00</td>
    <td>シネコ子会社の「心臓5分間テスト」が中国規制当局NMPAの品質検査に合格</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640780/0/en/Shineco-Subsidiary-s-Cardiac-5-Minute-Test-Passes-Quality-Inspection-by-China-Regulator-NMPA.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640780/0/en/Shineco-Subsidiary-s-Cardiac-5-Minute-Test-Passes-Quality-Inspection-by-China-Regulator-NMPA.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 21:48</td>
    <td>ファイザー、メルクが中国で錠剤「新型コロナ」を値下げしたとされる。</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 22:00</td>
    <td>セルラリティ、2023年バイオマテリアル学会年次大会でのポスター発表の受諾を発表</td>
    <td><a href=https://finance.yahoo.com/quote/CELUW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CELUW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 22:00</td>
    <td>Clearmind Medicine社、350万米ドルの公募増資の価格決定を発表</td>
    <td><a href=https://finance.yahoo.com/quote/CMND target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CMND</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 21:40</td>
    <td>Zevra社、睡眠障害ナルコレプシーに対するKP1077の試験開始をFDAに承認されるよう求める</td>
    <td><a href=https://finance.yahoo.com/quote/ZVRA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ZVRA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 21:39</td>
    <td>エア・ウェルネス 最高執行責任者 ジェン・ドレイクが辞任</td>
    <td><a href=https://finance.yahoo.com/quote/AYRWF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AYRWF</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 21:45</td>
    <td>AIMイミュノテック社、「アンプリゲン®」をCOVID後の治療に用いる第2相試験プロトコルの中央IRB承認取得を発表</td>
    <td><a href=https://finance.yahoo.com/quote/AIM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AIM</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 21:38</td>
    <td>アキャスティファーマ、CEO交代を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ACST target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ACST</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 21:35</td>
    <td>アマリン、イスラエルが心臓病治療薬を承認したことで急騰</td>
    <td><a href=https://finance.yahoo.com/quote/AMRN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMRN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 21:30</td>
    <td>ニューロネティクス社、SLRキャピタル・パートナーズから最大6,000万ドルの新規借入を実施、Greenbrook TMS社に60万ドルの約束手形を提供</td>
    <td><a href=https://finance.yahoo.com/quote/STIM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/STIM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 21:30</td>
    <td>Predictive Oncology社、オンコロジー・トランスレーショナル・リサーチのリーダーであるChristoph Reinhard博士（MBA）を科学諮問委員会に任命したことを発表</td>
    <td><a href=https://finance.yahoo.com/quote/POAI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/POAI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 21:30</td>
    <td>LIXTE Biotechnology、Sarah Cannon Research InstituteがCity of Hopeの小細胞肺がんを対象とした抗がん剤「LB-100」の臨床試験（フェーズ1b）に参加したことを発表</td>
    <td><a href=https://finance.yahoo.com/quote/LIXTW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LIXTW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 21:30</td>
    <td>OMNIMED™、SmartOR™をAxis Research & Technologiesの施設に統合することを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640674/0/en/OMNIMED-Announces-Integration-of-SmartOR-Into-Axis-Research-Technologies-Facilities.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640674/0/en/OMNIMED-Announces-Integration-of-SmartOR-Into-Axis-Research-Technologies-Facilities.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 21:30</td>
    <td>イノザイム・ファーマ、新任の最高業務責任者に対するナスダック上場規則5635(c)(4)に基づく誘引付与のお知らせ</td>
    <td><a href=https://finance.yahoo.com/quote/INZY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/INZY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 21:30</td>
    <td>インフルエンザによる重症急性呼吸困難症候群を対象としたサビザブリングプログラムの前臨床試験結果および新型コロナプログラムに関する最新情報を発表</td>
    <td><a href=https://finance.yahoo.com/quote/VERU target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VERU</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 21:15</td>
    <td>サイスパーク、トゥレット症候群を対象としたSCI-110の第IIb相臨床試験開始の最終承認を取得</td>
    <td><a href=https://finance.yahoo.com/quote/SPRC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SPRC</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 21:05</td>
    <td>Avid Bioservices、哺乳類細胞設備の増設を完了し、既存および将来の顧客に大幅な能力向上を実現</td>
    <td><a href=https://finance.yahoo.com/quote/CDMO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CDMO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 21:00</td>
    <td>Axial Therapeutics社、自閉症スペクトラム障害（ASD）に伴うイライラを対象としたグローバル第2b相臨床試験で年齢を拡大することを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640627/0/en/Axial-Therapeutics-Announces-Age-Expansion-in-Global-Phase-2b-Clinical-Trial-for-Irritability-Associated-with-Autism-Spectrum-Disorder-ASD.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640627/0/en/Axial-Therapeutics-Announces-Age-Expansion-in-Global-Phase-2b-Clinical-Trial-for-Irritability-Associated-with-Autism-Spectrum-Disorder-ASD.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 21:00</td>
    <td>インスパイア・メディカル・システムズ社、2023年第1四半期決算を5月2日に発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/INSP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/INSP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 21:00</td>
    <td>SAB Biotherapeutics、Erick Lucera氏（CFA）の取締役就任を発表</td>
    <td><a href=https://finance.yahoo.com/quote/SABSW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SABSW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 21:00</td>
    <td>エンライベックス、Tislelizumabの臨床共同研究、2022年通期決算を発表、事業の最新情報を提供</td>
    <td><a href=https://finance.yahoo.com/quote/ENLV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ENLV</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 21:00</td>
    <td>イミックス・バイオファーマの子会社であるネクセラ社が、欧州血液・骨髄移植学会第49回年次総会でポスター発表を行うことを発表</td>
    <td><a href=https://finance.yahoo.com/quote/IMMX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IMMX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 21:00</td>
    <td>ファトム社、2023年の逆流性食道炎およびピロリ菌の市販予定と規制当局の最新情報を発表</td>
    <td><a href=https://finance.yahoo.com/quote/PHAT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PHAT</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 20:46</td>
    <td>フリーラインとフォースフィールド、心臓病の遺伝子治療薬開発で提携</td>
    <td><a href=https://finance.yahoo.com/quote/FRLN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/FRLN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 21:00</td>
    <td>ProFound AI Riskは、短期および長期のリスク評価の両方において、広く受け入れられている従来の乳がんリスクモデルを凌駕する。</td>
    <td><a href=https://finance.yahoo.com/quote/ICAD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ICAD</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 21:00</td>
    <td>アマリン社、「VAZKEPA®」（イコサペントエチル）がイスラエル保健省から承認されたことを発表</td>
    <td><a href=https://finance.yahoo.com/quote/AMRN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMRN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 20:37</td>
    <td>トニックス、ポートフォリオの見直しでCOVIDプログラムを後回しに</td>
    <td><a href=https://finance.yahoo.com/quote/TNXP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TNXP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 21:00</td>
    <td>TELUS Health、MyPetでオンタリオ州の犬猫にバーチャル獣医療を提供</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640595/0/en/TELUS-Health-brings-virtual-veterinary-care-to-cats-and-dogs-in-Ontario-with-MyPet.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640595/0/en/TELUS-Health-brings-virtual-veterinary-care-to-cats-and-dogs-in-Ontario-with-MyPet.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 20:29</td>
    <td>ANI Pharma社のコレステロール低下剤のジェネリック医薬品がFDAの承認を取得</td>
    <td><a href=https://finance.yahoo.com/quote/ANIP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ANIP</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 20:16</td>
    <td>マインツバイオメッド、企業向け健康プログラム「ColoAlert」を拡充</td>
    <td><a href=https://finance.yahoo.com/quote/MYNZ target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MYNZ</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 20:15</td>
    <td>ファイザーのBraftoviとMektoviが肺がんへの使用拡大でFDAの審査を受ける</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 20:30</td>
    <td>ネプロス、2023年第1四半期業績速報を発表</td>
    <td><a href=https://finance.yahoo.com/quote/NEPH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NEPH</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 20:30</td>
    <td>Aurora Spine社、DEXA-C™頸椎インターボディシステムのIRBマルチサイト選択の承認を取得</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640514/36935/en/Aurora-Spine-Receives-IRB-Multi-Site-Selection-Approval-for-its-DEXA-C-Cervical-Interbody-System.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640514/36935/en/Aurora-Spine-Receives-IRB-Multi-Site-Selection-Approval-for-its-DEXA-C-Cervical-Interbody-System.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 20:30</td>
    <td>バイオジェン社、コーポレート・ディベロップメント部門長にアダム・キーニーを任命</td>
    <td><a href=https://finance.yahoo.com/quote/BIIB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BIIB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 20:30</td>
    <td>Zevra Therapeutics社、ナルコレプシーを対象としたKP1077のINDを提出と発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640518/16626/en/Zevra-Therapeutics-Announces-Submission-of-IND-for-KP1077-in-Narcolepsy.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640518/16626/en/Zevra-Therapeutics-Announces-Submission-of-IND-for-KP1077-in-Narcolepsy.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 20:30</td>
    <td>スモールファーマ、SPL026の第IIa相試験で良好な6ヶ月間データを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640520/0/en/Small-Pharma-Announces-Positive-Six-month-Data-from-Phase-IIa-Trial-of-SPL026.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640520/0/en/Small-Pharma-Announces-Positive-Six-month-Data-from-Phase-IIa-Trial-of-SPL026.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 20:30</td>
    <td>Quipt Home Medical、米国で会員数上位5社の医療保険会社と新たに国保契約を締結したと発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640522/0/en/Quipt-Home-Medical-Announces-New-National-Insurance-Contract-with-Top-5-Health-Insurer-Based-on-Membership-in-the-United-States.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640522/0/en/Quipt-Home-Medical-Announces-New-National-Insurance-Contract-with-Top-5-Health-Insurer-Based-on-Membership-in-the-United-States.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 20:25</td>
    <td>Alterity Therapeutics、英国で多系統萎縮症を対象としたATH434第2相臨床試験で最初の患者を登録</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640506/0/en/Alterity-Therapeutics-Enrolls-First-Patient-in-the-United-Kingdom-in-ATH434-Phase-2-Clinical-Trial-in-Multiple-System-Atrophy.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640506/0/en/Alterity-Therapeutics-Enrolls-First-Patient-in-the-United-Kingdom-in-ATH434-Phase-2-Clinical-Trial-in-Multiple-System-Atrophy.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 20:00</td>
    <td>マニトバ・ハーベスト、ホールフーズ・マーケットでの取り扱いを拡大</td>
    <td><a href=https://finance.yahoo.com/quote/TLRY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TLRY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 20:00</td>
    <td>Annals of Rheumatic Diseases誌、二次性HLH/マクロファージ活性化症候群患者を対象としたemapalumabの第2相試験結果を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640441/0/en/Annals-of-Rheumatic-Diseases-Publishes-Results-from-Phase-2-Study-of-emapalumab-in-Patients-with-Secondary-HLH-Macrophage-Activation-Syndrome.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640441/0/en/Annals-of-Rheumatic-Diseases-Publishes-Results-from-Phase-2-Study-of-emapalumab-in-Patients-with-Secondary-HLH-Macrophage-Activation-Syndrome.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 20:00</td>
    <td>エントラーダ・セラピューティクス、ベルンハルト・ツァイハー博士を取締役に任命</td>
    <td><a href=https://finance.yahoo.com/quote/TRDA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TRDA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 20:00</td>
    <td>ワンワールドプロダクト、共同創業者のカルロス・デフェクスを国際事業部長に迎え入れました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640451/0/en/One-World-Products-Brings-Back-Co-Founder-Carlos-DeFex-as-Director-International-Operations.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640451/0/en/One-World-Products-Brings-Back-Co-Founder-Carlos-DeFex-as-Director-International-Operations.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 20:00</td>
    <td>バイオカーディア、インターベンショナル治療を導く技術に関する2つの特許を取得したと発表</td>
    <td><a href=https://finance.yahoo.com/quote/BCDAW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BCDAW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 20:00</td>
    <td>Algernon NeuroScience社、DMT臨床試験フェーズ1の第2コホートの投与に成功したことを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640454/0/en/Algernon-NeuroScience-Announces-Successful-Dosing-of-2nd-Cohort-in-Phase-1-DMT-Clinical-Study.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640454/0/en/Algernon-NeuroScience-Announces-Successful-Dosing-of-2nd-Cohort-in-Phase-1-DMT-Clinical-Study.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 20:00</td>
    <td>Forcefield Therapeutics、Freeline Therapeuticsと特許およびノウハウの独占ライセンス契約を締結</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640455/0/en/Forcefield-Therapeutics-signs-exclusive-patent-and-know-how-license-agreement-with-Freeline-Therapeutics.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640455/0/en/Forcefield-Therapeutics-signs-exclusive-patent-and-know-how-license-agreement-with-Freeline-Therapeutics.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 20:00</td>
    <td>オキュリス、2023年4月13日にカンファレンスコールを開催し、後期パイプラインと近未来の臨床的マイルストーンについて説明</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640457/0/en/Oculis-to-Host-Conference-Call-on-April-13-2023-to-Discuss-Late-Stage-Pipeline-and-Near-Term-Clinical-Milestones.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640457/0/en/Oculis-to-Host-Conference-Call-on-April-13-2023-to-Discuss-Late-Stage-Pipeline-and-Near-Term-Clinical-Milestones.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 20:00</td>
    <td>Tiziana社、抗CD3モノクローナル抗体の脳内出血を対象とした経鼻投与で良好なデータが得られたと発表</td>
    <td><a href=https://finance.yahoo.com/quote/TLSA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TLSA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 19:45</td>
    <td>Vivaniの株価は、人工視覚装置研究のための最終的な100万ドルのNIH助成金でポップアップします。</td>
    <td><a href=https://finance.yahoo.com/quote/VANI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VANI</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 19:06</td>
    <td>ハッチメッド、中国の規制当局との協議の結果、がん臨床試験の登録フェーズを開始</td>
    <td><a href=https://finance.yahoo.com/quote/AZN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AZN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 19:30</td>
    <td>カナダの病院が「Mohawk Medbuy」を通じて「CloudMD」のサービス群を利用可能に</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640402/0/en/CloudMD-Suite-of-Services-Available-to-Canadian-Hospitals-through-Mohawk-Medbuy.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640402/0/en/CloudMD-Suite-of-Services-Available-to-Canadian-Hospitals-through-Mohawk-Medbuy.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 18:25</td>
    <td>Lancet誌、サノフィの問題児である血友病治療薬fitusiranの可能性を強調</td>
    <td><a href=https://finance.yahoo.com/quote/SNY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SNY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 18:30</td>
    <td>HUTCHMED社、IHCCに対するHMPL-453および胃がんに対するSavolitinibのNMPA協議に基づく登録段階の登録を開始</td>
    <td><a href=https://finance.yahoo.com/quote/HCM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HCM</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 17:35</td>
    <td>ノバルティス ヒュミラ バイオシミラーの高濃度製剤がEUで承認取得</td>
    <td><a href=https://finance.yahoo.com/quote/NVS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NVS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 16:44</td>
    <td>Supernus Pharmaceuticals社が$402Mの上級転換社債を払い込む。</td>
    <td><a href=https://finance.yahoo.com/quote/SUPN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SUPN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 16:16</td>
    <td>バタフライネットワーク、AI搭載の肺ツールでFDAの認可を取得</td>
    <td><a href=https://finance.yahoo.com/quote/BFLY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BFLY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 16:01</td>
    <td>Mainz Biomed社、ドイツで新たに3社を追加し、ColoAlertの企業向け健康プログラムを拡大</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640313/0/en/Mainz-Biomed-Expands-Corporate-Health-Program-for-ColoAlert-with-the-Addition-of-Three-New-Companies-in-Germany.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640313/0/en/Mainz-Biomed-Expands-Corporate-Health-Program-for-ColoAlert-with-the-Addition-of-Three-New-Companies-in-Germany.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 16:00</td>
    <td>リズムファーマシューティカルズ、Xinvento B.V.と治験薬ポートフォリオの買収を発表</td>
    <td><a href=https://finance.yahoo.com/quote/RYTM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RYTM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 16:00</td>
    <td>IRBMが全米ケミカルバイオロジーコンソーシアムに採択されました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640309/0/en/IRBM-Selected-for-Participation-in-National-Chemical-Biology-Consortium.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640309/0/en/IRBM-Selected-for-Participation-in-National-Chemical-Biology-Consortium.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 15:32</td>
    <td>ニュージーランド・ファーマ、増資の登録を完了</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640299/0/en/Zealand-Pharma-completes-registration-of-capital-increase.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640299/0/en/Zealand-Pharma-completes-registration-of-capital-increase.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 15:00</td>
    <td>ロンドン証券取引所からの上場廃止の意向に関するお知らせ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640262/0/en/Notice-of-Intention-to-Delist-From-The-London-Stock-Exchange.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640262/0/en/Notice-of-Intention-to-Delist-From-The-London-Stock-Exchange.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 15:00</td>
    <td>メンダス、ネグマグループによる転換社債の転換要請を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640281/0/en/Mendus-announces-request-for-conversion-of-convertible-bonds-by-Negma-Group.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640281/0/en/Mendus-announces-request-for-conversion-of-convertible-bonds-by-Negma-Group.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 15:00</td>
    <td>メンダス、ネグマグループからの転換社債の転換要請を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640281/0/sv/Mendus-tillk%C3%A4nnager-beg%C3%A4ran-fr%C3%A5n-Negma-Group-om-konvertering-av-konvertibla-skuldebrev.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640281/0/sv/Mendus-tillk%C3%A4nnager-beg%C3%A4ran-fr%C3%A5n-Negma-Group-om-konvertering-av-konvertibla-skuldebrev.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 14:00</td>
    <td>プラティドナドゥッツィ社、原薬メーカーBrains Bioceutical社と世界最大規模の天然カンナビノイドの医薬品供給契約を締結</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640242/0/en/Prati-Donaduzzi-Secures-the-Largest-Global-Pharma-Supply-Agreement-for-Natural-Cannabinoids-with-API-Manufacturer-Brains-Bioceutical.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640242/0/en/Prati-Donaduzzi-Secures-the-Largest-Global-Pharma-Supply-Agreement-for-Natural-Cannabinoids-with-API-Manufacturer-Brains-Bioceutical.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 14:00</td>
    <td>プレスリリース Lancet誌およびThe Lancet Haematology誌に掲載されたfitusiranの2つのフェーズ3試験により、あらゆるタイプの血友病におけるアンメットニーズに対応できる可能性が示される</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640246/0/en/Press-Release-Two-fitusiran-Phase-3-studies-published-in-The-Lancet-and-The-Lancet-Haematology-highlight-potential-to-address-unmet-needs-across-all-types-of-hemophilia.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640246/0/en/Press-Release-Two-fitusiran-Phase-3-studies-published-in-The-Lancet-and-The-Lancet-Haematology-highlight-potential-to-address-unmet-needs-across-all-types-of-hemophilia.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 14:00</td>
    <td>プレスリリース Lancet誌およびThe Lancet Haematology誌に掲載されたfitusiranの2つの第III相試験の結果は、すべての血友病患者の医療ニーズに対応できる可能性を示している</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640246/0/fr/Communiqu%C3%A9-de-presse-Les-r%C3%A9sultats-de-2-%C3%A9tudes-de-phase-III-sur-fitusiran-publi%C3%A9es-dans-The-Lancet-et-The-Lancet-Haematology-montrent-son-potentiel-%C3%A0-r%C3%A9pondre-aux-besoins-m%C3%A9dicaux-.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640246/0/fr/Communiqu%C3%A9-de-presse-Les-r%C3%A9sultats-de-2-%C3%A9tudes-de-phase-III-sur-fitusiran-publi%C3%A9es-dans-The-Lancet-et-The-Lancet-Haematology-montrent-son-potentiel-%C3%A0-r%C3%A9pondre-aux-besoins-m%C3%A9dicaux-.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 14:00</td>
    <td>パーキンソン病の運動症状および非運動症状に対するジプラグルラントのin vivo有効性を示すデータをAddex社が発表</td>
    <td><a href=https://finance.yahoo.com/quote/ADXN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ADXN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 14:00</td>
    <td>プレスリリース Biocartis Group NV: BiocartisとAPIS Assay TechnologiesがIdylla™プラットフォームによる乳がんサブタイピング検査の開発・商業化に向けて協業に合意</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640250/0/en/Press-release-Biocartis-Group-NV-Biocartis-and-APIS-Assay-Technologies-Sign-Collaboration-to-Develop-and-Commercialise-a-Breast-Cancer-Subtyping-Test-on-the-Idylla-platform.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640250/0/en/Press-release-Biocartis-Group-NV-Biocartis-and-APIS-Assay-Technologies-Sign-Collaboration-to-Develop-and-Commercialise-a-Breast-Cancer-Subtyping-Test-on-the-Idylla-platform.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 14:00</td>
    <td>プレスリリース Biocartis Group NV: バイオカルティスとAPIS Assay TechnologiesがIdylla™プラットフォームによる乳がんサブタイピング検査の開発・商業化に関する協力協定を締結</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/04/2640250/0/nl/Persbericht-Biocartis-Group-NV-Biocartis-en-APIS-Assay-Technologies-tekenen-samenwerkingsovereenkomst-voor-de-ontwikkeling-en-commercialisering-van-een-subtyperingstest-voor-borstk.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/04/2640250/0/nl/Persbericht-Biocartis-Group-NV-Biocartis-en-APIS-Assay-Technologies-tekenen-samenwerkingsovereenkomst-voor-de-ontwikkeling-en-commercialisering-van-een-subtyperingstest-voor-borstk.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 10:08</td>
    <td>骨がん治療薬開発企業OS Therapeuticsが$10MのIPOを申請</td>
    <td><a href=https://finance.yahoo.com/quote/OSTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OSTX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 07:44</td>
    <td>FDAは、一部の人に2回目のOmicron COVIDブースターを認可する用意がある - WaPo</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 08:30</td>
    <td>スカイライトヘルスの取締役退任のお知らせ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2640226/0/en/Skylight-Health-Announces-Resignation-of-Board-Member.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2640226/0/en/Skylight-Health-Announces-Resignation-of-Board-Member.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/03 09:01</td>
    <td>Q1のEV納入台数 $TSLA - 422,875 $LI - 52,584 $NIO - 31,041 $XPEV - 18,230</td>
    <td><a href=https://finance.yahoo.com/quote/TSLA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TSLA</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/03 19:48</td>
    <td>LQDAと$GSK、吸入用途のPRINT技術に関するライセンスを再編</td>
    <td><a href=https://finance.yahoo.com/quote/LQDA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LQDA</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/03 20:02</td>
    <td>副甲状腺機能低下症を適応症とするTransCon PTH（palopegteriparatide）のNDAに不備があり、現時点では表示や市販後の要件・約束についてさらなる議論を行うことができないとFDAは判断しました。</td>
    <td><a href=https://finance.yahoo.com/quote/ASND target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ASND</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/03 20:03</td>
    <td>特発性肺線維症を対象としたPamrevlumabの第3相臨床試験ZEPHYRUS-2の患者登録完了を発表。トップラインデータは2024年半ばに予想される</td>
    <td><a href=https://finance.yahoo.com/quote/FGEN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/FGEN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 07:24</td>
    <td>プログレッシブ・ケア社（Progressive Care Inc. 2022年の年次決算を発表、総収入は4060万ドル</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2640217/0/en/Progressive-Care-Inc-Announces-2022-Annual-Financial-Results-40-6-Million-Total-Revenue.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2640217/0/en/Progressive-Care-Inc-Announces-2022-Annual-Financial-Results-40-6-Million-Total-Revenue.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 07:00</td>
    <td>メサ・ラボ、四半期配当を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2640214/30771/en/MESA-LABS-DECLARES-QUARTERLY-DIVIDEND.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2640214/30771/en/MESA-LABS-DECLARES-QUARTERLY-DIVIDEND.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/03 20:19</td>
    <td>ONCSは、第2相KEYNOTE-695臨床試験の主要評価項目データを発表しました。主要評価項目であるRECIST v1.1によるORRは、盲検独立中央審査（BICR）により評価されたが、達成されなかった。</td>
    <td><a href=https://finance.yahoo.com/quote/ONCS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ONCS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 05:30</td>
    <td>管理職およびその密接な関係者によるGenmab A / Sの株式およびリンク証券との取引。</td>
    <td><a href=https://finance.yahoo.com/quote/GMAB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GMAB</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/03 20:31</td>
    <td>ARWR社、$GSK社から$30Mのマイルストーン支払を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ARWR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ARWR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 05:15</td>
    <td>ブリッケンリッジ蒸溜所がウイスキーマガジン誌の2023年ワールド・ウイスキー・アワードで大賞を受賞</td>
    <td><a href=https://finance.yahoo.com/quote/TLRY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TLRY</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/03 20:32</td>
    <td>CYCN社、独占交渉期間および拘束力のある株式投資契約を締結</td>
    <td><a href=https://finance.yahoo.com/quote/CYCN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CYCN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 05:15</td>
    <td>TCR² Therapeutics、ナスダック上場規則5635(c)(4)に基づく誘引助成金を報告</td>
    <td><a href=https://finance.yahoo.com/quote/TCRR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TCRR</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 07:16</td>
    <td>FDA、Merck社とAstellas-Seagen社の膀胱癌の併用療法を承認</td>
    <td><a href=https://finance.yahoo.com/quote/MRK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRK</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/03 20:56</td>
    <td>PRDSハルト</td>
    <td><a href=https://finance.yahoo.com/quote/PRDS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PRDS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 05:15</td>
    <td>チェンビオCEOの株主への手紙</td>
    <td><a href=https://finance.yahoo.com/quote/CEMI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CEMI</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 07:16</td>
    <td>なぜ今日、UnitedHealth Groupの株価は上がったのか？メディケアの料金値上げ</td>
    <td><a href=https://finance.yahoo.com/quote/UNH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/UNH</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 05:05</td>
    <td>Histogen社、ジョンズ・ホプキンス大学との独占的知的財産ライセンス契約締結を発表</td>
    <td><a href=https://finance.yahoo.com/quote/HSTO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HSTO</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/03 21:01</td>
    <td>$VRTX $CRSP 鎌状赤血球症および輸血依存性βサラセミア治療薬exa-celのローリングBLAの提出を完了</td>
    <td><a href=https://finance.yahoo.com/quote/VRTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VRTX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 06:18</td>
    <td>Histogen inks license deal with Johns Hopkins University, stock rises ~5% after hours
</td>
    <td><a href=https://finance.yahoo.com/quote/HSTO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HSTO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 05:05</td>
    <td>Supernus社、転換社債型新株予約権付社債の償還を発表</td>
    <td><a href=https://finance.yahoo.com/quote/SUPN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SUPN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/03 21:02</td>
    <td>PRDSは、新型コロナの治療薬としてPomotrelvirを評価する第2相試験のトップライン結果を発表しました。 Pomotrelvirは主要評価項目を満たさなかった</td>
    <td><a href=https://finance.yahoo.com/quote/PRDS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PRDS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 06:16</td>
    <td>Gossamer社、臨床保留となった第1相リンパ腫候補の開発を終了</td>
    <td><a href=https://finance.yahoo.com/quote/GOSS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GOSS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 05:05</td>
    <td>オルソペディアトリクス社、第22回ニードハム・バーチャル・ヘルスケア・カンファレンスに参加決定</td>
    <td><a href=https://finance.yahoo.com/quote/KIDS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/KIDS</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/03 21:05</td>
    <td>CTXR、痔の処方箋治療薬Halo-Lidoのフェーズ2b試験の登録を完了。第2四半期末にはトップラインデータを取得</td>
    <td><a href=https://finance.yahoo.com/quote/CTXR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CTXR</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/04 05:55</td>
    <td>Oncternal Therapeutics ends two cancer studies, stock craters ~31% after hours
</td>
    <td><a href=https://finance.yahoo.com/quote/ONCT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ONCT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/04 05:05</td>
    <td>サイトサイエンス、最高財務責任者にAli Bauerleinを任命</td>
    <td><a href=https://finance.yahoo.com/quote/SGHT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SGHT</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/03 22:07</td>
    <td>HRTXのCEOが退任。 本日付でCraig Collardを新CEOに任命</td>
    <td><a href=https://finance.yahoo.com/quote/HRTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HRTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 22:21</td>
    <td>C-POLARテクノロジーは、病原体を除去する技術を医療業界に提供するため、事業を拡大しています。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639715/0/en/C-POLAR-Technologies-is-Expanding-to-Equip-Healthcare-Industries-with-Pathogen-Eradicating-Technologies.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639715/0/en/C-POLAR-Technologies-is-Expanding-to-Equip-Healthcare-Industries-with-Pathogen-Eradicating-Technologies.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 22:10</td>
    <td>アルファータウと日本消化器病学会、進行性膵臓がん臨床試験でアルファータウが最初の患者さんを治療したことを発表</td>
    <td><a href=https://finance.yahoo.com/quote/DRTSW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DRTSW</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/03 21:50</td>
    <td>マースの買収合意でヘスカが上昇</td>
    <td><a href=https://finance.yahoo.com/quote/HSKA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HSKA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 22:05</td>
    <td>ZyVersa Therapeutics、2022年第4四半期および年末の企業業績および決算を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ZVSA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ZVSA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/03 21:48</td>
    <td>OncoSec crashes ~60% after TAVO-EP, Keytruda combo fails phase 2 skin cancer trial
</td>
    <td><a href=https://finance.yahoo.com/quote/MRK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRK</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/03 21:39</td>
    <td>Vertex社とCRISPR社、鎌状赤血球候補の申請ローリング提出を終える</td>
    <td><a href=https://finance.yahoo.com/quote/VRTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VRTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 22:00</td>
    <td>アニカ、注射用骨補填材「タクトセット®」のFDAによる追加承認取得で対応可能な市場を継続的に拡大</td>
    <td><a href=https://finance.yahoo.com/quote/ANIK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ANIK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 22:00</td>
    <td>INmune Bio, Inc. INKmune™の転移性去勢抵抗性前立腺がん治療に関する治験薬（IND）申請を米国食品医薬品局へ提出したことを発表</td>
    <td><a href=https://finance.yahoo.com/quote/INMB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/INMB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 22:00</td>
    <td>AER-901 (吸入イマチニブ)がフェーズ2に向けて前進する中、Aerami Therapeuticsが肺高血圧症の第一人者を招いたバーチャルインベスターデーを開催</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639642/0/en/Aerami-Therapeutics-to-Host-Virtual-Investor-Day-with-Leading-Experts-in-Pulmonary-Hypertension-as-AER-901-Inhaled-Imatinib-Advances-Toward-Phase-2.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639642/0/en/Aerami-Therapeutics-to-Host-Virtual-Investor-Day-with-Leading-Experts-in-Pulmonary-Hypertension-as-AER-901-Inhaled-Imatinib-Advances-Toward-Phase-2.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 22:00</td>
    <td>セルラリティ社、米国食品医薬品局（FDA）より、セルラリティ社の治験用骨空洞充填剤「フューズ」がFDAの機器・放射線保健センターから機器として規制されるとの予備評価を受ける。</td>
    <td><a href=https://finance.yahoo.com/quote/CELUW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CELUW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 22:00</td>
    <td>PetMeds®、PetCareRx社の買収を完了</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639659/10002/en/PetMeds-Completes-Acquisition-of-PetCareRx.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639659/10002/en/PetMeds-Completes-Acquisition-of-PetCareRx.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 22:00</td>
    <td>エノキアンバイオサイエンス社CEOの株主への手紙</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639669/0/en/Enochian-BioSciences-CEO-Letter-to-Shareholders.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639669/0/en/Enochian-BioSciences-CEO-Letter-to-Shareholders.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 21:45</td>
    <td>国際骨髄腫財団、「マイルス・フォー・ミエローマ」5Kラン/ウォークを発表：骨髄腫コミュニティに変化をもたらす15年の歴史</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639620/0/en/The-International-Myeloma-Foundation-Announces-the-Annual-Miles-for-Myeloma-5K-Run-Walk-15-Years-of-Making-a-Difference-in-the-Myeloma-Community.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639620/0/en/The-International-Myeloma-Foundation-Announces-the-Annual-Miles-for-Myeloma-5K-Run-Walk-15-Years-of-Making-a-Difference-in-the-Myeloma-Community.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 21:36</td>
    <td>ヘルスケア・トライアングル、医療文書自動化ソリューション「readabl.ai」で長年の顧客との関係を拡大</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639615/0/en/Healthcare-Triangle-Expands-Long-Standing-Customer-Engagement-with-readabl-ai-Medical-Document-Automation-Solution.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639615/0/en/Healthcare-Triangle-Expands-Long-Standing-Customer-Engagement-with-readabl-ai-Medical-Document-Automation-Solution.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 21:30</td>
    <td>コメーラライフサイエンス社、コアとなる賦形剤技術に関する特許ポートフォリオの拡充を発表</td>
    <td><a href=https://finance.yahoo.com/quote/CMRAW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CMRAW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 21:30</td>
    <td>パンベラ、ジョンズ・ホプキンス大学医学部との新たな研究契約締結を発表</td>
    <td><a href=https://finance.yahoo.com/quote/PBLA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PBLA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 21:30</td>
    <td>Ashvattha Therapeutics、AACRおよびARVO 2023年年次総会で前臨床データを発表へ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639576/0/en/Ashvattha-Therapeutics-to-Present-Preclinical-Data-at-the-AACR-and-ARVO-2023-Annual-Meetings.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639576/0/en/Ashvattha-Therapeutics-to-Present-Preclinical-Data-at-the-AACR-and-ARVO-2023-Annual-Meetings.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 21:30</td>
    <td>RespireRx Pharmaceuticals Inc. GABAA受容体増強剤KRM-II-81の鎮静を伴わない抗けいれん作用と制吐作用を有する新規構造類似体を開示しました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639578/0/en/RespireRx-Pharmaceuticals-Inc-Discloses-Novel-Structural-Analogs-of-its-GABAA-Receptor-Potentiator-KRM-II-81-with-Antiseizure-Efficacy-and-Antitremor-Effects-without-Sedation.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639578/0/en/RespireRx-Pharmaceuticals-Inc-Discloses-Novel-Structural-Analogs-of-its-GABAA-Receptor-Potentiator-KRM-II-81-with-Antiseizure-Efficacy-and-Antitremor-Effects-without-Sedation.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 21:30</td>
    <td>CPI-818のデータにより、T細胞リンパ腫に対する新たな免疫療法アプローチとしてのITK阻害の可能性が示される</td>
    <td><a href=https://finance.yahoo.com/quote/CRVS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CRVS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 21:30</td>
    <td>ContraFect社、膝の慢性人工関節感染症患者を対象としたExebacaseの第1b/2相試験開始を発表</td>
    <td><a href=https://finance.yahoo.com/quote/CFRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CFRX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 21:30</td>
    <td>BioCorRx社、2022年のビジネスアップデートを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639586/0/en/BioCorRx-Provides-Business-Update-for-2022.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639586/0/en/BioCorRx-Provides-Business-Update-for-2022.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/03 21:04</td>
    <td>イチョウ、センシブル社と提携し、新しいmRNA製造プラットフォームを開発</td>
    <td><a href=https://finance.yahoo.com/quote/DNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DNA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 21:30</td>
    <td>GeneDx社、Devin K. Schaffer, J.D., M.B.A. をゼネラルカウンセルとして任命</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639592/0/en/GeneDx-Appoints-Devin-K-Schaffer-J-D-M-B-A-as-General-Counsel.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639592/0/en/GeneDx-Appoints-Devin-K-Schaffer-J-D-M-B-A-as-General-Counsel.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/03 20:55</td>
    <td>過小評価されている銘柄 レイモンド・ジェームズが選ぶ攻めと守りの銘柄</td>
    <td><a href=https://finance.yahoo.com/quote/SPY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SPY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 21:30</td>
    <td>Vaccinex社、500万ドルのコミットメントを伴うプライベート・プレースメントを発表</td>
    <td><a href=https://finance.yahoo.com/quote/VCNX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VCNX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/03 20:46</td>
    <td>Ascendis stock slumps ~35% after FDA finds 'deficiencies' in TransCon application
</td>
    <td><a href=https://finance.yahoo.com/quote/ASND target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ASND</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 21:30</td>
    <td>Palisade Bio社、600万ドルの登録型直接募集と同時にナスダック規則による市場価格を上回る私募債を発表</td>
    <td><a href=https://finance.yahoo.com/quote/PALI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PALI</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/03 20:21</td>
    <td>BioNTech社、抗がん剤2資産のライセンス契約で契約一時金1億7000万ドルを支払う。</td>
    <td><a href=https://finance.yahoo.com/quote/BNTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BNTX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/03 20:21</td>
    <td>Enovis社がNovastep社を買収、世界の足首市場においてポジションを強化</td>
    <td><a href=https://finance.yahoo.com/quote/ENOV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ENOV</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 21:00</td>
    <td>インテグラライフサイエンス、2023年第1四半期決算カンファレンスコールを4月26日に開催へ</td>
    <td><a href=https://finance.yahoo.com/quote/IART target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IART</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 21:00</td>
    <td>PDSバイオテック、4月中の「口腔・頭頸部がん啓発月間」と2023年4月16日～22日の「口腔・頭頸部がん啓発週間」を支援</td>
    <td><a href=https://finance.yahoo.com/quote/PDSB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PDSB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 21:00</td>
    <td>NewAmsterdam Pharma、Janneke van der Kampを取締役に選任</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639498/0/en/NewAmsterdam-Pharma-Appoints-Janneke-van-der-Kamp-to-its-Board-of-Directors.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639498/0/en/NewAmsterdam-Pharma-Appoints-Janneke-van-der-Kamp-to-its-Board-of-Directors.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 21:00</td>
    <td>アリメラ、販売パートナーであるHorus Pharma社との契約を拡大し、北欧諸国における「ILUVIEN®」の販売も開始すると発表</td>
    <td><a href=https://finance.yahoo.com/quote/ALIM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ALIM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 21:00</td>
    <td>欧州血液・骨髄移植学会（EBMT）第49回年次総会でNomacopanの小児造血幹細胞移植を対象とした第3相パートA臨床試験の症例が発表されることを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639508/0/en/Akari-Therapeutics-Announces-a-Case-Study-from-the-Phase-3-Part-A-Clinical-Trial-of-Nomacopan-in-Pediatric-HSCT-TMA-Will-Be-Presented-at-The-European-Society-for-Blood-and-Marrow-T.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639508/0/en/Akari-Therapeutics-Announces-a-Case-Study-from-the-Phase-3-Part-A-Clinical-Trial-of-Nomacopan-in-Pediatric-HSCT-TMA-Will-Be-Presented-at-The-European-Society-for-Blood-and-Marrow-T.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 21:00</td>
    <td>Enlivex社、固形がん患者を対象としたAllocetraとPD-1阻害剤Tislelizumabの併用療法を評価する臨床共同研究を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ENLV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ENLV</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 21:00</td>
    <td>ORYZON社、境界性パーソナリティ障害を対象とした第2b相適応症試験PORTICOの中間解析予定結果が良好であることを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639521/0/en/ORYZON-Announces-Positive-Results-from-Planned-Interim-Analysis-of-PORTICO-a-Phase-2b-Adaptive-Trial-in-Borderline-Personality-Disorder.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639521/0/en/ORYZON-Announces-Positive-Results-from-Planned-Interim-Analysis-of-PORTICO-a-Phase-2b-Adaptive-Trial-in-Borderline-Personality-Disorder.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 21:00</td>
    <td>PROCEPT BioRobotics Corp. 前立腺肥大症の男性に対するアクアブレーション療法が米国医療保険でカバーされることを発表</td>
    <td><a href=https://finance.yahoo.com/quote/PRCT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PRCT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 21:00</td>
    <td>パルデスバイオサイエンス、新型コロナの治療薬としてPomotrelvirを評価する第2相試験のトップライン結果について発表</td>
    <td><a href=https://finance.yahoo.com/quote/PRDS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PRDS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 21:00</td>
    <td>Corcept Therapeutics、公開買付けの予備的結果を発表</td>
    <td><a href=https://finance.yahoo.com/quote/CORT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CORT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 20:35</td>
    <td>Windtree Therapeutics、2022年第4四半期および年末の決算報告および主要なビジネスアップデートについて</td>
    <td><a href=https://finance.yahoo.com/quote/WINT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/WINT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 20:33</td>
    <td>サンド、「ハイリモズ®」（アダリムマブ）高濃度製剤の欧州委員会による承認取得について</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639458/0/en/Sandoz-receives-approval-by-European-Commission-for-Hyrimoz-adalimumab-high-concentration-formulation.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639458/0/en/Sandoz-receives-approval-by-European-Commission-for-Hyrimoz-adalimumab-high-concentration-formulation.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 20:30</td>
    <td>ノボ ノルディスク A / S - 株式買戻しプログラム</td>
    <td><a href=https://finance.yahoo.com/quote/NVO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NVO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 20:30</td>
    <td>Theratechnologies、2023年第1四半期決算の発表とビジネスアップデートの提供について</td>
    <td><a href=https://finance.yahoo.com/quote/THTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/THTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 20:30</td>
    <td>テラテクノロジーズ、2023年度第1四半期決算を発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/THTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/THTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 20:30</td>
    <td>コンテクスト・セラピューティクス、2023年4月に2つの投資家向けカンファレンスに参加決定</td>
    <td><a href=https://finance.yahoo.com/quote/CNTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CNTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 20:30</td>
    <td>OpGen社の子会社であるCuretis社がInfectoGnostics社との共同研究プロジェクトでマイルストーン達成</td>
    <td><a href=https://finance.yahoo.com/quote/OPGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OPGN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 20:30</td>
    <td>アビカンナ、2022年12月期の有価証券報告書提出を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639440/0/en/Avicanna-Announces-Filing-of-Annual-Financial-Statements-for-Year-Ended-December-31-2022.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639440/0/en/Avicanna-Announces-Filing-of-Annual-Financial-Statements-for-Year-Ended-December-31-2022.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 20:30</td>
    <td>Entourage Health Corp.の繰延株式ユニットの発行および株式対債務契約締結について</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639442/0/en/Entourage-Health-Corp-Issues-Deferred-Share-Units-and-Enters-into-Shares-for-Debt-Agreements.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639442/0/en/Entourage-Health-Corp-Issues-Deferred-Share-Units-and-Enters-into-Shares-for-Debt-Agreements.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 20:30</td>
    <td>Cyclerion Therapeutics、独占交渉期間および拘束力のある株式投資契約を締結</td>
    <td><a href=https://finance.yahoo.com/quote/CYCN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CYCN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 20:05</td>
    <td>アセンジス・ファーマのTransCon™ IL-2 β / γの進行中のフェーズ1 / 2試験の最初の用量漸増結果がASCO 2023でオンライン公開を受理されました。</td>
    <td><a href=https://finance.yahoo.com/quote/ASND target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ASND</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 20:00</td>
    <td>アルビナス、オンコロジー戦略およびプログラムリーダーシップのグローバル責任者であるシニアバイスプレジデントにKelly Pageを任命</td>
    <td><a href=https://finance.yahoo.com/quote/ARVN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ARVN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 20:00</td>
    <td>アトラス、神経変性疾患をターゲットとした汎アミロイド除去治療薬AT-04およびAT-07の新しい前臨床データをAD / PD 2023で発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639387/0/en/Attralus-Presents-New-Preclinical-Data-on-AT-04-and-AT-07-Pan-Amyloid-Removal-Therapeutics-Targeting-Neurodegenerative-Disorders-at-AD-PD-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639387/0/en/Attralus-Presents-New-Preclinical-Data-on-AT-04-and-AT-07-Pan-Amyloid-Removal-Therapeutics-Targeting-Neurodegenerative-Disorders-at-AD-PD-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 20:00</td>
    <td>Tango Therapeutics社、ファーストインクラスのCoREST阻害剤であるTNG260のSTK11変異体がん治療に関する治験薬申請をFDAに承認されたと発表</td>
    <td><a href=https://finance.yahoo.com/quote/TNGX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TNGX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 20:00</td>
    <td>Shattuck Labs、第22回Needham Virtual Healthcare Conferenceへの出展を発表</td>
    <td><a href=https://finance.yahoo.com/quote/STTK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/STTK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 20:00</td>
    <td>アジオス、2023年版環境・社会・ガバナンス（ESG）報告書を発行</td>
    <td><a href=https://finance.yahoo.com/quote/AGIO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AGIO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 20:00</td>
    <td>ジェネンタ社、Ospedale San Raffaele社とのライセンス契約をすべての固形がんの適応症に延長することを発表</td>
    <td><a href=https://finance.yahoo.com/quote/GNTA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GNTA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 20:00</td>
    <td>Revive Therapeutics社、PharmAla Biotech社からMDMAの供給を受け、MDMA経皮パッチの開発を推進</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639397/0/en/Revive-Therapeutics-Advances-MDMA-Transdermal-Patch-Development-with-Purchase-of-MDMA-Supply-from-PharmAla-Biotech.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639397/0/en/Revive-Therapeutics-Advances-MDMA-Transdermal-Patch-Development-with-Purchase-of-MDMA-Supply-from-PharmAla-Biotech.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 20:00</td>
    <td>Algernon NeuroScience、最大1,000万米ドルを調達するRegulation A+ Tier II Offeringの米国SEC適格認定を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639398/0/en/Algernon-NeuroScience-Announces-U-S-SEC-Qualification-of-Regulation-A-Tier-II-Offering-to-Raise-up-to-USD-10M.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639398/0/en/Algernon-NeuroScience-Announces-U-S-SEC-Qualification-of-Regulation-A-Tier-II-Offering-to-Raise-up-to-USD-10M.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 20:00</td>
    <td>ファイブロジェン社、特発性肺線維症を対象としたパムレブルマブの第3相臨床試験「ZEPHYRUS-2」の患者登録が完了したと発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639399/33525/en/FibroGen-Announces-Completion-of-Patient-Enrollment-in-ZEPHYRUS-2-a-Phase-3-Clinical-Study-of-Pamrevlumab-in-Idiopathic-Pulmonary-Fibrosis.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639399/33525/en/FibroGen-Announces-Completion-of-Patient-Enrollment-in-ZEPHYRUS-2-a-Phase-3-Clinical-Study-of-Pamrevlumab-in-Idiopathic-Pulmonary-Fibrosis.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/03 19:29</td>
    <td>マイデシンがビジネスモデルを変更、財務体質が改善されたと発表</td>
    <td><a href=https://finance.yahoo.com/quote/MYCOF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MYCOF</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 19:30</td>
    <td>CloudMD、米国で処方箋のオンライン更新を開始し、ヘルスケアナビをビジョンケアに拡大</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639369/0/en/CloudMD-Expands-Health-Care-Navigation-to-Vision-Care-with-Launch-of-Online-Prescription-Renewals-in-the-United-States.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639369/0/en/CloudMD-Expands-Health-Care-Navigation-to-Vision-Care-with-Launch-of-Online-Prescription-Renewals-in-the-United-States.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 19:30</td>
    <td>キネータ、第22回Needhamヘルスケアカンファレンスでプレゼンテーションを実施</td>
    <td><a href=https://finance.yahoo.com/quote/KA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/KA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 19:00</td>
    <td>Mydecine Innovations Group、コーポレートアップデートを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639344/0/en/Mydecine-Innovations-Group-Provides-Corporate-Update.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639344/0/en/Mydecine-Innovations-Group-Provides-Corporate-Update.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/03 18:25</td>
    <td>AnPacの株価は、$3MのADSとワラント募集の価格決定後に上昇した。</td>
    <td><a href=https://finance.yahoo.com/quote/ANPC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ANPC</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 18:20</td>
    <td>インファント・バクテリア・セラピューティクス社定時株主総会のお知らせ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639311/0/en/Notice-of-Annual-General-Meeting-of-Infant-Bacterial-Therapeutics.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639311/0/en/Notice-of-Annual-General-Meeting-of-Infant-Bacterial-Therapeutics.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 18:20</td>
    <td>乳幼児用細菌治療薬の研究開発について</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639311/0/sv/Kallelse-till-%C3%A5rsst%C3%A4mma-i-Infant-Bacterial-Therapeutics.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639311/0/sv/Kallelse-till-%C3%A5rsst%C3%A4mma-i-Infant-Bacterial-Therapeutics.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 16:29</td>
    <td>ニュージーランドファーマ社、ナスダック・コペンハーゲンに6,578,948株の新株を上場するための上場目論見書を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639260/0/en/Zealand-Pharma-A-S-publishes-a-listing-prospectus-regarding-admission-to-trading-and-official-listing-of-6-578-948-new-shares-on-Nasdaq-Copenhagen.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639260/0/en/Zealand-Pharma-A-S-publishes-a-listing-prospectus-regarding-admission-to-trading-and-official-listing-of-6-578-948-new-shares-on-Nasdaq-Copenhagen.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 16:01</td>
    <td>キャンサーバックス、バイロン・エルトンを起用</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639256/0/en/CancerVAX-Lands-Byron-Elton.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639256/0/en/CancerVAX-Lands-Byron-Elton.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 16:00</td>
    <td>BCプラットフォームズ、チーフ・メディカル・オフィサーにキャロライン・ベンダー博士を任命</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639247/0/en/BC-Platforms-appoints-Dr-Carolin-Bender-as-Chief-Medical-Officer.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639247/0/en/BC-Platforms-appoints-Dr-Carolin-Bender-as-Chief-Medical-Officer.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 16:00</td>
    <td>aVaxziPen社、World Vaccine Congressにおいて、針なしワクチン、熱安定性デリバリープラットフォームに関する複数の疾患でのポジティブデータを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639248/0/en/aVaxziPen-Announces-Positive-Data-in-Multiple-Diseases-on-Novel-Needle-Free-Vaccine-Thermally-Stable-Delivery-Platform-at-World-Vaccine-Congress.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639248/0/en/aVaxziPen-Announces-Positive-Data-in-Multiple-Diseases-on-Novel-Needle-Free-Vaccine-Thermally-Stable-Delivery-Platform-at-World-Vaccine-Congress.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 15:03</td>
    <td>ジェノミック・ビジョン社がフランス・バイオリード社に参加、フランスにおけるバイオ医薬品の開発・革新に参画</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639232/0/en/Genomic-Vision-rejoint-France-BioLead-pour-participer-au-d%C3%A9veloppement-et-%C3%A0-l-innovation-des-produits-biopharmaceutiques-en-France.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639232/0/en/Genomic-Vision-rejoint-France-BioLead-pour-participer-au-d%C3%A9veloppement-et-%C3%A0-l-innovation-des-produits-biopharmaceutiques-en-France.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 15:00</td>
    <td>Jounce Therapeutics, Inc.とRedx Pharma plcの経営統合提案の終了について</td>
    <td><a href=https://finance.yahoo.com/quote/JNCE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/JNCE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 14:30</td>
    <td>バイオセニック、チーフ・メディカル・オフィサーにLieven Huysse医学博士を任命</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639203/0/en/BioSenic-appoints-Lieven-Huysse-MD-as-Chief-Medical-Officer.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639203/0/en/BioSenic-appoints-Lieven-Huysse-MD-as-Chief-Medical-Officer.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 14:30</td>
    <td>バイオセニック、Lieven Huysse医学博士をメディカルディレクターに任命</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639203/0/fr/BioSenic-nomme-Lieven-Huysse-MD-en-qualit%C3%A9-de-Directeur-M%C3%A9dical.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639203/0/fr/BioSenic-nomme-Lieven-Huysse-MD-en-qualit%C3%A9-de-Directeur-M%C3%A9dical.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 14:00</td>
    <td>ドライAMDにおけるPrima SystemのFDAブレークスルーデバイス指定発表に伴うコミュニケーションについて</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639191/0/en/Communication-following-the-announcement-of-FDA-Breakthrough-Device-Designation-for-the-Prima-System-in-Dry-AMD.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639191/0/en/Communication-following-the-announcement-of-FDA-Breakthrough-Device-Designation-for-the-Prima-System-in-Dry-AMD.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 14:00</td>
    <td>Prima Systemのドライ型AMDに対するFDAブレークスルーデバイス認定発表に伴うコミュニケーションについて</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639191/0/fr/Communication-faisant-suite-%C3%A0-l-annonce-de-l-obtention-du-statut-Breakthrough-Device-de-la-FDA-pour-le-Syst%C3%A8me-Prima-dans-le-traitement-de-la-DMLA-s%C3%A8che.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639191/0/fr/Communication-faisant-suite-%C3%A0-l-annonce-de-l-obtention-du-statut-Breakthrough-Device-de-la-FDA-pour-le-Syst%C3%A8me-Prima-dans-le-traitement-de-la-DMLA-s%C3%A8che.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 14:00</td>
    <td>アドデックス、5.0百万ドルのエクイティファイナンスを実施</td>
    <td><a href=https://finance.yahoo.com/quote/ADXN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ADXN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 14:00</td>
    <td>Sequana Medical社、DSR®2.0のうっ血性心不全治療薬として治験薬（IND）申請を行うことを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639197/0/en/Sequana-Medical-announces-submission-of-Investigational-New-Drug-IND-application-for-DSR-2-0-for-treatment-of-congestive-heart-failure.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639197/0/en/Sequana-Medical-announces-submission-of-Investigational-New-Drug-IND-application-for-DSR-2-0-for-treatment-of-congestive-heart-failure.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 13:32</td>
    <td>OMFAの最新作で、全く新しいレベルのビタミンCサプリメントを体験してみませんか？</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/03/2639188/0/en/Get-ready-to-experience-a-whole-new-level-of-Vitamin-C-supplements-with-the-latest-addition-to-the-market-from-OMFA.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/03/2639188/0/en/Get-ready-to-experience-a-whole-new-level-of-Vitamin-C-supplements-with-the-latest-addition-to-the-market-from-OMFA.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/03 08:00</td>
    <td>微生物を利用した精密腫瘍治療法の開発を加速させるために Trobix Bio社がChartered Groupから300万ドルを調達
</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/02/2639171/0/ja/%E5%BE%AE%E7%94%9F%E7%89%A9%E3%82%92%E5%88%A9%E7%94%A8%E3%81%97%E3%81%9F%E7%B2%BE%E5%AF%86%E8%85%AB%E7%98%8D%E6%B2%BB%E7%99%82%E6%B3%95%E3%81%AE%E9%96%8B%E7%99%BA%E3%82%92%E5%8A%A0%E9%80%9F%E3%81%95%E3%81%9B%E3%82%8B%E3%81%9F%E3%82%81%E3%81%AB-Trobix-Bio%E7%A4%BE%E3%81%8CChartered-Group%E3%81%8B%E3%82%89300%E4%B8%87%E3%83%89%E3%83%AB%E3%82%92%E8%AA%BF%E9%81%94.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/02/2639171/0/ja/%E5%BE%AE%E7%94%9F%E7%89%A9%E3%82%92%E5%88%A9%E7%94%A8%E3%81%97%E3%81%9F%E7%B2%BE%E5%AF%86%E8%85%AB%E7%98%8D%E6%B2%BB%E7%99%82%E6%B3%95%E3%81%AE%E9%96%8B%E7%99%BA%E3%82%92%E5%8A%A0%E9%80%9F%E3%81%95%E3%81%9B%E3%82%8B%E3%81%9F%E3%82%81%E3%81%AB-Trobix-Bio%E7%A4%BE%E3%81%8CChartered-Group%E3%81%8B%E3%82%89300%E4%B8%87%E3%83%89%E3%83%AB%E3%82%92%E8%AA%BF%E9%81%94.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 17:30</td>
    <td>Travere Therapeutics、FILSPARI™（Sparsentan）のIgA腎症に対する第3相PROTECT試験の中間解析結果をThe Lancetに掲載、2023年世界腎臓病学会で発表すると発表</td>
    <td><a href=https://finance.yahoo.com/quote/TVTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TVTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 10:06</td>
    <td>AnPac Bio-Medical Science社、300万ドルの登録型ダイレクトオファリングの価格決定を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ANPC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ANPC</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 09:21</td>
    <td>マイデシネ、2022年12月期決算を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/01/2639107/0/en/Mydecine-Reports-Financial-Results-for-the-Year-Ended-December-2022.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/01/2639107/0/en/Mydecine-Reports-Financial-Results-for-the-Year-Ended-December-2022.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 09:00</td>
    <td>IMACホールディングス、2022年12月期決算とコーポレートアップデートを発表</td>
    <td><a href=https://finance.yahoo.com/quote/IMACW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IMACW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 08:03</td>
    <td>ベリテバイオ、2022年通期のオペレーショナルハイライトと決算を発表</td>
    <td><a href=https://finance.yahoo.com/quote/BLTE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BLTE</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/03 05:32</td>
    <td>アペリス・ファーマシューティカルズ、大手製薬会社から買収の関心 - Bloomberg</td>
    <td><a href=https://finance.yahoo.com/quote/APLS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/APLS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 08:00</td>
    <td>アリディス、コーポレート・アップデートを発表</td>
    <td><a href=https://finance.yahoo.com/quote/ARDS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ARDS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/03 01:00</td>
    <td>メディケイド保険会社、数百万人のCOVID保護が失効し業績悪化</td>
    <td><a href=https://finance.yahoo.com/quote/CNC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CNC</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 07:49</td>
    <td>ABVCバイオファーマ、2022年3月期の財務・事業概況を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ABVC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ABVC</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/02 23:00</td>
    <td>セーゲン／ファイザーのディールスプレッドがますます魅力的になってきたとアナリストが指摘</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 06:42</td>
    <td>バイオサイアント、制限付き株式ユニットの付与を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2639075/0/en/BioSyent-Announces-Grant-of-Restricted-Share-Units.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2639075/0/en/BioSyent-Announces-Grant-of-Restricted-Share-Units.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/02 05:00</td>
    <td>ファイザーによるシーゲン社買収のカギを握る抗体薬物複合体</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 06:32</td>
    <td>スマートフォーライフ、2022年度決算報告およびビジネスアップデートを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2639074/0/en/Smart-for-Life-Reports-2022-Financial-Results-and-Provides-Business-Update.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2639074/0/en/Smart-for-Life-Reports-2022-Financial-Results-and-Provides-Business-Update.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/03 09:01</td>
    <td>Q1のEV納入台数 $TSLA - 422,875 $LI - 52,584 $NIO - 31,041 $XPEV - 18,230</td>
    <td><a href=https://finance.yahoo.com/quote/TSLA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TSLA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/01 06:35</td>
    <td>マゼンタ、不要な入札を阻止するために株主権利プランを採択</td>
    <td><a href=https://finance.yahoo.com/quote/MGTA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MGTA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 17:30</td>
    <td>Travere Therapeutics、FILSPARI™（Sparsentan）のIgA腎症に対する第3相PROTECT試験の中間解析結果をThe Lancetに掲載、2023年世界腎臓病学会で発表すると発表</td>
    <td><a href=https://finance.yahoo.com/quote/TVTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TVTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 10:06</td>
    <td>AnPac Bio-Medical Science社、300万ドルの登録型ダイレクトオファリングの価格決定を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ANPC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ANPC</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 09:21</td>
    <td>マイデシネ、2022年12月期決算を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/01/2639107/0/en/Mydecine-Reports-Financial-Results-for-the-Year-Ended-December-2022.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/01/2639107/0/en/Mydecine-Reports-Financial-Results-for-the-Year-Ended-December-2022.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 09:00</td>
    <td>IMACホールディングス、2022年12月期決算とコーポレートアップデートを発表</td>
    <td><a href=https://finance.yahoo.com/quote/IMACW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IMACW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 08:03</td>
    <td>ベリテバイオ、2022年通期のオペレーショナルハイライトと決算を発表</td>
    <td><a href=https://finance.yahoo.com/quote/BLTE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BLTE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 08:00</td>
    <td>アリディス、コーポレート・アップデートを発表</td>
    <td><a href=https://finance.yahoo.com/quote/ARDS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ARDS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/02 05:00</td>
    <td>ファイザーによるシーゲン社買収のカギを握る抗体薬物複合体</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/01 06:35</td>
    <td>マゼンタ、不要な入札を阻止するために株主権利プランを採択</td>
    <td><a href=https://finance.yahoo.com/quote/MGTA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MGTA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 07:49</td>
    <td>ABVCバイオファーマ、2022年3月期の財務・事業概況を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ABVC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ABVC</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/01 06:32</td>
    <td>エイミリス、株式の売出しに着手 - 出願</td>
    <td><a href=https://finance.yahoo.com/quote/AMRS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMRS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 06:42</td>
    <td>バイオサイアント、制限付き株式ユニットの付与を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2639075/0/en/BioSyent-Announces-Grant-of-Restricted-Share-Units.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2639075/0/en/BioSyent-Announces-Grant-of-Restricted-Share-Units.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/01 05:54</td>
    <td>Medicare finalizes 3.3% rise for 2024 Medicare Advantage pay rates
</td>
    <td><a href=https://finance.yahoo.com/quote/UNH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/UNH</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 06:32</td>
    <td>スマートフォーライフ、2022年度決算報告およびビジネスアップデートを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2639074/0/en/Smart-for-Life-Reports-2022-Financial-Results-and-Provides-Business-Update.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2639074/0/en/Smart-for-Life-Reports-2022-Financial-Results-and-Provides-Business-Update.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/01 10:10</td>
    <td>ChatGPT、プライバシーへの配慮からイタリアで禁止に</td>
    <td><a href=https://t.co/mm2hhQK64d target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://t.co/mm2hhQK64d</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 06:00</td>
    <td>オンコサイト、2022年第4四半期および通期決算の速報値およびForm 10-Kの提出期限を延長するForm 12b-25の提出予定について</td>
    <td><a href=https://finance.yahoo.com/quote/OCX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OCX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/01 05:09</td>
    <td>ヴィアトリス、最初のオファーが期待外れだったため、OTC事業の新たな入札を要請 - レポート</td>
    <td><a href=https://finance.yahoo.com/quote/VTRS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VTRS</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/04/01 23:08</td>
    <td>ウォーレン・バフェットのバークシャー・ハサウェイは今年、アップル株で300億ドルの利益を獲得したようです。$AAPL 🐐」。</td>
    <td><a href=https://t.co/HA8k5Ly6LJ target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://t.co/HA8k5Ly6LJ</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 17:30</td>
    <td>Travere Therapeutics、FILSPARI™（Sparsentan）のIgA腎症に対する第3相PROTECT試験の中間解析結果をThe Lancetに掲載、2023年世界腎臓病学会で発表すると発表</td>
    <td><a href=https://finance.yahoo.com/quote/TVTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TVTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 10:06</td>
    <td>AnPac Bio-Medical Science社、300万ドルの登録型ダイレクトオファリングの価格決定を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ANPC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ANPC</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 09:21</td>
    <td>マイデシネ、2022年12月期決算を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/04/01/2639107/0/en/Mydecine-Reports-Financial-Results-for-the-Year-Ended-December-2022.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/04/01/2639107/0/en/Mydecine-Reports-Financial-Results-for-the-Year-Ended-December-2022.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 09:00</td>
    <td>IMACホールディングス、2022年12月期決算とコーポレートアップデートを発表</td>
    <td><a href=https://finance.yahoo.com/quote/IMACW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IMACW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 08:03</td>
    <td>ベリテバイオ、2022年通期のオペレーショナルハイライトと決算を発表</td>
    <td><a href=https://finance.yahoo.com/quote/BLTE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BLTE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 08:00</td>
    <td>アリディス、コーポレート・アップデートを発表</td>
    <td><a href=https://finance.yahoo.com/quote/ARDS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ARDS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/01 06:35</td>
    <td>マゼンタ、不要な入札を阻止するために株主権利プランを採択</td>
    <td><a href=https://finance.yahoo.com/quote/MGTA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MGTA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 07:49</td>
    <td>ABVCバイオファーマ、2022年3月期の財務・事業概況を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ABVC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ABVC</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/01 06:32</td>
    <td>エイミリス、株式の売出しに着手 - 出願</td>
    <td><a href=https://finance.yahoo.com/quote/AMRS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMRS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 06:42</td>
    <td>バイオサイアント、制限付き株式ユニットの付与を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2639075/0/en/BioSyent-Announces-Grant-of-Restricted-Share-Units.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2639075/0/en/BioSyent-Announces-Grant-of-Restricted-Share-Units.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 06:32</td>
    <td>スマートフォーライフ、2022年度決算報告およびビジネスアップデートを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2639074/0/en/Smart-for-Life-Reports-2022-Financial-Results-and-Provides-Business-Update.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2639074/0/en/Smart-for-Life-Reports-2022-Financial-Results-and-Provides-Business-Update.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 06:00</td>
    <td>オンコサイト、2022年第4四半期および通期決算の速報値およびForm 10-Kの提出期限を延長するForm 12b-25の提出予定について</td>
    <td><a href=https://finance.yahoo.com/quote/OCX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OCX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 06:00</td>
    <td>Pyxis Oncology社、ナスダック上場規則5635(c)(4)に基づく誘引付与の報告について</td>
    <td><a href=https://finance.yahoo.com/quote/PYXS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PYXS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 06:00</td>
    <td>SAB Biotherapeutics、2022年通年の会社概要を発表</td>
    <td><a href=https://finance.yahoo.com/quote/SABSW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SABSW</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/01 05:54</td>
    <td>Medicare finalizes 3.3% rise for 2024 Medicare Advantage pay rates
</td>
    <td><a href=https://finance.yahoo.com/quote/UNH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/UNH</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 05:51</td>
    <td>株式会社太平洋医療機構 2022年12月期決算のご報告</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2639056/27443/en/Pacific-Health-Care-Organization-Inc-Reports-its-2022-Year-End-Financial-Results.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2639056/27443/en/Pacific-Health-Care-Organization-Inc-Reports-its-2022-Year-End-Financial-Results.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/31 09:45</td>
    <td>DICE、Ra Capitalによる$14.8Mの普通株式取得を報告</td>
    <td><a href=https://finance.yahoo.com/quote/DICE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DICE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 05:50</td>
    <td>Heart to Heart CPRが、最も必要としているコミュニティに対して、無料のナロキソンキットとオピオイド対応トレーニングを提供するようになりました！</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2639055/0/en/Heart-to-Heart-CPR-Now-Offering-Free-Naloxone-Kits-and-Opioid-Response-Training-to-Communities-Most-in-Need.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2639055/0/en/Heart-to-Heart-CPR-Now-Offering-Free-Naloxone-Kits-and-Opioid-Response-Training-to-Communities-Most-in-Need.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/01 05:09</td>
    <td>ヴィアトリス、最初のオファーが期待外れだったため、OTC事業の新たな入札を要請 - レポート</td>
    <td><a href=https://finance.yahoo.com/quote/VTRS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VTRS</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/31 09:56</td>
    <td>HCM、難治性転移性大腸がん治療薬Fruquintinibの新薬承認申請のローリングサブミッションを完了</td>
    <td><a href=https://finance.yahoo.com/quote/HCM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HCM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 05:48</td>
    <td>グッドネス・グロース・ホールディングス、2022年第4四半期および通期決算を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2639053/0/en/Goodness-Growth-Holdings-Announces-Fourth-Quarter-and-Full-Year-2022-Results.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2639053/0/en/Goodness-Growth-Holdings-Announces-Fourth-Quarter-and-Full-Year-2022-Results.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/01 04:00</td>
    <td>カタリストウォッチ： テスラ納品、ウォルマートイベント、雇用統計がビッグウィークのヘッドラインを飾る</td>
    <td><a href=https://finance.yahoo.com/quote/SPY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SPY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 05:30</td>
    <td>議決権および株式の総数に関する情報</td>
    <td><a href=https://finance.yahoo.com/quote/NYXH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NYXH</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/01 03:17</td>
    <td>メディケアの保険適用決定でLucid Diagnosticsが急騰</td>
    <td><a href=https://finance.yahoo.com/quote/LUCD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LUCD</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/31 21:00</td>
    <td>CYTK ALS治療薬の開発中止 ph3試験の中間解析で薬効がないと判断されたため。将来性あり。</td>
    <td><a href=https://finance.yahoo.com/quote/CYTK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CYTK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/04/01 05:30</td>
    <td>議決権および株式の総数に関する情報</td>
    <td><a href=https://finance.yahoo.com/quote/NYXH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NYXH</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/04/01 02:44</td>
    <td>イマティクス、みずほで買い入れ開始、TCRの機会が過小評価されたため</td>
    <td><a href=https://finance.yahoo.com/quote/IMTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IMTX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/31 21:01</td>
    <td>$TGTX TG Therapeutics Announces Positive CHMP Opinion for BRIUMVI™ (ublituximab-xiiy) for the Treatment of Relapsing Forms of Multiple Sclerosis in Adults | TG Therapeutics, Inc.        
</td>
    <td><a href=https://finance.yahoo.com/quote/TGTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TGTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 22:35</td>
    <td>クワッドエムソリューションズ株式会社 退職金の貯蓄を促進する革新的な保険商品を提供するため、Stayput Insurance Inc.を立ち上げ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2638747/0/en/Quad-M-Solutions-Inc-Launches-Stayput-Insurance-Inc-to-Offer-Innovative-Insurance-Products-to-Encourage-Workers-to-Save-for-Retirement.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2638747/0/en/Quad-M-Solutions-Inc-Launches-Stayput-Insurance-Inc-to-Offer-Innovative-Insurance-Products-to-Encourage-Workers-to-Save-for-Retirement.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 22:25</td>
    <td>ベターチョイスの新製品「Halo Elevate」がペット専門店チャネルで好調な売上成長を達成</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2638718/0/en/Better-Choice-New-Product-Line-Halo-Elevate-Achieves-Strong-Sales-Growth-in-Pet-Specialty-Channel.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2638718/0/en/Better-Choice-New-Product-Line-Halo-Elevate-Achieves-Strong-Sales-Growth-in-Pet-Specialty-Channel.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 22:18</td>
    <td>Assure Holdings、2022年第4四半期および年末のカンファレンスコールを2023年4月3日（月）午前9時（日本時間）に設定。</td>
    <td><a href=https://finance.yahoo.com/quote/IONM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IONM</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/31 21:42</td>
    <td>UnitedHealthによるEMISの買収が英国で詳細な調査の対象に</td>
    <td><a href=https://finance.yahoo.com/quote/UNH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/UNH</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/31 21:36</td>
    <td>サムスンバイオエピスのアストラゼネカ社「ソリリス」に対するバイオシミラー、EU承認に向け背中を押す</td>
    <td><a href=https://finance.yahoo.com/quote/AZN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AZN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 22:00</td>
    <td>Telesis Bio社、DNA増幅とスケールアップを可能にする「BioXp® Select」キットを発売</td>
    <td><a href=https://finance.yahoo.com/quote/TBIO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TBIO</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/31 21:32</td>
    <td>チェックポイント・セラピューティクス、株式公開で610万ドル調達へ</td>
    <td><a href=https://finance.yahoo.com/quote/CKPT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CKPT</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/31 21:21</td>
    <td>フェネックのPedmarqsiがEMAのパネルでEU承認に向け承認される</td>
    <td><a href=https://finance.yahoo.com/quote/FENC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/FENC</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/31 21:02</td>
    <td>リリーの潰瘍性大腸炎治療薬「Omvoh」、EMAの承認でEU承認に大きく近づく</td>
    <td><a href=https://finance.yahoo.com/quote/LLY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LLY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 21:30</td>
    <td>ベレロフォン、臨床プログラムの最新情報および2022年通期決算を発表</td>
    <td><a href=https://finance.yahoo.com/quote/BLPH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BLPH</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 21:15</td>
    <td>Ocugen Chief Scientific Officerが2023年World Vaccine Congressで発表</td>
    <td><a href=https://finance.yahoo.com/quote/OCGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OCGN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 21:03</td>
    <td>フェネック社、小児がん患者の難聴リスク軽減を目的としたPedmarqsi™（チオ硫酸ナトリウム）のCHMP肯定的意見を受領</td>
    <td><a href=https://finance.yahoo.com/quote/FENC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/FENC</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 21:00</td>
    <td>サムスンバイオエピス、エクリズマブ・バイオシミラー「EPYSQLI™」のCHMPにおける肯定的な意見を受領</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2638602/0/en/Samsung-Bioepis-Receives-Positive-CHMP-Opinion-for-Eculizumab-Biosimilar-EPYSQLI.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2638602/0/en/Samsung-Bioepis-Receives-Positive-CHMP-Opinion-for-Eculizumab-Biosimilar-EPYSQLI.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 21:00</td>
    <td>チェックポイント・セラピューティクス社、6.1百万ドルの登録型直接公募をナスダック規則により市場価格で実施すると発表</td>
    <td><a href=https://finance.yahoo.com/quote/CKPT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CKPT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 21:00</td>
    <td>イミックス・バイオファーマの子会社であるネクセラ社が、米国食品医薬品局承認のBCMA CAR T細胞におけるNXC-201の有効性を強調する2023年Hematologica誌の論説を発表</td>
    <td><a href=https://finance.yahoo.com/quote/IMMX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IMMX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 21:00</td>
    <td>シダラ・セラピューティクス、投資家向けカンファレンスに参加決定</td>
    <td><a href=https://finance.yahoo.com/quote/CDTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CDTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 21:00</td>
    <td>Jasper Therapeutics、Cantor Fitzgerald's The Future of Oncology Virtual Symposiumでプレゼンテーションを実施</td>
    <td><a href=https://finance.yahoo.com/quote/JSPR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/JSPR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 21:00</td>
    <td>TScan Therapeutics、CEOの交代を発表</td>
    <td><a href=https://finance.yahoo.com/quote/TCRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TCRX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 21:00</td>
    <td>STRATA Skin Sciences、2022年第4四半期に過去最高の売上高を記録</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2638591/23161/en/STRATA-Skin-Sciences-Reports-Record-Fourth-Quarter-2022-Revenue.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2638591/23161/en/STRATA-Skin-Sciences-Reports-Record-Fourth-Quarter-2022-Revenue.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/31 20:19</td>
    <td>ループスに対するCAR T細胞療法「Cabaletta」がFDAから試験開始の承認を取得</td>
    <td><a href=https://finance.yahoo.com/quote/CABA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CABA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/31 20:16</td>
    <td>P3 Health Partners、株式公開で9000万ドル調達へ</td>
    <td><a href=https://finance.yahoo.com/quote/PIII target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PIII</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 20:30</td>
    <td>TGセラピューティクス、成人の再発型多発性硬化症治療薬BRIUMVI™（ublituximab-xiiy）のCHMPにおける肯定的な意見を発表</td>
    <td><a href=https://finance.yahoo.com/quote/TGTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TGTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 20:30</td>
    <td>サイトキネティクス社、COURAGE-ALSが第2中間解析で不妊症の基準を満たしたと発表</td>
    <td><a href=https://finance.yahoo.com/quote/CYTK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CYTK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 20:18</td>
    <td>ゲルベ：2022年版ユニバーサル登録証の提供開始について</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2638538/0/fr/GUERBET-Mise-%C3%A0-disposition-du-Document-d-enregistrement-universel-2022.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2638538/0/fr/GUERBET-Mise-%C3%A0-disposition-du-Document-d-enregistrement-universel-2022.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 20:00</td>
    <td>バイオパス・ホールディングス、2022年通期決算を発表</td>
    <td><a href=https://finance.yahoo.com/quote/BPTH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BPTH</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 20:00</td>
    <td>バイオクリスト、ナンシー・ハトソン博士を取締役会議長に任命</td>
    <td><a href=https://finance.yahoo.com/quote/BCRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BCRX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 20:00</td>
    <td>マイルストン・サイエンティフィック、2022年末の事業概況を発表</td>
    <td><a href=https://finance.yahoo.com/quote/MLSS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MLSS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 20:00</td>
    <td>バイオベンタス社、財務および経営の柔軟性を高めるため、クレジット契約の貸し手と修正契約を締結</td>
    <td><a href=https://finance.yahoo.com/quote/BVS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BVS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 20:00</td>
    <td>Tiziana Life Sciences、スウェーデンで開催される「アルツハイマー病・パーキンソン病および関連神経疾患に関する国際会議」でHoward Weiner博士が発表するアルツハイマー病治療のための抗CD3 mAb研究についての発表を発表</td>
    <td><a href=https://finance.yahoo.com/quote/TLSA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TLSA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 20:00</td>
    <td>カバレッタ・バイオ、CABA-201の全身性エリテマトーデス治療薬IND申請のFDAクリアランスを取得</td>
    <td><a href=https://finance.yahoo.com/quote/CABA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CABA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/31 19:32</td>
    <td>Eledon tegoprubart、第1b相試験で腎臓移植患者さんに有望な結果を示す</td>
    <td><a href=https://finance.yahoo.com/quote/ELDN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ELDN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/31 19:17</td>
    <td>Aurora Cannabis repurchased a portion of convertible notes at a 2.5% discount to par value, maintains strong balance sheet
</td>
    <td><a href=https://finance.yahoo.com/quote/ACB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ACB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 19:00</td>
    <td>InvestmentPitch Media Videoで、Reliq Healthと10件の契約を締結し、年末までに5,000人の新規患者をiUGOプラットフォームに追加する可能性があることを議論しました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2638458/0/en/InvestmentPitch-Media-Video-Discusses-Reliq-Health-and-its-Signing-of-10-Contracts-Potentially-Adding-5-000-new-Patients-to-its-iUGO-Platform-by-Year-End.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2638458/0/en/InvestmentPitch-Media-Video-Discusses-Reliq-Health-and-its-Signing-of-10-Contracts-Potentially-Adding-5-000-new-Patients-to-its-iUGO-Platform-by-Year-End.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 19:00</td>
    <td>エレドン、腎移植患者を対象としたTegoprubartの臨床第1b相試験データを世界腎臓学会で発表</td>
    <td><a href=https://finance.yahoo.com/quote/ELDN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ELDN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 19:00</td>
    <td>ネクスティム・ピーエルシー 定時株主総会の決議事項</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2638466/0/en/Nexstim-Plc-Resolutions-of-the-Annual-General-Meeting-of-Shareholders.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2638466/0/en/Nexstim-Plc-Resolutions-of-the-Annual-General-Meeting-of-Shareholders.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 19:00</td>
    <td>Nexstim Oyj：年次総会の決定事項</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2638466/0/fi/Nexstim-Oyj-varsinaisen-yhti%C3%B6kokouksen-p%C3%A4%C3%A4t%C3%B6kset.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2638466/0/fi/Nexstim-Oyj-varsinaisen-yhti%C3%B6kokouksen-p%C3%A4%C3%A4t%C3%B6kset.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 19:00</td>
    <td>Nexstim Plc：定時株主総会での決議内容</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2638466/0/sv/Nexstim-Abp-ordinarie-bolagsst%C3%A4mmans-beslut.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2638466/0/sv/Nexstim-Abp-ordinarie-bolagsst%C3%A4mmans-beslut.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/31 18:00</td>
    <td>ナビデアの最高医療責任者が退任、G2Gベンチャーズをコンサルタントに採用</td>
    <td><a href=https://finance.yahoo.com/quote/NAVB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NAVB</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/31 17:32</td>
    <td>サノフィ、インドの消費者向け事業を分社化する計画-報告書</td>
    <td><a href=https://finance.yahoo.com/quote/SNY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SNY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 17:00</td>
    <td>ジュンシバイオサイエンス、2022年通期決算の発表と企業情報の更新について</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2638412/0/en/Junshi-Biosciences-Announces-2022-Full-Year-Financial-Results-and-Provides-Corporate-Updates.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2638412/0/en/Junshi-Biosciences-Announces-2022-Full-Year-Financial-Results-and-Provides-Corporate-Updates.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 15:00</td>
    <td>Mendus AB: Mendus AB (publ) の株式数および議決権数の変更について</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2638354/0/en/Mendus-AB-Change-in-number-of-shares-and-votes-in-Mendus-AB-publ.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2638354/0/en/Mendus-AB-Change-in-number-of-shares-and-votes-in-Mendus-AB-publ.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 15:00</td>
    <td>Mendus AB: Mendus AB (publ) の株式数および議決権数の変更について</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2638354/0/sv/Mendus-AB-%C3%84ndring-av-antalet-aktier-och-r%C3%B6ster-i-Mendus-AB-publ.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2638354/0/sv/Mendus-AB-%C3%84ndring-av-antalet-aktier-och-r%C3%B6ster-i-Mendus-AB-publ.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 14:55</td>
    <td>コロプラのLuja™が他社製カテーテルと比較して膀胱の空洞化を有意に改善することを示す試験結果</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2638352/0/en/Study-shows-significant-improvement-in-bladder-emptying-with-Coloplast-s-Luja-compared-to-competitor-catheter.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2638352/0/en/Study-shows-significant-improvement-in-bladder-emptying-with-Coloplast-s-Luja-compared-to-competitor-catheter.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 14:55</td>
    <td>コロプラのLuja™が他社製カテーテルと比較して膀胱の空洞化を有意に改善することを示す試験結果</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2638352/0/da/Studie-viser-signifikant-forbedring-af-bl%C3%A6ret%C3%B8mning-med-Coloplasts-Luja-sammenlignet-med-konkurrentkateter.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2638352/0/da/Studie-viser-signifikant-forbedring-af-bl%C3%A6ret%C3%B8mning-med-Coloplasts-Luja-sammenlignet-med-konkurrentkateter.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 14:00</td>
    <td>Valneva社、2022年世界登録文書および米国フォーム20-Fの提出を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2638339/0/en/Valneva-Announces-Filing-of-2022-Universal-Registration-Document-and-US-Form-20-F.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2638339/0/en/Valneva-Announces-Filing-of-2022-Universal-Registration-Document-and-US-Form-20-F.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 14:00</td>
    <td>バルネバ、ユニバーサル登録文書2022および米国年次報告書（Form 20-F）の提出を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2638339/0/fr/Valneva-annonce-le-d%C3%A9p%C3%B4t-de-son-Document-d-Enregistrement-Universel-2022-et-de-son-rapport-annuel-am%C3%A9ricain-Form-20-F.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2638339/0/fr/Valneva-annonce-le-d%C3%A9p%C3%B4t-de-son-Document-d-Enregistrement-Universel-2022-et-de-son-rapport-annuel-am%C3%A9ricain-Form-20-F.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 14:00</td>
    <td>Pixium Vision、Prima SystemのドライAMDに対するFDAブレークスルーデバイス指定について発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2638340/0/en/Pixium-Vision-announces-FDA-Breakthrough-Device-Designation-for-the-Prima-System-in-Dry-AMD.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2638340/0/en/Pixium-Vision-announces-FDA-Breakthrough-Device-Designation-for-the-Prima-System-in-Dry-AMD.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 14:00</td>
    <td>Pixium Vision社、Prima Systemのドライ型AMDに対するFDAブレークスルーデバイス認定を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2638340/0/fr/Pixium-Vision-annonce-l-obtention-du-statut-Breakthrough-Device-de-la-FDA-pour-le-Syst%C3%A8me-Prima-dans-le-traitement-de-la-DMLA-s%C3%A8che.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2638340/0/fr/Pixium-Vision-annonce-l-obtention-du-statut-Breakthrough-Device-de-la-FDA-pour-le-Syst%C3%A8me-Prima-dans-le-traitement-de-la-DMLA-s%C3%A8che.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 14:00</td>
    <td>バイオセニック、決算短信と財務カレンダー（2023年）を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2638341/0/en/BioSenic-provides-Financial-Update-and-Financial-Calendar-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2638341/0/en/BioSenic-provides-Financial-Update-and-Financial-Calendar-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 14:00</td>
    <td>バイオセニック、決算短信と2023年財務カレンダーを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2638341/0/fr/BioSenic-publie-une-mise-%C3%A0-jour-financi%C3%A8re-et-pr%C3%A9sente-le-calendrier-financier-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2638341/0/fr/BioSenic-publie-une-mise-%C3%A0-jour-financi%C3%A8re-et-pr%C3%A9sente-le-calendrier-financier-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 13:33</td>
    <td>Theriva Biologics社、第4四半期および2022年度の事業ハイライトと決算を発表</td>
    <td><a href=https://finance.yahoo.com/quote/TOVX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TOVX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 09:05</td>
    <td>ジェイミソン・ウェルネス・インク（Jamieson Wellness Inc. 年次株主総会および臨時株主総会のための経営情報サーキュラーの提出を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/31/2638312/0/en/Jamieson-Wellness-Inc-Announces-Filing-of-Management-Information-Circular-for-Annual-and-Special-Meeting-of-Shareholders.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/31/2638312/0/en/Jamieson-Wellness-Inc-Announces-Filing-of-Management-Information-Circular-for-Annual-and-Special-Meeting-of-Shareholders.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 09:00</td>
    <td>チェックポイント・セラピューティクス、2022年通期決算と最近のコーポレートハイライトを発表</td>
    <td><a href=https://finance.yahoo.com/quote/CKPT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CKPT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 09:00</td>
    <td>HUTCHMED、難治性転移性大腸がん治療薬Fruquintinibの米国FDAへの新薬承認申請（Rolling Submission）を完了</td>
    <td><a href=https://finance.yahoo.com/quote/HCM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HCM</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/31 07:50</td>
    <td>第1四半期の米国IPO市場は、世界市場が沈む中、緩やかに上昇した</td>
    <td><a href=https://finance.yahoo.com/quote/IPO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IPO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 08:30</td>
    <td>レカネマブの第2相試験201試験の追加詳細解析結果が査読付きジャーナルに3報掲載されました。</td>
    <td><a href=https://finance.yahoo.com/quote/BIIB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BIIB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 08:30</td>
    <td>エーザイ、AD / PD™ 2023年次総会でクラリティADにおけるレカネマブのARIAおよびQOLに関する新しい解析結果を発表</td>
    <td><a href=https://finance.yahoo.com/quote/BIIB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BIIB</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/30 06:30</td>
    <td>メタバースは急速にメチャクチャになりつつある $DIS $META $MANA $MSFT $SAND</td>
    <td><a href=https://finance.yahoo.com/quote/DIS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DIS</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/30 20:02</td>
    <td>AVXL ANAVEX®2-73、パーキンソン病認知症患者を対象とした48週投与の長期第2相試験で臨床的有用性を示す</td>
    <td><a href=https://finance.yahoo.com/quote/AVXL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AVXL</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/30 20:03</td>
    <td>TRVN社、200人規模の実臨床試験で得られたOLINVYKの初期トップラインデータを発表</td>
    <td><a href=https://finance.yahoo.com/quote/TRVN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TRVN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/30 20:04</td>
    <td>DFN社とEIP Pharma社が合併し、神経変性疾患を治療する中枢神経系に特化したリーディングカンパニーを設立することを発表</td>
    <td><a href=https://finance.yahoo.com/quote/DFFN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DFFN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/30 20:05</td>
    <td>SCYX $GSK GSKとSCYNEXISは、真菌感染症を治療する新規のファーストインクラス医薬品であるBrexafemme（イブレキサファンガープ）の商業化とさらなる開発に関する独占契約を締結したと発表 90Mドルの契約金を支払う</td>
    <td><a href=https://finance.yahoo.com/quote/SCYX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SCYX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 07:10</td>
    <td>モレキュラー・テンプレーツ・インク（Molecular Templates, Inc. 2022年第4四半期決算とビジネスアップデートを発表</td>
    <td><a href=https://finance.yahoo.com/quote/MTEM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MTEM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 06:00</td>
    <td>ローウェル・ファームズ・インク（Lowell Farms Inc. 2022年第4四半期および会計年度の監査済み財務・経営成績を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2638248/0/en/Lowell-Farms-Inc-Announces-Audited-Fourth-Quarter-and-Fiscal-Year-2022-Financial-and-Operational-Results.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2638248/0/en/Lowell-Farms-Inc-Announces-Audited-Fourth-Quarter-and-Fiscal-Year-2022-Financial-and-Operational-Results.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/30 21:13</td>
    <td>Brainstorm $BCLI 2022年12月31日時点で現金$3Mにダウン。  同社は第1四半期にATMで$3.3Mを調達した。  NurOwnとFDAのadcommのことは忘れて、この会社はどうやってビジネスを維持するつもりなんだ？</td>
    <td><a href=https://finance.yahoo.com/quote/BCLI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BCLI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 05:45</td>
    <td>ニュージーランド・ファーマ、総額15億デンマーククローネを調達する6,578,948百万株の普通株式の発行と私募を完了したと発表しました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2638243/0/en/Zealand-Pharma-announces-completion-of-a-directed-issue-and-private-placement-of-6-578-948-million-new-ordinary-shares-raising-gross-proceeds-of-DKK-1-5-billion.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2638243/0/en/Zealand-Pharma-announces-completion-of-a-directed-issue-and-private-placement-of-6-578-948-million-new-ordinary-shares-raising-gross-proceeds-of-DKK-1-5-billion.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/30 21:14</td>
    <td>PDSB、頭頸部がんを対象としたPDS0101とKEYTRUDAの併用によるフェーズ3試験の開始計画を発表。</td>
    <td><a href=https://finance.yahoo.com/quote/PDSB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PDSB</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/31 07:39</td>
    <td>Galapagos社、フランスでの創薬・研究活動をNovAliX社に移管へ</td>
    <td><a href=https://finance.yahoo.com/quote/GLPG target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GLPG</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 05:39</td>
    <td>マイクロンソリューションズ、Inc. 2022年第4四半期および通期決算を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2638238/31213/en/Micron-Solutions-Inc-Reports-Fourth-Quarter-and-Full-Year-2022-Results.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2638238/31213/en/Micron-Solutions-Inc-Reports-Fourth-Quarter-and-Full-Year-2022-Results.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/30 21:32</td>
    <td>VTGN 社交不安障害治療薬Fasedienol（PH94B）のフェーズ3開発におけるエンドポイントとしてのLiebowitz Social Anxiety Scale（LSAS）の使用について、FDAからポジティブなフィードバックがあった。</td>
    <td><a href=https://finance.yahoo.com/quote/VTGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VTGN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/31 07:04</td>
    <td>Ambrx Biopharma、株式とADSの販売で3億ドルを調達へ-ファイリング</td>
    <td><a href=https://finance.yahoo.com/quote/AMAM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMAM</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/30 21:34</td>
    <td>銀行危機の時のナスダック😂。</td>
    <td><a href=https://t.co/aDb4nczPYp target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://t.co/aDb4nczPYp</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 05:30</td>
    <td>ガラパゴスとNovAliX社、統合的な創薬共同研究を開始</td>
    <td><a href=https://finance.yahoo.com/quote/GLPG target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GLPG</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/31 06:59</td>
    <td>Y-mAbs Therapeutics社が$150Mの混合シェルフオファリングを申請。</td>
    <td><a href=https://finance.yahoo.com/quote/YMAB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/YMAB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 05:30</td>
    <td>ガラパゴスとNovAliX社、統合的な創薬研究の提携を締結</td>
    <td><a href=https://finance.yahoo.com/quote/GLPG target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GLPG</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/30 21:38</td>
    <td>GDP (QoQ) (Q4) 2.6% vs 2.7% Est. Jobless Claims +7K To 198K vs. 195K Est.
</td>
    <td><a href= target="_blank" rel="noopener noreferrer" style="display: inline-block;"></a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/31 06:33</td>
    <td>カール・アイカーン、イルミナの戦いは決闘声明で続く</td>
    <td><a href=https://finance.yahoo.com/quote/ILMN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ILMN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 05:30</td>
    <td>Sutro Biopharma、2022年通期決算、ビジネスハイライトおよび予想されるマイルストーンの選定を発表</td>
    <td><a href=https://finance.yahoo.com/quote/STRO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/STRO</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/31 05:55</td>
    <td>GreenLight Biosciences draws private equity interest; up 10%
</td>
    <td><a href=https://finance.yahoo.com/quote/GRNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GRNA</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/30 21:50</td>
    <td>BCTX、臨床前段階の資産をスピンアウトし、新たに設立される「SpinCo」にて、株主が保有するBriaCellの株式1株に加え、「SpinCo」の株式1株を取得する意向を発表</td>
    <td><a href=https://finance.yahoo.com/quote/BCTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BCTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/31 05:15</td>
    <td>IN8bio、2022年第4四半期および通期の決算報告とコーポレートアップデートを発表</td>
    <td><a href=https://finance.yahoo.com/quote/INAB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/INAB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 22:05</td>
    <td>HearingLife Canada、AIを搭載した新しい補聴器を全国のクリニックに導入</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637732/0/en/HearingLife-Canada-Brings-New-AI-Powered-Hearing-Aids-to-Clinics-Nationwide.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637732/0/en/HearingLife-Canada-Brings-New-AI-Powered-Hearing-Aids-to-Clinics-Nationwide.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 22:00</td>
    <td>移植ロジスティクスのリーダーであるMediGOが、臓器調達・移植ネットワーク近代化イニシアチブに関するHRSAの発表を歓迎する声明を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637682/0/en/Transplant-Logistics-Leader-MediGO-Issues-Statement-Welcoming-HRSA-Announcement-on-Organ-Procurement-and-Transplantation-Network-Modernization-Initiative.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637682/0/en/Transplant-Logistics-Leader-MediGO-Issues-Statement-Welcoming-HRSA-Announcement-on-Organ-Procurement-and-Transplantation-Network-Modernization-Initiative.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 22:00</td>
    <td>リリーバント メドシステムズ、2023年ギャラップ優秀職場賞を受賞</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637679/0/en/Relievant-Medsystems-Receives-2023-Gallup-Exceptional-Workplace-Award.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637679/0/en/Relievant-Medsystems-Receives-2023-Gallup-Exceptional-Workplace-Award.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 22:00</td>
    <td>ラコビナ・セラピューティクス・インク（Rakovina Therapeutics Inc. 流動性の向上と投資家向け啓発プログラムの実施を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637711/0/en/Rakovina-Therapeutics-Inc-Announces-Enhanced-Liquidity-and-Investor-Awareness-Programs.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637711/0/en/Rakovina-Therapeutics-Inc-Announces-Enhanced-Liquidity-and-Investor-Awareness-Programs.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 21:45</td>
    <td>ブライセル社、臨床前段階の資産をスピンアウトし、新たに設立される「SpinCo」にて、株主が保有するブライセル社株式1株に加え、「SpinCo」株式1株を取得する意向を発表</td>
    <td><a href=https://finance.yahoo.com/quote/BCTXW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BCTXW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 21:45</td>
    <td>ヘピオン・ファーマシューティカルズ、4名の肝疾患KOLを任命しSABを拡大</td>
    <td><a href=https://finance.yahoo.com/quote/HEPA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HEPA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 21:45</td>
    <td>AIMイミュノテック、製薬業界のベテラン、ナンシー・K・ブライアンの起用で取締役会を強化、商業、マーケティング、事業開発、コーポレートファイナンスに精通</td>
    <td><a href=https://finance.yahoo.com/quote/AIM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AIM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 21:40</td>
    <td>NurExone Announces Q4 and Full-year 2022 Financial Results and Provides Company Update, Highlighting 143.9% Scientific Research Investment Growth
</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637644/0/en/NurExone-Announces-Q4-and-Full-year-2022-Financial-Results-and-Provides-Company-Update-Highlighting-143-9-Scientific-Research-Investment-Growth.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637644/0/en/NurExone-Announces-Q4-and-Full-year-2022-Financial-Results-and-Provides-Company-Update-Highlighting-143-9-Scientific-Research-Investment-Growth.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 21:30</td>
    <td>プレディクティブ・オンコロジー社、遺伝子治療の進展に向けたインテグラ・セラピューティクス社との協業を発表</td>
    <td><a href=https://finance.yahoo.com/quote/POAI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/POAI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 21:30</td>
    <td>Sofwave™が2023年NewBeauty AwardのBest Non-Invasive Cellulite Treatment賞を受賞しました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637620/0/en/Sofwave-Wins-2023-NewBeauty-Award-For-Best-Non-Invasive-Cellulite-Treatment.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637620/0/en/Sofwave-Wins-2023-NewBeauty-Award-For-Best-Non-Invasive-Cellulite-Treatment.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 21:30</td>
    <td>Vaxcyte社、乳幼児の侵襲性肺炎球菌感染症予防を目的としたVAX-24を評価する第2相試験で最初の参加者を投与</td>
    <td><a href=https://finance.yahoo.com/quote/PCVX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PCVX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 21:30</td>
    <td>Allogene Therapeutics、2022年版環境・社会・ガバナンス（ESG）報告書を発行</td>
    <td><a href=https://finance.yahoo.com/quote/ALLO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ALLO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 21:30</td>
    <td>Dyadic、World Vaccine Congress Washington 2023でプレゼンテーションを実施</td>
    <td><a href=https://finance.yahoo.com/quote/DYAI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DYAI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 21:30</td>
    <td>メドベイル、第4四半期および2022年度決算の発表を延期</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637633/0/en/MedAvail-Postpones-Reporting-of-Fourth-Quarter-and-FY-2022-Financial-Results.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637633/0/en/MedAvail-Postpones-Reporting-of-Fourth-Quarter-and-FY-2022-Financial-Results.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 21:19</td>
    <td>インベンティバ、2022年版ユニバーサル登録文書および2022年版年次報告書（Form 20-F）の提出を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637608/0/en/Inventiva-announces-filing-of-its-2022-Universal-Registration-Document-and-2022-Annual-Report-on-Form-20-F.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637608/0/en/Inventiva-announces-filing-of-its-2022-Universal-Registration-Document-and-2022-Annual-Report-on-Form-20-F.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 21:19</td>
    <td>インヴェンティバ、ユニバーサル登録文書2022および年次報告書2022（「フォーム20-F」）の提出を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637608/0/fr/Inventiva-annonce-le-d%C3%A9p%C3%B4t-de-son-Document-d-Enregistrement-Universel-2022-et-de-son-Rapport-Annuel-2022-Form-20-F.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637608/0/fr/Inventiva-annonce-le-d%C3%A9p%C3%B4t-de-son-Document-d-Enregistrement-Universel-2022-et-de-son-Rapport-Annuel-2022-Form-20-F.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 21:00</td>
    <td>IMUNON、2022年度決算報告およびビジネス・アップデートを発表</td>
    <td><a href=https://finance.yahoo.com/quote/IMNN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IMNN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 21:00</td>
    <td>ルミ・サイエンティフィック社、Allen A. Fienberg博士を最高経営責任者兼取締役会会長に任命</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637568/0/en/Rumi-Scientific-Appoints-Allen-A-Fienberg-Ph-D-as-Chief-Executive-Officer-and-Chairman-of-the-Board-of-Directors.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637568/0/en/Rumi-Scientific-Appoints-Allen-A-Fienberg-Ph-D-as-Chief-Executive-Officer-and-Chairman-of-the-Board-of-Directors.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 21:00</td>
    <td>アチーブメントライフサイエンス、取締役会改選のお知らせ</td>
    <td><a href=https://finance.yahoo.com/quote/ACHV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ACHV</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 21:00</td>
    <td>Theriva Biologics社、2022年第4四半期および通年のオペレーショナルハイライトと決算を発表</td>
    <td><a href=https://finance.yahoo.com/quote/TOVX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TOVX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/30 20:50</td>
    <td>ラー・メディカル・システムズ、新CFOに就任</td>
    <td><a href=https://finance.yahoo.com/quote/RMED target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RMED</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 21:00</td>
    <td>InnovAge、新たな独立取締役を迎え、取締役会の多様化を図る</td>
    <td><a href=https://finance.yahoo.com/quote/INNV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/INNV</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 21:00</td>
    <td>PDS Biotech、頭頸部がんを対象としたPDS0101のKEYTRUDA®との併用療法を評価する第3相試験を2023年に開始する計画を発表</td>
    <td><a href=https://finance.yahoo.com/quote/PDSB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PDSB</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/30 20:47</td>
    <td>Aptevo Therapeutics、960万ドルを非希薄化資金として調達</td>
    <td><a href=https://finance.yahoo.com/quote/APVO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/APVO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 21:00</td>
    <td>サイトサイエンス社、米国特許庁でアルコン社およびアイバンティス社から提起された無効審判を退ける</td>
    <td><a href=https://finance.yahoo.com/quote/SGHT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SGHT</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/30 20:44</td>
    <td>オピオイド系疼痛治療薬「オリンビック」が実地試験で有望視され、トレベナ社の株価が上昇</td>
    <td><a href=https://finance.yahoo.com/quote/TRVN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TRVN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 21:00</td>
    <td>フェマシス社（Femasys Inc. 2022年12月期決算の発表とコーポレートアップデートのお知らせ</td>
    <td><a href=https://finance.yahoo.com/quote/FEMY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/FEMY</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/30 20:40</td>
    <td>SCYNEXIS jumps 92% on licensing deal with GSK for anti-fungal agent
</td>
    <td><a href=https://finance.yahoo.com/quote/GSK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GSK</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/30 20:17</td>
    <td>リジェネロン社、Xeris Biopharma社との研究契約について</td>
    <td><a href=https://finance.yahoo.com/quote/XERS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/XERS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 20:30</td>
    <td>アトラス・グローバル・ブランズ、Benzinga Cannabis Capital Conferenceに参加決定</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637528/0/en/Atlas-Global-Brands-to-Participate-in-Benzinga-Cannabis-Capital-Conference.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637528/0/en/Atlas-Global-Brands-to-Participate-in-Benzinga-Cannabis-Capital-Conference.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 20:30</td>
    <td>センセイバイオセラピューティクス、カントル・フィッツジェラルドの「Future of Oncology Virtual Symposium」に参画</td>
    <td><a href=https://finance.yahoo.com/quote/SNSE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SNSE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 20:30</td>
    <td>Zevra Therapeutics、バイオファーマのベテランであるWendy Dixon博士を取締役に任命</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637531/16626/en/Zevra-Therapeutics-Appoints-Biopharma-Veteran-Wendy-Dixon-Ph-D-to-Board-of-Directors.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637531/16626/en/Zevra-Therapeutics-Appoints-Biopharma-Veteran-Wendy-Dixon-Ph-D-to-Board-of-Directors.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 20:30</td>
    <td>XOMA、ロイヤリティとマイルストーンのポートフォリオにキャッシュフローを生み出す資産を取得</td>
    <td><a href=https://finance.yahoo.com/quote/XOMAP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/XOMAP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 20:19</td>
    <td>ノボザイムズA / S社の2023年3月30日臨時株主総会での決議事項</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637516/0/en/Resolutions-from-Novozymes-A-S-Extraordinary-Shareholders-Meeting-on-30-March-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637516/0/en/Resolutions-from-Novozymes-A-S-Extraordinary-Shareholders-Meeting-on-30-March-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 20:08</td>
    <td>ノボザイムズとChr.Hansenの統合がノボザイムズの株主総会で承認される</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637508/0/en/Combination-between-Novozymes-and-Chr-Hansen-approved-by-the-Novozymes-shareholders.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637508/0/en/Combination-between-Novozymes-and-Chr-Hansen-approved-by-the-Novozymes-shareholders.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 20:02</td>
    <td>トレベナ社、200人規模の実臨床試験で得られたOLINVYKの初期トップラインデータを発表</td>
    <td><a href=https://finance.yahoo.com/quote/TRVN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TRVN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 20:00</td>
    <td>オメガ・セラピューティクス、肝細胞がんに対するOTX-2002とアテゾリズマブの併用療法を評価する臨床供給契約を締結したと発表</td>
    <td><a href=https://finance.yahoo.com/quote/OMGA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OMGA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 20:00</td>
    <td>Alaunos Therapeutics、Robert J. Hofmeister博士を取締役に任命</td>
    <td><a href=https://finance.yahoo.com/quote/TCRT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TCRT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 20:00</td>
    <td>メディセナ、ABILITY試験（フェーズ1/2）の単剤用量漸増部分の臨床最新情報を提供</td>
    <td><a href=https://finance.yahoo.com/quote/MDNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MDNA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 20:00</td>
    <td>センテッサ・ファーマシューティカルズ、直近の事業進捗と2022年第4四半期および通期の決算を発表</td>
    <td><a href=https://finance.yahoo.com/quote/CNTA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CNTA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 20:00</td>
    <td>EIPファーマとディフュージョン・ファーマシューティカルズが合併し、神経変性疾患治療の中枢神経系に特化したリーディングカンパニーを設立すると発表</td>
    <td><a href=https://finance.yahoo.com/quote/DFFN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DFFN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 20:00</td>
    <td>Renalytix社、2023年度第2四半期および上半期の決算を発表</td>
    <td><a href=https://finance.yahoo.com/quote/RNLX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RNLX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 20:00</td>
    <td>トニックス・ファーマシューティカルズ、線維筋痛症治療薬TNX-102 SLの第3相RELIEF試験の良好な有効性および安全性データを第5回線維筋痛症に関する国際会議で発表</td>
    <td><a href=https://finance.yahoo.com/quote/TNXP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TNXP</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/30 19:54</td>
    <td>ModernaとGandeeva、タンパク質の表面構造に関する研究契約を締結</td>
    <td><a href=https://finance.yahoo.com/quote/MRNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRNA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 20:00</td>
    <td>Decibel Therapeutics社、遺伝子治療薬「DB-OTO」の欧州における希少疾病用医薬品指定を受ける</td>
    <td><a href=https://finance.yahoo.com/quote/DBTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DBTX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/30 19:37</td>
    <td>Novo Nordisk社のWegovy、Ozempicを止めると体重が戻る可能性がある-報告書</td>
    <td><a href=https://finance.yahoo.com/quote/NVO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NVO</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/30 19:14</td>
    <td>ハイタイド、インサイダーによる株式買付を報告</td>
    <td><a href=https://finance.yahoo.com/quote/HITI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HITI</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/30 19:01</td>
    <td>アストラゼネカとKYMバイオサイエンシズが抗がん剤「CMG901」のライセンス契約を完了</td>
    <td><a href=https://finance.yahoo.com/quote/AZN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AZN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 19:33</td>
    <td>NTG Nordic Transport Group A %5C%2F S - Annual General Meeting 2023
</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637455/0/en/NTG-Nordic-Transport-Group-A-S-Annual-General-Meeting-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637455/0/en/NTG-Nordic-Transport-Group-A-S-Annual-General-Meeting-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 19:30</td>
    <td>EDAP、2022年第4四半期および通期で過去最高の業績を達成、グローバルグループ戦略展開のためのリーダーシップ継承計画を発表</td>
    <td><a href=https://finance.yahoo.com/quote/EDAP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EDAP</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/30 18:44</td>
    <td>フィリップス、CEOが今年中のリコール和解を視野に入れ、株価が急騰</td>
    <td><a href=https://finance.yahoo.com/quote/PHG target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PHG</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 18:55</td>
    <td>フェネック・ファーマシューティカルズ、2022年通期および第4四半期決算を発表</td>
    <td><a href=https://finance.yahoo.com/quote/FENC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/FENC</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/30 18:21</td>
    <td>バイオメアフュージョン、1億5000万ドルの株式募集を実施</td>
    <td><a href=https://finance.yahoo.com/quote/BMEA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BMEA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/30 18:13</td>
    <td>Viatris、Aurobindo、CiplaがViiV社のHIV治療薬の低所得国向けジェネリック医薬品を製造へ</td>
    <td><a href=https://finance.yahoo.com/quote/GSK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GSK</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/30 18:06</td>
    <td>バイキング・セラピューティクス、2億5000万ドルの株式募集の価格決定で塩漬け</td>
    <td><a href=https://finance.yahoo.com/quote/VKTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VKTX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/30 17:31</td>
    <td>Reliq、バーチャルケアのために米国3州での拠点を拡大</td>
    <td><a href=https://finance.yahoo.com/quote/RQHTF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RQHTF</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 17:24</td>
    <td>スマートイミューン、欧州イノベーションカウンシル（EIC）からEICアクセラレータを通じて250万ユーロの助成金と1,500万ユーロの株式投資コミットメントを獲得</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637376/0/en/Smart-Immune-receives-2-5m-grant-and-15m-equity-investment-commitment-from-the-European-Innovation-Council-EIC-via-the-EIC-Accelerator.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637376/0/en/Smart-Immune-receives-2-5m-grant-and-15m-equity-investment-commitment-from-the-European-Innovation-Council-EIC-via-the-EIC-Accelerator.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 17:00</td>
    <td>NRG Therapeutics、国際的な科学諮問委員会を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637357/0/en/NRG-Therapeutics-Announces-International-Scientific-Advisory-Board.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637357/0/en/NRG-Therapeutics-Announces-International-Scientific-Advisory-Board.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 16:30</td>
    <td>カナダでは約半数の労働者が負債に押しつぶされそうになっている</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637346/0/en/Nearly-half-of-workers-in-Canada-are-feeling-overwhelmed-by-debt.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637346/0/en/Nearly-half-of-workers-in-Canada-are-feeling-overwhelmed-by-debt.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 16:30</td>
    <td>働くカナダ人の約半数が借金の負担を感じている</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637346/0/fr/Pr%C3%A8s-de-la-moiti%C3%A9-des-Canadiens-actifs-se-sentent-accabl%C3%A9s-par-leurs-dettes.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637346/0/fr/Pr%C3%A8s-de-la-moiti%C3%A9-des-Canadiens-actifs-se-sentent-accabl%C3%A9s-par-leurs-dettes.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 16:30</td>
    <td>米国の労働者の5人に2人が負債に押しつぶされそうになっている</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637347/0/en/Two-in-five-US-workers-feel-overwhelmed-by-debt.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637347/0/en/Two-in-five-US-workers-feel-overwhelmed-by-debt.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 16:00</td>
    <td>Trobix Bio社がChartered Groupから300万ドルを調達し、精密マイクロバイオーム腫瘍治療薬の開発を推進へ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637334/0/en/Trobix-Bio-Raises-3-Million-from-Chartered-Group-to-Advance-Precision-Microbiome-Oncology-Therapeutics.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637334/0/en/Trobix-Bio-Raises-3-Million-from-Chartered-Group-to-Advance-Precision-Microbiome-Oncology-Therapeutics.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 16:00</td>
    <td>モレキュア、2022年通期決算を発表 ～大きな飛躍の1年となった</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637336/0/en/Molecure-Announces-Full-Year-Financial-2022-Results-A-Year-of-Significant-Progress.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637336/0/en/Molecure-Announces-Full-Year-Financial-2022-Results-A-Year-of-Significant-Progress.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 15:48</td>
    <td>バイオポルト、2022年12月期の年次決算を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637332/0/en/BioPorto-Announces-Annual-Results-for-the-Year-ended-December-31-2022.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637332/0/en/BioPorto-Announces-Annual-Results-for-the-Year-ended-December-31-2022.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 15:30</td>
    <td>Orionはフィンランドで独自の製薬研究エコシステムを構築している - データと人工知能を活用して革新的な新薬の開発期間を短縮できる</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637328/0/en/Orion-is-building-a-unique-pharmaceutical-research-ecosystem-in-Finland-using-data-and-artificial-intelligence-to-shorten-the-development-time-of-new-innovative-medicines.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637328/0/en/Orion-is-building-a-unique-pharmaceutical-research-ecosystem-in-Finland-using-data-and-artificial-intelligence-to-shorten-the-development-time-of-new-innovative-medicines.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 15:30</td>
    <td>オリオン、フィンランドで独自の製薬研究エコシステムを構築 ～データと人工知能の活用で革新的新薬の開発期間短縮を目指す</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637328/0/fi/Orion-rakentaa-ainutlaatuista-l%C3%A4%C3%A4kealan-tutkimusekosysteemi%C3%A4-Suomeen-tavoitteena-lyhent%C3%A4%C3%A4-uusien-innovatiivisten-l%C3%A4%C3%A4kkeiden-kehitysaikaa-dataa-ja-teko%C3%A4ly%C3%A4-hy%C3%B6dynt%C3%A4m%C3%A4ll%C3%A4.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637328/0/fi/Orion-rakentaa-ainutlaatuista-l%C3%A4%C3%A4kealan-tutkimusekosysteemi%C3%A4-Suomeen-tavoitteena-lyhent%C3%A4%C3%A4-uusien-innovatiivisten-l%C3%A4%C3%A4kkeiden-kehitysaikaa-dataa-ja-teko%C3%A4ly%C3%A4-hy%C3%B6dynt%C3%A4m%C3%A4ll%C3%A4.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/30 15:28</td>
    <td>アカンダ、ナスダックへの準拠を回復</td>
    <td><a href=https://finance.yahoo.com/quote/AKAN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AKAN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 15:01</td>
    <td>当社取締役が株式を取得したことをお知らせします。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637324/0/en/OKYO-Pharma-Today-Announces-Director-Acquires-Shares.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637324/0/en/OKYO-Pharma-Today-Announces-Director-Acquires-Shares.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 15:00</td>
    <td>メンダス、第8回イネイトキラーサミットでDCOneプラットフォームによる高品質なNK細胞治療薬の供給に関する最新情報を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637320/0/en/Mendus-presents-an-update-on-the-use-of-its-DCOne-platform-to-source-high-quality-NK-cell-therapies-at-the-8th-Annual-Innate-Killer-Summit.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637320/0/en/Mendus-presents-an-update-on-the-use-of-its-DCOne-platform-to-source-high-quality-NK-cell-therapies-at-the-8th-Annual-Innate-Killer-Summit.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 15:00</td>
    <td>メンダスは、第8回イネイトキラー会議において、高品質のNK細胞に基づく治療薬を製造するためのDCOneプラットフォームの使用に関する最新情報を発表しました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637320/0/sv/Mendus-presenterar-en-uppdatering-vid-den-8-e-%C3%A5rliga-Innate-Killer-konferensen-avseende-anv%C3%A4ndningen-av-sin-DCOne-plattform-f%C3%B6r-att-producera-terapier-baserade-p%C3%A5-h%C3%B6gkvalitativa-NK.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637320/0/sv/Mendus-presenterar-en-uppdatering-vid-den-8-e-%C3%A5rliga-Innate-Killer-konferensen-avseende-anv%C3%A4ndningen-av-sin-DCOne-plattform-f%C3%B6r-att-producera-terapier-baserade-p%C3%A5-h%C3%B6gkvalitativa-NK.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 14:30</td>
    <td>プレスリリースを掲載しました： 2023年第1四半期のモデリング用備忘録の提供について</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637310/0/en/Press-Release-Availability-of-the-Q1-2023-Memorandum-for-modelling-purposes.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637310/0/en/Press-Release-Availability-of-the-Q1-2023-Memorandum-for-modelling-purposes.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 14:30</td>
    <td>プレスリリース：「2023年第1四半期 モデリング用メモランダム」オンライン公開中</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637310/0/fr/Communiqu%C3%A9-de-presse-Mise-en-ligne-du-document-Q1-2023-Memorandum-for-modelling-purposes.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637310/0/fr/Communiqu%C3%A9-de-presse-Mise-en-ligne-du-document-Q1-2023-Memorandum-for-modelling-purposes.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 14:30</td>
    <td>オンワード、「第1回ESGサマリー」を発行</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637313/0/en/ONWARD-Publishes-First-Annual-ESG-Summary.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637313/0/en/ONWARD-Publishes-First-Annual-ESG-Summary.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 14:30</td>
    <td>オンワード、初の年次ESGサマリーを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637313/0/fr/ONWARD-publie-un-premier-r%C3%A9sum%C3%A9-annuel-sur-l-ESG.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637313/0/fr/ONWARD-publie-un-premier-r%C3%A9sum%C3%A9-annuel-sur-l-ESG.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 14:30</td>
    <td>オンワード、初の年次ESGレビューを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637313/0/nl/ONWARD-publiceert-eerste-jaarlijkse-ESG-overzicht.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637313/0/nl/ONWARD-publiceert-eerste-jaarlijkse-ESG-overzicht.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 14:30</td>
    <td>オンワード、初の年次ESG報告書を発行</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637313/0/de/ONWARD-ver%C3%B6ffentlicht-ersten-j%C3%A4hrlichen-ESG-Bericht.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637313/0/de/ONWARD-ver%C3%B6ffentlicht-ersten-j%C3%A4hrlichen-ESG-Bericht.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 14:00</td>
    <td>バイオセニック、三酸化二ヒ素（ATO）の作用機序に関する新データを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637305/0/en/BioSenic-publishes-new-data-on-the-mechanism-of-action-of-arsenic-trioxide-ATO.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637305/0/en/BioSenic-publishes-new-data-on-the-mechanism-of-action-of-arsenic-trioxide-ATO.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 14:00</td>
    <td>バイオセニック、三酸化二ヒ素（ATO）の作用機序に関する新データを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637305/0/fr/BioSenic-publie-de-nouvelles-donn%C3%A9es-sur-le-m%C3%A9canisme-d-action-du-trioxyde-d-arsenic-ATO.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637305/0/fr/BioSenic-publie-de-nouvelles-donn%C3%A9es-sur-le-m%C3%A9canisme-d-action-du-trioxyde-d-arsenic-ATO.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 14:00</td>
    <td>バルネバ、ワシントンD.C.で開催される第23回世界ワクチン会議でチクングニアワクチン候補について発表、ラウンドテーブルを開催へ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637306/0/en/Valneva-to-Present-on-its-Chikungunya-Vaccine-Candidate-and-Host-a-Roundtable-at-the-23rd-World-Vaccine-Congress-in-Washington-D-C.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637306/0/en/Valneva-to-Present-on-its-Chikungunya-Vaccine-Candidate-and-Host-a-Roundtable-at-the-23rd-World-Vaccine-Congress-in-Washington-D-C.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 14:00</td>
    <td>Valnevaは、ワシントンDCで開催される第23回世界ワクチン会議で、チクングニアワクチン候補を発表し、パネルディスカッションを開催する予定です。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637306/0/fr/Valneva-fera-une-pr%C3%A9sentation-sur-son-candidat-vaccin-contre-le-chikungunya-et-animera-une-table-ronde-lors-du-23%C3%A8me-World-Vaccine-Congress-%C3%A0-Washington-D-C.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637306/0/fr/Valneva-fera-une-pr%C3%A9sentation-sur-son-candidat-vaccin-contre-le-chikungunya-et-animera-une-table-ronde-lors-du-23%C3%A8me-World-Vaccine-Congress-%C3%A0-Washington-D-C.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 12:15</td>
    <td>バイオメアフュージョン、普通株式の公募増資の価格決定について</td>
    <td><a href=https://finance.yahoo.com/quote/BMEA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BMEA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 10:32</td>
    <td>持続可能な健康のためのケベック・アクション・ネットワークは、健康に関する新しい法案15が環境問題を考慮することを望んでいる。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/30/2637276/0/fr/Le-R%C3%A9seau-d-action-pour-la-sant%C3%A9-durable-du-Qu%C3%A9bec-souhaite-que-le-nouveau-projet-de-loi-15-en-sant%C3%A9-consid%C3%A8re-les-enjeux-environnementaux.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/30/2637276/0/fr/Le-R%C3%A9seau-d-action-pour-la-sant%C3%A9-durable-du-Qu%C3%A9bec-souhaite-que-le-nouveau-projet-de-loi-15-en-sant%C3%A9-consid%C3%A8re-les-enjeux-environnementaux.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 10:27</td>
    <td>アヴァデル・ファーマシューティカルズ、3月30日に会社概要の説明と2022年第4四半期および通期決算の報告を実施</td>
    <td><a href=https://finance.yahoo.com/quote/AVDL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AVDL</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 08:21</td>
    <td>パクスメディカ、Inc. ビジネスアップデートと2022年第4四半期決算を発表</td>
    <td><a href=https://finance.yahoo.com/quote/PXMD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PXMD</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/29 19:30</td>
    <td>レイモンド・ジェームズで$VKTXのPTを$35に引き上げた。</td>
    <td><a href=https://finance.yahoo.com/quote/VKTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VKTX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/29 19:33</td>
    <td>AFMD社、CD123陽性再発難治性AML患者を対象としたAFM28のファーストインヒト試験で最初の患者を投与</td>
    <td><a href=https://finance.yahoo.com/quote/AFMD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AFMD</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/29 19:58</td>
    <td>シティで$BMEAのPTを$60に引き上げた。</td>
    <td><a href=https://finance.yahoo.com/quote/BMEA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BMEA</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/29 20:05</td>
    <td>BLUE LOVO-CELのBLA申請、数週間以内にFDAから分析比較データの回答が得られると予想。 24年第4四半期までのキャッシュランウェイ</td>
    <td><a href=https://finance.yahoo.com/quote/BLUE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BLUE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 06:30</td>
    <td>Alaunos Therapeutics社、4月に開催される投資家向けカンファレンスに参加決定</td>
    <td><a href=https://finance.yahoo.com/quote/TCRT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TCRT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 05:51</td>
    <td>バイオポルト、2023年の業績見通しを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/29/2637187/0/en/BioPorto-Announces-Financial-Guidance-for-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/29/2637187/0/en/BioPorto-Announces-Financial-Guidance-for-2023.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/29 21:16</td>
    <td>予想arel Nerve BlocksのsNDAをFDAが受理、下肢の処置における局所鎮痛が可能に PDUFA 11 / 13 / 23</td>
    <td><a href=https://finance.yahoo.com/quote/PCRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PCRX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 05:50</td>
    <td>エアロベイト・セラピューティクス、2022年通期決算とビジネスハイライトを発表</td>
    <td><a href=https://finance.yahoo.com/quote/AVTE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AVTE</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/29 21:17</td>
    <td>ACHV社、禁煙治療薬Cytisiniclineの第3相臨床試験ORCA-3において最終被験者の最終訪問を完了したと発表。トップラインデータ第2四半期</td>
    <td><a href=https://finance.yahoo.com/quote/ACHV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ACHV</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/30 06:43</td>
    <td>大塚製薬とLundbeck社、アルツハイマー型認知症治療薬RexultiのFDA Adcomミーティングを取得</td>
    <td><a href=https://finance.yahoo.com/quote/OTSKF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OTSKF</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 05:19</td>
    <td>管理職及びその近親者によるGenmab A / Sの株式及び関連する証券の取引について</td>
    <td><a href=https://finance.yahoo.com/quote/GMAB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GMAB</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/29 21:22</td>
    <td>PRQR 12月31日現在、現金および現金同等物94.8百万ユーロ。2月に$LLYから$60Mを受領。 2026年半ばまで運営資金を賄うことができるキャッシュランの見込み</td>
    <td><a href=https://finance.yahoo.com/quote/PRQR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PRQR</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/30 06:24</td>
    <td>S&P指数の動きでNektar Therapeuticsが下落、PacWest Bancorpが上昇</td>
    <td><a href=https://finance.yahoo.com/quote/NKTR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NKTR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 05:15</td>
    <td>マスタングバイオ、2022年12月期通期決算と最近のコーポレートハイライトを発表</td>
    <td><a href=https://finance.yahoo.com/quote/MBIO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MBIO</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/29 21:25</td>
    <td>特発性過眠症（IH）の成人患者を対象としたピトリサントの安全性と有効性を評価する第3相INTUNE試験の完了スケジュールを早めたと発表。 トップラインデータQ4 @ScorpionFund</td>
    <td><a href=https://finance.yahoo.com/quote/HRMY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HRMY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 05:13</td>
    <td>アバデル・ファーマシューティカルズ、ADSおよびシリーズB優先株の引受公募を提案と発表</td>
    <td><a href=https://finance.yahoo.com/quote/AVDL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AVDL</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/30 06:21</td>
    <td>ヘッジアイの新規ショートコールを受けてプロジェニーが下落</td>
    <td><a href=https://finance.yahoo.com/quote/PGNY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PGNY</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/29 22:40</td>
    <td>$BLUE ↓ 20%       
</td>
    <td><a href=https://finance.yahoo.com/quote/BLUE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BLUE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 05:10</td>
    <td>Genmab A / Sにおける取締役会の構成、Genmabにおける経営陣および従業員への制限付き株式ユニットの付与、従業員へのワラントの付与について</td>
    <td><a href=https://finance.yahoo.com/quote/GMAB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GMAB</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/30 06:11</td>
    <td>メルク キートルーダ、特定の腫瘍種で正式承認取得</td>
    <td><a href=https://finance.yahoo.com/quote/MRK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/30 05:06</td>
    <td>Lyra Therapeutics、2022年第4四半期および通年の決算報告および企業情報の提供について</td>
    <td><a href=https://finance.yahoo.com/quote/LYRA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LYRA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/30 06:10</td>
    <td>Seelos Therapeutics、運動障害治療薬の治験を一時中断</td>
    <td><a href=https://finance.yahoo.com/quote/SEEL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SEEL</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/30 06:30</td>
    <td>メタバースは急速にメチャクチャになりつつある $DIS $META $MANA $MSFT $SAND</td>
    <td><a href=https://finance.yahoo.com/quote/DIS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DIS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 21:30</td>
    <td>Aquestive Therapeutics社、Pharmanovia社とのLibervant™（ジアゼパム）バッカルフィルムのライセンス・供給契約をグローバル市場に追加拡大</td>
    <td><a href=https://finance.yahoo.com/quote/AQST target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AQST</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 21:30</td>
    <td>マイルストン・サイエンティフィック、2022年12月期決算およびビジネスアップデートに関するカンファレンスコールを開催</td>
    <td><a href=https://finance.yahoo.com/quote/MLSS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MLSS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 21:30</td>
    <td>リード治療薬候補のPMN310が他のアミロイドベータ指向性抗体と比較して毒性オリゴマーに対する選択性が高いことをAD / PD 2023のポスター発表で実証</td>
    <td><a href=https://finance.yahoo.com/quote/PMN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PMN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/29 20:40</td>
    <td>ClearPoint、セルラーデリバリーデバイスのライセンス契約を締結</td>
    <td><a href=https://finance.yahoo.com/quote/CLPT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CLPT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 21:15</td>
    <td>バイオカーディア、2022年第4四半期および通年の事業ハイライトと決算を発表</td>
    <td><a href=https://finance.yahoo.com/quote/BCDAW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BCDAW</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/29 20:31</td>
    <td>リジェネロン社「Libtayo」、EUで肺がんサブタイプに対する拡大承認を取得</td>
    <td><a href=https://finance.yahoo.com/quote/SNY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SNY</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/29 20:28</td>
    <td>イノベーティブ・インダストリアル・プロパティーズ、CFOがCOOに昇格</td>
    <td><a href=https://finance.yahoo.com/quote/IIPR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IIPR</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/29 20:26</td>
    <td>STAAR Surgical、COOにWarren Foust氏を迎える。</td>
    <td><a href=https://finance.yahoo.com/quote/STAA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/STAA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 21:00</td>
    <td>アクシアル・セラピューティクス、低分子マイクロバイオーム治療薬の臨床・前臨床パイプラインを推進するための主要研究開発者の昇進を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/29/2636631/0/en/Axial-Therapeutics-Announces-Key-Research-and-Development-Promotions-to-Advance-Clinical-and-Preclinical-Pipeline-of-Small-Molecule-Microbiome-Therapeutics.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/29/2636631/0/en/Axial-Therapeutics-Announces-Key-Research-and-Development-Promotions-to-Advance-Clinical-and-Preclinical-Pipeline-of-Small-Molecule-Microbiome-Therapeutics.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 21:00</td>
    <td>ProQR社、R&Dイベントでパイプラインの初期ターゲットを発表、Axiomer® RNA Editing Platform Technologyを紹介</td>
    <td><a href=https://finance.yahoo.com/quote/PRQR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PRQR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 21:00</td>
    <td>スウェーデンのOlink社の技術により、南アフリカの研究・技術革新のさらなる発展を目指す</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/29/2636592/0/en/Swedish-Olink-technology-enables-further-development-of-South-African-research-and-innovation.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/29/2636592/0/en/Swedish-Olink-technology-enables-further-development-of-South-African-research-and-innovation.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 21:00</td>
    <td>BetterLife社の気分障害治療用非幻覚性LSD（BETR-001）がDrug Discovery & Development誌で注目される</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/29/2636598/0/en/BetterLife-s-Non-hallucinogenic-LSD-BETR-001-For-Treating-Mood-Disorders-Highlighted-in-Drug-Discovery-Development-Article.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/29/2636598/0/en/BetterLife-s-Non-hallucinogenic-LSD-BETR-001-For-Treating-Mood-Disorders-Highlighted-in-Drug-Discovery-Development-Article.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 21:00</td>
    <td>Wave Life Sciences社、Guggenheim Genomic Medicines and Rare Disease Daysでプレゼンテーションを実施</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/29/2636600/0/en/Wave-Life-Sciences-to-Present-at-the-Guggenheim-Genomic-Medicines-and-Rare-Disease-Days.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/29/2636600/0/en/Wave-Life-Sciences-to-Present-at-the-Guggenheim-Genomic-Medicines-and-Rare-Disease-Days.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 21:00</td>
    <td>Kala Pharmaceuticals、Chief Medical AdvisorにFrancis Mah博士を任命</td>
    <td><a href=https://finance.yahoo.com/quote/KALA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/KALA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 21:00</td>
    <td>CRISPR Therapeutics、取締役会メンバーの退任を発表</td>
    <td><a href=https://finance.yahoo.com/quote/CRSP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CRSP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 21:00</td>
    <td>ヴァクサート、4月5日～6日に開催される「World Vaccine Congress Washington 2023」でプレゼンテーションを実施</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/29/2636610/25416/en/Vaxart-to-Present-at-World-Vaccine-Congress-Washington-2023-on-April-5-6.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/29/2636610/25416/en/Vaxart-to-Present-at-World-Vaccine-Congress-Washington-2023-on-April-5-6.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/29 19:54</td>
    <td>Teva in pact with Neurocrine to delay Ingrezza generics
</td>
    <td><a href=https://finance.yahoo.com/quote/NBIX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NBIX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 20:30</td>
    <td>PDS Biotech to Participate in Cantor’s Future of Oncology Virtual Symposium
</td>
    <td><a href=https://finance.yahoo.com/quote/PDSB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PDSB</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/29 19:51</td>
    <td>Affimed starts dosing of blood cancer drug in early-stage trial
</td>
    <td><a href=https://finance.yahoo.com/quote/AFMD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AFMD</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 20:30</td>
    <td>PharmaTher Holdings Announces Update of Type C Meeting with the FDA for KETARX™ (Ketamine) in Parkinson’s Disease
</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/29/2636558/0/en/PharmaTher-Holdings-Announces-Update-of-Type-C-Meeting-with-the-FDA-for-KETARX-Ketamine-in-Parkinson-s-Disease.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/29/2636558/0/en/PharmaTher-Holdings-Announces-Update-of-Type-C-Meeting-with-the-FDA-for-KETARX-Ketamine-in-Parkinson-s-Disease.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/29 19:37</td>
    <td>Columbia Care extends maturity of senior notes by a year
</td>
    <td><a href=https://finance.yahoo.com/quote/CCHWF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CCHWF</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/29 19:05</td>
    <td>Junshi, Rxilient form JV for cancer drug toripalimab in Southeast Asia
</td>
    <td><a href=https://finance.yahoo.com/quote/SHJBF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SHJBF</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 20:00</td>
    <td>Healthcare Triangle、300万ドルのクラウドDevOpsマネージドサービス契約を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/29/2636514/0/en/Healthcare-Triangle-Announces-3-Million-Cloud-DevOps-Managed-Services-Agreement.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/29/2636514/0/en/Healthcare-Triangle-Announces-3-Million-Cloud-DevOps-Managed-Services-Agreement.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 20:00</td>
    <td>テラバイオの強化組織マトリックス「OviTex®」がSAGES 2023で3つの症例報告に取り上げられる</td>
    <td><a href=https://finance.yahoo.com/quote/TELA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TELA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 20:00</td>
    <td>エントラーダ・セラピューティクス、Guggenheim Genomic Medicines and Rare Disease Conferenceに参加へ</td>
    <td><a href=https://finance.yahoo.com/quote/TRDA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TRDA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 20:00</td>
    <td>バイオキシトラン、第2相臨床試験の良好な結果が査読付き雑誌「Vaccines」に掲載されたと発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/29/2636519/0/en/Bioxytran-Announces-Positive-Phase-2-Trial-Results-were-Featured-in-Vaccines-a-Peer-Reviewed-Journal.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/29/2636519/0/en/Bioxytran-Announces-Positive-Phase-2-Trial-Results-were-Featured-in-Vaccines-a-Peer-Reviewed-Journal.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 20:00</td>
    <td>ブリッケンリッジ蒸溜所、3月31日を「ナショナル・アプレス・デー」に制定</td>
    <td><a href=https://finance.yahoo.com/quote/TLRY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TLRY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 20:00</td>
    <td>リブタヨ®」（一般名：セミピリマブ）の化学療法との併用療法が欧州委員会より「PD-L1陽性の進行性非小細胞肺がん（NSCLC）の一次治療」として承認を取得</td>
    <td><a href=https://finance.yahoo.com/quote/REGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/REGN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 20:00</td>
    <td>バイオシネックス、Chemio Diagnostics, Inc.株式に対する公開買付けを延長</td>
    <td><a href=https://finance.yahoo.com/quote/CEMI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CEMI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 19:30</td>
    <td>テレフレックス、革新的なタイタンSGS®ステープラーにゴア®シームガード®生体吸収性ステープルライン用補強材を選択</td>
    <td><a href=https://finance.yahoo.com/quote/TFX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TFX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 19:30</td>
    <td>AFM28の再発・難治性CD123陽性急性骨髄性白血病患者を対象としたファーストインヒト試験において、最初の患者さんの投与に成功したと発表</td>
    <td><a href=https://finance.yahoo.com/quote/AFMD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AFMD</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 19:30</td>
    <td>バイオメアフュージョン社、普通株式の公募を発表</td>
    <td><a href=https://finance.yahoo.com/quote/BMEA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BMEA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 19:00</td>
    <td>ネクストメッド、ウォール・ストリート・ジャーナルの記事に掲載された同名の非関連会社に関する声明を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/29/2636455/0/en/NextMed-Provides-Statement-Regarding-Unaffiliated-Entity-With-Same-Name-in-Wall-Street-Journal-Article.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/29/2636455/0/en/NextMed-Provides-Statement-Regarding-Unaffiliated-Entity-With-Same-Name-in-Wall-Street-Journal-Article.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/29 18:26</td>
    <td>アムジェンとアストラゼネカの喘息治療薬「Tezspire」が英国NICEの支持を得る</td>
    <td><a href=https://finance.yahoo.com/quote/AMGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMGN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/29 17:41</td>
    <td>アステラス製薬とロシュ・ダイアベートが協業し、アキュチェックをBlueStarアプリに統合</td>
    <td><a href=https://finance.yahoo.com/quote/ALPMY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ALPMY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 16:01</td>
    <td>Mainz Biomed社、進行した大腸腺腫の早期発見を目的とした新規mRNAバイオマーカーのポートフォリオを評価するフィージビリティスタディで良好な結果を報告</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/29/2636376/0/en/Mainz-Biomed-Reports-Positive-Results-from-Feasibility-Study-Evaluating-its-Portfolio-of-Novel-mRNA-Biomarkers-for-Early-Detection-of-Advanced-Colorectal-Adenomas.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/29/2636376/0/en/Mainz-Biomed-Reports-Positive-Results-from-Feasibility-Study-Evaluating-its-Portfolio-of-Novel-mRNA-Biomarkers-for-Early-Detection-of-Advanced-Colorectal-Adenomas.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 15:00</td>
    <td>当社取締役が株式を取得したことをお知らせします。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/29/2636351/0/en/OKYO-Pharma-Today-Announces-Director-Acquires-Shares.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/29/2636351/0/en/OKYO-Pharma-Today-Announces-Director-Acquires-Shares.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 14:30</td>
    <td>Medigene AG、2022年通期決算の報告とコーポレート・アップデートを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/29/2636344/0/en/Medigene-AG-Reports-Full-Year-2022-Financial-Results-and-Provides-Corporate-Update.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/29/2636344/0/en/Medigene-AG-Reports-Full-Year-2022-Financial-Results-and-Provides-Corporate-Update.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 14:00</td>
    <td>プレスリリース Biocartis Group NV: Biocartis、2022年の年次報告書を2023年4月11日に発行へ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/29/2636333/0/en/Press-release-Biocartis-Group-NV-Biocartis-To-Publish-2022-Annual-Report-on-11-April-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/29/2636333/0/en/Press-release-Biocartis-Group-NV-Biocartis-To-Publish-2022-Annual-Report-on-11-April-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 14:00</td>
    <td>プレスリリース Biocartis Group NV: Biocartisは2023年4月11日に年次報告書2022を発行します。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/29/2636333/0/nl/Persbericht-Biocartis-Group-NV-Biocartis-zal-jaarverslag-2022-publiceren-op-11-april-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/29/2636333/0/nl/Persbericht-Biocartis-Group-NV-Biocartis-zal-jaarverslag-2022-publiceren-op-11-april-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 12:39</td>
    <td>東南アジアにおけるトリパリマブの共同開発・商業化を目的としたRxilient Biotech社との合弁会社設立について（Junshi Biosciences</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/29/2636317/0/en/Junshi-Biosciences-Announces-Establishment-of-Joint-Venture-with-Rxilient-Biotech-to-Jointly-Develop-and-Commercialize-Toripalimab-in-Southeast-Asia.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/29/2636317/0/en/Junshi-Biosciences-Announces-Establishment-of-Joint-Venture-with-Rxilient-Biotech-to-Jointly-Develop-and-Commercialize-Toripalimab-in-Southeast-Asia.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/28 19:34</td>
    <td>VKTX社、デュアルGLP-1/GIPレセプターアゴニストVK2735の第1相臨床試験の結果を発表</td>
    <td><a href=https://finance.yahoo.com/quote/VKTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VKTX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/28 19:52</td>
    <td>BNTXは、新たに$500Mの自己株式取得プログラムを発表した。 22年3月に発表された前回の買戻しプログラムは、総額$1.3Bの買戻しで終了。</td>
    <td><a href=https://finance.yahoo.com/quote/BNTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BNTX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/28 20:01</td>
    <td>BCYC、$NVSとバイシクルラジオコンジュゲートの発見、開発、商品化に関する戦略的協業を発表。先行投資額$50M</td>
    <td><a href=https://finance.yahoo.com/quote/BCYC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BCYC</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/28 20:02</td>
    <td>ITCI社、ルマテペロン単剤療法を評価する403試験で良好なトップライン結果を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ITCI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ITCI</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/28 20:07</td>
    <td>$VKTX ↑ 46% PM       
</td>
    <td><a href=https://finance.yahoo.com/quote/VKTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VKTX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/28 20:08</td>
    <td>SLN社は、$MNK社との共同研究契約に基づき、2つのsiRNA創薬ターゲットの全世界での権利を取り戻します</td>
    <td><a href=https://finance.yahoo.com/quote/SLN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SLN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/28 20:13</td>
    <td>MIST、1億2500万ドルの戦略的資金調達を発表</td>
    <td><a href=https://finance.yahoo.com/quote/MIST target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MIST</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/28 20:33</td>
    <td>PDSB事業アップデートと2022年第4四半期および通期決算の報告</td>
    <td><a href=https://finance.yahoo.com/quote/PDSB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PDSB</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/28 20:51</td>
    <td>FHTXはバンクオブアメリカのBuyで開始されました。PT 10ドル</td>
    <td><a href=https://finance.yahoo.com/quote/FHTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/FHTX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/28 20:58</td>
    <td>BMEAハルト</td>
    <td><a href=https://finance.yahoo.com/quote/BMEA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BMEA</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/28 21:01</td>
    <td>$BMEA Announces Positive Data from Initial Cohorts of Ongoing Phase 2 Study (COVALENT-111) of BMF-219 in Patients with Type 2 Diabetes.  100 mg Cohort 3 Demonstrated an 89% Response Rate and 1% Median Reduction in HbA1c at Day 28       
</td>
    <td><a href=https://finance.yahoo.com/quote/BMEA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BMEA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 08:45</td>
    <td>クローバーリーフ・バイオ、法人向け事業の最新情報と2022年通期決算を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2636281/0/zh-hans/%E4%B8%89%E5%8F%B6%E8%8D%89%E7%94%9F%E7%89%A9%E5%85%AC%E5%B8%83%E5%85%AC%E5%8F%B8%E4%B8%9A%E5%8A%A1%E6%9B%B4%E6%96%B0%E5%8F%8A2022%E5%B9%B4%E5%85%A8%E5%B9%B4%E8%B4%A2%E5%8A%A1%E4%B8%9A%E7%BB%A9.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2636281/0/zh-hans/%E4%B8%89%E5%8F%B6%E8%8D%89%E7%94%9F%E7%89%A9%E5%85%AC%E5%B8%83%E5%85%AC%E5%8F%B8%E4%B8%9A%E5%8A%A1%E6%9B%B4%E6%96%B0%E5%8F%8A2022%E5%B9%B4%E5%85%A8%E5%B9%B4%E8%B4%A2%E5%8A%A1%E4%B8%9A%E7%BB%A9.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 08:17</td>
    <td>ダックスファイ™」が「ザ・ウェル・ラウンジ・メッド・スパ」で販売開始</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2636277/0/en/Daxxify-Is-Available-at-The-Well-Lounge-Med-Spa.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2636277/0/en/Daxxify-Is-Available-at-The-Well-Lounge-Med-Spa.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/28 21:02</td>
    <td>VACC社、B型慢性肝炎患者を対象としたHBV002試験の良好なトップライン最終データを発表 VTP-300の完了したフェーズ1b/2a試験は、主要評価項目および副次評価項目を達成</td>
    <td><a href=https://finance.yahoo.com/quote/VACC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VACC</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 06:57</td>
    <td>ClearPoint Neuro、UCSFと革新的な脳内細胞送達プラットフォームに関する独占的複数年ライセンス契約を締結したと発表</td>
    <td><a href=https://finance.yahoo.com/quote/CLPT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CLPT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 06:57</td>
    <td>ClearPoint Neuro、UCSFと革新的な脳内細胞導入プラットフォームに関する複数年の独占ライセンス契約を発表</td>
    <td><a href=https://finance.yahoo.com/quote/CLPT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CLPT</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/28 21:05</td>
    <td>$BMEA in Cohort 3, after 4 weeks of once-daily 100 mg dosing with BMF-219, 89% of patients achieved a reduction in A1c, 78% of patients achieved at least a 0.5% reduction in A1c, and 56% achieved at least a 1% reduction in A1c.         
</td>
    <td><a href=https://finance.yahoo.com/quote/BMEA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BMEA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/29 07:30</td>
    <td>エリザベス・ウォーレン上院議員、メディケア・アドバンテージの支払いに関する規則を最終化するようCMSに要請</td>
    <td><a href=https://finance.yahoo.com/quote/CVS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CVS</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/28 21:07</td>
    <td>ANEB-001の急性カンナビノイド中毒治療薬としての可能性を示す完全なフェーズ2データを発表しました。ANEB-001は全コホートでVAS Feeling Highを統計的に有意に減少（THC30mg投与レベルでp=<0.0001）。</td>
    <td><a href=https://finance.yahoo.com/quote/ANEB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ANEB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 06:05</td>
    <td>グリーンライト・バイオサイエンス、2022年第4四半期および通期決算を発表</td>
    <td><a href=https://finance.yahoo.com/quote/GRNAW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GRNAW</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/29 07:08</td>
    <td>Arcturus Therapeutics up 21% after hours on quarterly beats, cash runway extension
</td>
    <td><a href=https://finance.yahoo.com/quote/ARCT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ARCT</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/28 21:24</td>
    <td>$DIS ディズニー、レイオフ第一弾でメタバース部門を廃止</td>
    <td><a href=https://finance.yahoo.com/quote/DIS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DIS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 06:00</td>
    <td>Precipio、2022年第4四半期および年末の株主アップデートコールを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2636246/0/en/Precipio-Announces-2022-Fourth-Quarter-and-Year-End-Shareholder-Update-Call.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2636246/0/en/Precipio-Announces-2022-Fourth-Quarter-and-Year-End-Shareholder-Update-Call.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 06:00</td>
    <td>マラバイライフサイエンス、「2022年版環境・社会・ガバナンス（ESG）レポート」を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2636247/0/en/Maravai-LifeSciences-Releases-2022-Environmental-Social-and-Governance-ESG-Report.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2636247/0/en/Maravai-LifeSciences-Releases-2022-Environmental-Social-and-Governance-ESG-Report.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/29 06:48</td>
    <td>FDA、Blueprint Medicine社のがん候補化合物「BLU-222」の一部臨床保留を解除</td>
    <td><a href=https://finance.yahoo.com/quote/BPMC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BPMC</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/28 21:36</td>
    <td>$VKTX ↑ 40%, $BMEA ↑ 25%, $ANEB ↑ 22%, $ITCI ↑ 20% PM. biotech       
</td>
    <td><a href=https://finance.yahoo.com/quote/VKTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VKTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 05:45</td>
    <td>Eloxx Pharmaceuticals社、ZKN-013の治験薬（IND）申請提出を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ELOX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ELOX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/29 05:30</td>
    <td>ザ・スタンダード、エレバンス・ヘルス社から生命・身体障害者部門を買収へ</td>
    <td><a href=https://finance.yahoo.com/quote/ELV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ELV</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/29 05:30</td>
    <td>メレオバイオファーマ、2022年12月期通期決算と最近のハイライトを発表</td>
    <td><a href=https://finance.yahoo.com/quote/MREO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MREO</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/28 22:47</td>
    <td>アナフィラキシーを含むアレルギー反応の治療薬「Neffy」の新薬承認申請を審査するため、5月11日に$SPRYアドコムを実施</td>
    <td><a href=https://finance.yahoo.com/quote/SPRY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SPRY</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/29 05:25</td>
    <td>ポリピッドが株式公開を提案、時間外で株価下落</td>
    <td><a href=https://finance.yahoo.com/quote/PYPD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PYPD</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 22:00</td>
    <td>Chiesi USA、2022年に地域社会と非営利団体に83万ドル以上を寄付</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2635729/0/en/Chiesi-USA-donates-more-than-830-000-to-local-communities-and-nonprofits-in-2022.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2635729/0/en/Chiesi-USA-donates-more-than-830-000-to-local-communities-and-nonprofits-in-2022.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/28 21:52</td>
    <td>Regeneron社、自己免疫疾患治療薬の開発でSonoma社に7500万ドルの契約一時金を支払う。</td>
    <td><a href=https://finance.yahoo.com/quote/REGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/REGN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 22:00</td>
    <td>セルラリティ、AD Ports Groupと湾岸協力会議地域およびエジプトの各地域における製品の独占販売に関する契約を締結</td>
    <td><a href=https://finance.yahoo.com/quote/CELUW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CELUW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 22:00</td>
    <td>SciSparc completes the sale of a 49% interest in its Subsidiary that owns Wellution for $3 million
</td>
    <td><a href=https://finance.yahoo.com/quote/SPRC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SPRC</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/28 21:43</td>
    <td>Intra-Cellular jumps 14% after early data for depression candidate
</td>
    <td><a href=https://finance.yahoo.com/quote/ITCI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ITCI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 21:47</td>
    <td>ヒルストリーム・バイオファーマ、2023年4月に2つの主要な業界カンファレンスに参加決定</td>
    <td><a href=https://finance.yahoo.com/quote/HILS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HILS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/28 21:38</td>
    <td>TCバイオファーム、550万ドルの公募増資を実施</td>
    <td><a href=https://finance.yahoo.com/quote/TCBP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TCBP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 21:45</td>
    <td>Morphogenesis Inc. TυHURA Biopharmaのがん免疫療法に対する後天性抵抗性を克服するファーストインクラスの抗体薬物複合体（ADC）技術を取得</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2635700/0/en/Morphogenesis-Inc-Acquires-T%CF%85HURA-Biopharma-s-First-in-Class-Antibody-Drug-Conjugates-ADCs-Technology-Designed-to-Overcome-Acquired-Resistance-to-Cancer-Immunotherapy.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2635700/0/en/Morphogenesis-Inc-Acquires-T%CF%85HURA-Biopharma-s-First-in-Class-Antibody-Drug-Conjugates-ADCs-Technology-Designed-to-Overcome-Acquired-Resistance-to-Cancer-Immunotherapy.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/28 21:32</td>
    <td>ブリストル・マイヤーズの乾癬治療薬「Sotyktu」がEUで承認取得</td>
    <td><a href=https://finance.yahoo.com/quote/BMY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BMY</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/28 21:11</td>
    <td>Silence stock rises ~10%  on deal to buy back rights to 2 drug targets from Mallinckrodt
</td>
    <td><a href=https://finance.yahoo.com/quote/SLN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SLN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 21:30</td>
    <td>Jeff Karp, Ph.D.がエテルナ社の科学諮問委員会に参加</td>
    <td><a href=https://finance.yahoo.com/quote/ERNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ERNA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 21:30</td>
    <td>Compass Therapeutics社がCantor Fitzgerald Future of Oncology Symposiumに参加することになりました。</td>
    <td><a href=https://finance.yahoo.com/quote/CMPX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CMPX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 21:30</td>
    <td>OMNIMED、新ナショナル・テクノロジー・ディレクターを紹介</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2635670/0/en/OMNIMED-Introduces-New-National-Director-of-Technology.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2635670/0/en/OMNIMED-Introduces-New-National-Director-of-Technology.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 21:30</td>
    <td>Smart for Life's Greens First CEO Ryan Benson、ボックスアウトの販売契約に関する最新情報を動画で提供</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2635671/0/en/Smart-for-Life-s-Greens-First-CEO-Ryan-Benson-Provides-Video-Update-on-Boxout-Distribution-Agreement.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2635671/0/en/Smart-for-Life-s-Greens-First-CEO-Ryan-Benson-Provides-Video-Update-on-Boxout-Distribution-Agreement.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 21:30</td>
    <td>eFFECTOR Therapeutics社、投資家向けカンファレンスに参加予定</td>
    <td><a href=https://finance.yahoo.com/quote/EFTRW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EFTRW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 21:30</td>
    <td>RespireRx Pharmaceuticals Inc. Joseph Siegelbaumの取締役会独立メンバーへの就任を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2635685/0/en/RespireRx-Pharmaceuticals-Inc-Announces-the-Appointment-Joseph-Siegelbaum-as-an-Independent-Member-of-the-Board-of-Directors.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2635685/0/en/RespireRx-Pharmaceuticals-Inc-Announces-the-Appointment-Joseph-Siegelbaum-as-an-Independent-Member-of-the-Board-of-Directors.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 21:05</td>
    <td>Lucira Health社、米国で唯一の家庭用新型コロナ＆インフルエンザ検査薬の発売を発表 売却手続き中</td>
    <td><a href=https://finance.yahoo.com/quote/LHDX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LHDX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 21:00</td>
    <td>ヴァクシニティ、4月に開催されるWorld Vaccine Congress、American Academy of Neurology、BNA2023 Festival of Neuroscienceで講演を実施</td>
    <td><a href=https://finance.yahoo.com/quote/VAXX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VAXX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 21:00</td>
    <td>ワクチンテック、B型慢性肝炎患者を対象としたHBV002試験の良好な最終データ（トップライン）を発表</td>
    <td><a href=https://finance.yahoo.com/quote/VACC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VACC</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 21:00</td>
    <td>HMNC Brain Health社とDevelco Pharma社、治療抵抗性うつ病を対象とした経口徐放性ケタミン（KET01）試験で最後の患者さんがランダム化されることを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2635586/0/en/HMNC-Brain-Health-and-Develco-Pharma-Announce-Last-Patient-Being-Randomized-in-Oral-Prolonged-Release-Ketamine-KET01-Trial-for-Treatment-Resistant-Depression.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2635586/0/en/HMNC-Brain-Health-and-Develco-Pharma-Announce-Last-Patient-Being-Randomized-in-Oral-Prolonged-Release-Ketamine-KET01-Trial-for-Treatment-Resistant-Depression.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 21:00</td>
    <td>アルナの共同創業者で最高科学責任者のスティーブン・スタイス博士が、ジョージア大学システム理事会から「アントレプレナー・ディスティンクション」を授与されました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2635593/0/en/Aruna-s-Co-Founder-and-Chief-Scientific-Officer-Dr-Steven-Stice-Receives-Entrepreneur-Distinction-from-The-University-System-of-Georgia-Board-of-Regents.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2635593/0/en/Aruna-s-Co-Founder-and-Chief-Scientific-Officer-Dr-Steven-Stice-Receives-Entrepreneur-Distinction-from-The-University-System-of-Georgia-Board-of-Regents.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 21:00</td>
    <td>バイオアダプティブス、LYリサーチ社とグルコースマネジメントの特許製品の販売に関する非独占的ライセンス契約を締結</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2635594/0/en/BioAdaptives-Signs-Non-Exclusive-License-With-LY-Research-to-Market-Patented-Product-for-Glucose-Management.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2635594/0/en/BioAdaptives-Signs-Non-Exclusive-License-With-LY-Research-to-Market-Patented-Product-for-Glucose-Management.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 21:00</td>
    <td>BrainsWay社の市販後調査において、Deep TMS™のうつ病および不安性うつ病に対する実質的な臨床効果が確認されました。</td>
    <td><a href=https://finance.yahoo.com/quote/BWAY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BWAY</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/28 20:46</td>
    <td>SNDL社、Lightbox社から大麻小売店4店舗を7.8Mカナダドルで買収へ</td>
    <td><a href=https://finance.yahoo.com/quote/SNDL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SNDL</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 21:00</td>
    <td>Covant社とBoehringer Ingelheim社、がん患者さんに使用される新規ADAR1阻害剤の開発で提携</td>
    <td><a href=https://finance.yahoo.com/quote/ROIVW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ROIVW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 21:00</td>
    <td>LifeMD、シリーズA累積永久優先株式に対する四半期配当金を決定</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2635608/0/en/LifeMD-Declares-Quarterly-Dividend-on-Series-A-Cumulative-Perpetual-Preferred-Stock.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2635608/0/en/LifeMD-Declares-Quarterly-Dividend-on-Series-A-Cumulative-Perpetual-Preferred-Stock.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/28 20:31</td>
    <td>オスカーヘルス、CEO就任で上昇</td>
    <td><a href=https://finance.yahoo.com/quote/OSCR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OSCR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 21:00</td>
    <td>アキュメン・ファーマシューティカルズ、アルツハイマー病におけるアミロイドβオリゴマーとの結合を評価するin vitroヒトニューロンモデルを発表</td>
    <td><a href=https://finance.yahoo.com/quote/ABOS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ABOS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/28 20:27</td>
    <td>ノバルティスとのがん創薬契約でバイシクル株が急騰、先行投資で5000万ドルを獲得</td>
    <td><a href=https://finance.yahoo.com/quote/NVS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NVS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 21:00</td>
    <td>Immuneering社、Harold E. Brakewoodを最高事業責任者に任命</td>
    <td><a href=https://finance.yahoo.com/quote/IMRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IMRX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/28 20:19</td>
    <td>Viking jumps 39% on early-stage data for obesity candidate
</td>
    <td><a href=https://finance.yahoo.com/quote/VKTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VKTX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/28 20:06</td>
    <td>登録者数の問題でがん試験データが年末に押しやられる中、Allarityの株価が下落</td>
    <td><a href=https://finance.yahoo.com/quote/ALLR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ALLR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 20:30</td>
    <td>コグニション・セラピューティクス、「CT1812」のアルツハイマー病に対する顕著な効果を示すプロテオミクスバイオマーカーデータを発表</td>
    <td><a href=https://finance.yahoo.com/quote/CGTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CGTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 20:30</td>
    <td>リジェネロンとソノマ・バイオセラピューティクス、自己免疫疾患に対するTreg細胞治療薬の発見、開発、商業化に関する共同研究を発表</td>
    <td><a href=https://finance.yahoo.com/quote/REGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/REGN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 20:30</td>
    <td>ザイネルバ・ファーマシューティカルズ、2022年第4四半期および通年の決算とオペレーショナルハイライトを発表</td>
    <td><a href=https://finance.yahoo.com/quote/ZYNE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ZYNE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 20:00</td>
    <td>イントラセルラー社、ルマテペロン単剤療法を評価する第403試験で良好なトップライン結果を発表 〜大うつ病混合型および双極性障害混合型うつ病患者を対象に</td>
    <td><a href=https://finance.yahoo.com/quote/ITCI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ITCI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 20:00</td>
    <td>フリーライン・セラピューティクス、2022年通期決算説明会を開催</td>
    <td><a href=https://finance.yahoo.com/quote/FRLN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/FRLN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 20:00</td>
    <td>Monopar社、Jefferies Radiopharma Innovation Summitでプレゼンテーションを実施</td>
    <td><a href=https://finance.yahoo.com/quote/MNPR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MNPR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 20:00</td>
    <td>ボイジャー・セラピューティクス、AD / PD™カンファレンスでアルツハイマー病のタウ抗体プログラムおよびパーキンソン病のGBA1遺伝子治療プログラムをサポートする新データを発表</td>
    <td><a href=https://finance.yahoo.com/quote/VYGR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VYGR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 20:00</td>
    <td>プラス・セラピューティクス社、ReSPECT-GBMフェーズ1/2a試験のコホート8で最初の患者さんの治療に成功</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2635515/0/en/Plus-Therapeutics-Successfully-Treats-First-Patient-in-Cohort-8-of-ReSPECT-GBM-Phase-1-2a-Trial.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2635515/0/en/Plus-Therapeutics-Successfully-Treats-First-Patient-in-Cohort-8-of-ReSPECT-GBM-Phase-1-2a-Trial.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 20:00</td>
    <td>Tiziana Life Sciences社、非活性型二次性進行性多発性硬化症（SPMS）患者を対象とした第2相臨床試験を実施へ</td>
    <td><a href=https://finance.yahoo.com/quote/TLSA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TLSA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 20:00</td>
    <td>アスラン・ファーマシューティカルズ、ナスダック上場要件に適合へ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2635524/0/en/ASLAN-Pharmaceuticals-Regains-Compliance-With-Nasdaq-Listing-Requirements.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2635524/0/en/ASLAN-Pharmaceuticals-Regains-Compliance-With-Nasdaq-Listing-Requirements.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 20:00</td>
    <td>Revive Therapeutics社、覚せい剤使用障害を対象としたPsilocybinの臨床試験に関する最新情報を提供</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2635528/0/en/Revive-Therapeutics-Provides-Update-on-Psilocybin-Clinical-Study-for-Methamphetamine-Use-Disorder.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2635528/0/en/Revive-Therapeutics-Provides-Update-on-Psilocybin-Clinical-Study-for-Methamphetamine-Use-Disorder.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 20:00</td>
    <td>マインドセット・ファーマ社CEOのJames Lanthierが、非ハルシン系新規治療薬への創薬活動の拡大について、株主宛に書簡を発行しました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2635529/0/en/Mindset-Pharma-CEO-James-Lanthier-Issues-Letter-to-Shareholders-Discussing-Expansion-of-Drug-Discovery-Efforts-into-Novel-Non-Hallucinogenic-Therapeutics.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2635529/0/en/Mindset-Pharma-CEO-James-Lanthier-Issues-Letter-to-Shareholders-Discussing-Expansion-of-Drug-Discovery-Efforts-into-Novel-Non-Hallucinogenic-Therapeutics.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/28 19:51</td>
    <td>アルジェンクス、がん治療薬のグローバル権利を売却</td>
    <td><a href=https://finance.yahoo.com/quote/ARGX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ARGX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 19:45</td>
    <td>BioNTech社、新しいADS買戻しプログラムを発表</td>
    <td><a href=https://finance.yahoo.com/quote/BNTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BNTX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/28 19:24</td>
    <td>エボテック、神経疾患治療薬の開発でブリストル・マイヤーズから契約一時金$50Mを獲得</td>
    <td><a href=https://finance.yahoo.com/quote/BMY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BMY</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/28 18:57</td>
    <td>Monopar stock crashes ~50% as Validive program gets axed after trial failure
</td>
    <td><a href=https://finance.yahoo.com/quote/MNPR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MNPR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 19:00</td>
    <td>ノボザイムスとChr.Hansenの統合に関する最新情報：米国反トラスト規制の待機期間が終了し、完了への道筋をサポート</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2635465/0/en/Update-on-the-combination-of-Novozymes-and-Chr-Hansen-U-S-antitrust-regulation-waiting-period-has-expired-supporting-the-path-to-completion.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2635465/0/en/Update-on-the-combination-of-Novozymes-and-Chr-Hansen-U-S-antitrust-regulation-waiting-period-has-expired-supporting-the-path-to-completion.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 19:00</td>
    <td>Allarity Therapeutics、IXEMPRAおよびStenoparibの第2相単剤療法の臨床試験に関する最新情報を提供</td>
    <td><a href=https://finance.yahoo.com/quote/ALLR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ALLR</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/28 18:13</td>
    <td>ノボ ノルディスク、Health2Sync、Biocorpが協力し、マルヤデバイスでインスリンデータを統合する。</td>
    <td><a href=https://finance.yahoo.com/quote/NVO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NVO</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/28 17:53</td>
    <td>GSK's Jemperli cuts risk of death in uterus cancer patients subset by 72% but lower overall in trial
</td>
    <td><a href=https://finance.yahoo.com/quote/GSK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GSK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 18:00</td>
    <td>私たちは、このような問題を解決するために、さまざまな努力を行ってきました。</td>
    <td><a href=https://finance.yahoo.com/quote/ALVOW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ALVOW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 18:00</td>
    <td>アルボテック、コーポレート・サステナビリティ・フレームワークの最新情報を提供</td>
    <td><a href=https://finance.yahoo.com/quote/ALVOW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ALVOW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 17:54</td>
    <td>ニュージーランド・ファーマ、アミリンアナログ「ZP8396」の良好な第1相臨床結果を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2635429/0/en/Zealand-Pharma-Announces-Positive-Phase-1-Clinical-Results-with-Amylin-Analogue-ZP8396.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2635429/0/en/Zealand-Pharma-Announces-Positive-Phase-1-Clinical-Results-with-Amylin-Analogue-ZP8396.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 17:06</td>
    <td>11,577,957株の新規B株増資の登記完了</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2635409/0/en/REGISTRATION-OF-SHARE-CAPITAL-INCREASE-OF-11-577-957-NEW-B-SHARES-COMPLETED.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2635409/0/en/REGISTRATION-OF-SHARE-CAPITAL-INCREASE-OF-11-577-957-NEW-B-SHARES-COMPLETED.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 16:00</td>
    <td>EnteroBiotix社、微生物製剤EBX-102の肝硬変・肝性脳症に対するフェーズ2試験を開始</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2635376/0/en/EnteroBiotix-Initiates-Phase-2-study-of-microbiome-drug-EBX-102-in-liver-cirrhosis-and-hepatic-encephalopathy.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2635376/0/en/EnteroBiotix-Initiates-Phase-2-study-of-microbiome-drug-EBX-102-in-liver-cirrhosis-and-hepatic-encephalopathy.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 15:08</td>
    <td>バーニングロック、2022年第4四半期および通期決算を発表</td>
    <td><a href=https://finance.yahoo.com/quote/BNR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BNR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 15:00</td>
    <td>Captor Therapeutics、パイプラインのリードアセットの分子標的を開示、ウェブキャストに関係者を招待</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2635336/0/en/Captor-Therapeutics-Discloses-Molecular-Targets-of-Pipeline-s-Lead-Assets-and-Invites-Stakeholders-to-Webcast.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2635336/0/en/Captor-Therapeutics-Discloses-Molecular-Targets-of-Pipeline-s-Lead-Assets-and-Invites-Stakeholders-to-Webcast.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 15:00</td>
    <td>Genmab社、Martine van Vugtの最高戦略責任者就任を発表</td>
    <td><a href=https://finance.yahoo.com/quote/GMAB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GMAB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 15:00</td>
    <td>Philogen社、Google社との共同研究により、DNA暗号化ケミカルライブラリー技術に機械学習モデルを適用した新しい研究を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2635346/0/en/Philogen-Announces-Publication-of-a-New-Study-in-Collaboration-with-Google-focused-on-Machine-Learning-models-applied-to-DNA-Encoded-Chemical-Library-Technology.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2635346/0/en/Philogen-Announces-Publication-of-a-New-Study-in-Collaboration-with-Google-focused-on-Machine-Learning-models-applied-to-DNA-Encoded-Chemical-Library-Technology.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 14:00</td>
    <td>Athira Pharma、AD / PD™ 2023国際会議において、アルツハイマー病およびパーキンソン病に対するFosgonimetonの治療可能性を裏付ける前臨床試験データを発表</td>
    <td><a href=https://finance.yahoo.com/quote/ATHA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ATHA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 14:00</td>
    <td>Vivoryon Therapeutics N.V.、アルツハイマー病治療薬Varoglutamstatの臨床開発に関する進捗状況をお知らせします。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2635326/0/en/Vivoryon-Therapeutics-N-V-Provides-Progress-Update-on-Varoglutamstat-Clinical-Development-for-the-Treatment-of-Alzheimer-s-Disease.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2635326/0/en/Vivoryon-Therapeutics-N-V-Provides-Progress-Update-on-Varoglutamstat-Clinical-Development-for-the-Treatment-of-Alzheimer-s-Disease.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 14:00</td>
    <td>アデクス・セラピューティクス、2022年通期決算の発表とカンファレンスコールの開催を2023年3月30日に決定</td>
    <td><a href=https://finance.yahoo.com/quote/ADXN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ADXN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 11:25</td>
    <td>ジン・メディカル・インターナショナル社（Jin Medical International Ltd. 8,000,000ドルの新規株式公開の価格決定を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2635321/0/en/Jin-Medical-International-Ltd-Announces-Pricing-of-8-000-000-Initial-Public-Offering.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2635321/0/en/Jin-Medical-International-Ltd-Announces-Pricing-of-8-000-000-Initial-Public-Offering.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 10:01</td>
    <td>アクシオム、「臨床試験におけるアウトソーシング Southeast 2023」に出展</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/28/2635315/0/en/Axiom-Exhibiting-at-Outsourcing-in-Clinical-Trials-Southeast-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/28/2635315/0/en/Axiom-Exhibiting-at-Outsourcing-in-Clinical-Trials-Southeast-2023.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/27 19:04</td>
    <td>BCLIは、NurOwnのBLAを審査するFDA AdCommを発表。</td>
    <td><a href=https://finance.yahoo.com/quote/BCLI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BCLI</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/27 19:07</td>
    <td>イオン $AZN、ATTRv-PN患者を対象としたフェーズ3試験「NEURO-TTRansform」の66週解析で良好なトップライン結果が得られたと発表</td>
    <td><a href=https://finance.yahoo.com/quote/IONS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IONS</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/27 19:53</td>
    <td>BNTXのQ4'22とFY'22の売上はそれぞれ43億ユーロと173億ユーロ。FY'22の純利益は9.4Bユーロ。完全希薄化後の1株当たり利益は37.77ユーロ 現金および現金同等物は139億ユーロ 23年度のCOVID19ワクチンの売上は〜50億ユーロと予想されます。</td>
    <td><a href=https://finance.yahoo.com/quote/BNTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BNTX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/27 20:01</td>
    <td>CDAKが破産を申請</td>
    <td><a href=https://finance.yahoo.com/quote/CDAK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CDAK</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/27 20:03</td>
    <td>EYP-1901の湿性AMDの維持療法を対象とした第2相DAVIO 2臨床試験の登録が完了   第4四半期にトップラインデータ</td>
    <td><a href=https://finance.yahoo.com/quote/EYPT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EYPT</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/27 20:04</td>
    <td>アミカス・セラピューティクス、遅発性ポンペ病患者に対するPombiliti™の欧州委員会承認取得を発表</td>
    <td><a href=https://finance.yahoo.com/quote/FOLD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/FOLD</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 07:50</td>
    <td>AnaptysBio社とGSK社が共同開発した免疫腫瘍剤Jemperli（dostarlimab-gxly）と化学療法の併用は、第3相RUBY試験において、化学療法単独に対して、原発性進行・再発子宮内膜がんに対する無増悪生存期間に統計的に有意かつ臨床的に意味のある改善を示すことが判明</td>
    <td><a href=https://finance.yahoo.com/quote/ANAB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ANAB</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/27 20:09</td>
    <td>$GMDA to discontinue development of preclinical NK cell therapy candidates.  Reduce workforce by 17%. The company will also close its operations in Jerusalem.  Cash runway through Q3. 😬       
</td>
    <td><a href=https://finance.yahoo.com/quote/GMDA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GMDA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 06:00</td>
    <td>Monopar社、重症口腔粘膜炎に対するValidiveを評価するフェーズ2b/3試験「VOICE」の中間解析結果を発表</td>
    <td><a href=https://finance.yahoo.com/quote/MNPR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MNPR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 05:19</td>
    <td>ACTG、「Journal of Infectious Diseases」誌にHIVの保存期間と寛解の見通しに関する新たな知見を掲載したと発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2635252/0/en/ACTG-Announces-Publication-of-New-Insights-Into-HIV-Reservoirs-and-Prospects-for-Remission-in-the-Journal-of-Infectious-Diseases.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2635252/0/en/ACTG-Announces-Publication-of-New-Insights-Into-HIV-Reservoirs-and-Prospects-for-Remission-in-the-Journal-of-Infectious-Diseases.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/27 21:17</td>
    <td>$CRSPは$100Mの前払いを受ける。$VRTX</td>
    <td><a href=https://finance.yahoo.com/quote/CRSP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CRSP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 05:15</td>
    <td>Tilray Brands, Inc.、2023年度第3四半期決算を4月10日に発表</td>
    <td><a href=https://finance.yahoo.com/quote/TLRY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TLRY</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/28 07:16</td>
    <td>メルク社の「キイトルーダ」が複数のタイプの子宮内膜がんに成功</td>
    <td><a href=https://finance.yahoo.com/quote/MRK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 05:15</td>
    <td>Nanobiotix社、2022年度決算発表およびカンファレンスコールの開催を延期</td>
    <td><a href=https://finance.yahoo.com/quote/NBTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NBTX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/27 21:19</td>
    <td>$DCTH FDAがHepzato KitのNDA再申請を受理。PDUFA 08 / 14 / 23</td>
    <td><a href=https://finance.yahoo.com/quote/DCTH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DCTH</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/27 21:24</td>
    <td>BXRX社、BX1000の無作為化フェーズ2試験の第2回中間解析で良好な結果を発表。 トップラインデータは4月下旬から5月上旬に期待される</td>
    <td><a href=https://finance.yahoo.com/quote/BXRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BXRX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/28 06:50</td>
    <td>Exelixisの株主であるFarallonがバイオテックの取締役会に3名を推薦へ</td>
    <td><a href=https://finance.yahoo.com/quote/EXEL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EXEL</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 05:15</td>
    <td>CytomX Therapeutics、2022年通期決算の報告とビジネスアップデートを発表</td>
    <td><a href=https://finance.yahoo.com/quote/CTMX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CTMX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/27 21:33</td>
    <td>UBX、ウェットAMD患者を対象としたUBX1325の第2相ENVISION試験の結果を発表。 UBX1325単剤療法は、抗VEGF対照群で予想外の3.5レター増を示したこともあり、24週まで非劣性を達成しなかった。🤷‍♂️</td>
    <td><a href=https://finance.yahoo.com/quote/UBX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/UBX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/28 06:43</td>
    <td>Retractable Technologies slashes its workforce by 22%
</td>
    <td><a href=https://finance.yahoo.com/quote/RVP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RVP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 05:05</td>
    <td>Nyxoahが市場公募で300万ドルを調達しました。</td>
    <td><a href=https://finance.yahoo.com/quote/NYXH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NYXH</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 05:05</td>
    <td>Nyxoah、市場からの株式発行で300万ドルを調達</td>
    <td><a href=https://finance.yahoo.com/quote/NYXH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NYXH</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/27 21:58</td>
    <td>JNCEハルト</td>
    <td><a href=https://finance.yahoo.com/quote/JNCE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/JNCE</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/28 06:07</td>
    <td>なぜ今日、ノバルティスの株価は上がったのか？初期の乳がん試験結果</td>
    <td><a href=https://finance.yahoo.com/quote/NVS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NVS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/28 05:05</td>
    <td>MaxCyte社、Douglas Swirskyを最高財務責任者に任命</td>
    <td><a href=https://finance.yahoo.com/quote/MXCT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MXCT</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/27 22:01</td>
    <td>JNCE、Concentra Biosciencesに1株あたり1.85ドルの現金とCVRで買収される予定</td>
    <td><a href=https://finance.yahoo.com/quote/JNCE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/JNCE</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/28 05:42</td>
    <td>ナノバイオティクス、2022年度決算の発表を延期</td>
    <td><a href=https://finance.yahoo.com/quote/NNBXF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NNBXF</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 22:28</td>
    <td>NATALEE（TRIO033）第III相試験でリボシクリブが早期乳がん患者の再発リスクを有意に低減することが中間解析で証明される</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634854/0/en/NATALEE-TRIO033-Phase-III-trial-demonstrates-ribociclib-significantly-reduces-the-risk-of-recurrence-for-patients-with-early-breast-cancer-at-interim-analysis.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634854/0/en/NATALEE-TRIO033-Phase-III-trial-demonstrates-ribociclib-significantly-reduces-the-risk-of-recurrence-for-patients-with-early-breast-cancer-at-interim-analysis.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 22:07</td>
    <td>bioLytical Laboratories Inc.がINSTI® Multiplex HIV-1 / 2 Syphilis Antibody Testのカナダ保健省の認可を取得しました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634831/21560/zh-hans/bioLytical-Laboratories-Inc-%E7%9A%84INSTI-%E5%A4%9A%E9%87%8DHIV-1-2%E6%A2%85%E6%AF%92%E6%8A%97%E4%BD%93%E6%A3%80%E6%B5%8B%E8%AF%95%E5%89%82%E7%9B%92%E8%8E%B7%E5%BE%97%E5%8A%A0%E6%8B%BF%E5%A4%A7%E5%8D%AB%E7%94%9F%E9%83%A8%E6%8E%88%E6%9D%83.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634831/21560/zh-hans/bioLytical-Laboratories-Inc-%E7%9A%84INSTI-%E5%A4%9A%E9%87%8DHIV-1-2%E6%A2%85%E6%AF%92%E6%8A%97%E4%BD%93%E6%A3%80%E6%B5%8B%E8%AF%95%E5%89%82%E7%9B%92%E8%8E%B7%E5%BE%97%E5%8A%A0%E6%8B%BF%E5%A4%A7%E5%8D%AB%E7%94%9F%E9%83%A8%E6%8E%88%E6%9D%83.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 22:07</td>
    <td>bioLytical Laboratories Inc.、「INSTI® Multiplex HIV-1 / 2 and Syphilis Antibody Test」がカナダ保健省の承認を取得。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634831/21560/es/bioLytical-Laboratories-Inc-obtiene-autorizaci%C3%B3n-de-Health-Canada-para-su-prueba-de-anticuerpos-INSTI-Multiplex-VIH-1-2-y-S%C3%ADfilis.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634831/21560/es/bioLytical-Laboratories-Inc-obtiene-autorizaci%C3%B3n-de-Health-Canada-para-su-prueba-de-anticuerpos-INSTI-Multiplex-VIH-1-2-y-S%C3%ADfilis.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 22:05</td>
    <td>エイムイムノテック、2023年3月31日に2022年通期決算を発表、初の四半期カンファレンスコールとウェブキャストを開催へ</td>
    <td><a href=https://finance.yahoo.com/quote/AIM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AIM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 22:00</td>
    <td>株式買戻しプログラムに関連する取引</td>
    <td><a href=https://finance.yahoo.com/quote/GMAB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GMAB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 22:00</td>
    <td>ジェフリーズ主催の「ラジオファーマ・イノベーション・サミット」で講演</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634794/0/en/Nusano-to-Present-at-Jefferies-Inaugural-Radiopharma-Innovation-Summit.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634794/0/en/Nusano-to-Present-at-Jefferies-Inaugural-Radiopharma-Innovation-Summit.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 22:00</td>
    <td>Jounce TherapeuticsがConcentra Biosciencesに1株当たり1.85ドルの現金と偶発的価値のある権利で買収される契約を締結</td>
    <td><a href=https://finance.yahoo.com/quote/JNCE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/JNCE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 22:00</td>
    <td>2023年4月6日開催予定の定時株主総会における証券会社による当社普通株式4400万株以上の大幅な過少申告の報告およびScilex Holding Company普通株式の配当に関する既発行の「FAQ」の補足のお知らせ</td>
    <td><a href=https://finance.yahoo.com/quote/SCLX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SCLX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 22:00</td>
    <td>Teladoc Healthの新しい研究により、単一で統合されたケア体験の有効性がさらに検証されました。</td>
    <td><a href=https://finance.yahoo.com/quote/TDOC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TDOC</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/27 21:55</td>
    <td>キロンライフサイエンス、市場投入投資口の規模を発表</td>
    <td><a href=https://finance.yahoo.com/quote/KHRNF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/KHRNF</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 22:00</td>
    <td>Oncternal Therapeutics、ナスダック上場規則5635(c)(4)に基づく誘引賞の受賞を報告</td>
    <td><a href=https://finance.yahoo.com/quote/ONCT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ONCT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 22:00</td>
    <td>フィリップスのバーチャル・ケア・マネジメントは、患者、プロバイダー、支払者のために、テレヘルスの包括的なアプローチを提供します。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634814/0/en/Philips-Virtual-Care-Management-offers-a-comprehensive-approach-to-telehealth-for-patients-providers-and-payers.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634814/0/en/Philips-Virtual-Care-Management-offers-a-comprehensive-approach-to-telehealth-for-patients-providers-and-payers.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/27 21:53</td>
    <td>デルキャス、抗がん剤用デバイスのFDA審査を獲得</td>
    <td><a href=https://finance.yahoo.com/quote/DCTH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DCTH</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 21:55</td>
    <td>アニカ、予備的委任状（Preliminary Proxy Statement）を提出</td>
    <td><a href=https://finance.yahoo.com/quote/ANIK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ANIK</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/27 21:32</td>
    <td>Unity Biotech sheds 48% after mid-stage setback for wet AMD candidate
</td>
    <td><a href=https://finance.yahoo.com/quote/UBX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/UBX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 21:38</td>
    <td>BioSig、新たなアドバイザリーボードメンバー「Edwin Wang」を発表</td>
    <td><a href=https://finance.yahoo.com/quote/BSGM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BSGM</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/27 21:24</td>
    <td>バーテックス、CRISPR Therapeuticsと糖尿病治療薬に関するライセンス契約を締結</td>
    <td><a href=https://finance.yahoo.com/quote/VRTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VRTX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/27 21:23</td>
    <td>デルキャス・システムズ、最大8500万ドルの資金調達を発表</td>
    <td><a href=https://finance.yahoo.com/quote/DCTH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DCTH</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 21:30</td>
    <td>セレバンス、「Chief Medical Officer Summit 360˚」に出展</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634746/0/en/Cerevance-to-Participate-in-Chief-Medical-Officer-Summit-360.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634746/0/en/Cerevance-to-Participate-in-Chief-Medical-Officer-Summit-360.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 21:30</td>
    <td>アンビレックス、2023年AACR年次総会でARX517とARX305の前臨床データを発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/AMAM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMAM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 21:08</td>
    <td>g medical innovationsとMicare Path、革新的な遠隔患者モニタリングソリューションをグローバルに提供するため、共同で協業することを発表</td>
    <td><a href=https://finance.yahoo.com/quote/GMVDW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GMVDW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 21:05</td>
    <td>Terns Pharmaceuticals、Terns Oncologyの最高医学責任者にEmil Kuriakose, M.D.を任命</td>
    <td><a href=https://finance.yahoo.com/quote/TERN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TERN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 21:01</td>
    <td>プライアント・セラピューティクス、2023年米国胸部学会国際会議でのポスター発表のお知らせ</td>
    <td><a href=https://finance.yahoo.com/quote/PLRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PLRX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 21:00</td>
    <td>センテッサ・ファーマシューティカルズ、今後開催される投資家向けカンファレンスに出展</td>
    <td><a href=https://finance.yahoo.com/quote/CNTA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CNTA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 21:00</td>
    <td>リズム製薬、バルデット・ビードル症候群の患者・介護者が見たセトメラノチドによる空腹感とQOLに関する見解を発表</td>
    <td><a href=https://finance.yahoo.com/quote/RYTM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RYTM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 21:00</td>
    <td>Revolo Biotherapeutics社、アレルギー疾患を対象とした'1104のフェーズ2a試験終了を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634685/0/en/Revolo-Biotherapeutics-Announces-Completion-of-Phase-2a-Trial-of-1104-in-Allergic-Disease.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634685/0/en/Revolo-Biotherapeutics-Announces-Completion-of-Phase-2a-Trial-of-1104-in-Allergic-Disease.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 21:00</td>
    <td>Kala社、PCED患者を対象としたKPI-012のCHASEフェーズ2b臨床試験のコホート1における良好な安全性アップデートを発表</td>
    <td><a href=https://finance.yahoo.com/quote/KALA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/KALA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 21:00</td>
    <td>bioLytical Laboratories Inc. INSTI® Multiplex HIV-1 / 2 Syphilis Antibody Testのカナダ保健省の認可を取得しました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634692/21560/en/bioLytical-Laboratories-Inc-Receives-Health-Canada-Authorization-for-its-INSTI-Multiplex-HIV-1-2-Syphilis-Antibody-Test.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634692/21560/en/bioLytical-Laboratories-Inc-Receives-Health-Canada-Authorization-for-its-INSTI-Multiplex-HIV-1-2-Syphilis-Antibody-Test.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/27 20:57</td>
    <td>CVS、シグニファイヘルス社の買収を今週中に完了へ</td>
    <td><a href=https://finance.yahoo.com/quote/CVS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CVS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 21:00</td>
    <td>ダクソー、心不全患者向け血液量診断装置「BVA-100®」を5病院に導入し、大幅な拡大を発表</td>
    <td><a href=https://finance.yahoo.com/quote/DXR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DXR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 21:00</td>
    <td>オルガノジェネシス社、監察官事務所の調査結果を称賛</td>
    <td><a href=https://finance.yahoo.com/quote/ORGO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ORGO</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/27 20:55</td>
    <td>ベラーノ、種類株式の転換により資本構成を簡素化</td>
    <td><a href=https://finance.yahoo.com/quote/VRNOF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VRNOF</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 21:00</td>
    <td>ペトビボ・ホールディングス株式会社 米国ジョージア州アトランタで開催されるIVAPM疼痛管理フォーラムに出展決定</td>
    <td><a href=https://finance.yahoo.com/quote/PETVW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PETVW</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/27 20:47</td>
    <td>アミカス社の遅発性ポンペ病治療薬「ポンビリチ」をECが承認</td>
    <td><a href=https://finance.yahoo.com/quote/FOLD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/FOLD</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/27 20:42</td>
    <td>ロイヤリティ・ファーマ、10億ドルの自社株買戻しプログラムを開始</td>
    <td><a href=https://finance.yahoo.com/quote/RPRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RPRX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/27 20:34</td>
    <td>Ionis社とAstraZeneca社、eplontersen試験で良好な結果を報告</td>
    <td><a href=https://finance.yahoo.com/quote/AZN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AZN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 20:32</td>
    <td>Smart ImmuneがFrench Tech Health20プログラムの第1期生に選出されました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634664/0/en/Smart-Immune-is-selected-for-the-first-cohort-of-the-French-Tech-Health20-program.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634664/0/en/Smart-Immune-is-selected-for-the-first-cohort-of-the-French-Tech-Health20-program.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 20:30</td>
    <td>Syneos Health社、メディカルアフェアーズ・デジタルアンプを販売開始</td>
    <td><a href=https://finance.yahoo.com/quote/SYNH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SYNH</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 20:30</td>
    <td>サイトウキネティクス社、第1回企業責任報告書を発表</td>
    <td><a href=https://finance.yahoo.com/quote/CYTK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CYTK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 20:30</td>
    <td>A & Fスプリンクラー、ランダム薬物検査プログラムのサポートにインテリジェント・バイオ・ソリューションズの最新型DSR-Plusスクリーニングユニットを選択</td>
    <td><a href=https://finance.yahoo.com/quote/INBS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/INBS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 20:30</td>
    <td>Olink、2022年版アニュアルレポートを発行</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634656/0/en/Olink-publishes-2022-annual-report.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634656/0/en/Olink-publishes-2022-annual-report.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 20:30</td>
    <td>Entourage Health、CBDチューインガム発売で医療製品の提供を拡大し続け、Starseed Medicinal Programに新たなユニオングループを契約</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634660/0/en/Entourage-Health-Continues-to-Expand-Medical-Offerings-with-Launch-of-CBD-Chewing-Gum-and-Signs-New-Union-Group-to-the-Starseed-Medicinal-Program.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634660/0/en/Entourage-Health-Continues-to-Expand-Medical-Offerings-with-Launch-of-CBD-Chewing-Gum-and-Signs-New-Union-Group-to-the-Starseed-Medicinal-Program.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 20:25</td>
    <td>STALICLA社とFirefly Neuroscience社がASD患者のサブグループに対するバイオマーカーとしての脳波の開発に関するパートナーシップ契約を締結</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634637/0/en/STALICLA-and-Firefly-Neuroscience-enter-Partnership-Agreement-for-the-Development-of-Electroencephalogram-EEG-as-a-Biomarker-for-Subgroups-of-Patients-with-ASD.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634637/0/en/STALICLA-and-Firefly-Neuroscience-enter-Partnership-Agreement-for-the-Development-of-Electroencephalogram-EEG-as-a-Biomarker-for-Subgroups-of-Patients-with-ASD.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 20:16</td>
    <td>トドス・メディカル、OTCピンク・マーケットプレイスで取引開始</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634634/0/en/Todos-Medical-Begins-Trading-on-the-OTC-Pink-Marketplace.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634634/0/en/Todos-Medical-Begins-Trading-on-the-OTC-Pink-Marketplace.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 20:00</td>
    <td>アミカスセラピューティクス、遅発性ポンペ病患者に対するPombiliti™の欧州委員会承認取得を発表</td>
    <td><a href=https://finance.yahoo.com/quote/FOLD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/FOLD</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 20:00</td>
    <td>カリナン・オンコロジー社、IL-2およびIL-12サイトカインを利用した新規融合タンパク質「CLN-617」の米国FDAによる新薬承認申請を完了と発表</td>
    <td><a href=https://finance.yahoo.com/quote/CGEM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CGEM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 20:00</td>
    <td>アクラリス・セラピューティクスがH.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conferenceに参加する件</td>
    <td><a href=https://finance.yahoo.com/quote/ACRS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ACRS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 20:00</td>
    <td>パッセージバイオ、グッゲンハイム・ヘルスケア・トークスでプレゼンテーションを実施： ゲノム医薬品と希少疾病の日々</td>
    <td><a href=https://finance.yahoo.com/quote/PASG target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PASG</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 20:00</td>
    <td>トニックス・ファーマシューティカルズ、ワールド・ワクチン・コングレスでの口頭発表のお知らせ</td>
    <td><a href=https://finance.yahoo.com/quote/TNXP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TNXP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 20:00</td>
    <td>アイポイント・ファーマシューティカルズ、湿性AMDの維持療法を対象としたEYP-1901の第2相DAVIO 2臨床試験において、定員を超える登録が完了</td>
    <td><a href=https://finance.yahoo.com/quote/EYPT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EYPT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 20:00</td>
    <td>Tango Therapeutics、2022年第4四半期および通年の決算報告とビジネスハイライトを発表</td>
    <td><a href=https://finance.yahoo.com/quote/TNGX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TNGX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 20:00</td>
    <td>アキュメン・ファーマシューティカルズ、2022年12月期通期決算とビジネスハイライトを発表</td>
    <td><a href=https://finance.yahoo.com/quote/ABOS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ABOS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/27 19:48</td>
    <td>Brainstorm社、ALS治療薬でFDA AdComミーティングを取得</td>
    <td><a href=https://finance.yahoo.com/quote/BCLI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BCLI</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/27 19:41</td>
    <td>コディアック・バイオサイエンス、連邦破産法11条の適用申請で急落：レポート</td>
    <td><a href=https://finance.yahoo.com/quote/CDAK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CDAK</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/27 19:27</td>
    <td>インサイト社、骨がん治療薬「ペマジール」の日本での承認を取得</td>
    <td><a href=https://finance.yahoo.com/quote/INCY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/INCY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 19:30</td>
    <td>Bram LowskyがCloudMDのヘルス＆ウェルネスサービス（旧エンタープライズヘルスソリューション）担当の新ヘッドとして入社</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634581/0/en/Bram-Lowsky-joins-CloudMD-as-new-Head-of-Health-and-Wellness-Services-formerly-Enterprise-Health-Solutions.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634581/0/en/Bram-Lowsky-joins-CloudMD-as-new-Head-of-Health-and-Wellness-Services-formerly-Enterprise-Health-Solutions.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 18:39</td>
    <td>ゲルベ：2023年2月28日現在の同社の資本を構成する株式数および議決権数</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634553/0/fr/GUERBET-Nombre-d-actions-et-de-droits-de-vote-composant-le-capital-de-la-soci%C3%A9t%C3%A9-au-28-f%C3%A9vrier-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634553/0/fr/GUERBET-Nombre-d-actions-et-de-droits-de-vote-composant-le-capital-de-la-soci%C3%A9t%C3%A9-au-28-f%C3%A9vrier-2023.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/27 18:46</td>
    <td>ノバルティスの株価、がん試験成功で急上昇</td>
    <td><a href=https://finance.yahoo.com/quote/NVS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NVS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/27 18:45</td>
    <td>ファーミンググループ、希少な免疫疾患治療薬でFDAの承認を獲得</td>
    <td><a href=https://finance.yahoo.com/quote/PHAR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PHAR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 17:00</td>
    <td>ESCAPE-TRD試験（フェーズ3b）の新たなデータにより、SPRAVATO®▼（エスケタミン点鼻薬［NS］）を投与された参加者は、Quetiapine Extended-Release を投与された参加者と比較して、高い奏効率と寛解率を達成し、時間の経過と共に増加することが示されました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634493/0/en/New-Data-from-the-Phase-3b-ESCAPE-TRD-Study-Show-that-Participants-Receiving-SPRAVATO-Esketamine-Nasal-Spray-NS-Achieved-Higher-Response-and-Remission-Rates-Increasing-Over-Time-Co.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634493/0/en/New-Data-from-the-Phase-3b-ESCAPE-TRD-Study-Show-that-Participants-Receiving-SPRAVATO-Esketamine-Nasal-Spray-NS-Achieved-Higher-Response-and-Remission-Rates-Increasing-Over-Time-Co.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 17:00</td>
    <td>キャリバーサイエンティフィック社、英国の科学機器・消耗品・サービスプロバイダーであるSciQuip社を買収</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634496/0/en/Calibre-Scientific-Acquires-SciQuip-a-UK-Provider-of-Scientific-Equipment-Supplies-and-Services.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634496/0/en/Calibre-Scientific-Acquires-SciQuip-a-UK-Provider-of-Scientific-Equipment-Supplies-and-Services.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 17:00</td>
    <td>キャリバーサイエンティフィック社、英国を拠点とする科学サービス、消耗品、機器のプロバイダーであるSciQuip社を買収</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634496/0/fr/Calibre-Scientific-fait-l-acquisition-de-SciQuip-un-fournisseur-britannique-de-services-de-fournitures-et-d-%C3%A9quipements-scientifiques.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634496/0/fr/Calibre-Scientific-fait-l-acquisition-de-SciQuip-un-fournisseur-britannique-de-services-de-fournitures-et-d-%C3%A9quipements-scientifiques.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 17:00</td>
    <td>キャリバーサイエンティフィック社、科学機器・実験用品・サービスを提供する英国SciQuip社を買収</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634496/0/de/Calibre-Scientific-erwirbt-SciQuip-einen-britischen-Anbieter-von-wissenschaftlicher-Ausr%C3%BCstung-Laborbedarf-und-Dienstleistungen.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634496/0/de/Calibre-Scientific-erwirbt-SciQuip-einen-britischen-Anbieter-von-wissenschaftlicher-Ausr%C3%BCstung-Laborbedarf-und-Dienstleistungen.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/27 15:33</td>
    <td>オーロラ・キャンナビス、ナスダックからコンプライアンス違反の通知を受ける</td>
    <td><a href=https://finance.yahoo.com/quote/ACB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ACB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 17:00</td>
    <td>ESCAPE-TRD試験（フェーズ3b）の新たなデータにより、SPRAVATO®▼（エスケタミン点鼻薬［NS］）を投与された参加者は、Quetiapine Extended-Release を投与された参加者と比較して、高い奏効率と寛解率を達成し、時間の経過と共に増加することが示されました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634493/0/en/New-Data-from-the-Phase-3b-ESCAPE-TRD-Study-Show-that-Participants-Receiving-SPRAVATO-Esketamine-Nasal-Spray-NS-Achieved-Higher-Response-and-Remission-Rates-Increasing-Over-Time-Co.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634493/0/en/New-Data-from-the-Phase-3b-ESCAPE-TRD-Study-Show-that-Participants-Receiving-SPRAVATO-Esketamine-Nasal-Spray-NS-Achieved-Higher-Response-and-Remission-Rates-Increasing-Over-Time-Co.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 17:00</td>
    <td>キャリバーサイエンティフィック社、英国の科学機器・消耗品・サービスプロバイダーであるSciQuip社を買収</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634496/0/en/Calibre-Scientific-Acquires-SciQuip-a-UK-Provider-of-Scientific-Equipment-Supplies-and-Services.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634496/0/en/Calibre-Scientific-Acquires-SciQuip-a-UK-Provider-of-Scientific-Equipment-Supplies-and-Services.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 17:00</td>
    <td>キャリバーサイエンティフィック社、英国を拠点とする科学サービス、消耗品、機器のプロバイダーであるSciQuip社を買収</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634496/0/fr/Calibre-Scientific-fait-l-acquisition-de-SciQuip-un-fournisseur-britannique-de-services-de-fournitures-et-d-%C3%A9quipements-scientifiques.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634496/0/fr/Calibre-Scientific-fait-l-acquisition-de-SciQuip-un-fournisseur-britannique-de-services-de-fournitures-et-d-%C3%A9quipements-scientifiques.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 17:00</td>
    <td>キャリバーサイエンティフィック社、科学機器・実験用品・サービスを提供する英国SciQuip社を買収</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634496/0/de/Calibre-Scientific-erwirbt-SciQuip-einen-britischen-Anbieter-von-wissenschaftlicher-Ausr%C3%BCstung-Laborbedarf-und-Dienstleistungen.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634496/0/de/Calibre-Scientific-erwirbt-SciQuip-einen-britischen-Anbieter-von-wissenschaftlicher-Ausr%C3%BCstung-Laborbedarf-und-Dienstleistungen.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/27 15:33</td>
    <td>オーロラ・カンナビス、ナスダックからコンプライアンス違反の通知を受ける</td>
    <td><a href=https://finance.yahoo.com/quote/ACB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ACB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 15:00</td>
    <td>10,000件以上の症例に使用されたVersius</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634451/0/en/Versius-used-to-perform-over-10-000-cases.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634451/0/en/Versius-used-to-perform-over-10-000-cases.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 15:00</td>
    <td>2023年1月1日付のオリオンの新組織体制および会計慣行改訂に基づく2022年の比較売上高データ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634455/0/en/Comparative-net-sales-data-for-2022-under-Orion-s-new-organisational-structure-and-revised-accounting-practice-as-of-1-January-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634455/0/en/Comparative-net-sales-data-for-2022-under-Orion-s-new-organisational-structure-and-revised-accounting-practice-as-of-1-January-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/27 15:00</td>
    <td>2022年の比較売上高データおよびオリオンの新組織体制に伴う2023年1月1日からの計算方法の変更について</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/27/2634455/0/fi/Orionin-uuden-organisaatiorakenteen-mukaiset-liikevaihdon-vertailutiedot-vuodelta-2022-ja-muutos-laskentak%C3%A4yt%C3%A4nn%C3%B6ss%C3%A4-1-1-2023-alkaen.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/27/2634455/0/fi/Orionin-uuden-organisaatiorakenteen-mukaiset-liikevaihdon-vertailutiedot-vuodelta-2022-ja-muutos-laskentak%C3%A4yt%C3%A4nn%C3%B6ss%C3%A4-1-1-2023-alkaen.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/26 05:34</td>
    <td>Teladoc Health、竜巻の影響を受けたミシシッピ州の住民に無料のバーチャル・ヘルスケア・サービスを提供中</td>
    <td><a href=https://finance.yahoo.com/quote/TDOC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TDOC</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/26 03:11</td>
    <td>atai Life Sciences、2022年第4四半期および通年の決算を発表、臨床パイプラインのハイライトを提示</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/25/2634387/0/de/atai-Life-Sciences-gibt-Finanzergebnisse-f%C3%BCr-das-vierte-Quartal-und-das-Gesamtjahr-2022-bekannt-und-stellt-Highlights-aus-der-klinischen-Pipeline-vor.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/25/2634387/0/de/atai-Life-Sciences-gibt-Finanzergebnisse-f%C3%BCr-das-vierte-Quartal-und-das-Gesamtjahr-2022-bekannt-und-stellt-Highlights-aus-der-klinischen-Pipeline-vor.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/25 05:30</td>
    <td>Ordinary and Extraordinary General Meeting of April 12, 2023
</td>
    <td><a href=https://finance.yahoo.com/quote/DBVT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DBVT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/26 01:51</td>
    <td>Theriva Biologics社は、2022年第4四半期および通年の財務および営業ハイライトに関する電話会議およびウェブキャストを再延期します。</td>
    <td><a href=https://finance.yahoo.com/quote/TOVX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TOVX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/25 05:30</td>
    <td>2023年4月12日開催の合同総会</td>
    <td><a href=https://finance.yahoo.com/quote/DBVT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DBVT</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/27 01:00</td>
    <td>世界の持続的グルコースモニタリング市場は2031年までに320億ドルに達する-報告書</td>
    <td><a href=https://finance.yahoo.com/quote/DXCM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DXCM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/25 05:15</td>
    <td>インテルジェネックス、2022年第4四半期および通期の決算報告およびカンファレンスコール開催日を2023年3月29日に変更</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/24/2634317/0/en/IntelGenx-Revises-Fourth-Quarter-and-Full-Year-2022-Financial-Results-Reporting-and-Conference-Call-Date-to-March-29-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/24/2634317/0/en/IntelGenx-Revises-Fourth-Quarter-and-Full-Year-2022-Financial-Results-Reporting-and-Conference-Call-Date-to-March-29-2023.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/26 05:00</td>
    <td>安価な糖尿病治療薬がファイザーの抗ウイルス剤「COVID」の売上に与える影響について</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/25 05:05</td>
    <td>アリメラ・サイエンス、2022年第4四半期および通期決算を2023年3月31日（金）に発表、コーポレート・アップデートを提供へ</td>
    <td><a href=https://finance.yahoo.com/quote/ALIM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ALIM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/25 05:05</td>
    <td>Theriva Biologics社、2022年第4四半期および通年のオペレーショナルハイライトと業績に関する電話会議およびウェブキャストの予定を変更する。</td>
    <td><a href=https://finance.yahoo.com/quote/TOVX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TOVX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/25 07:23</td>
    <td>ウェルネスサービスプロバイダーのNava Health MDが$8M IPOの計画を撤回</td>
    <td><a href=https://finance.yahoo.com/quote/NAVA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NAVA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/25 05:01</td>
    <td>Iovance Biotherapeutics社、進行性黒色腫を対象としたLifileucelの生物製剤承認申請（BLA）提出を完了</td>
    <td><a href=https://finance.yahoo.com/quote/IOVA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IOVA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/25 05:01</td>
    <td>バイオパス・ホールディングス、2022年第4四半期および通期決算を2023年3月31日に発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/BPTH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BPTH</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/26 03:08</td>
    <td>ロシアはベラルーシに戦術核兵器を駐留させる。 飛行機、ミサイルをベラルーシに送る、とロシア大統領。ウクライナロシア戦争</td>
    <td><a href=https://t.co/b7wvRTTBjl target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://t.co/b7wvRTTBjl</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/25 07:00</td>
    <td>キュラレイフ、2022年第4四半期決算の発表を延期</td>
    <td><a href=https://finance.yahoo.com/quote/CURLF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CURLF</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/26 05:00</td>
    <td>安価な糖尿病治療薬がファイザーの抗ウイルス剤「COVID」の売上に与える影響について</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/26 05:34</td>
    <td>Teladoc Health、竜巻の影響を受けたミシシッピ州の住民に無料のバーチャル・ヘルスケア・サービスを提供中</td>
    <td><a href=https://finance.yahoo.com/quote/TDOC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TDOC</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/26 03:11</td>
    <td>atai Life Sciences、2022年第4四半期および通年の決算を発表、臨床パイプラインのハイライトを提示</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/25/2634387/0/de/atai-Life-Sciences-gibt-Finanzergebnisse-f%C3%BCr-das-vierte-Quartal-und-das-Gesamtjahr-2022-bekannt-und-stellt-Highlights-aus-der-klinischen-Pipeline-vor.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/25/2634387/0/de/atai-Life-Sciences-gibt-Finanzergebnisse-f%C3%BCr-das-vierte-Quartal-und-das-Gesamtjahr-2022-bekannt-und-stellt-Highlights-aus-der-klinischen-Pipeline-vor.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/26 01:51</td>
    <td>Theriva Biologics社は、2022年第4四半期および通年の財務および営業ハイライトに関する電話会議およびウェブキャストを再延期します。</td>
    <td><a href=https://finance.yahoo.com/quote/TOVX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TOVX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/25 05:30</td>
    <td>Ordinary and Extraordinary General Meeting of April 12, 2023
</td>
    <td><a href=https://finance.yahoo.com/quote/DBVT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DBVT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/25 05:30</td>
    <td>2023年4月12日開催の合同総会</td>
    <td><a href=https://finance.yahoo.com/quote/DBVT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DBVT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/25 05:15</td>
    <td>インテルジェネックス、2022年第4四半期および通期の決算報告およびカンファレンスコール開催日を2023年3月29日に変更</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/24/2634317/0/en/IntelGenx-Revises-Fourth-Quarter-and-Full-Year-2022-Financial-Results-Reporting-and-Conference-Call-Date-to-March-29-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/24/2634317/0/en/IntelGenx-Revises-Fourth-Quarter-and-Full-Year-2022-Financial-Results-Reporting-and-Conference-Call-Date-to-March-29-2023.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/26 05:00</td>
    <td>安価な糖尿病治療薬がファイザーの抗ウイルス剤「COVID」の売上に与える影響について</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/25 05:05</td>
    <td>アリメラ・サイエンス、2022年第4四半期および通期決算を2023年3月31日（金）に発表、コーポレート・アップデートを提供へ</td>
    <td><a href=https://finance.yahoo.com/quote/ALIM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ALIM</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/25 07:23</td>
    <td>ウェルネスサービスプロバイダーのNava Health MDが$8M IPOの計画を撤回</td>
    <td><a href=https://finance.yahoo.com/quote/NAVA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NAVA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/25 05:05</td>
    <td>Theriva Biologics社、2022年第4四半期および通年のオペレーショナルハイライトと業績に関する電話会議およびウェブキャストの予定を変更する。</td>
    <td><a href=https://finance.yahoo.com/quote/TOVX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TOVX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/25 07:22</td>
    <td>Iovance up 13% on completing Biologics License Application submission for lifileucel
</td>
    <td><a href=https://finance.yahoo.com/quote/IOVA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IOVA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/25 05:01</td>
    <td>バイオパス・ホールディングス、2022年第4四半期および通期決算を2023年3月31日に発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/BPTH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BPTH</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/25 07:00</td>
    <td>キュラレイフ、2022年第4四半期決算の発表を延期</td>
    <td><a href=https://finance.yahoo.com/quote/CURLF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CURLF</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/25 06:52</td>
    <td>シグニファイヘルス、CVSへの売却予定に伴うNYSE上場廃止通知で上昇</td>
    <td><a href=https://finance.yahoo.com/quote/CVS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CVS</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/24 10:01</td>
    <td>$INCY FDAがRuxolitinib XR tabletsのCRLを発行。</td>
    <td><a href=https://finance.yahoo.com/quote/INCY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/INCY</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/24 10:30</td>
    <td>Twitter、4月1日から「レガシー」認証バッジを剥奪、有料会員のみ青いチェックマークが残る。ツイッターブルー</td>
    <td><a href= target="_blank" rel="noopener noreferrer" style="display: inline-block;"></a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/24 19:14</td>
    <td>$ALLR 1対35のリバース・スプリット</td>
    <td><a href=https://finance.yahoo.com/quote/ALLR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ALLR</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/24 20:03</td>
    <td>エブラサキマブのTREK-ADフェーズ2b試験が完全に登録された。 7月上旬にトップラインデータ。</td>
    <td><a href=https://finance.yahoo.com/quote/ASLN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ASLN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/24 20:14</td>
    <td>LPTXは、Flame Biosciencesの買収に伴い、シリーズXの転換型優先株を137K株発行しました。6月の年次総会で承認されれば、優先株は1億3680万株の普通株に転換される。😬</td>
    <td><a href=https://finance.yahoo.com/quote/LPTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LPTX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/24 20:33</td>
    <td>PTCTスチュアート・ペルツがCEOを退任へ。</td>
    <td><a href=https://finance.yahoo.com/quote/PTCT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PTCT</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/24 21:59</td>
    <td>AFMDコンボ24のデータが第3四半期に波及する可能性がある。遅れても、有効性については軽微なものになる可能性がある。カンファレンスコールより：   "何人かの患者さんにお会いする予定ですが、やはり、有効性データは年末か来年初めになると思います..."</td>
    <td><a href=https://finance.yahoo.com/quote/AFMD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AFMD</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/24 22:34</td>
    <td>カール・アイカーン、$ILMN株主への公開書簡。 アイカーン、イルミナの取締役会による価値破壊の調査を開始する。   $ILMN</td>
    <td><a href=https://finance.yahoo.com/quote/ILMN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ILMN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/22 19:01</td>
    <td>Mesoblast 社の Remestemcel-L 製造に関するライセンス前検査を FDA が予定しています。 PDUFA 08 / 02 / 23</td>
    <td><a href=https://finance.yahoo.com/quote/MESO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MESO</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/22 20:12</td>
    <td>$REGN 超希少な高コレステロールの幼児に対するファーストインクラスのEvkeeza（evinacumab-dgnb） をFDAが承認</td>
    <td><a href=https://finance.yahoo.com/quote/REGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/REGN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/22 20:15</td>
    <td>ETNB社 NASHを対象としたPegozaferminのフェーズ2b ENLIVEN試験において、24週時点の週1回投与（QW）と2週毎投与（Q2W）で主要組織型エンドポイントの両方で高い統計的有意性を達成 $VKTX $MDGL $AKRO</td>
    <td><a href=https://finance.yahoo.com/quote/ETNB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ETNB</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/22 20:42</td>
    <td>TDコーウェンで$SRPTのPTが175ドルに引き上げられた。</td>
    <td><a href=https://finance.yahoo.com/quote/SRPT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SRPT</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/22 20:46</td>
    <td>MRNA、COVID19ワクチンの価格を1回130ドルとする。  pfe $bntx $nvax</td>
    <td><a href=https://finance.yahoo.com/quote/MRNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRNA</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/22 21:32</td>
    <td>VTGN社、Fasedienol（PH94B）の成人社会不安障害患者を対象とした第3相非盲検試験で良好なデータが得られたと発表</td>
    <td><a href=https://finance.yahoo.com/quote/VTGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VTGN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/22 22:05</td>
    <td>ABBVは、進行したパーキンソン病の成人における運動ゆらぎの治療薬ABBV-951 NDAのCRLを取得しました。</td>
    <td><a href=https://finance.yahoo.com/quote/ABBV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ABBV</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/21 08:50</td>
    <td>NWBOとAdvent BioServices、英国ソーストン施設での商業生産に関するライセンス取得を発表</td>
    <td><a href=https://finance.yahoo.com/quote/NWBO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NWBO</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/21 19:16</td>
    <td>SELB社 SEL-212の慢性難治性痛風を対象としたフェーズ3「DISSOLVEプログラム」が主要評価項目を達成</td>
    <td><a href=https://finance.yahoo.com/quote/SELB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SELB</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/21 19:24</td>
    <td>XFORは4WHIM試験の追加データが第2四半期に期待される。 MavorixaforのNDA提出は23年下期初頭。慢性好中球減少症フェーズ2試験のデータは第2四半期後半から第3四半期にかけて。 現金、等価物1億2,300万ドル。CCは9:00 am ETに</td>
    <td><a href=https://finance.yahoo.com/quote/XFOR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/XFOR</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/21 19:34</td>
    <td>MREOがAlvelestatに関する規制当局の最新情報を提供。 米国および欧州での承認取得に向け、12-18カ月後に240mg投与時のアルベスタットとプラセボを比較する単一フェーズ3試験を提案し、前進する。</td>
    <td><a href=https://finance.yahoo.com/quote/MREO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MREO</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/21 19:53</td>
    <td>バーンスタインが$BMRNをアンダーパフォームで開始しました。PT $81</td>
    <td><a href=https://finance.yahoo.com/quote/BMRN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BMRN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/21 20:01</td>
    <td>ALT社、PemvidutideのMOMENTUMフェーズ2肥満症試験および12週間のフェーズ1b2型糖尿病安全性試験の24週目の中間解析で良好な結果を得たと発表</td>
    <td><a href=https://finance.yahoo.com/quote/ALT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ALT</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/21 20:31</td>
    <td>NTLA再生医療先進治療薬（RMAT）の指定を受けた「NTLA-2002」が遺伝性血管性浮腫の治療薬に指定される</td>
    <td><a href=https://finance.yahoo.com/quote/NTLA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NTLA</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/21 21:21</td>
    <td>Twitterは、TwitterBlueの購読者向けに、政府機関のIDを提出する新しい認証プロセスをテストしているようです。</td>
    <td><a href=https://t.co/yFBW3nf9uX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://t.co/yFBW3nf9uX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/22 19:01</td>
    <td>Mesoblast 社の Remestemcel-L 製造に関するライセンス前検査を FDA が予定しています。 PDUFA 08 / 02 / 23</td>
    <td><a href=https://finance.yahoo.com/quote/MESO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MESO</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/22 20:12</td>
    <td>$REGN 超希少な高コレステロールの幼児に対するファーストインクラスのEvkeeza（evinacumab-dgnb） をFDAが承認</td>
    <td><a href=https://finance.yahoo.com/quote/REGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/REGN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/22 20:15</td>
    <td>ETNB社 NASHを対象としたPegozaferminのフェーズ2b ENLIVEN試験において、24週時点の週1回投与（QW）と2週毎投与（Q2W）の両方の主要組織型エンドポイントにおいて高い統計的有意性を達成 $VKTX $MDGL $AKRO</td>
    <td><a href=https://finance.yahoo.com/quote/ETNB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ETNB</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/19 03:22</td>
    <td>$MSFT マイクロソフトはMicrosoft Edgeに内蔵された暗号ウォレットをテストしています。   ビットコイン NFT</td>
    <td><a href=https://finance.yahoo.com/quote/MSFT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MSFT</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/19 03:22</td>
    <td>$MSFT マイクロソフトはMicrosoft Edgeに内蔵された暗号ウォレットをテストしています。   ビットコイン NFT</td>
    <td><a href=https://finance.yahoo.com/quote/MSFT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MSFT</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/18 12:50</td>
    <td>ファイザー、リコールに伴うNurtec ODTの新パッケージを開発 - Bloomberg</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/17 19:01</td>
    <td>VKTXがStifelのBuyで開始された。PT $22</td>
    <td><a href=https://finance.yahoo.com/quote/VKTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VKTX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/17 19:18</td>
    <td>RDHL 1：40のADS逆分割。  BPTS 1:10のADS逆分割。</td>
    <td><a href=https://finance.yahoo.com/quote/RDHL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RDHL</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/17 21:07</td>
    <td>GOSSが中枢神経系への浸透剤BTKをbeastfit/risk profileのため一時停止中。疑わしいPAHプログラムを優先!!!</td>
    <td><a href=https://finance.yahoo.com/quote/GOSS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GOSS</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/17 21:12</td>
    <td>SIVB、連邦破産法第11条の適用を開始。SVB</td>
    <td><a href=https://finance.yahoo.com/quote/SIVB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SIVB</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/17 21:30</td>
    <td>ACER エイサー・セラピューティクス、ACER-801（Osanetant）フェーズ2a試験のトップライン結果を発表 失敗</td>
    <td><a href=https://finance.yahoo.com/quote/ACER target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ACER</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/18 06:01</td>
    <td>セリアドオンコロジー、2022年通期決算の発表とカンファレンスコールの開催について</td>
    <td><a href=https://finance.yahoo.com/quote/CYAD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CYAD</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/18 05:56</td>
    <td>GENETWORX 診断薬研究所の買収や提携を検討中。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/17/2629743/32924/en/GENETWORx-Looking-to-acquire-or-partner-with-Diagnostic-Laboratories.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/17/2629743/32924/en/GENETWORx-Looking-to-acquire-or-partner-with-Diagnostic-Laboratories.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/18 05:05</td>
    <td>ヒレバックス、2022年通期決算の報告と最近の会社の進捗状況を発表</td>
    <td><a href=https://finance.yahoo.com/quote/HLVX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HLVX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/18 07:11</td>
    <td>ノバルティス社とバイオジェン社の共同研究終了に伴い、Sangamoが市場投入後にダウン。</td>
    <td><a href=https://finance.yahoo.com/quote/BIIB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BIIB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/18 05:01</td>
    <td>argenx社、2023年5月2日に定時株主総会を開催することを発表</td>
    <td><a href=https://finance.yahoo.com/quote/ARGX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ARGX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/18 04:21</td>
    <td>ニューヨークの大麻規制当局、制限的なライセンスをめぐり複数州の事業者から提訴される</td>
    <td><a href=https://finance.yahoo.com/quote/GTBIF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GTBIF</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/18 05:01</td>
    <td>Sutro Biopharma社、ナスダック上場規則5635(c)(4)に基づく誘引付与を発表</td>
    <td><a href=https://finance.yahoo.com/quote/STRO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/STRO</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/18 03:36</td>
    <td>ニューハンプシャー州下院、規制の少ない大麻を合法化する法案を承認</td>
    <td><a href=https://finance.yahoo.com/quote/MJ target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MJ</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/18 05:00</td>
    <td>アークポイント株式会社 株式の流動性を高めるため、ロックアップ株式の解除を加速することを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/17/2629716/0/en/ARCPOINT-INC-ANNOUNCES-ACCELERATED-RELEASE-OF-LOCK-UP-SHARES-TO-INCREASE-TRADING-LIQUIDITY-OF-SHARES.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/17/2629716/0/en/ARCPOINT-INC-ANNOUNCES-ACCELERATED-RELEASE-OF-LOCK-UP-SHARES-TO-INCREASE-TRADING-LIQUIDITY-OF-SHARES.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/18 01:45</td>
    <td>Lucy Scientific DiscoveryがPramanthaを採用し、連邦政府との契約をさらに獲得。</td>
    <td><a href=https://finance.yahoo.com/quote/LSDI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LSDI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/18 02:00</td>
    <td>エシロール・ルクソティカ 2023年2月28日現在の発行済株式総数および議決権数の開示について</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/17/2629667/0/en/EssilorLuxottica-Disclosure-of-Share-Capital-and-Voting-Rights-Outstanding-as-of-February-28-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/17/2629667/0/en/EssilorLuxottica-Disclosure-of-Share-Capital-and-Voting-Rights-Outstanding-as-of-February-28-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/18 02:00</td>
    <td>エシロール・ルクソティカ：2023年2月28日現在の議決権数および株式資本を構成する株式の総数</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/17/2629667/0/fr/EssilorLuxottica-Nombre-total-de-droits-de-vote-et-d-actions-composant-le-capital-social-au-28-f%C3%A9vrier-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/17/2629667/0/fr/EssilorLuxottica-Nombre-total-de-droits-de-vote-et-d-actions-composant-le-capital-social-au-28-f%C3%A9vrier-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/18 01:00</td>
    <td>イヤーゴ、2022年第4四半期決算を3月23日に発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/EAR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EAR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 23:00</td>
    <td>PetVivo Holdings, Inc.のSpryngの臨床試験結果について モンタナ州ビッグスカイで開催された獣医整形外科学会年次大会にて発表</td>
    <td><a href=https://finance.yahoo.com/quote/PETVW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PETVW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 23:00</td>
    <td>PetVivo Holdings, Inc.のSpryngの臨床試験結果について モンタナ州ビッグスカイで開催された獣医整形外科学会年次大会にて発表</td>
    <td><a href=https://finance.yahoo.com/quote/PETVW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PETVW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 23:00</td>
    <td>ベターチョイスのペットフードブランド「Halo」、中国ペット産業白書で「2022年消費者が好む輸入猫ブランド」を受賞</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/17/2629569/0/en/Better-Choice-s-Halo-Pet-Food-Brand-Awarded-2022-Consumer-s-Favorite-Imported-Cat-Brand-by-the-China-Pet-Industry-White-Paper.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/17/2629569/0/en/Better-Choice-s-Halo-Pet-Food-Brand-Awarded-2022-Consumer-s-Favorite-Imported-Cat-Brand-by-the-China-Pet-Industry-White-Paper.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 22:46</td>
    <td>UCLAが開発中の万能がんワクチン「CancerVax」について</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/17/2629551/0/en/CancerVax-Universal-Cancer-Vaccine-Being-Developed-by-UCLA.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/17/2629551/0/en/CancerVax-Universal-Cancer-Vaccine-Being-Developed-by-UCLA.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/17 22:43</td>
    <td>Pear Therapeuticsの株価が下落、売却を含む代替案を検討する計画がある中で</td>
    <td><a href=https://finance.yahoo.com/quote/PEAR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PEAR</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/17 22:16</td>
    <td>Acer stock slumps ~45% as ACER-801 paused after hot flashes trial disappoints; cash woes
</td>
    <td><a href=https://finance.yahoo.com/quote/SNY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SNY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 22:27</td>
    <td>ヘルスケア・インテグレーテッド・テクノロジーズ（Healthcare Integrated Technologies, Inc. プライバシーを考慮したモニタリングシステムによる転倒検証に関する米国特許の取得を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/17/2629537/0/en/Healthcare-Integrated-Technologies-Inc-Announces-Approval-of-U-S-Patent-for-Fall-Validation-with-Privacy-Aware-Monitoring-System.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/17/2629537/0/en/Healthcare-Integrated-Technologies-Inc-Announces-Approval-of-U-S-Patent-for-Fall-Validation-with-Privacy-Aware-Monitoring-System.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 22:10</td>
    <td>AlvotechはAVT04で、Stelaraで使用されている高血圧症治療薬（AAD）の開発に成功しました。</td>
    <td><a href=https://finance.yahoo.com/quote/ALVOW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ALVOW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 22:10</td>
    <td>Alvotech社、2023年米国皮膚科学会（AAD）年次総会で「ステララ®」のバイオシミラー候補「AVT04」の臨床試験データを発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/ALVOW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ALVOW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 22:00</td>
    <td>ポーレックス生命科学研究所、フィルター付き唾液採取装置「Saletto®」を遺伝子検査市場へ拡大</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/17/2629496/0/en/Porex-Life-Sciences-Institute-Expands-Saletto-Filtered-Saliva-Collection-Device-to-the-Genetic-Testing-Market.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/17/2629496/0/en/Porex-Life-Sciences-Institute-Expands-Saletto-Filtered-Saliva-Collection-Device-to-the-Genetic-Testing-Market.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 22:00</td>
    <td>ルーシーサイエンティフィック、プラマンサグループと提携し、製造能力を強化するための重要な政府契約および助成金を獲得</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/17/2629501/0/en/Lucy-Scientific-Teams-Up-with-Pramantha-Group-to-Secure-Key-Government-Contracts-and-Grants-to-Enhance-its-Manufacturing-Capabilities.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/17/2629501/0/en/Lucy-Scientific-Teams-Up-with-Pramantha-Group-to-Secure-Key-Government-Contracts-and-Grants-to-Enhance-its-Manufacturing-Capabilities.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/17 21:31</td>
    <td>Ra Medical stock rises ~10% on Japanese patent linked to imaging system
</td>
    <td><a href=https://finance.yahoo.com/quote/RMED target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RMED</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/17 21:04</td>
    <td>ゼブラ、睡眠障害治療薬に関連する米国特許を取得へ</td>
    <td><a href=https://finance.yahoo.com/quote/ZVRA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ZVRA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/17 20:57</td>
    <td>ブルカー、英国から1.2GHz NMRシステム2台を受注。</td>
    <td><a href=https://finance.yahoo.com/quote/BRKR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BRKR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 21:30</td>
    <td>Acer Therapeutics社、ACER-801（Osanetant）の第2a相臨床試験のトップライン結果を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ACER target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ACER</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 21:10</td>
    <td>ティツィアナライフサイエンス、会長兼CEO代理による普通株式の取得を発表</td>
    <td><a href=https://finance.yahoo.com/quote/TLSA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TLSA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 21:00</td>
    <td>ヴァクサート社、ノロウイルスの健康への影響と疾病負担について、キーオピニオンリーダーを招いたウェブキャストを開催</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/17/2629445/25416/en/Vaxart-to-Host-Webcast-with-Key-Opinion-Leaders-to-Discuss-the-Health-Impact-and-Disease-Burden-for-Norovirus.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/17/2629445/25416/en/Vaxart-to-Host-Webcast-with-Key-Opinion-Leaders-to-Discuss-the-Health-Impact-and-Disease-Burden-for-Norovirus.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 21:00</td>
    <td>Nuvectis Pharma、2023年米国癌学会総会での発表予定について</td>
    <td><a href=https://finance.yahoo.com/quote/NVCT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NVCT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 21:00</td>
    <td>アチーブメントライフサイエンス、新入社員奨励賞授与のお知らせ</td>
    <td><a href=https://finance.yahoo.com/quote/ACHV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ACHV</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 20:30</td>
    <td>グラミー賞・アカデミー賞受賞の音楽アイコン「Melissa Etheridge」が「Psychedelic Science 2023」で講演を実施</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/17/2629409/0/en/Grammy-and-Academy-Award-Winning-Music-Icon-Melissa-Etheridge-to-Speak-at-Psychedelic-Science-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/17/2629409/0/en/Grammy-and-Academy-Award-Winning-Music-Icon-Melissa-Etheridge-to-Speak-at-Psychedelic-Science-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 20:30</td>
    <td>肢帯型筋ジストロフィー2型（LGMD2I）患者における糖化α-ジストログリカン（⍺）を測定する新規バイオアッセイに関する予備的知見について発表</td>
    <td><a href=https://finance.yahoo.com/quote/BBIO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BBIO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 20:30</td>
    <td>バイタルハブ社、第4四半期および2022年度決算のカンファレンスコール開催日を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/17/2629411/0/en/VitalHub-Announces-Q4-and-Fiscal-Year-2022-Conference-Call-Date.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/17/2629411/0/en/VitalHub-Announces-Q4-and-Fiscal-Year-2022-Conference-Call-Date.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 20:30</td>
    <td>Zevra Therapeutics、新たな睡眠データイニシアチブの創設メンバーとしてRARE-XおよびSleep Consortiumとの協業を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/17/2629413/16626/en/Zevra-Therapeutics-Announces-Collaboration-with-RARE-X-and-the-Sleep-Consortium-as-Founding-Member-of-New-Sleep-Data-Initiative.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/17/2629413/16626/en/Zevra-Therapeutics-Announces-Collaboration-with-RARE-X-and-the-Sleep-Consortium-as-Founding-Member-of-New-Sleep-Data-Initiative.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 20:30</td>
    <td>F2G、「Bionow 2022 Award」の「Investment Deal of the Year」を受賞</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/17/2629416/0/en/F2G-Wins-Investment-Deal-of-the-Year-Bionow-2022-Award.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/17/2629416/0/en/F2G-Wins-Investment-Deal-of-the-Year-Bionow-2022-Award.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 20:00</td>
    <td>HOOPPは、困難な年でも強固な積立状態を維持。福利厚生を改善し、拠出金の水準を据え置く</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/17/2629382/0/en/HOOPP-maintains-strong-funded-status-in-challenging-year-Improves-benefits-and-keeps-contribution-levels-unchanged.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/17/2629382/0/en/HOOPP-maintains-strong-funded-status-in-challenging-year-Improves-benefits-and-keeps-contribution-levels-unchanged.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 20:00</td>
    <td>サムスンバイオエピス、ステララのバイオシミラー候補であるSB17（ウステキヌマブ）の第1相試験結果を2023年AAD年次総会で発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/17/2629384/0/en/Samsung-Bioepis-Presents-Phase-1-Study-Results-of-SB17-Ustekinumab-A-Proposed-Biosimilar-to-Stelara-at-2023-AAD-Annual-Meeting.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/17/2629384/0/en/Samsung-Bioepis-Presents-Phase-1-Study-Results-of-SB17-Ustekinumab-A-Proposed-Biosimilar-to-Stelara-at-2023-AAD-Annual-Meeting.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 20:00</td>
    <td>Akero Therapeutics、2022年第4四半期および通期の決算を発表</td>
    <td><a href=https://finance.yahoo.com/quote/AKRO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AKRO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 20:00</td>
    <td>プレディクティブ・オンコロジーとキャンサー・リサーチ・ホライズンズが抗がん剤開発で提携</td>
    <td><a href=https://finance.yahoo.com/quote/POAI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/POAI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 20:00</td>
    <td>ティツィアナ ライフサイエンスがForbesの記事で紹介されました。</td>
    <td><a href=https://finance.yahoo.com/quote/TLSA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TLSA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/17 19:30</td>
    <td>ファイザー、アステラス製薬のXtandi、前立腺がんサブタイプを対象とした第3相試験で主要目標を達成</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/17 18:45</td>
    <td>ノバルティスのTafinlar Mekinistコンボが小児の脳腫瘍の治療薬としてFDAの承認を取得</td>
    <td><a href=https://finance.yahoo.com/quote/NVS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NVS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 19:00</td>
    <td>ザ・エンサイン・グループ、Inc. 一株当たり0.0575ドルの四半期配当金を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ENSG target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ENSG</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 19:00</td>
    <td>InvestmentPitch Media Videoで、Reliq Healthと米国の大規模ヘルスケアシステムとの新たな契約、7つの州で1,200以上のケアセンターが追加されたことについて説明しました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/17/2629349/0/en/InvestmentPitch-Media-Video-Discusses-Reliq-Health-and-its-New-Contract-with-Large-U-S-Healthcare-System-adding-more-than-1-200-Care-Centers-across-7-States.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/17/2629349/0/en/InvestmentPitch-Media-Video-Discusses-Reliq-Health-and-its-New-Contract-with-Large-U-S-Healthcare-System-adding-more-than-1-200-Care-Centers-across-7-States.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/17 17:47</td>
    <td>薬価圧力とインフレ懸念の中、アムジェンが人員削減を深化させ、米国企業のレイオフが増える</td>
    <td><a href=https://finance.yahoo.com/quote/AMGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMGN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/17 15:19</td>
    <td>RedHill Biopharma社、ADS比率変更の実施計画を発表</td>
    <td><a href=https://finance.yahoo.com/quote/RDHL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RDHL</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 15:00</td>
    <td>名目価額の引き下げによる損失による株式資本の減少：株式数は変更なし</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/17/2629282/0/en/Reduction-of-share-capital-due-to-losses-by-reduction-of-nominal-value-number-of-shares-unchanged.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/17/2629282/0/en/Reduction-of-share-capital-due-to-losses-by-reduction-of-nominal-value-number-of-shares-unchanged.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 15:00</td>
    <td>名目価額の引き下げによる損失による株式資本の減少：株式数は変更なし</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/17/2629282/0/fr/R%C3%A9duction-du-capital-social-motiv%C3%A9e-par-des-pertes-par-r%C3%A9duction-de-la-valeur-nominale-nombre-d-actions-inchang%C3%A9.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/17/2629282/0/fr/R%C3%A9duction-du-capital-social-motiv%C3%A9e-par-des-pertes-par-r%C3%A9duction-de-la-valeur-nominale-nombre-d-actions-inchang%C3%A9.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 15:00</td>
    <td>世界睡眠の日」に、イドルシアは、慢性不眠症の経済的・社会的影響に関する世界的な調査結果を発表しました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/17/2629283/0/de/On-World-Sleep-Day-Idorsia-highlights-the-publication-of-a-global-study-on-the-economic-and-societal-impact-of-chronic-insomnia-disorder.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/17/2629283/0/de/On-World-Sleep-Day-Idorsia-highlights-the-publication-of-a-global-study-on-the-economic-and-societal-impact-of-chronic-insomnia-disorder.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 07:58</td>
    <td>Totally Safe Air、AirAnswers® Air Diagnostic™ Systemを含むビジネス提供を拡大</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/16/2629250/0/en/Totally-Safe-Air-Expands-Business-Offerings-to-Include-AirAnswers-Air-Diagnostic-System.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/16/2629250/0/en/Totally-Safe-Air-Expands-Business-Offerings-to-Include-AirAnswers-Air-Diagnostic-System.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 07:47</td>
    <td>ノバルティス「Tafinlar」＋「Mekinist」、小児脳腫瘍で最も多いBRAF V600E低悪性度グリオーマの小児患者にFDAが承認</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/16/2629247/0/en/Novartis-Tafinlar-Mekinist-approved-by-FDA-for-pediatric-patients-with-BRAF-V600E-low-grade-glioma-the-most-common-pediatric-brain-cancer.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/16/2629247/0/en/Novartis-Tafinlar-Mekinist-approved-by-FDA-for-pediatric-patients-with-BRAF-V600E-low-grade-glioma-the-most-common-pediatric-brain-cancer.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 07:45</td>
    <td>キュリア、フィリップ・マクナブを最高経営責任者に任命</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/16/2629246/0/en/Curia-Appoints-Philip-Macnabb-as-Chief-Executive-Officer.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/16/2629246/0/en/Curia-Appoints-Philip-Macnabb-as-Chief-Executive-Officer.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 06:15</td>
    <td>プレディクティブ・オンコロジー社、シリーズF優先株の普通株式保有者への分配を発表</td>
    <td><a href=https://finance.yahoo.com/quote/POAI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/POAI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 06:14</td>
    <td>ハーバード・バイオサイエンス、2023年3月22日～23日に開催されるシドッチ・インベスター・コンファレンスでプレゼンテーションを実施</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/16/2629229/11635/en/Harvard-Bioscience-to-Present-at-Sidoti-Investor-Conference-March-22-23-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/16/2629229/11635/en/Harvard-Bioscience-to-Present-at-Sidoti-Investor-Conference-March-22-23-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 05:30</td>
    <td>AVITA Medical、新たな社外取締役を選任</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/16/2629208/0/en/AVITA-Medical-Appoints-New-Non-Executive-Member-to-the-Board-of-Directors.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/16/2629208/0/en/AVITA-Medical-Appoints-New-Non-Executive-Member-to-the-Board-of-Directors.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 05:30</td>
    <td>Jounce Therapeutics、プラチナ製剤抵抗性卵巣がんに対するJTX-8064とPimivalimabの深い耐久性のある反応を示すINNATEフェーズ2試験の事前計画データレビューの結果を発表</td>
    <td><a href=https://finance.yahoo.com/quote/JNCE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/JNCE</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/17 07:20</td>
    <td>Sanofi cuts list price on Lantus insulin by 78% in the U.S.
</td>
    <td><a href=https://finance.yahoo.com/quote/SNY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SNY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 05:30</td>
    <td>エンゾバイオケム、ラボコープ社への臨床検査室売却に合意</td>
    <td><a href=https://finance.yahoo.com/quote/ENZ target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ENZ</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 05:24</td>
    <td>Lifecore Biomedical社、既存の長期顧客とCDMO関係を拡大するためのタームシートを締結</td>
    <td><a href=https://finance.yahoo.com/quote/LFCR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LFCR</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/17 07:06</td>
    <td>Sarepta stock -20% on FDA advisory meeting for its muscular dystrophy treatment
</td>
    <td><a href=https://finance.yahoo.com/quote/SRPT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SRPT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/17 05:24</td>
    <td>アダミス・ファーマシューティカルズ、2022年通期決算の報告とコーポレートアップデートを発表</td>
    <td><a href=https://finance.yahoo.com/quote/ADMP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ADMP</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/17 06:18</td>
    <td>Amyris、10億ドルの混合シェルフオファリングを申請</td>
    <td><a href=https://finance.yahoo.com/quote/AMRS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMRS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/17 06:07</td>
    <td>Enzo Biochem stock surges 77% after divesting Clinical Labs unit to Labcorp
</td>
    <td><a href=https://finance.yahoo.com/quote/LH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LH</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/17 04:30</td>
    <td>ファイザー、ピル「COVID」の全面承認に向けたFDAパネル投票を獲得</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/16 19:32</td>
    <td>BIIB、「TECFIDERA」の規制データおよびマーケティング保護に関して欧州司法裁判所から好意的な判決を受領</td>
    <td><a href=https://finance.yahoo.com/quote/BIIB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BIIB</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/16 19:36</td>
    <td>LQDAは、2023年後半から2024年半ばに訴訟が解決した時点でYUTREPIAを発売する可能性があることを明らかにした。現金および現金同等物 93.3百万ドル</td>
    <td><a href=https://finance.yahoo.com/quote/LQDA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LQDA</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/16 20:00</td>
    <td>ゴールドマン・サックスで$ESPRのレーティングが停止されました。</td>
    <td><a href=https://finance.yahoo.com/quote/ESPR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ESPR</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/16 20:02</td>
    <td>ALDX社、ADX-2191の網膜色素変性症を対象とした臨床第2相試験の登録が完了。23年上半期のトップラインデータ</td>
    <td><a href=https://finance.yahoo.com/quote/ALDX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ALDX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/16 22:49</td>
    <td>経営陣による取引および経営陣の密接な関係</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/16/2628865/0/en/Trading-by-management-and-close-relations-of-management.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/16/2628865/0/en/Trading-by-management-and-close-relations-of-management.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/16 22:48</td>
    <td>ITM、ENETSカンファレンスでPhase III COMPOSEのポスター発表およびNETがんにおける放射線治療薬に関するサテライトシンポジウムを開催</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/16/2628861/0/en/ITM-to-Present-Phase-III-COMPOSE-Poster-and-Host-Satellite-Symposium-on-Radiotheranostics-in-NET-cancer-at-ENETS-Conference.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/16/2628861/0/en/ITM-to-Present-Phase-III-COMPOSE-Poster-and-Host-Satellite-Symposium-on-Radiotheranostics-in-NET-cancer-at-ENETS-Conference.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/16 22:46</td>
    <td>Clene社、神経学の専門家をエグゼクティブチームに任命</td>
    <td><a href=https://finance.yahoo.com/quote/CLNNW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CLNNW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/16 22:45</td>
    <td>オキュリス社、第3相OCS-01 OPTIMIZE試験の登録が完了</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/16/2628855/0/en/Oculis-Completes-Enrollment-in-Phase-3-OCS-01-OPTIMIZE-Trial.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/16/2628855/0/en/Oculis-Completes-Enrollment-in-Phase-3-OCS-01-OPTIMIZE-Trial.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/16 22:25</td>
    <td>ハーバード・バイオサイエンス、2023年3月21日に開催されるKeyBanc Capital Markets Life Sciences & MedTech Investor Forumでプレゼンテーションを実施</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/16/2628822/11635/en/Harvard-Bioscience-to-Present-at-KeyBanc-Capital-Markets-Life-Sciences-MedTech-Investor-Forum-on-March-21-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/16/2628822/11635/en/Harvard-Bioscience-to-Present-at-KeyBanc-Capital-Markets-Life-Sciences-MedTech-Investor-Forum-on-March-21-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/16 22:00</td>
    <td>株式会社アルファプロ・テック 2022年第4四半期および通期決算を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/16/2628730/37245/en/Alpha-Pro-Tech-Ltd-Announces-Fourth-Quarter-and-Full-Year-2022-Financial-Results.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/16/2628730/37245/en/Alpha-Pro-Tech-Ltd-Announces-Fourth-Quarter-and-Full-Year-2022-Financial-Results.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/16 22:00</td>
    <td>Bicycle Health社の新しい研究により、遠隔OUD治療が患者の再発リスクの低減と関連することが示されました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/16/2628756/0/en/New-Study-from-Bicycle-Health-shows-tele-OUD-treatment-associated-with-reductions-in-patient-risks-for-relapse.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/16/2628756/0/en/New-Study-from-Bicycle-Health-shows-tele-OUD-treatment-associated-with-reductions-in-patient-risks-for-relapse.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/16 22:00</td>
    <td>マイクロボットメディカル、英国での事業展開を開始 インターベンショナル・ラジオロジストのマーク・W・リトル教授が科学諮問委員会に参加 LIBERTY® Robotic Systemの事業化を加速</td>
    <td><a href=https://finance.yahoo.com/quote/MBOT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MBOT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/16 21:56</td>
    <td>ニューロスター®アドバンストセラピーがLife Sciences PAからPatient Impact Awardを受賞</td>
    <td><a href=https://finance.yahoo.com/quote/STIM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/STIM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/16 21:45</td>
    <td>アクセラス社、2D透視ベースのイメージングシステムと併用するRemiロボットナビゲーションシステムのFDA 510(k)クリアランスを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/16/2628708/0/en/Accelus-Announces-FDA-510-k-Clearance-of-Remi-Robotic-Navigation-System-for-Use-with-2D-Fluoroscopy-Based-Imaging-System.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/16/2628708/0/en/Accelus-Announces-FDA-510-k-Clearance-of-Remi-Robotic-Navigation-System-for-Use-with-2D-Fluoroscopy-Based-Imaging-System.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/16 22:42</td>
    <td>ファイザー、パッケージの不具合で片頭痛治療薬420万個をリコール</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/16 22:36</td>
    <td>アルコール使用障害治療薬の試験開始をFDAに申請したClearmindの株価が上昇</td>
    <td><a href=https://finance.yahoo.com/quote/CMND target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CMND</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/16 22:12</td>
    <td>メディカル・プロパティーズ・トラストをバンクオブアメリカでニュートラルに引き下げ、プロスペクトの解決を待つ。</td>
    <td><a href=https://finance.yahoo.com/quote/MPW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MPW</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/16 22:09</td>
    <td>ガレクチン、肝疾患治療薬ベラペクチンの試験継続を安全委員会に承認される</td>
    <td><a href=https://finance.yahoo.com/quote/GALT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GALT</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/16 07:27</td>
    <td>Amyris down 8% in after-hours trading on Q4 2022 revenue miss
</td>
    <td><a href=https://finance.yahoo.com/quote/AMRS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMRS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/16 06:30</td>
    <td>Lowell Farms、債務整理案、資産売却案、資金調達案を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/15/2628232/0/en/Lowell-Farms-Announces-Proposed-Debt-Settlement-Asset-Sale-and-Financing.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/15/2628232/0/en/Lowell-Farms-Announces-Proposed-Debt-Settlement-Asset-Sale-and-Financing.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/16 05:05</td>
    <td>DICE Therapeutics、2022年第4四半期および通期決算と最近のハイライトを発表</td>
    <td><a href=https://finance.yahoo.com/quote/DICE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DICE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/16 05:05</td>
    <td>ヴェンティクス・バイオサイエンス、2022年第4四半期および通期決算を2023年3月23日に発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/VTYX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VTYX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/16 05:05</td>
    <td>マティナス・バイオファーマ、2022年決算報告およびビジネスアップデートを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/15/2628143/32419/en/Matinas-BioPharma-Reports-2022-Financial-Results-and-Provides-a-Business-Update.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/15/2628143/32419/en/Matinas-BioPharma-Reports-2022-Financial-Results-and-Provides-a-Business-Update.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/15 10:17</td>
    <td>$JNCE Confirms Receipt of Unsolicited Proposal from Concentra Biosciences.  The Proposal consists of $1.80 %5C%2F share cash plus a CVR representing the right to receive 80% of the net proceeds payable from any license or disposition of certain of         
</td>
    <td><a href=https://finance.yahoo.com/quote/JNCE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/JNCE</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/15 20:46</td>
    <td>OBSV、3月23日付で上場廃止へ</td>
    <td><a href=https://finance.yahoo.com/quote/OBSV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OBSV</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/15 20:49</td>
    <td>PTGX社、多血症を対象としたRusfertideのREVIVE試験において、統計学的に有意な結果を発表。 ルスフェルティドは、本試験の主要評価項目を達成し、統計学的に有意に高い数値を示しました。</td>
    <td><a href=https://finance.yahoo.com/quote/PTGX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PTGX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 20:10</td>
    <td>鎌田製薬、2023年CEOレターを株主向けに発行</td>
    <td><a href=https://finance.yahoo.com/quote/KMDA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/KMDA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 20:10</td>
    <td>Evaxion Biotech、米国がん研究協会（AACR）2023年年次総会で個別化DNAがんワクチン「EVX-02」の臨床データを発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/EVAX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EVAX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 20:10</td>
    <td>Evaxion Biotech、米国がん研究協会（AACR）年次総会2023で、個別化DNAがんワクチン「EVX-02」の臨床データを発表</td>
    <td><a href=https://finance.yahoo.com/quote/EVAX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EVAX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 20:00</td>
    <td>メディセナ、AACR年次総会での発表予定を発表</td>
    <td><a href=https://finance.yahoo.com/quote/MDNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MDNA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 20:00</td>
    <td>iSTAR Medical社、白内障手術にMINIjectを併用する国際STAR-VI試験を開始</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/15/2627474/0/en/iSTAR-Medical-initiates-international-STAR-VI-trial-for-the-use-of-MINIject-in-conjunction-with-cataract-surgery.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/15/2627474/0/en/iSTAR-Medical-initiates-international-STAR-VI-trial-for-the-use-of-MINIject-in-conjunction-with-cataract-surgery.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/15 19:38</td>
    <td>サミットの株主がワクチンメーカーYishengBioとの合併を承認</td>
    <td><a href=https://finance.yahoo.com/quote/SMIH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SMIH</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 20:00</td>
    <td>HOOKIPA、2022年第4四半期および通期決算の報告と2023年の見通しを発表</td>
    <td><a href=https://finance.yahoo.com/quote/HOOK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HOOK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 20:00</td>
    <td>鎌田製薬、好調な2022年度通期および第4四半期決算を発表、大幅な利益成長を示す2023年度ガイダンスを提示</td>
    <td><a href=https://finance.yahoo.com/quote/KMDA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/KMDA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 20:00</td>
    <td>チェンビオ、公開買付けに関する株主への書簡を発表</td>
    <td><a href=https://finance.yahoo.com/quote/CEMI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CEMI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 20:00</td>
    <td>Gritstone bio、2023年AACR年次総会でネオアンチゲン予測能力およびがんワクチンプログラムに関する発表を行うことを発表</td>
    <td><a href=https://finance.yahoo.com/quote/GRTS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GRTS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 20:00</td>
    <td>バイオシネックス、Chemio Diagnostics, Inc.株式に対する公開買付けを延長</td>
    <td><a href=https://finance.yahoo.com/quote/CEMI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CEMI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 19:50</td>
    <td>イートン・ファーマシューティカルズ、希少疾患治療薬候補化合物ET-600の取得を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ETON target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ETON</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 19:50</td>
    <td>RVL Pharmaceuticals plc、2022年第4四半期および通期決算の説明とコマーシャルアップデートの提供について</td>
    <td><a href=https://finance.yahoo.com/quote/RVLP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RVLP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 19:01</td>
    <td>マリベル・ヘルス、自宅での高度なケアの未来を創造するために2500万ドルのシリーズAを調達</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/15/2627424/0/en/Maribel-Health-Raises-25M-Series-A-to-Create-the-Future-of-Advanced-Care-at-Home.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/15/2627424/0/en/Maribel-Health-Raises-25M-Series-A-to-Create-the-Future-of-Advanced-Care-at-Home.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 19:00</td>
    <td>シアノバクテリアを利用した廃水からのレアアース回収が特許出願されました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/15/2627417/0/en/Rare-Earth-Elements-Collected-from-Wastewater-Utilizing-Cyanobacteria-Now-Patent-Pending.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/15/2627417/0/en/Rare-Earth-Elements-Collected-from-Wastewater-Utilizing-Cyanobacteria-Now-Patent-Pending.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/15 18:33</td>
    <td>Celyad slumps ~30% as board to put proposal to continue activities on vote at shareholders' meet
</td>
    <td><a href=https://finance.yahoo.com/quote/CYAD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CYAD</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/15 18:25</td>
    <td>Concentra Biosciencesからの買収提案を確認したJounceの株価が急上昇</td>
    <td><a href=https://finance.yahoo.com/quote/JNCE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/JNCE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 18:00</td>
    <td>Champalimaud Foundation partners with Philips to reduce its diagnostic imaging carbon footprint by 50% in five years
</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/15/2627389/0/en/Champalimaud-Foundation-partners-with-Philips-to-reduce-its-diagnostic-imaging-carbon-footprint-by-50-in-five-years.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/15/2627389/0/en/Champalimaud-Foundation-partners-with-Philips-to-reduce-its-diagnostic-imaging-carbon-footprint-by-50-in-five-years.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/15 17:52</td>
    <td>マインツ、Labor Staber社と提携し、大腸がん検査「ColoAlert」をドイツで販売開始</td>
    <td><a href=https://finance.yahoo.com/quote/MYNZ target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MYNZ</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/15 17:34</td>
    <td>バイエルとマイクロソフト、農業食品分野向けクラウド型エンタープライズソリューションを発表</td>
    <td><a href=https://finance.yahoo.com/quote/BAYRY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BAYRY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 17:35</td>
    <td>経営陣による取引および経営陣の密接な関係</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/15/2627386/0/en/Trading-by-management-and-close-relations-of-management.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/15/2627386/0/en/Trading-by-management-and-close-relations-of-management.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 17:00</td>
    <td>GPCR Therapeutics社、新規抗がん剤治療についてNature Scientific Reportsに掲載される</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/15/2627375/0/en/GPCR-Therapeutics-Announces-Publication-in-Nature-Scientific-Reports-on-Novel-Anticancer-Therapy.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/15/2627375/0/en/GPCR-Therapeutics-Announces-Publication-in-Nature-Scientific-Reports-on-Novel-Anticancer-Therapy.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 17:00</td>
    <td>Nouscom、個別化ネオアンチゲンがん免疫療法「NOUS-PEV」のトランスレーショナルフェーズ1bデータをAACR2023で後期発表すると発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/15/2627377/0/en/Nouscom-Announces-AACR-2023-Late-Breaking-Presentation-of-Translational-Phase-1b-Data-of-NOUS-PEV-a-Personalized-Neoantigen-Cancer-Immunotherapy.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/15/2627377/0/en/Nouscom-Announces-AACR-2023-Late-Breaking-Presentation-of-Translational-Phase-1b-Data-of-NOUS-PEV-a-Personalized-Neoantigen-Cancer-Immunotherapy.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 16:01</td>
    <td>マインツバイオメッド社、ドイツにおけるColoAlertの商業化拡大に向けてLabor Staber社との提携を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/15/2627365/0/en/Mainz-Biomed-Announces-Partnership-with-Labor-Staber-to-Expand-ColoAlert-Commercialization-in-Germany.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/15/2627365/0/en/Mainz-Biomed-Announces-Partnership-with-Labor-Staber-to-Expand-ColoAlert-Commercialization-in-Germany.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 16:00</td>
    <td>Mendus AB: Mendus、AACR年次総会2023で卵巣がんを対象としたALISON試験の良好な中間データを発表へ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/15/2627358/0/en/Mendus-AB-Mendus-to-present-positive-interim-data-from-the-ALISON-trial-in-ovarian-cancer-at-the-AACR-Annual-Meeting-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/15/2627358/0/en/Mendus-AB-Mendus-to-present-positive-interim-data-from-the-ALISON-trial-in-ovarian-cancer-at-the-AACR-Annual-Meeting-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 16:00</td>
    <td>Mendus AB: Mendus、AACR 2023で卵巣がんを対象としたALISON試験のポジティブな中間データを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/15/2627358/0/sv/Mendus-AB-Mendus-presenterar-positiva-interimsdata-fr%C3%A5n-ALISON-studien-i-%C3%A4ggstockscancer-vid-AACR-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/15/2627358/0/sv/Mendus-AB-Mendus-presenterar-positiva-interimsdata-fr%C3%A5n-ALISON-studien-i-%C3%A4ggstockscancer-vid-AACR-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 15:00</td>
    <td>ObsEva社、スイスでの事業統合計画の進捗状況を発表。2023年3月23日付でナスダック証券取引所からOBSVの上場廃止を発表</td>
    <td><a href=https://finance.yahoo.com/quote/OBSV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OBSV</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 15:00</td>
    <td>セリアド・オンコロジー、非現金性減損を発表</td>
    <td><a href=https://finance.yahoo.com/quote/CYAD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CYAD</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/15 14:10</td>
    <td>アクセラレート・ダイアグノスティックスCFOのスティーブ・ライヒリングが退任へ</td>
    <td><a href=https://finance.yahoo.com/quote/AXDX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AXDX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/15 10:17</td>
    <td>$JNCE Confirms Receipt of Unsolicited Proposal from Concentra Biosciences.  The Proposal consists of $1.80 %5C%2F share cash plus a CVR representing the right to receive 80% of the net proceeds payable from any license or disposition of certain of         
</td>
    <td><a href=https://finance.yahoo.com/quote/JNCE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/JNCE</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/14 09:04</td>
    <td>INVA、4月17日にSulbactam-Durlobactam (SUL-DUR) NDAを審査するFDA AdComm Meetingを開催と発表。</td>
    <td><a href=https://finance.yahoo.com/quote/INVA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/INVA</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/15 10:17</td>
    <td>$JNCE Confirms Receipt of Unsolicited Proposal from Concentra Biosciences.  The Proposal consists of $1.80 %5C%2F share cash plus a CVR representing the right to receive 80% of the net proceeds payable from any license or disposition of certain of         
</td>
    <td><a href=https://finance.yahoo.com/quote/JNCE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/JNCE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 10:30</td>
    <td>RNA分子の構造、メディアの偏り、小児心臓病の診断法に関する素晴らしい科学的研究により、2023 Regeneron Science Talent Searchで学生たちが180万ドル以上の賞金を獲得</td>
    <td><a href=https://finance.yahoo.com/quote/REGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/REGN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 10:00</td>
    <td>Jounce Therapeutics、Concentra Biosciences社からの未承諾提案の受領を確認</td>
    <td><a href=https://finance.yahoo.com/quote/JNCE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/JNCE</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/14 09:04</td>
    <td>INVA、4月17日にSulbactam-Durlobactam (SUL-DUR) NDAを審査するFDA AdComm Meetingを開催と発表。</td>
    <td><a href=https://finance.yahoo.com/quote/INVA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/INVA</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/14 09:09</td>
    <td>META、インスタグラムとフェイスブックでのNFTのサポートを終了する。   クリプト</td>
    <td><a href=https://finance.yahoo.com/quote/META target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/META</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/14 18:50</td>
    <td>GSK社、5-in-1髄膜炎菌ABCWYワクチン候補のポジティブな第3相試験データを発表。</td>
    <td><a href=https://finance.yahoo.com/quote/GSK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GSK</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/14 20:36</td>
    <td>RPHM社、Mavodelpar（REN001）のミトコンドリア原性ミオパチーを対象としたピボタルSTRIDE試験で目標登録数を達成しました。トップラインデータQ4</td>
    <td><a href=https://finance.yahoo.com/quote/RPHM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RPHM</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/14 20:52</td>
    <td>META、水曜日に第2弾の人員削減を開始。</td>
    <td><a href=https://finance.yahoo.com/quote/META target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/META</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/14 21:01</td>
    <td>PRQR、ADARを介したRNA編集を保護するAxiomerの重要特許の防御に成功したと発表</td>
    <td><a href=https://finance.yahoo.com/quote/PRQR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PRQR</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/14 21:31</td>
    <td>Core CPI (MoM) (Feb) 0.5% vs 0.4% Est. CPI YoY For Feb. 6.0% Vs 6.0% Expected; 6.4% Prior Core CPI (YoY) (Feb) 5.5% vs 5.5% Est.
</td>
    <td><a href= target="_blank" rel="noopener noreferrer" style="display: inline-block;"></a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/14 21:33</td>
    <td>$NVO to lower U.S. prices of several pre-filled insulin pens and vials up to 75% for people living with diabetes in Jan'24       
</td>
    <td><a href=https://finance.yahoo.com/quote/NVO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NVO</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/14 21:36</td>
    <td>ACRX社、FDA承認の疼痛治療薬「Dsuvia」をAlora Pharma社に譲渡</td>
    <td><a href=https://finance.yahoo.com/quote/ACRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ACRX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 09:05</td>
    <td>創成ヘプタレス、東京証券取引所プライムマーケットへの上場区分変更を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/15/2627310/0/en/Sosei-Heptares-Announces-Change-of-Market-Listing-Segment-to-the-Tokyo-Stock-Exchange-Prime-Market.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/15/2627310/0/en/Sosei-Heptares-Announces-Change-of-Market-Listing-Segment-to-the-Tokyo-Stock-Exchange-Prime-Market.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 07:42</td>
    <td>Theratechnologies、コールド腫瘍モデルにおけるTH1902と抗PD-L1免疫療法の相乗効果を示す前臨床データをAACRで発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/THTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/THTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 07:42</td>
    <td>Theratechnologies、AACRにおいて、低温腫瘍モデルにおけるTH1902と抗PD-L1免疫療法の相乗効果を示す前臨床データを発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/THTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/THTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 07:21</td>
    <td>Harpoon Therapeutics、AACR年次総会（2023年）で発表する5つの演題の受理を発表</td>
    <td><a href=https://finance.yahoo.com/quote/HARP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HARP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 07:09</td>
    <td>キネイトバイオファーマ株式会社、汎RAF阻害剤Exarafenib（KIN-2787）の初臨床データをAACR2023年次総会で口頭発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/KNTE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/KNTE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 07:02</td>
    <td>CRISPR Therapeutics、米国がん研究学会2023年年次総会で発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/CRSP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CRSP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 07:00</td>
    <td>アダジーン、4月に開催される米国がん研究協会（AACR）年次総会で抗CTLA-4 SAFEbody®「ADG126」のポスター発表を行うことを発表</td>
    <td><a href=https://finance.yahoo.com/quote/ADAG target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ADAG</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 06:58</td>
    <td>Mablinkバイオサイエンス、AACR年次総会2023でADC候補のリード化合物MBK-103の有望な前臨床試験データを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2627277/0/en/Mablink-Bioscience-to-Present-Promising-Preclinical-Data-for-Lead-ADC-Candidate-MBK-103-at-the-AACR-Annual-Meeting-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2627277/0/en/Mablink-Bioscience-to-Present-Promising-Preclinical-Data-for-Lead-ADC-Candidate-MBK-103-at-the-AACR-Annual-Meeting-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/15 06:56</td>
    <td>フロンティア・メディシンズ、2023年AACR年次総会でリード候補の新規KRASG12C阻害剤FMC-376とFrontier™ プラットフォームを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2627276/0/en/Frontier-Medicines-to-Spotlight-Lead-Candidate-Novel-Dual-KRASG12C-Inhibitor-FMC-376-and-the-Frontier-Platform-at-the-2023-AACR-Annual-Meeting.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2627276/0/en/Frontier-Medicines-to-Spotlight-Lead-Candidate-Novel-Dual-KRASG12C-Inhibitor-FMC-376-and-the-Frontier-Platform-at-the-2023-AACR-Annual-Meeting.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/15 07:10</td>
    <td>Moderna社、個別化がんワクチンに関する中間解析結果を4月に発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/MRNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRNA</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/15 06:51</td>
    <td>ファイザー／バイオンテック、米国で小児用ブースターの更新を認可</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/15 06:12</td>
    <td>ファイザー、EUのCOVIDワクチン契約を修正する計画で抵抗に遭う - FT</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/15 05:23</td>
    <td>ヴェルー、FDAの拒否にもかかわらず、COVID療法の試験を推進へ</td>
    <td><a href=https://finance.yahoo.com/quote/VERU target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VERU</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/15 04:55</td>
    <td>イルミナはグレイルをスピンオフすべき、アクティビストのCarl Icahn氏が発言</td>
    <td><a href=https://finance.yahoo.com/quote/ILMN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ILMN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 22:39</td>
    <td>Reunion Neurosciences社からの提訴に対するMindset Pharma社の抗弁について</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626811/0/en/Mindset-Pharma-To-Defend-Against-Lawsuit-Filed-By-Reunion-Neurosciences.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626811/0/en/Mindset-Pharma-To-Defend-Against-Lawsuit-Filed-By-Reunion-Neurosciences.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 22:34</td>
    <td>ルメートル、タイで直販を開始</td>
    <td><a href=https://finance.yahoo.com/quote/LMAT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/LMAT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 22:30</td>
    <td>HUTCHMED社、武田薬品へのFruquintinibの中国国外でのライセンス供与の完了を発表</td>
    <td><a href=https://finance.yahoo.com/quote/HCM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HCM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 22:30</td>
    <td>オゾップ・エナジー・ソリューションズ社（Ozop Energy Solutions, Inc. 再生可能エネルギープロジェクトの資金調達先としてPace Equity, LLCと契約</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626799/0/en/Ozop-Energy-Solutions-Inc-Signs-with-Pace-Equity-LLC-as-Renewable-Energy-Project-Financing-Partner.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626799/0/en/Ozop-Energy-Solutions-Inc-Signs-with-Pace-Equity-LLC-as-Renewable-Energy-Project-Financing-Partner.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 22:15</td>
    <td>マイルストン・サイエンティフィック社、ニュージャージー州およびニューヨーク州に7つの拠点を持つユニバーシティ・ペイン＆スパイン・センターで「CompuFlo®硬膜外用剤」の販売を開始</td>
    <td><a href=https://finance.yahoo.com/quote/MLSS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MLSS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 22:00</td>
    <td>IR-Med、「National Pressure Injury Advisory Panel 2023」で講演を実施</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626736/0/en/IR-Med-to-present-at-National-Pressure-Injury-Advisory-Panel-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626736/0/en/IR-Med-to-present-at-National-Pressure-Injury-Advisory-Panel-2023.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 21:49</td>
    <td>Perspective stock rises ~10% on pact with PharmaLogic to make radiopharmaceuticals
</td>
    <td><a href=https://finance.yahoo.com/quote/CATX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CATX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 22:00</td>
    <td>MediGO、ファスト・カンパニーが毎年発表する「2023年世界で最も革新的な企業リスト」に選出される</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626729/0/en/MediGO-Named-to-Fast-Company-s-Annual-List-of-the-World-s-Most-Innovative-Companies-for-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626729/0/en/MediGO-Named-to-Fast-Company-s-Annual-List-of-the-World-s-Most-Innovative-Companies-for-2023.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 21:46</td>
    <td>Electromedical Technologies expects Q4 revenue to be up 79% Y %5C%2F Y
</td>
    <td><a href=https://finance.yahoo.com/quote/EMED target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EMED</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 22:00</td>
    <td>プロジニー、生殖泌尿器科医ネットワークの拡大により男性不妊治療サービスを強化</td>
    <td><a href=https://finance.yahoo.com/quote/PGNY target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PGNY</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 22:00</td>
    <td>アクシムバイオテクノロジーズ、光診断アッセイ製造に用いる新規手法の仮特許を取得</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626712/0/en/AXIM-Biotechnologies-Files-Provisional-Patent-on-Novel-Methodology-for-Use-in-Optical-Diagnostic-Assay-Manufacturing.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626712/0/en/AXIM-Biotechnologies-Files-Provisional-Patent-on-Novel-Methodology-for-Use-in-Optical-Diagnostic-Assay-Manufacturing.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 21:45</td>
    <td>Novo Nordisk to bring down insulin prices by up to 75% - WSJ
</td>
    <td><a href=https://finance.yahoo.com/quote/NVO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NVO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 22:00</td>
    <td>IBAは2023年6月までにベルギーで100人の新しい協力者を募集しています。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626714/0/en/IBA-is-looking-for-100-new-collaborators-in-Belgium-by-June-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626714/0/en/IBA-is-looking-for-100-new-collaborators-in-Belgium-by-June-2023.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 21:38</td>
    <td>Adamis Pharmaceuticals、$3Mの証券募集で下落。</td>
    <td><a href=https://finance.yahoo.com/quote/ADMP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ADMP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 22:00</td>
    <td>IBA、2023年6月までにベルギーで100名の新規採用者を募集</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626714/0/fr/IBA-recherche-100-nouveaux-collaborateurs-en-Belgique-d-ici-juin-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626714/0/fr/IBA-recherche-100-nouveaux-collaborateurs-en-Belgique-d-ici-juin-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 22:00</td>
    <td>ヴィスタントがInc. ミッドアトランティックリストに選出</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626716/0/en/Vistant-Named-to-Inc-Mid-Atlantic-List.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626716/0/en/Vistant-Named-to-Inc-Mid-Atlantic-List.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:55</td>
    <td>クリアマインド・メディシン、Henry R. Kranzler教授を科学諮問委員会に任命</td>
    <td><a href=https://finance.yahoo.com/quote/CMND target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CMND</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:45</td>
    <td>ロシュ年次総会 2023年</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626667/0/en/Roche-Annual-General-Meeting-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626667/0/en/Roche-Annual-General-Meeting-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:45</td>
    <td>ロシュ総会 2023年</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626667/0/fr/Assembl%C3%A9e-g%C3%A9n%C3%A9rale-2023-de-Roche.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626667/0/fr/Assembl%C3%A9e-g%C3%A9n%C3%A9rale-2023-de-Roche.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:45</td>
    <td>ロシュ・ゼネラルヴァーサムルング 2023</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626667/0/de/Roche-Generalversammlung-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626667/0/de/Roche-Generalversammlung-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:32</td>
    <td>357 Hemp Logistics」社長、3月30日開催の「NoCo Hemp 予想o」で「物流・サプライチェーンの課題解決」の戦略を明かす</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626651/0/en/357-Hemp-Logistics-President-to-Reveal-Strategies-for-Solving-Logistics-and-Supply-Chain-Issues-at-NoCo-Hemp-Expo-March-30th.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626651/0/en/357-Hemp-Logistics-President-to-Reveal-Strategies-for-Solving-Logistics-and-Supply-Chain-Issues-at-NoCo-Hemp-Expo-March-30th.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:31</td>
    <td>Cingulate社とIndegene社、ADHDの有力候補CTx-1301の共同商業化契約を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626650/0/zh-hans/Cingulate%E5%92%8CIndegene%E5%AE%A3%E5%B8%83%E5%85%B3%E4%BA%8E%E4%B8%BB%E8%A6%81ADHD%E5%80%99%E9%80%89%E8%8D%AF%E7%89%A9CTx-1301%E7%9A%84%E8%81%94%E5%90%88%E5%95%86%E4%B8%9A%E5%8C%96%E5%8D%8F%E8%AE%AE.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626650/0/zh-hans/Cingulate%E5%92%8CIndegene%E5%AE%A3%E5%B8%83%E5%85%B3%E4%BA%8E%E4%B8%BB%E8%A6%81ADHD%E5%80%99%E9%80%89%E8%8D%AF%E7%89%A9CTx-1301%E7%9A%84%E8%81%94%E5%90%88%E5%95%86%E4%B8%9A%E5%8C%96%E5%8D%8F%E8%AE%AE.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:31</td>
    <td>シンギュレート （Cingulate） とインデジン （Indegene）、ADHD治療薬候補であるCTx-1301の共同商業化契約締結を発表
</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626650/0/ja/%E3%82%B7%E3%83%B3%E3%82%AE%E3%83%A5%E3%83%AC%E3%83%BC%E3%83%88-Cingulate-%E3%81%A8%E3%82%A4%E3%83%B3%E3%83%87%E3%82%B8%E3%83%B3-Indegene-ADHD%E6%B2%BB%E7%99%82%E8%96%AC%E5%80%99%E8%A3%9C%E3%81%A7%E3%81%82%E3%82%8BCTx-1301%E3%81%AE%E5%85%B1%E5%90%8C%E5%95%86%E6%A5%AD%E5%8C%96%E5%A5%91%E7%B4%84%E7%B7%A0%E7%B5%90%E3%82%92%E7%99%BA%E8%A1%A8.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626650/0/ja/%E3%82%B7%E3%83%B3%E3%82%AE%E3%83%A5%E3%83%AC%E3%83%BC%E3%83%88-Cingulate-%E3%81%A8%E3%82%A4%E3%83%B3%E3%83%87%E3%82%B8%E3%83%B3-Indegene-ADHD%E6%B2%BB%E7%99%82%E8%96%AC%E5%80%99%E8%A3%9C%E3%81%A7%E3%81%82%E3%82%8BCTx-1301%E3%81%AE%E5%85%B1%E5%90%8C%E5%95%86%E6%A5%AD%E5%8C%96%E5%A5%91%E7%B4%84%E7%B7%A0%E7%B5%90%E3%82%92%E7%99%BA%E8%A1%A8.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:30</td>
    <td>プレディクティブ・オンコロジー、LifeSci Advisorsを戦略的な投資家対応パートナーとして起用</td>
    <td><a href=https://finance.yahoo.com/quote/POAI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/POAI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:30</td>
    <td>ノバン、Oppenheimer 33rd Annual Healthcare Conferenceでプレゼンテーションを実施</td>
    <td><a href=https://finance.yahoo.com/quote/NOVN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NOVN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:30</td>
    <td>ウルトラジェニックス、Eric Crombez博士をチーフ・メディカル・オフィサー兼エグゼクティブ・バイス・プレジデントに任命</td>
    <td><a href=https://finance.yahoo.com/quote/RARE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RARE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:30</td>
    <td>アダミス・ファーマシューティカルズ、300万ドルの登録制直接募集を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ADMP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ADMP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:30</td>
    <td>エレクトロコアは、シリコンバレー銀行、シルバーゲート銀行、シグネチャー銀行への直接的なエクスポージャーがないことを確認しています。</td>
    <td><a href=https://finance.yahoo.com/quote/ECOR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ECOR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:05</td>
    <td>AMIA Informatics Summitで発表されたカスタムリサーチが、ヘルスケアイノベーションに向けた有望な知見を明らかにしました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626599/0/en/Custom-Research-Presented-at-AMIA-Informatics-Summit-Reveals-Promising-Findings-for-Healthcare-Innovation.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626599/0/en/Custom-Research-Presented-at-AMIA-Informatics-Summit-Reveals-Promising-Findings-for-Healthcare-Innovation.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:03</td>
    <td>LumiraDx社、2022年第4四半期および通期決算の発表と四半期カンファレンスコールを3月21日に開催</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626598/0/en/LumiraDx-to-Announce-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Host-Quarterly-Conference-Call-on-March-21.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626598/0/en/LumiraDx-to-Announce-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Host-Quarterly-Conference-Call-on-March-21.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:01</td>
    <td>オーシャンバイオメディカル（NASDAQ：OCEA）、EF Huttonによる「買い」推奨のエクイティ・アナリスト・カバレッジの開始を発表</td>
    <td><a href=https://finance.yahoo.com/quote/OCEA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OCEA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:00</td>
    <td>Healthy Directions、Kulreet Chaudhary博士と提携し、アーユルヴェーダの伝統と現代科学の融合を目指す</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626590/0/en/Healthy-Directions-Partners-with-Dr-Kulreet-Chaudhary-to-Combine-the-Tradition-Of-Ayurvedic-Practice-with-Modern-Day-Science.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626590/0/en/Healthy-Directions-Partners-with-Dr-Kulreet-Chaudhary-to-Combine-the-Tradition-Of-Ayurvedic-Practice-with-Modern-Day-Science.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:00</td>
    <td>VBL Therapeutics、2022年通期決算の報告とコーポレートアップデートを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626587/0/en/VBL-Therapeutics-Reports-Full-Year-2022-Financial-Results-and-Provides-Corporate-Update.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626587/0/en/VBL-Therapeutics-Reports-Full-Year-2022-Financial-Results-and-Provides-Corporate-Update.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 20:49</td>
    <td>Ainos stock surges 80% on research pact with Merdury for Veldona
</td>
    <td><a href=https://finance.yahoo.com/quote/AIMD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AIMD</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 20:20</td>
    <td>Autolus Therapeuticsの財務責任者が退任。</td>
    <td><a href=https://finance.yahoo.com/quote/AUTL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AUTL</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:00</td>
    <td>ProQR社、ADARを介したRNA編集を保護するAxiomer®の重要特許の防御に成功したと発表</td>
    <td><a href=https://finance.yahoo.com/quote/PRQR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PRQR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:00</td>
    <td>世界希少疾病用医薬品連合会、中国、イスラエル、ギリシャ・キプロス・マルタに拡大</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626539/0/en/World-Orphan-Drug-Alliance-Expands-to-China-Israel-and-Greece-Cyprus-and-Malta.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626539/0/en/World-Orphan-Drug-Alliance-Expands-to-China-Israel-and-Greece-Cyprus-and-Malta.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:00</td>
    <td>バイオヴィー、ウェビナー「BioVie Day」の登録内容を発表</td>
    <td><a href=https://finance.yahoo.com/quote/BIVI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BIVI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:00</td>
    <td>More Than Rehabのメディカルディレクター、マイケル・ジョーンズ博士がアディクション・メディシンのボード認定を取得</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626545/0/en/More-Than-Rehab-s-Medical-Director-Dr-Michael-Jones-now-Board-Certified-in-Addiction-Medicine.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626545/0/en/More-Than-Rehab-s-Medical-Director-Dr-Michael-Jones-now-Board-Certified-in-Addiction-Medicine.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:00</td>
    <td>Gradalis社、Clinical Cancer Research誌に「Vigil®」の再発ユーイング肉腫患者への併用療法に関する良好な結果を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626549/0/en/Gradalis-Announces-Publication-in-Clinical-Cancer-Research-Featuring-Positive-Results-from-a-Study-Evaluating-Vigil-in-Combination-Therapy-for-Patients-with-Recurrent-Ewing-s-Sarco.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626549/0/en/Gradalis-Announces-Publication-in-Clinical-Cancer-Research-Featuring-Positive-Results-from-a-Study-Evaluating-Vigil-in-Combination-Therapy-for-Patients-with-Recurrent-Ewing-s-Sarco.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:00</td>
    <td>STRATA Skin Sciences、2022年第4四半期決算を2023年3月28日に発表へ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626554/23161/en/STRATA-Skin-Sciences-to-Report-Fourth-Quarter-2022-Financial-Results-on-March-28-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626554/23161/en/STRATA-Skin-Sciences-to-Report-Fourth-Quarter-2022-Financial-Results-on-March-28-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:00</td>
    <td>イミューテップ社、転移性乳がんを対象としたEftilagimod Alphaとパクリタキセルの第II/III相臨床試験開始を発表</td>
    <td><a href=https://finance.yahoo.com/quote/IMMP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IMMP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:00</td>
    <td>コージェント・バイオサイエンス、最近の事業ハイライトと2022年第4四半期および通期決算を発表</td>
    <td><a href=https://finance.yahoo.com/quote/COGT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/COGT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:00</td>
    <td>カルチュア・バイオサイエンス、生物製剤に特化した技術・サービスプラットフォームを構築</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626569/0/en/Culture-Biosciences-Focuses-Technology-and-Service-Platform-on-Biologics.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626569/0/en/Culture-Biosciences-Focuses-Technology-and-Service-Platform-on-Biologics.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 21:00</td>
    <td>Proteovant Therapeutics社、エストロゲン受容体およびIKZF2タンパク質分解プログラムの前臨床試験データを発表</td>
    <td><a href=https://finance.yahoo.com/quote/ROIVW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ROIVW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 20:30</td>
    <td>リプリジェンコーポレーションがKeyBanc Life Science and MedTech Investor Forumでプレゼンテーションを実施</td>
    <td><a href=https://finance.yahoo.com/quote/RGEN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RGEN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 20:30</td>
    <td>Abeona Therapeutics、AAV眼科プログラムに関する最新情報を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ABEO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ABEO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 20:30</td>
    <td>Reneo Pharmaceuticals、Mavodelpar（REN001）のミトコンドリア原性ミオパチーを対象としたピボタルSTRIDE試験で目標登録人数を達成</td>
    <td><a href=https://finance.yahoo.com/quote/RPHM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RPHM</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 20:30</td>
    <td>バイオジェン社、チャック・トリアーノをインベスターリレーションズ部門責任者に任命</td>
    <td><a href=https://finance.yahoo.com/quote/BIIB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BIIB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 20:25</td>
    <td>Alterity Therapeutics社、新規物質組成特許の取得とアルツハイマー病領域における資産の独占的ライセンス契約を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626493/0/en/Alterity-Therapeutics-Announces-Granting-of-New-Composition-of-Matter-Patent-and-Exclusive-License-Agreement-for-Assets-in-Alzheimer-s-Disease.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626493/0/en/Alterity-Therapeutics-Announces-Granting-of-New-Composition-of-Matter-Patent-and-Exclusive-License-Agreement-for-Assets-in-Alzheimer-s-Disease.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 20:00</td>
    <td>第4回IPITA/HSCI/JDRFサミットで、iPS細胞とセルポーチ™の組み合わせによる1型糖尿病治療について発表予定</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626439/0/en/Sernova-Announces-Upcoming-Podium-Presentation-of-iPSC-and-Cell-Pouch-Combination-Treatment-for-Type-One-Diabetes-at-the-4th-IPITA-HSCI-JDRF-Summit.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626439/0/en/Sernova-Announces-Upcoming-Podium-Presentation-of-iPSC-and-Cell-Pouch-Combination-Treatment-for-Type-One-Diabetes-at-the-4th-IPITA-HSCI-JDRF-Summit.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 20:00</td>
    <td>Cara Therapeutics社、環境・社会・ガバナンス報告書を発表</td>
    <td><a href=https://finance.yahoo.com/quote/CARA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CARA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 20:00</td>
    <td>イケナ・オンコロジー、2022年第4四半期および通期決算を発表</td>
    <td><a href=https://finance.yahoo.com/quote/IKNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/IKNA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 20:00</td>
    <td>アスラン・ファーマシューティカルズ、第1回国際研究皮膚科学会でポスター発表する2件の演題を受理したと発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626456/0/en/ASLAN-Pharmaceuticals-Announces-Acceptance-of-Two-Abstracts-for-Poster-Presentation-at-the-1st-International-Societies-for-Investigative-Dermatology-Meeting.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626456/0/en/ASLAN-Pharmaceuticals-Announces-Acceptance-of-Two-Abstracts-for-Poster-Presentation-at-the-1st-International-Societies-for-Investigative-Dermatology-Meeting.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 20:00</td>
    <td>歯科用痛み止めが業界最高賞のイノベーションアワードを受賞</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626461/0/en/Game-Changing-Dental-Pain-Eraser-Recognized-with-Top-Industry-Innovation-Award.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626461/0/en/Game-Changing-Dental-Pain-Eraser-Recognized-with-Top-Industry-Innovation-Award.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 20:00</td>
    <td>新型コロナおよびC型肝炎治療薬「Bemnifosbuvir」の良好なプロファイルを示す新データを2023年国際抗ウイルス剤学会で発表</td>
    <td><a href=https://finance.yahoo.com/quote/AVIR target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AVIR</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 20:00</td>
    <td>ジェニファー・バーマン博士がELITONEのメディカルアドバイザリーボードに就任</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626463/0/en/Dr-Jennifer-Berman-Joins-ELITONE-Medical-Advisory-Board.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626463/0/en/Dr-Jennifer-Berman-Joins-ELITONE-Medical-Advisory-Board.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 20:00</td>
    <td>TScan Therapeutics、血液悪性腫瘍治療薬TSC-100とTSC-101を評価する第1相アンブレラ臨床試験で最初の患者を投与したことを発表</td>
    <td><a href=https://finance.yahoo.com/quote/TCRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TCRX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 20:00</td>
    <td>iSpecimen、2022年通期決算を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ISPC target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ISPC</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 19:50</td>
    <td>ノバルティス、一部のアイケア資産の売却を開始-報告書</td>
    <td><a href=https://finance.yahoo.com/quote/NVS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NVS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 19:13</td>
    <td>キロンライフがユニット提供を開始</td>
    <td><a href=https://finance.yahoo.com/quote/KHRNF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/KHRNF</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 18:42</td>
    <td>メディビル社、肝臓がんを対象としたフォストロクス／レンビマ併用療法の中間ステージ試験で投与開始</td>
    <td><a href=https://finance.yahoo.com/quote/MVRBF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MVRBF</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 19:30</td>
    <td>クラウドMD、KeyBanc Capital Markets Life Sciences & MedTech Investor Forumに参加</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626423/0/en/CloudMD-to-Participate-in-KeyBanc-Capital-Markets-Life-Sciences-MedTech-Investor-Forum.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626423/0/en/CloudMD-to-Participate-in-KeyBanc-Capital-Markets-Life-Sciences-MedTech-Investor-Forum.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 19:00</td>
    <td>Telesis Bio社、RNA Leaders Europe Congressでプレゼンテーションを実施</td>
    <td><a href=https://finance.yahoo.com/quote/TBIO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TBIO</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 18:23</td>
    <td>フィリップス、ジブラルタル・ヘルスと心臓治療の推進と心臓研究所の建設で協定を締結</td>
    <td><a href=https://finance.yahoo.com/quote/PHG target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PHG</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 17:59</td>
    <td>GSKの5in1髄膜炎菌ワクチンが第3相の目標を達成、ファイザーとの新たな競争の舞台となる</td>
    <td><a href=https://finance.yahoo.com/quote/GSK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GSK</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 17:47</td>
    <td>ディフェンス・セラピューティクスとオラノ社、がんに対する次世代標的放射性免疫療法の開発で合意</td>
    <td><a href=https://finance.yahoo.com/quote/DTCFF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DTCFF</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 18:00</td>
    <td>フィリップスとジブラルタル保健局が16年間の戦略的パートナーシップを発表、セント・バーナード病院における患者の画像診断と心臓治療に変革をもたらす</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626361/0/en/Philips-and-Gibraltar-Health-Authority-announce-16-year-strategic-partnership-transforming-patient-imaging-and-cardiac-care-at-St-Bernard-s-Hospital.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626361/0/en/Philips-and-Gibraltar-Health-Authority-announce-16-year-strategic-partnership-transforming-patient-imaging-and-cardiac-care-at-St-Bernard-s-Hospital.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 17:22</td>
    <td>重症喘息治療薬「GSK Nucala」が中国で審査を取得</td>
    <td><a href=https://finance.yahoo.com/quote/GSK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GSK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 16:48</td>
    <td>経営陣による取引および経営陣の密接な関係</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626333/0/en/Trading-by-management-and-close-relations-of-management.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626333/0/en/Trading-by-management-and-close-relations-of-management.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 16:00</td>
    <td>OKYO Pharma Limited、574万ドルのグローバル第三者割当増資と取締役および上級管理職による出資を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626311/0/en/OKYO-Pharma-Limited-announces-U-S-5-74-million-Global-Private-Placement-and-investment-by-directors-and-members-of-senior-management.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626311/0/en/OKYO-Pharma-Limited-announces-U-S-5-74-million-Global-Private-Placement-and-investment-by-directors-and-members-of-senior-management.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 15:12</td>
    <td>DocGoは2023年のスタート以来、米国、英国で1億8000万ドルの契約を獲得している</td>
    <td><a href=https://finance.yahoo.com/quote/DCGO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/DCGO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 15:30</td>
    <td>オンワード、2022年通期決算の発表とウェブキャストを2023年3月28日に開催へ</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626300/0/en/ONWARD-to-Publish-Full-Year-2022-Financial-Results-and-Host-Webcast-on-March-28-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626300/0/en/ONWARD-to-Publish-Full-Year-2022-Financial-Results-and-Host-Webcast-on-March-28-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 15:30</td>
    <td>オンワード、2022年通期決算を発表、2023年3月28日にウェブキャストを開催</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626300/0/nl/ONWARD-publiceert-financi%C3%ABle-resultaten-voor-het-volledige-jaar-2022-en-Host-een-Webcast-op-28-maart-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626300/0/nl/ONWARD-publiceert-financi%C3%ABle-resultaten-voor-het-volledige-jaar-2022-en-Host-een-Webcast-op-28-maart-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 15:30</td>
    <td>オンワード、2022年度決算を2023年3月28日に発表、ウェブキャストを募集中</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626300/0/de/ONWARD-ver%C3%B6ffentlicht-Finanzergebnisse-f%C3%BCr-das-Gesch%C3%A4ftsjahr-2022-am-28-M%C3%A4rz-2023-und-l%C3%A4dt-zum-Webcast-ein.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626300/0/de/ONWARD-ver%C3%B6ffentlicht-Finanzergebnisse-f%C3%BCr-das-Gesch%C3%A4ftsjahr-2022-am-28-M%C3%A4rz-2023-und-l%C3%A4dt-zum-Webcast-ein.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 15:30</td>
    <td>オンワードは、2023年3月28日に2022年度決算を発表し、ウェブキャストを実施する予定です</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626300/0/fr/ONWARD-publiera-ses-r%C3%A9sultats-financiers-pour-l-exercice-2022-et-organisera-une-webdiffusion-le-28-mars-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626300/0/fr/ONWARD-publiera-ses-r%C3%A9sultats-financiers-pour-l-exercice-2022-et-organisera-une-webdiffusion-le-28-mars-2023.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/09 23:03</td>
    <td>NVIV社、急性脊髄損傷を対象としたINSPIRE 2.0試験のトップラインデータを発表 主要評価項目である標準障害尺度の改善は達成されず InVivo社、全データセットと会社の戦略オプションを評価する</td>
    <td><a href=https://finance.yahoo.com/quote/NVIV target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NVIV</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 14:30</td>
    <td>テカン、2桁の大幅な成長で売上高10億スイスフランを大きく上回る。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626292/0/en/Tecan-driving-sales-well-beyond-CHF-1-billion-with-strong-double-digit-growth.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626292/0/en/Tecan-driving-sales-well-beyond-CHF-1-billion-with-strong-double-digit-growth.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 14:30</td>
    <td>Tecan、2桁の力強い成長で売上高を10億スイスフランを大きく上回る</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/14/2626292/0/de/Tecan-steigert-den-Umsatz-deutlich-%C3%BCber-CHF-1-Milliarde-mit-starkem-zweistelligem-Wachstum.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/14/2626292/0/de/Tecan-steigert-den-Umsatz-deutlich-%C3%BCber-CHF-1-Milliarde-mit-starkem-zweistelligem-Wachstum.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/14 09:09</td>
    <td>META、インスタグラムとフェイスブックでのNFTのサポートを終了する。   クリプト</td>
    <td><a href=https://finance.yahoo.com/quote/META target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/META</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 12:49</td>
    <td>アムジェン、100億ドル以上の裏金と罰金の支払いについて集団訴訟に直面</td>
    <td><a href=https://finance.yahoo.com/quote/AMGN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMGN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 10:54</td>
    <td>なぜ今日、モデルナの株価が上がったのでしょうか？</td>
    <td><a href=https://finance.yahoo.com/quote/MRNA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRNA</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/08 23:15</td>
    <td>$CVM Multikine Phase 3 Cancer Study Shows 43% Survival Extension.          
</td>
    <td><a href=https://finance.yahoo.com/quote/CVM target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CVM</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/09 09:41</td>
    <td>FSTX invoX Pharma、F-star Therapeuticsの買収を完了</td>
    <td><a href=https://finance.yahoo.com/quote/FSTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/FSTX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/09 21:02</td>
    <td>AZN IMFINZI、切除可能なNSCLC患者を対象としたAEGEANフェーズ3試験で無イベント生存期間を有意に改善</td>
    <td><a href=https://finance.yahoo.com/quote/AZN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AZN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/09 21:07</td>
    <td>アレルギー性結膜炎を対象としたReproxalapの第3相試験INVIGORATE-2のトップラインデータを23年上半期に発表 -網膜色素変性症を対象としたADX-2191の第2相試験のトップラインデータを23年上半期に発表 -慢性咳嗽を対象としたADX-629の第2相試験のトップラインデータを23年上半期に発表 -現金及び同等物 1億7400ドル</td>
    <td><a href=https://finance.yahoo.com/quote/ALDX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ALDX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/09 21:12</td>
    <td>AZN TAGRISSOは、早期EGFR変異肺がん患者の術後補助療法を対象としたADAURAフェーズ3試験において、強い全生存期間延長効果を示しました。</td>
    <td><a href=https://finance.yahoo.com/quote/AZN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AZN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/09 22:19</td>
    <td>EXELがWells FargoのOverweightで開始されました。PT $23</td>
    <td><a href=https://finance.yahoo.com/quote/EXEL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EXEL</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/09 22:27</td>
    <td>VCNX KEYNOTE B-84試験の登録目標人数に達し、予定されていた中間解析に入る。 データは年央に。</td>
    <td><a href=https://finance.yahoo.com/quote/VCNX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VCNX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/10 20:03</td>
    <td>$SIVB ↓ 45% PM       
</td>
    <td><a href=https://finance.yahoo.com/quote/SIVB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SIVB</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/10 20:48</td>
    <td>KEYTRUDAと化学療法の併用療法を評価する$MRK Phase 2 / 3 CCTG IND.227 / KEYNOTE-483試験は、切除不能な進行または転移性の悪性胸膜中皮腫患者の一次治療として主要評価項目のOSを達成しました。</td>
    <td><a href=https://finance.yahoo.com/quote/MRK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRK</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/10 21:03</td>
    <td>ASLN、ADS比率の変更を実施する計画を発表。ADS1枚で普通株式5株を表すものから、普通株式25株を表すものへ。</td>
    <td><a href=https://finance.yahoo.com/quote/ASLN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ASLN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/10 22:23</td>
    <td>HCWとその価格目標!!!</td>
    <td><a href=https://t.co/PRXXLHrXtH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://t.co/PRXXLHrXtH</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/10 22:31</td>
    <td>Nonfarm Payrolls For February 311K Vs 205K est. 504K Prior. Unemployment Rate For February 3.6% Vs 3.4% est.; 3.4% Prior
</td>
    <td><a href= target="_blank" rel="noopener noreferrer" style="display: inline-block;"></a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/10 23:29</td>
    <td>NASHによる前硬化性肝線維症の治療薬としてのオベチコール酸の$ICPT FDA AdComm Meetingが5月19日に予定されています。</td>
    <td><a href=https://finance.yahoo.com/quote/ICPT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ICPT</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/11 11:03</td>
    <td>SIVB SVBのメルトダウンが、資金不足のバイオテクノロジー業界に新たな打撃を与える $XBI</td>
    <td><a href=https://finance.yahoo.com/quote/SIVB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SIVB</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/11 11:05</td>
    <td>S&P500のSVBファイナンシャルに代わってインスレットが採用される $POOD $SIVB</td>
    <td><a href=https://finance.yahoo.com/quote/POOD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/POOD</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/11 11:07</td>
    <td>英中央銀行がシリコンバレーバンクUKを債務超過にすることが決まった。ドルSIVB</td>
    <td><a href=https://finance.yahoo.com/quote/SIVB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SIVB</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/11 21:43</td>
    <td>ROKU ロクは$SIVBで4億8700万円の現金を持っていた 😬。</td>
    <td><a href=https://finance.yahoo.com/quote/ROKU target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ROKU</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/11 23:20</td>
    <td>SVBの終焉で空売りが5億円儲ける。$SIVB 課題は、いかにしてポジションを閉じるか。   SVBCクラッシュ</td>
    <td><a href=https://t.co/7QSf2Ht8mF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://t.co/7QSf2Ht8mF</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/12 07:17</td>
    <td>過去10年以上で最大級の米国銀行の経営破綻で、SVBの預金者、投資家は木曜日に420億ドルを引き出そうとした。SIVB SVBCollapse</td>
    <td><a href=https://t.co/jupFUQ36a9 target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://t.co/jupFUQ36a9</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 08:26</td>
    <td>トドス・メディカル、転換社債の保有者との間で転換停止契約を締結</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2626253/0/en/Todos-Medical-Enters-Into-Moratorium-on-Conversions-Agreement-With-Convertible-Note-Holders.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2626253/0/en/Todos-Medical-Enters-Into-Moratorium-on-Conversions-Agreement-With-Convertible-Note-Holders.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 05:30</td>
    <td>ZyVersa Therapeutics、ナスダック上場規則5635(c)(4)に基づく新規雇用誘発助成金について報告</td>
    <td><a href=https://finance.yahoo.com/quote/ZVSA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ZVSA</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/13 01:39</td>
    <td>ジャネット・イエレン、シリコンバレー銀行救済にNOを突きつける「We're not going to do that again」 $SIVB</td>
    <td><a href=https://finance.yahoo.com/quote/SIVB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SIVB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 05:15</td>
    <td>OKYO Pharma Limited、530万ドルのADSの公募を開始</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2626199/0/en/OKYO-Pharma-Limited-Prices-5-3-Million-Offering-of-ADSs.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2626199/0/en/OKYO-Pharma-Limited-Prices-5-3-Million-Offering-of-ADSs.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/13 19:46</td>
    <td>PFE、$SGENを229ドル/株で買収へ</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 05:15</td>
    <td>CRISPR Therapeutics、最高財務責任者の交代を発表</td>
    <td><a href=https://finance.yahoo.com/quote/CRSP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CRSP</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/13 21:03</td>
    <td>AR-501の嚢胞性線維症患者を対象としたフェーズ2a試験において、$ARDS Aridisが主要評価項目および副次的評価項目を達成</td>
    <td><a href=https://finance.yahoo.com/quote/ARDS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ARDS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 05:15</td>
    <td>ザイネルバ・ファーマシューティカルズ、シリコンバレー銀行で現金預金および有価証券を保有していないことを確認</td>
    <td><a href=https://finance.yahoo.com/quote/ZYNE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ZYNE</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/13 21:04</td>
    <td>$MRSN resumes. ↓ 30% PM       
</td>
    <td><a href=https://finance.yahoo.com/quote/MRSN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRSN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 07:18</td>
    <td>Amylx Pharmaceuticals jumps 20% on Q4 top and bottom line beats
</td>
    <td><a href=https://finance.yahoo.com/quote/AMLX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMLX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 05:05</td>
    <td>UpHealth, Inc. 450万ドルの第三者割当増資の完了を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2626178/0/en/UpHealth-Inc-Announces-Closing-of-4-5-Million-Private-Placement.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2626178/0/en/UpHealth-Inc-Announces-Closing-of-4-5-Million-Private-Placement.html</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/13 21:07</td>
    <td>CRIS、TakeAim白血病試験において、FDAから要請された9名の追加患者の登録を予定より早く完了。 第3四半期のFDAとの協議において、この9名の追加患者からのデータを含めることで、RP2Dの決定と解決につながることを期待している。</td>
    <td><a href=https://finance.yahoo.com/quote/CRIS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CRIS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 06:53</td>
    <td>Gitlab down 34% on soft 2023 revenue forecast despite quarterly beats
</td>
    <td><a href=https://finance.yahoo.com/quote/GTLB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GTLB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 05:05</td>
    <td>ターサス、2022年12月期通期決算と直近の事業成果に関するお知らせ</td>
    <td><a href=https://finance.yahoo.com/quote/TARS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TARS</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/13 21:12</td>
    <td>SIVBは、持株会社およびSVB CapitalとSVB Securitiesの事業、ならびにその他の資産および投資について、戦略的な選択肢を検討するために$SIVBを設立しました。SVBキャピタルおよびSVBセキュリティーズで事業を継続。  SVBCの崩壊</td>
    <td><a href=https://finance.yahoo.com/quote/SIVB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SIVB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 05:05</td>
    <td>TScan TherapeuticsがBarclays Global Healthcare Conferenceに参加します。</td>
    <td><a href=https://finance.yahoo.com/quote/TCRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TCRX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 06:45</td>
    <td>アイノス、300万ドルの転換社債を第三者割当増資で発行</td>
    <td><a href=https://finance.yahoo.com/quote/AIMD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AIMD</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/13 21:18</td>
    <td>バイデン大統領、午前9時（日本時間）に銀行業務に関する講演を行う $SIVB $FRC</td>
    <td><a href=https://finance.yahoo.com/quote/SIVB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SIVB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 05:05</td>
    <td>Avid Bioservices、2023年1月31日に終了した第3四半期の決算と最近の動向について発表</td>
    <td><a href=https://finance.yahoo.com/quote/CDMO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CDMO</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 06:38</td>
    <td>アメディシス、新社長兼CEOにリチャード・アシュワース氏を指名</td>
    <td><a href=https://finance.yahoo.com/quote/AMED target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/AMED</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/13 21:35</td>
    <td>BIVI社、腹水フェーズ2b試験の患者登録の一時停止を発表、有望な有効性データを発表、枢要登録試験の実施に向けてFDAとの協議に入る</td>
    <td><a href=https://finance.yahoo.com/quote/BIVI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BIVI</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 06:22</td>
    <td>CRISPR Therapeuticsの次期CFOにRaju Prasadが就任しました。</td>
    <td><a href=https://finance.yahoo.com/quote/CRSP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CRSP</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/14 09:04</td>
    <td>INVA、4月17日にSulbactam-Durlobactam (SUL-DUR) NDAを審査するFDA AdComm Meetingを開催と発表。</td>
    <td><a href=https://finance.yahoo.com/quote/INVA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/INVA</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/09 22:19</td>
    <td>EXELがWells FargoのOverweightで開始されました。PT $23</td>
    <td><a href=https://finance.yahoo.com/quote/EXEL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EXEL</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/09 22:27</td>
    <td>VCNX KEYNOTE B-84試験の登録目標人数に達し、予定されていた中間解析に入る。 データは年央に。</td>
    <td><a href=https://finance.yahoo.com/quote/VCNX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/VCNX</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/10 20:03</td>
    <td>$SIVB ↓ 45% PM       
</td>
    <td><a href=https://finance.yahoo.com/quote/SIVB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SIVB</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/10 20:48</td>
    <td>KEYTRUDAと化学療法の併用療法を評価する$MRK Phase 2 / 3 CCTG IND.227 / KEYNOTE-483試験は、切除不能な進行または転移性の悪性胸膜中皮腫患者の一次治療として主要評価項目のOSを達成しました。</td>
    <td><a href=https://finance.yahoo.com/quote/MRK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRK</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/10 21:03</td>
    <td>ASLN、ADS比率の変更を実施する計画を発表。ADS1枚で普通株式5株を表すものから、普通株式25株を表すものへ。</td>
    <td><a href=https://finance.yahoo.com/quote/ASLN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ASLN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/10 22:23</td>
    <td>HCWとその価格目標!!!</td>
    <td><a href=https://t.co/PRXXLHrXtH target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://t.co/PRXXLHrXtH</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/10 22:31</td>
    <td>Nonfarm Payrolls For February 311K Vs 205K est. 504K Prior. Unemployment Rate For February 3.6% Vs 3.4% est.; 3.4% Prior
</td>
    <td><a href= target="_blank" rel="noopener noreferrer" style="display: inline-block;"></a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/10 23:29</td>
    <td>NASHによる前硬化性肝線維症の治療薬としてのオベチコール酸の$ICPT FDA AdComm Meetingが5月19日に予定されています。</td>
    <td><a href=https://finance.yahoo.com/quote/ICPT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ICPT</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/11 11:03</td>
    <td>SIVB SVBのメルトダウンが、資金不足のバイオテクノロジー業界に新たな打撃を与える $XBI</td>
    <td><a href=https://finance.yahoo.com/quote/SIVB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SIVB</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/11 11:05</td>
    <td>S&P500のSVBファイナンシャルに代わってインスレットが採用される $POOD $SIVB</td>
    <td><a href=https://finance.yahoo.com/quote/POOD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/POOD</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/11 11:07</td>
    <td>英中央銀行がシリコンバレーバンクUKを債務超過にすることが決まった。ドルSIVB</td>
    <td><a href=https://finance.yahoo.com/quote/SIVB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SIVB</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/11 21:43</td>
    <td>ROKU ロクは$SIVBで4億8700万円の現金を持っていた 😬。</td>
    <td><a href=https://finance.yahoo.com/quote/ROKU target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ROKU</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/11 23:20</td>
    <td>SVBの終焉で空売りが5億円儲ける。$SIVB 課題は、いかにしてポジションを閉じるか。   SVBCクラッシュ</td>
    <td><a href=https://t.co/7QSf2Ht8mF target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://t.co/7QSf2Ht8mF</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/12 07:17</td>
    <td>過去10年以上で最大級の米国銀行の経営破綻で、SVBの預金者、投資家は木曜日に420億ドルを引き出そうとした。SIVB SVBCollapse</td>
    <td><a href=https://t.co/jupFUQ36a9 target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://t.co/jupFUQ36a9</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/13 01:39</td>
    <td>ジャネット・イエレン、シリコンバレー銀行救済にNOを突きつける「We're not going to do that again」 $SIVB</td>
    <td><a href=https://finance.yahoo.com/quote/SIVB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SIVB</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/13 19:46</td>
    <td>PFE、$SGENを229ドル/株で買収へ</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/13 21:03</td>
    <td>AR-501の嚢胞性線維症患者を対象としたフェーズ2a試験において、$ARDS Aridisが主要評価項目および副次的評価項目を達成</td>
    <td><a href=https://finance.yahoo.com/quote/ARDS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ARDS</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/13 21:04</td>
    <td>$MRSN resumes. ↓ 30% PM       
</td>
    <td><a href=https://finance.yahoo.com/quote/MRSN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRSN</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/13 21:07</td>
    <td>CRIS、TakeAim白血病試験において、FDAから要請された9名の追加患者の登録を予定より早く完了。 第3四半期のFDAとの協議において、この9名の追加患者からのデータを含めることで、RP2Dの決定と解決につながることを期待している。</td>
    <td><a href=https://finance.yahoo.com/quote/CRIS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CRIS</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/13 21:12</td>
    <td>SIVBは、持株会社およびSVB CapitalとSVB Securitiesの事業、ならびにその他の資産および投資について、戦略的な選択肢を検討するために$SIVBを設立しました。SVBキャピタルおよびSVBセキュリティーズで事業を継続。  SVBCの崩壊</td>
    <td><a href=https://finance.yahoo.com/quote/SIVB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SIVB</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/13 21:18</td>
    <td>バイデン大統領、午前9時（日本時間）に銀行業務に関する講演を行う $SIVB $FRC</td>
    <td><a href=https://finance.yahoo.com/quote/SIVB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SIVB</a></td>
    </tr><tr>
    <td>BioStock</td>
    <td>2023/03/13 21:35</td>
    <td>BIVI社、腹水フェーズ2b試験の患者登録の一時停止を発表、有望な有効性データを発表、枢要登録試験の実施に向けてFDAとの協議に入る</td>
    <td><a href=https://finance.yahoo.com/quote/BIVI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BIVI</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 02:15</td>
    <td>Calliditas jumps 35% on prospects for full approval of kidney disease therapy
</td>
    <td><a href=https://finance.yahoo.com/quote/CALT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CALT</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 01:59</td>
    <td>Teva社、後期Austedo脳性麻痺試験での登録終了について</td>
    <td><a href=https://finance.yahoo.com/quote/TEVA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TEVA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 02:10</td>
    <td>ABサイエンス社、AB8939の第I/II相臨床試験（AB18001）の超低用量投与群から、再発難治性急性骨髄性白血病患者における初の完全骨髄反応について発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2626092/0/en/AB-Science-reports-a-first-complete-bone-marrow-response-in-a-relapsed-refractory-acute-myeloid-leukemia-patient-from-the-very-low-dose-arm-of-its-AB8939-Phase-I-II-clinical-trial-.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2626092/0/en/AB-Science-reports-a-first-complete-bone-marrow-response-in-a-relapsed-refractory-acute-myeloid-leukemia-patient-from-the-very-low-dose-arm-of-its-AB8939-Phase-I-II-clinical-trial-.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 02:10</td>
    <td>ABサイエンス社、AB8939（AB18001）の第I/II相臨床試験において、再発難治性急性骨髄性白血病の患者さんに超低用量で初の完全骨髄反応を示したと発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2626092/0/fr/AB-Science-annonce-une-premi%C3%A8re-r%C3%A9ponse-compl%C3%A8te-de-la-moelle-osseuse-chez-un-patient-atteint-de-leuc%C3%A9mie-my%C3%A9lo%C3%AFde-aigue-r%C3%A9fractaire-en-rechute-%C3%A0-tr%C3%A8s-faible-dose-dans-son-essai-cl.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2626092/0/fr/AB-Science-annonce-une-premi%C3%A8re-r%C3%A9ponse-compl%C3%A8te-de-la-moelle-osseuse-chez-un-patient-atteint-de-leuc%C3%A9mie-my%C3%A9lo%C3%AFde-aigue-r%C3%A9fractaire-en-rechute-%C3%A0-tr%C3%A8s-faible-dose-dans-son-essai-cl.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 02:00</td>
    <td>エシロール・ルクソティカ：自己株式売買の開示について</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2626074/0/fr/EssilorLuxottica-D%C3%A9claration-de-transactions-sur-actions-propres.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2626074/0/fr/EssilorLuxottica-D%C3%A9claration-de-transactions-sur-actions-propres.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 02:00</td>
    <td>メンダス、ネグマグループによる転換社債の転換要請を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2626078/0/en/Mendus-announces-request-for-conversion-of-convertible-bonds-by-Negma-Group.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2626078/0/en/Mendus-announces-request-for-conversion-of-convertible-bonds-by-Negma-Group.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 02:00</td>
    <td>メンダス、ネグマグループからの転換社債の転換要請を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2626078/0/sv/Mendus-tillk%C3%A4nnager-beg%C3%A4ran-fr%C3%A5n-Negma-Group-om-konvertering-av-konvertibla-skuldebrev.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2626078/0/sv/Mendus-tillk%C3%A4nnager-beg%C3%A4ran-fr%C3%A5n-Negma-Group-om-konvertering-av-konvertibla-skuldebrev.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 00:58</td>
    <td>第4四半期の純損失が縮小し、Myomoの株価は上昇した。</td>
    <td><a href=https://finance.yahoo.com/quote/MYO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MYO</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 00:51</td>
    <td>注目銘柄です。ZIMが決算で上昇、SGENが買収案件で急上昇、SVBの余波でFRC、SCHWが下落</td>
    <td><a href=https://finance.yahoo.com/quote/SCHW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SCHW</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/14 00:31</td>
    <td>Zynex stock soars 15% as Q4 revenue climbs, eyes 'double-digit growth going forward'
</td>
    <td><a href=https://finance.yahoo.com/quote/ZYXI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ZYXI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/14 00:34</td>
    <td>ノボ ノルディスク A / S - 株式買戻しプログラム</td>
    <td><a href=https://finance.yahoo.com/quote/NVO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NVO</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 23:43</td>
    <td>イルミナは、カール・アイカーンがグレイル社との取引をめぐる委任状争奪戦を開始したことで急騰（更新）。</td>
    <td><a href=https://finance.yahoo.com/quote/ILMN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ILMN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 23:17</td>
    <td>シナプティブ、カナダ輸出開発省（EDC）から4000万ドルの投資を受け、外科手術、画像処理、データ技術を加速させることを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625908/0/en/Synaptive-Announces-a-40-Million-Investment-from-Export-Development-Canada-EDC-to-Accelerate-Surgical-Imaging-and-Data-Technologies.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625908/0/en/Synaptive-Announces-a-40-Million-Investment-from-Export-Development-Canada-EDC-to-Accelerate-Surgical-Imaging-and-Data-Technologies.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 22:41</td>
    <td>株式買戻しプログラムに関連する取引</td>
    <td><a href=https://finance.yahoo.com/quote/GMAB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GMAB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 22:30</td>
    <td>HOOPP、2050年のネットゼロ達成に向けた気候計画を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625858/0/en/HOOPP-releases-climate-plan-for-achieving-net-zero-by-2050.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625858/0/en/HOOPP-releases-climate-plan-for-achieving-net-zero-by-2050.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 22:25</td>
    <td>ベターチョイス社、「Halo」ペットブランドに対する複数の未承諾の関心表明を受け、戦略的代替案を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625841/0/en/Better-Choice-Company-Announces-Strategic-Alternatives-After-Receiving-Multiple-Unsolicited-Expressions-of-Interest-for-the-Halo-Pet-Brand.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625841/0/en/Better-Choice-Company-Announces-Strategic-Alternatives-After-Receiving-Multiple-Unsolicited-Expressions-of-Interest-for-the-Halo-Pet-Brand.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 22:14</td>
    <td>業界のベテラン2人がAcuitive Technologies, Inc.の取締役に就任。取締役会に独立メンバーとして参加</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625832/0/en/Two-Industry-Veterans-Join-Acuitive-Technologies-Inc-Board-of-Directors-as-Independent-Members.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625832/0/en/Two-Industry-Veterans-Join-Acuitive-Technologies-Inc-Board-of-Directors-as-Independent-Members.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 22:00</td>
    <td>H1、「Advanced Diversity Insights」と「Clinical Trial Performance Insights」の販売を開始</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625774/0/en/H1-Launches-Advanced-Diversity-Insights-and-Clinical-Trial-Performance-Insights.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625774/0/en/H1-Launches-Advanced-Diversity-Insights-and-Clinical-Trial-Performance-Insights.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 22:00</td>
    <td>ProMIS Neurosciences、米国神経学会2023年年次総会での発表要旨の受付を発表</td>
    <td><a href=https://finance.yahoo.com/quote/PMN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PMN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 22:00</td>
    <td>マイクロボット・メディカル、ギリシャのキーオピニオンリーダーStavros Spiliopoulos（医学博士、EBIR-ES、FCIRSE）を科学諮問委員会に加え、EUでの存在感を強化</td>
    <td><a href=https://finance.yahoo.com/quote/MBOT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MBOT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 22:00</td>
    <td>シリュウ、次世代の植物性食品を解き放つタンパク質ベースの代替脂肪成分「OleoPro™」を販売開始</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625781/0/en/Shiru-launches-OleoPro-a-protein-based-alternative-fat-ingredient-to-unlock-the-next-generation-of-plant-based-foods.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625781/0/en/Shiru-launches-OleoPro-a-protein-based-alternative-fat-ingredient-to-unlock-the-next-generation-of-plant-based-foods.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 23:02</td>
    <td>Provention、Caleminderがヘルスケア関連で上昇、Cingulate、iCADが下降。</td>
    <td><a href=https://finance.yahoo.com/quote/ICAD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ICAD</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 22:46</td>
    <td>乳がんリスク検出におけるgeneTypeテストの優位性を示唆する研究結果をGeneticが発表</td>
    <td><a href=https://finance.yahoo.com/quote/GENE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GENE</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 22:41</td>
    <td>エノキアンバイオサイエンス、懸案事項の報告によりナスダックへの準拠を回復</td>
    <td><a href=https://finance.yahoo.com/quote/ENOB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ENOB</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 22:29</td>
    <td>CFOの退任に伴いEQRxが下落</td>
    <td><a href=https://finance.yahoo.com/quote/EQRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EQRX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 23:02</td>
    <td>Provention、Caleminderがヘルスケア関連で上昇、Cingulate、iCADが下降。</td>
    <td><a href=https://finance.yahoo.com/quote/ICAD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ICAD</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 22:46</td>
    <td>乳がんリスク検出におけるgeneTypeテストの優位性を示唆する研究結果をGeneticが発表</td>
    <td><a href=https://finance.yahoo.com/quote/GENE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GENE</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 22:41</td>
    <td>エノキアンバイオサイエンス、懸案事項の報告によりナスダックへの準拠を回復</td>
    <td><a href=https://finance.yahoo.com/quote/ENOB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ENOB</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 22:29</td>
    <td>CFOの退任に伴いEQRxが下落</td>
    <td><a href=https://finance.yahoo.com/quote/EQRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EQRX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 22:14</td>
    <td>Cingulate stock slumps ~15% on commercialization pact for ADHD drug CTx-1301
</td>
    <td><a href=https://finance.yahoo.com/quote/CING target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CING</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 23:17</td>
    <td>シナプティブ、カナダ輸出開発省（EDC）から4000万ドルの投資を受け、外科手術、画像処理、データ技術を加速させることを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625908/0/en/Synaptive-Announces-a-40-Million-Investment-from-Export-Development-Canada-EDC-to-Accelerate-Surgical-Imaging-and-Data-Technologies.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625908/0/en/Synaptive-Announces-a-40-Million-Investment-from-Export-Development-Canada-EDC-to-Accelerate-Surgical-Imaging-and-Data-Technologies.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 22:30</td>
    <td>HOOPP、2050年のネットゼロ達成に向けた気候計画を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625858/0/en/HOOPP-releases-climate-plan-for-achieving-net-zero-by-2050.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625858/0/en/HOOPP-releases-climate-plan-for-achieving-net-zero-by-2050.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 22:30</td>
    <td>HOOPP、2050年のネットゼロ達成に向けた気候計画を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625858/0/en/HOOPP-releases-climate-plan-for-achieving-net-zero-by-2050.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625858/0/en/HOOPP-releases-climate-plan-for-achieving-net-zero-by-2050.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 22:30</td>
    <td>HOOPP、2050年のネットゼロ達成に向けた気候計画を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625858/0/en/HOOPP-releases-climate-plan-for-achieving-net-zero-by-2050.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625858/0/en/HOOPP-releases-climate-plan-for-achieving-net-zero-by-2050.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 22:25</td>
    <td>ベターチョイス社、「Halo」ペットブランドに対する複数の未承諾の関心表明を受け、戦略的代替案を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625841/0/en/Better-Choice-Company-Announces-Strategic-Alternatives-After-Receiving-Multiple-Unsolicited-Expressions-of-Interest-for-the-Halo-Pet-Brand.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625841/0/en/Better-Choice-Company-Announces-Strategic-Alternatives-After-Receiving-Multiple-Unsolicited-Expressions-of-Interest-for-the-Halo-Pet-Brand.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 22:14</td>
    <td>業界のベテラン2人がAcuitive Technologies, Inc.の取締役に就任。取締役会に独立メンバーとして参加</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625832/0/en/Two-Industry-Veterans-Join-Acuitive-Technologies-Inc-Board-of-Directors-as-Independent-Members.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625832/0/en/Two-Industry-Veterans-Join-Acuitive-Technologies-Inc-Board-of-Directors-as-Independent-Members.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 22:00</td>
    <td>H1、「Advanced Diversity Insights」と「Clinical Trial Performance Insights」の販売を開始</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625774/0/en/H1-Launches-Advanced-Diversity-Insights-and-Clinical-Trial-Performance-Insights.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625774/0/en/H1-Launches-Advanced-Diversity-Insights-and-Clinical-Trial-Performance-Insights.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 21:48</td>
    <td>Aridis stock surges ~35% as lung disease drug AR-501 meets main goal in mid-stage study
</td>
    <td><a href=https://finance.yahoo.com/quote/ARDS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ARDS</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 21:40</td>
    <td>Mersana sheds 14% as FDA places clinical hold on cancer study
</td>
    <td><a href=https://finance.yahoo.com/quote/MRSN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRSN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 21:21</td>
    <td>iCAD、リーダー交代を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ICAD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ICAD</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 21:18</td>
    <td>SunStream、ミシガン州の裁判所がSkymint資産の管財人を任命する命令を承認したと発表</td>
    <td><a href=https://finance.yahoo.com/quote/SNDL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SNDL</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 22:00</td>
    <td>H1、「Advanced Diversity Insights」と「Clinical Trial Performance Insights」の販売を開始</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625774/0/en/H1-Launches-Advanced-Diversity-Insights-and-Clinical-Trial-Performance-Insights.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625774/0/en/H1-Launches-Advanced-Diversity-Insights-and-Clinical-Trial-Performance-Insights.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 22:00</td>
    <td>ProMIS Neurosciences、米国神経学会2023年年次総会での発表要旨の受付を発表</td>
    <td><a href=https://finance.yahoo.com/quote/PMN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PMN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 22:00</td>
    <td>マイクロボット・メディカル、ギリシャのキーオピニオンリーダーStavros Spiliopoulos（医学博士、EBIR-ES、FCIRSE）を科学諮問委員会に加え、EUでの存在感を強化</td>
    <td><a href=https://finance.yahoo.com/quote/MBOT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MBOT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 22:00</td>
    <td>シリュウ、次世代の植物性食品を解き放つタンパク質ベースの代替脂肪成分「OleoPro™」を販売開始</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625781/0/en/Shiru-launches-OleoPro-a-protein-based-alternative-fat-ingredient-to-unlock-the-next-generation-of-plant-based-foods.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625781/0/en/Shiru-launches-OleoPro-a-protein-based-alternative-fat-ingredient-to-unlock-the-next-generation-of-plant-based-foods.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 22:00</td>
    <td>Galaxy System™」のヒトへの初使用をオーストラリアのマッコーリー大学病院にて実施</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625798/0/en/First-Use-of-the-Galaxy-System-in-Human-Patients-Conducted-at-Macquarie-University-Hospital-in-Australia.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625798/0/en/First-Use-of-the-Galaxy-System-in-Human-Patients-Conducted-at-Macquarie-University-Hospital-in-Australia.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 21:38</td>
    <td>Little Leaves Behavioral Servicesがメリーランド州フレデリックに最新拠点を開設したことを発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625743/0/en/Little-Leaves-Behavioral-Services-Announces-the-Opening-of-Its-Newest-Location-in-Frederick-Maryland.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625743/0/en/Little-Leaves-Behavioral-Services-Announces-the-Opening-of-Its-Newest-Location-in-Frederick-Maryland.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 21:30</td>
    <td>Surgalign社、脊椎画像診断のための「HOLO™ AI Insights」を発表</td>
    <td><a href=https://finance.yahoo.com/quote/SRGA target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SRGA</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 21:30</td>
    <td>iCAD、第4四半期決算をプレビュー、2023年3月28日に完全版を発表</td>
    <td><a href=https://finance.yahoo.com/quote/ICAD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ICAD</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 21:30</td>
    <td>Intelligent Bio Solutions Inc. Selects HASTA Laboratory as Drug Testing Specialist in Australia
</td>
    <td><a href=https://finance.yahoo.com/quote/INBS target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/INBS</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 21:30</td>
    <td>富環境ソリューションズ、2022年第4四半期決算に関するカンファレンスコールを2023年3月16日に開催</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625710/34752/en/TOMI-Environmental-Solutions-Inc-to-Hold-Conference-Call-to-Discuss-Fourth-Quarter-2022-Financial-Results-on-March-16-2023.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625710/34752/en/TOMI-Environmental-Solutions-Inc-to-Hold-Conference-Call-to-Discuss-Fourth-Quarter-2022-Financial-Results-on-March-16-2023.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 21:30</td>
    <td>エノキアンバイオサイエンス、NASDAQへの届出要件を完全遵守</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625713/0/en/Enochian-BioSciences-Achieves-Full-Compliance-with-NASDAQ-Filing-Requirements.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625713/0/en/Enochian-BioSciences-Achieves-Full-Compliance-with-NASDAQ-Filing-Requirements.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 21:07</td>
    <td>米薬価交渉のリスクを抱える企業としてファイザー、アッヴィー、BMSが登場-報告書</td>
    <td><a href=https://finance.yahoo.com/quote/JNJ target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/JNJ</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 20:47</td>
    <td>次世代シーケンサーによる検査開始でネオジェノミクス社の株価が急上昇</td>
    <td><a href=https://finance.yahoo.com/quote/NEO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/NEO</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 20:43</td>
    <td>Thorne HealthTechに新しい財務責任者が誕生</td>
    <td><a href=https://finance.yahoo.com/quote/THRN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/THRN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 20:23</td>
    <td>BioRestorative社、細胞治療薬「BRTX-100」の臨床応用に向けアドバイザリー会社を起用</td>
    <td><a href=https://finance.yahoo.com/quote/BRTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BRTX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 20:02</td>
    <td>ファイザー、抗がん剤メーカー「セーゲン」を430億ドルで買収へ</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 21:05</td>
    <td>Indaptus Therapeutics社、進行性固形がん患者を対象としたDecoy20の第1相オープンラベル臨床試験であるINDP-D101の試験実施施設としてEmory Winship Cancer Instituteを認定</td>
    <td><a href=https://finance.yahoo.com/quote/INDP target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/INDP</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 21:05</td>
    <td>スペロ・セラピューティクス、2022年第4四半期および通期の決算発表とカンファレンスコールを2023年3月30日に再延期</td>
    <td><a href=https://finance.yahoo.com/quote/SPRO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SPRO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 21:01</td>
    <td>Pliant Therapeutics社、Bexotegrast（PLN-74809）の原発性硬化性胆管炎を対象とした320mg投与によるフェーズ2a試験のDSMB安全性審査が陽性となり登録が開始されたと発表</td>
    <td><a href=https://finance.yahoo.com/quote/PLRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PLRX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 21:00</td>
    <td>DLHの取締役にシニアファイナンシャルエグゼクティブのJudy Bjornaasが選出されました。</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625630/0/en/Senior-Financial-Executive-Judy-Bjornaas-Elected-to-DLH-Board-of-Directors.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625630/0/en/Senior-Financial-Executive-Judy-Bjornaas-Elected-to-DLH-Board-of-Directors.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 21:00</td>
    <td>ウィンドツリー、ナスダックへのコンプライアンスを回復</td>
    <td><a href=https://finance.yahoo.com/quote/WINT target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/WINT</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 21:00</td>
    <td>アライメントヘルスケア、2023年モルガンスタンレーC-Suiteコールシリーズに参加決定</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625638/0/en/Alignment-Healthcare-to-Participate-in-the-2023-Morgan-Stanley-C-Suite-Call-Series.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625638/0/en/Alignment-Healthcare-to-Participate-in-the-2023-Morgan-Stanley-C-Suite-Call-Series.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 21:00</td>
    <td>オックスフォード・ポピュレーション・ヘルスとSomaLogic、中国Kadoorie Biobankサンプルの2800万プロテオームデータポイントを提供</td>
    <td><a href=https://finance.yahoo.com/quote/SLGCW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/SLGCW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 21:00</td>
    <td>Atavistikバイオ社、共同創業者のJared Rutter氏がAtavistikメタボライト・プロテイン・スクリーニング（AMPS）プラットフォームの基盤技術についてScience誌に掲載されたと発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625643/0/en/Atavistik-Bio-Announces-Publication-in-Science-by-Co-Founder-Jared-Rutter-Describing-Foundational-Technology-for-its-Atavistik-Metabolite-Protein-Screening-AMPS-Platform.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625643/0/en/Atavistik-Bio-Announces-Publication-in-Science-by-Co-Founder-Jared-Rutter-Describing-Foundational-Technology-for-its-Atavistik-Metabolite-Protein-Screening-AMPS-Platform.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 21:00</td>
    <td>遺伝子型乳がんリスク検査の有効性を裏付ける連続した研究結果</td>
    <td><a href=https://finance.yahoo.com/quote/GENE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GENE</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 21:00</td>
    <td>ORYZON社、ORY-4001の中枢神経系疾患治療薬としての臨床試験候補の推薦を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625649/0/en/ORYZON-Announces-Clinical-Candidate-Nomination-of-ORY-4001-for-the-Treatment-of-CNS-Disorders.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625649/0/en/ORYZON-Announces-Clinical-Candidate-Nomination-of-ORY-4001-for-the-Treatment-of-CNS-Disorders.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 21:00</td>
    <td>ペプジェン社、2023年筋ジストロフィー協会臨床・学術会議でのデータ発表予定について</td>
    <td><a href=https://finance.yahoo.com/quote/PEPG target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PEPG</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 20:45</td>
    <td>バイオエヌテック、2022年通期および第4四半期決算とオペレーションアップデートを2023年3月27日に報告へ</td>
    <td><a href=https://finance.yahoo.com/quote/BNTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BNTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 20:45</td>
    <td>BioNTech、2022年度決算を2023年3月27日に発表、第4四半期の業務進捗状況について情報提供</td>
    <td><a href=https://finance.yahoo.com/quote/BNTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BNTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 20:30</td>
    <td>VitalHub社、カナダでSHREWDソリューションのライセンス供与を発表 ウィニペグ地域保健局と提携</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625594/0/en/VitalHub-Announces-Licensing-of-SHREWD-Solution-in-Canada-With-The-Winnipeg-Regional-Health-Authority.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625594/0/en/VitalHub-Announces-Licensing-of-SHREWD-Solution-in-Canada-With-The-Winnipeg-Regional-Health-Authority.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 20:30</td>
    <td>Mersana Therapeutics社、XMT-2056第1相臨床試験のクリニカルホールドを発表</td>
    <td><a href=https://finance.yahoo.com/quote/MRSN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/MRSN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 20:30</td>
    <td>Gracell Biotechnologies、2022年第4四半期および通年の未監査決算を報告、および企業情報を提供</td>
    <td><a href=https://finance.yahoo.com/quote/GRCL target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GRCL</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 20:18</td>
    <td>株式買戻しプログラムに関連する取引</td>
    <td><a href=https://finance.yahoo.com/quote/GMAB target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/GMAB</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 20:05</td>
    <td>uniQure社、ナスダック上場規則5635(c)(4)に基づく誘引付与を発表</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625574/0/en/uniQure-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625574/0/en/uniQure-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 20:05</td>
    <td>ザ・ジョイントコーポレーション 退任する取締役、ジェームス・H・エイモス・ジュニアに感謝</td>
    <td><a href=https://www.globenewswire.com/news-release/2023/03/13/2625575/32957/en/The-Joint-Corp-Thanks-Retiring-Board-Member-James-H-Amos-Jr.html target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://www.globenewswire.com/news-release/2023/03/13/2625575/32957/en/The-Joint-Corp-Thanks-Retiring-Board-Member-James-H-Amos-Jr.html</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 20:02</td>
    <td>Pfizer deal to acquire Seagen sends cancer drugmaker’s shares 18% higher
</td>
    <td><a href=https://finance.yahoo.com/quote/PFE target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PFE</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 20:02</td>
    <td>テレフレックス、前立腺肥大症に対する「UroLift System」のメリットを強調</td>
    <td><a href=https://finance.yahoo.com/quote/TFX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/TFX</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 19:34</td>
    <td>プレシジョン、シリコンバレー銀行危機のエクスポージャーへの不安を和らげる</td>
    <td><a href=https://finance.yahoo.com/quote/PGEN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PGEN</a></td>
    </tr><tr>
    <td>yahoofinance</td>
    <td>2023/03/13 19:31</td>
    <td>Organigram、分類論争でJoltsの一部製品の生産を一時停止</td>
    <td><a href=https://finance.yahoo.com/quote/OGI target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OGI</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 20:00</td>
    <td>ALX Oncology社とQuantum Leap Healthcare Collaborative™が乳がんを対象としたI-SPY-P1試験で最初の患者を投与したことを発表</td>
    <td><a href=https://finance.yahoo.com/quote/ALXO target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/ALXO</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 20:00</td>
    <td>BioRestorative Therapies社、「BRTX-100」の臨床応用拡大に向けてFDAの承認を申請へ</td>
    <td><a href=https://finance.yahoo.com/quote/BRTX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/BRTX</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 20:00</td>
    <td>レスメッド社の年次グローバル睡眠調査により、成人の10人に8人が睡眠の質に関連する障害の兆候を経験していることが判明しました。</td>
    <td><a href=https://finance.yahoo.com/quote/RMD target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/RMD</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 20:00</td>
    <td>フキパファーマ、Terry Coelhoを取締役に任命</td>
    <td><a href=https://finance.yahoo.com/quote/HOOK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/HOOK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 20:00</td>
    <td>Clene、2022年通期決算と最近の営業ハイライトを発表</td>
    <td><a href=https://finance.yahoo.com/quote/CLNNW target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/CLNNW</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 20:00</td>
    <td>ProMIS NeurosciencesがAD / PD 2023でPMN310の新たな前臨床データを発表へ</td>
    <td><a href=https://finance.yahoo.com/quote/PMN target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/PMN</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 20:00</td>
    <td>Outlook Therapeutics®、シリコンバレー銀行へのエクスポージャーがないことを確認</td>
    <td><a href=https://finance.yahoo.com/quote/OTLK target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/OTLK</a></td>
    </tr><tr>
    <td>globenewswire</td>
    <td>2023/03/13 19:50</td>
    <td>イーグル・ファーマシューティカルズ、2022年第4四半期および通期決算を発表</td>
    <td><a href=https://finance.yahoo.com/quote/EGRX target="_blank" rel="noopener noreferrer" style="display: inline-block;">https://finance.yahoo.com/quote/EGRX</a></td>
    </tr>
      </tbody>
    </table>
</body>



</html>
